data_2jqy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jqy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 66.31 118.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 110.821 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.15 119.72 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -88.0 128.86 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.52 135.46 40.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 tt -155.83 126.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.27 22.21 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.47 121.33 7.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.134 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -104.88 159.38 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.8 0.333 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.64 151.95 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -148.33 142.08 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -149.82 143.91 25.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -146.38 161.56 40.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.411 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.19 113.83 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.99 116.18 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.553 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.82 88.56 2.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.704 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -126.61 35.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.031 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.66 23.14 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.0 112.689 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.433 ' CH2' ' HB ' ' A' ' 73' ' ' VAL . 14.8 t-105 -140.42 110.85 6.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 26.7 mtp180 -108.37 108.77 19.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mt -83.85 120.62 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.138 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.32 121.69 34.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.17 113.18 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.09 146.73 43.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.21 117.43 34.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.09 120.88 43.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -152.36 123.0 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.826 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.404 ' CB ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.794 0.33 . . . . 0.0 110.932 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 68' ' ' ARG . 73.5 Cg_endo -76.27 -179.61 5.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.446 2.098 . . . . 0.0 112.326 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.2 167.34 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.95 149.12 50.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.805 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.55 140.28 24.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.433 ' HB ' ' CH2' ' A' ' 43' ' ' TRP . 15.4 m -142.11 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.461 ' N ' ' CD2' ' A' ' 74' ' ' HIS . 2.0 m-70 -112.78 139.35 48.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -138.04 104.27 5.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.77 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -95.31 111.01 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.11 -52.71 57.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 mt -129.37 145.35 51.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.69 94.95 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.72 130.38 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.39 -23.68 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -44.65 26.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -151.48 80.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.3 123.93 33.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -106.75 115.8 30.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.54 165.9 18.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.57 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.24 107.89 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.285 . . . . 0.0 110.533 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -105.85 107.83 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.38 123.44 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.244 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 153.64 17.42 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.778 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.77 126.63 53.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -109.95 134.7 51.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.957 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -125.91 121.74 34.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.786 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.26 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.384 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.78 154.94 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -108.45 125.19 51.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.75 139.7 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -108.36 134.2 51.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -143.34 129.21 19.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -90.87 148.45 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.736 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -142.09 103.71 4.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.6 144.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.87 93.28 8.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.317 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.81 87.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.172 . . . . 0.0 112.072 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 98.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -107.86 122.92 47.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.796 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -128.17 127.19 42.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.06 127.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 141.0 29.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.27 -32.31 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.813 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.52 177.88 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.16 54.52 3.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.5 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mp -99.37 141.86 31.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.2 144.0 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CD2' ' CD1' ' A' ' 157' ' ' LEU . 5.6 t80 -115.65 133.31 56.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -129.8 159.33 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.02 113.56 0.59 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.21 118.96 30.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.95 102.56 12.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 t -76.06 112.96 13.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.5 mtt -116.55 118.01 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.751 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -111.35 131.95 54.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.24 105.4 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.669 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -71.85 142.96 49.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.55 137.27 15.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.031 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.954 -179.896 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.772 0.32 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 57.0 m -127.58 122.42 33.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.14 133.18 43.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.71 116.59 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.06 121.69 30.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.5 t -95.05 138.8 32.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.47 117.61 18.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.424 ' CG2' ' CZ ' ' A' ' 128' ' ' PHE . 26.0 m -105.14 103.91 13.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.02 135.78 12.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.573 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.433 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 1.1 tp -131.05 115.01 15.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -114.64 110.89 20.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 2.5 p90 -130.01 125.0 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -98.88 138.16 36.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.045 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.45 -50.66 30.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.384 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -150.83 53.62 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.41 ' HA ' HG22 ' A' ' 160' ' ' THR . 8.1 tt0 61.55 76.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.89 -76.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.3 m -103.91 112.8 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.557 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -112.56 140.65 47.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.86 129.94 40.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.393 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -102.51 132.53 48.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.18 103.72 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -103.26 127.82 50.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.32 110.98 23.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.79 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.33 139.33 30.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.02 94.97 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.95 138.17 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.962 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -140.04 138.08 35.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.479 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.778 0.323 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 m -101.52 128.55 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.942 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -119.43 117.49 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -105.73 136.41 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.7 mt -97.06 154.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.034 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -147.06 117.02 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -110.85 137.2 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.003 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.411 ' CE2' ' HB ' ' A' ' 207' ' ' THR . 0.3 OUTLIER -150.49 173.82 13.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -175.18 80.35 0.31 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.669 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.25 113.86 2.61 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.556 2.171 . . . . 0.0 112.541 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.21 155.86 25.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -137.99 156.97 47.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.673 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.31 90.54 2.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 61.25 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.5 31.54 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -140.25 136.39 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.4 m -117.39 139.89 50.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.992 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.411 ' HB ' ' CE2' ' A' ' 196' ' ' TYR . 10.0 p -121.81 104.66 38.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.765 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.56 165.06 18.48 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.597 2.198 . . . . 0.0 112.406 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -120.5 139.67 52.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.21 159.29 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.808 0.337 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.74 145.85 42.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 4.0 mp -118.06 113.37 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -116.38 106.38 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -90.87 146.73 23.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -132.77 111.37 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.017 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.418 ' HB2' ' HB ' ' A' ' 250' ' ' VAL . 76.5 m-85 -104.5 166.22 10.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.249 0.547 . . . . 0.0 111.503 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.133 -179.889 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 3.0 pp . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.9 t -95.85 123.51 39.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.96 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 242' ' ' TYR . 40.1 t -105.82 116.92 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.798 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 16.0 m -108.03 152.07 24.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.169 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.91 142.11 47.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -118.43 128.58 54.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.09 123.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -144.93 145.4 14.71 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.138 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 249' ' ' SER . 29.6 m -126.39 159.15 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.487 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 249' ' ' SER . 9.8 m120 -148.12 95.53 2.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.176 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 4.3 t80 -88.55 121.29 30.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.79 138.7 37.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.441 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.1 m0 -91.42 113.15 25.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -119.25 152.05 37.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.93 119.94 20.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.633 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -131.81 139.8 48.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.065 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mm -121.8 113.75 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.864 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.51 143.52 15.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.2 125.79 8.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.312 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.64 120.68 42.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.972 0.415 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.2 t -134.27 158.71 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.75 151.6 43.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.053 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -145.08 146.63 31.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.64 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.92 157.39 45.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 111.197 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -167.22 113.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 6' ' ' TRP . . . -90.78 126.16 35.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.836 0.351 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -134.77 88.57 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.82 -126.2 31.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.65 21.35 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.682 2.255 . . . . 0.0 112.864 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -140.14 112.8 8.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.62 112.88 24.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.515 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 45' ' ' ILE . 24.0 mm -83.99 118.36 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.61 119.54 21.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.923 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.25 155.0 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.94 147.78 32.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.042 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -100.97 113.68 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.11 122.84 48.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -156.52 138.34 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.866 0.365 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.8 -160.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.871 2.381 . . . . 0.0 112.278 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -153.47 132.69 12.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.92 154.61 19.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -157.09 134.79 10.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 m -135.94 148.13 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.27 130.36 56.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -127.12 100.69 6.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -91.6 113.58 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -72.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -114.92 128.49 56.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -96.16 102.11 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -156.04 163.59 39.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.26 16.37 15.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.13 -43.02 2.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.882 0.372 . . . . 0.0 110.878 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 96.5 m-85 -146.0 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.75 112.75 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 83' ' ' PHE . 56.9 m-85 -114.91 121.31 42.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.043 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.26 -173.35 13.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.347 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 pp -158.15 124.27 4.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.0 m -99.95 98.96 9.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.57 134.76 11.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.49 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.13 162.76 26.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.632 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.95 121.47 42.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.861 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 118.44 36.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.984 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -110.75 98.05 7.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -113.4 126.94 55.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.47 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.768 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.95 144.39 8.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -150.66 104.37 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.7 mtt -130.8 129.56 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.21 150.48 22.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -147.22 121.28 9.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.106 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -91.24 122.77 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 108.25 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.23 146.34 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.65 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 91.04 7.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.493 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.51 86.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.961 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.12 106.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.258 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -107.35 132.64 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.495 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -138.32 128.59 25.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.201 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.2 100.87 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 156.22 40.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.47 29.05 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -32.85 11.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.598 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.9 -78.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -164.09 25.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp -142.33 152.4 42.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -102.53 111.11 23.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.619 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.95 137.93 31.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.88 118.91 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -105.01 139.85 14.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.53 120.28 16.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.77 98.97 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.846 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.4 t -87.47 110.11 20.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.8 ttp -112.12 122.88 48.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -105.24 128.79 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -108.37 98.92 8.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.54 128.56 33.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.54 135.12 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.3 p30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 t -137.09 142.08 42.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.401 ' NH1' ' HB3' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -133.59 113.01 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.812 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.0 t -102.35 137.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.045 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.49 118.74 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 m -97.18 136.51 37.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.01 101.47 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.7 m -94.99 108.41 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -107.63 134.45 12.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.699 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.3 mt -119.61 124.69 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.765 0.317 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -112.96 121.08 43.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -130.08 108.41 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.028 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.456 ' N ' ' HB3' ' A' ' 166' ' ' ALA . 0.8 OUTLIER -84.75 126.57 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.871 0.367 . . . . 0.0 110.953 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -52.5 -27.41 16.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.79 49.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 57.24 58.94 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.9 m -165.3 -73.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.72 112.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.412 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.456 ' HB3' ' N ' ' A' ' 160' ' ' THR . . . -117.83 153.16 33.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.1 0.476 . . . . 0.0 111.848 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.2 tt -100.01 138.09 37.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.998 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -112.49 125.89 54.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.305 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.02 103.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.586 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -97.36 134.7 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.03 25.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.82 132.64 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.248 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.0 mp -142.14 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.643 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -88.71 123.79 33.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 112.93 8.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.838 0.351 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.39 120.48 39.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -122.14 129.07 51.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.26 173.78 9.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.742 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.41 139.27 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -127.87 143.98 51.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.69 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -152.76 168.66 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.9 tt -176.62 85.41 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.524 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 207' ' ' THR . 19.8 Cg_endo -60.82 113.67 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.39 2.06 . . . . 0.0 112.672 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.0 mt -114.47 116.16 28.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.387 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 29.2 p -129.49 158.21 39.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 110.83 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 9.6 tp -143.1 90.5 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.182 0.515 . . . . 0.0 109.997 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.83 -73.86 2.49 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.417 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -125.93 -35.07 2.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.715 0.293 . . . . 0.0 111.347 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -65.34 135.09 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.2 t -128.1 115.85 19.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.038 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.34 119.48 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' A' ' 198' ' ' PRO . 5.0 t -122.68 104.76 36.24 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.208 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.19 161.83 39.92 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.693 2.262 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.423 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 43.7 p90 -150.39 142.63 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.017 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.4 m -137.34 143.3 41.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.812 0.339 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.418 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -98.65 159.75 20.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.467 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.5 mt -144.45 129.95 18.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.828 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.404 ' CE1' ' HG2' ' A' ' 253' ' ' GLU . 0.7 OUTLIER -112.28 99.15 7.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.914 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -84.58 151.91 24.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -164.64 106.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.476 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.2 155.09 40.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.804 179.835 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.427 ' CD1' ' HB2' ' A' ' 278' ' ' TYR . 1.9 mm? . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.511 0.196 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 277' ' ' ASN . 43.1 t -95.7 166.69 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.906 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.88 117.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 24.5 t -122.58 132.46 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.83 121.48 34.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.404 ' HG2' ' CE1' ' A' ' 239' ' ' PHE . 7.9 mt-10 -96.66 106.16 18.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 12.6 p -132.34 124.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.003 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -122.32 150.85 16.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.77 125.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.289 . . . . 0.0 111.181 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 249' ' ' SER . 8.1 m-20 -127.57 95.25 4.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.122 0.487 . . . . 0.0 111.235 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.427 ' HB2' ' CD1' ' A' ' 248' ' ' LEU . 2.3 t80 -88.7 125.74 34.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.727 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.9 141.46 45.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.9 m95 179.79 81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.77 111.56 22.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.71 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -91.21 126.09 36.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -131.98 127.31 36.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.56 122.93 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.26 160.82 13.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.99 129.27 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.4 ttm -109.92 132.95 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.851 0.357 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.7 t -105.43 157.04 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.47 147.52 38.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.58 114.07 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.622 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.72 153.13 26.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.69 113.93 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.67 122.46 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.315 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -134.8 88.45 2.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.99 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.68 -123.19 32.0 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.234 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.68 25.29 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -140.11 110.74 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.61 157.31 15.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.61 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.435 HG22 HD12 ' A' ' 45' ' ' ILE . 27.1 mm -126.38 134.75 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.141 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.14 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 tt -116.73 115.97 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.34 142.71 50.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -97.91 120.59 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.014 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -112.92 106.81 15.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.99 162.13 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.753 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.772 0.32 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.54 -166.88 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.87 2.38 . . . . 0.0 112.375 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -146.67 123.63 11.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 155.13 17.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.05 128.36 3.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.84 157.11 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -121.25 145.13 48.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -125.27 128.39 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.74 102.27 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.949 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.84 -73.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.56 120.35 41.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -97.3 107.34 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -159.55 142.75 14.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.46 -13.4 59.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -100.17 -42.75 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.988 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -141.37 87.5 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.72 159.05 17.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -145.03 137.96 26.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.816 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -148.46 141.3 8.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.599 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 tt -120.69 122.46 40.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 0.0 110.784 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.8 m -102.66 117.14 34.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.06 116.05 4.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.448 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -130.5 147.08 18.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.6 134.93 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 -106.0 132.67 51.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -137.81 115.18 11.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -140.49 148.02 40.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.787 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.545 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.771 0.32 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -166.03 148.03 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.59 100.01 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.6 mtt -118.61 142.64 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -132.53 133.33 43.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.7 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -135.76 129.66 32.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.049 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -85.94 142.89 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.585 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -127.19 133.05 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.448 . . . . 0.0 111.317 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.7 mt -131.48 143.48 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.93 66.0 31.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.24 65.99 5.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.41 2.073 . . . . 0.0 111.506 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 85' ' ' PHE . 2.8 p30 -80.47 179.48 7.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.491 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -152.88 123.85 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.527 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.85 128.71 35.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.14 100.93 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.24 152.67 48.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.156 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.65 32.78 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.37 -45.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -167.38 -42.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.419 ' HG ' ' CE1' ' A' ' 159' ' ' TYR . 2.0 mt -82.81 121.84 27.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -123.11 139.83 53.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -134.55 138.36 44.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -152.19 118.96 5.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.23 114.34 4.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.431 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -104.94 124.97 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 0.0 111.09 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.6 tt -109.24 105.62 15.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 116.68 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.955 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -96.88 118.99 34.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -104.23 119.92 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.001 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 145.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.81 151.76 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -164.8 150.34 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.903 0.382 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.7 p -102.98 109.57 21.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.016 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -146.57 170.99 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -118.52 148.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -125.03 138.63 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.638 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 34.3 m -93.92 145.35 24.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.124 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -136.88 98.99 3.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.81 108.0 20.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -110.29 141.93 16.43 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.583 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.5 mp -123.61 130.5 52.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.767 0.318 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -117.55 113.22 21.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.958 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.419 ' CE1' ' HG ' ' A' ' 126' ' ' LEU . 27.4 t80 -130.16 116.8 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 9.4 p -84.72 137.23 33.35 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.13 -38.61 91.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -149.93 42.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 61.72 70.82 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 175.75 -64.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.729 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.98 112.77 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.197 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -118.01 150.48 39.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.111 0.482 . . . . 0.0 111.818 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.81 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.225 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.0 114.62 25.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.94 100.91 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.581 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.67 133.98 42.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.182 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -103.2 112.31 25.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.502 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.83 137.99 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.1 tt -141.74 94.92 2.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.632 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.41 144.67 25.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.76 157.03 47.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.776 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.536 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.83 0.348 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 10.7 m -96.71 118.17 32.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -122.06 110.84 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -119.84 147.6 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 7.3 tp -112.51 120.02 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.412 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 0.1 OUTLIER -106.28 132.03 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -110.26 148.61 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 194' ' ' ARG . 89.4 m-85 -153.4 175.11 13.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.4 tp -172.29 71.32 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.69 113.7 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.27 151.31 33.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.739 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.11 157.85 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.731 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 13.0 tp -143.28 90.65 2.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.19 0.519 . . . . 0.0 110.144 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.71 -65.43 0.63 Allowed Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.408 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -148.49 32.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -123.92 154.99 38.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.2 m -128.06 128.25 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.54 112.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.6 t -125.74 105.01 26.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.056 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.3 165.07 26.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.528 2.152 . . . . 0.0 112.306 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.42 136.2 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.029 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 27.1 m -136.46 146.58 46.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.803 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.837 0.351 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -74.49 156.78 50.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 34.2 mt -147.03 106.06 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.94 128.85 38.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.21 144.96 30.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -141.34 122.15 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -123.27 137.83 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.389 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 2.8 tt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.688 0.28 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 277' ' ' ASN . 33.2 t -102.21 165.75 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.65 117.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 18.9 p -109.48 164.3 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.445 ' CD2' ' CE2' ' A' ' 254' ' ' TYR . 0.2 OUTLIER -145.58 136.31 24.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.4 113.83 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . 0.445 ' CE2' ' CD2' ' A' ' 252' ' ' LEU . 1.2 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.386 -0.286 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.03 141.76 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -126.44 179.12 16.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 22.7 t -153.96 140.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.679 0.276 . . . . 0.0 110.976 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 249' ' ' SER . 5.5 t-20 -148.09 95.31 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 111.394 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 280' ' ' PHE . 13.0 t80 -92.71 154.99 17.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.661 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.42 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 12.6 p -143.04 146.71 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.425 ' HB2' ' CE1' ' A' ' 278' ' ' TYR . 44.2 t80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.956 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.73 0.3 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.69 115.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.049 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -109.65 112.14 24.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.699 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.98 135.49 33.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -149.0 132.08 16.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.1 mt -125.97 154.0 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.49 119.33 0.89 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.33 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -128.18 157.74 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.8 127.86 35.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.732 0.301 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 t -117.16 157.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.285 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -157.46 132.96 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -134.42 157.34 46.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.747 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 149.45 33.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.4 113.83 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.727 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.49 120.58 34.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.302 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.72 88.59 2.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.65 -127.13 15.72 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.05 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -88.13 19.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.767 2.312 . . . . 0.0 112.792 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CZ3' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -140.11 121.97 15.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.906 0.384 . . . . 0.0 111.173 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 103.95 11.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.661 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 tp -83.89 139.63 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.199 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.04 119.64 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tp -104.66 148.71 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.793 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.94 157.36 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.185 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 114.64 22.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 111.8 22.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.98 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.13 156.98 42.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.927 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.69 0.281 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.47 -168.52 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.56 2.173 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.46 165.44 27.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mp -137.04 156.98 47.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.405 ' HA ' ' HA2' ' A' ' 90' ' ' GLY . 0.2 OUTLIER -146.25 152.99 40.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.997 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.9 m -143.6 141.8 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -123.27 110.12 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CE1' ' CZ3' ' A' ' 43' ' ' TRP . 2.2 t80 -96.42 86.92 4.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.32 127.19 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -84.28 -73.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -145.59 143.83 30.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.004 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -104.33 94.86 5.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.721 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -161.47 172.22 16.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.39 -68.3 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.1 -44.02 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.808 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.41 ' CD2' ' HE3' ' A' ' 121' ' ' LYS . 5.8 t80 -178.62 -75.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 p -147.26 159.2 43.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.827 0.346 . . . . 0.0 111.233 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.09 106.76 3.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.78 -146.78 4.47 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mp -143.67 117.7 9.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.662 0.268 . . . . 0.0 110.45 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -79.58 122.33 26.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.25 173.17 17.76 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.42 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 72' ' ' GLU . . . -178.05 156.12 18.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.722 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -142.66 110.3 5.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 110.749 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 133.65 52.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -147.31 140.87 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -146.1 158.22 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.181 179.769 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.688 0.28 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.79 137.68 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.726 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.33 117.61 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.32 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.25 131.04 55.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.77 137.77 51.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 111.378 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.16 135.85 41.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -104.69 138.53 40.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.142 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 134' ' ' MET . 0.1 OUTLIER -132.0 102.44 5.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 pp -139.61 149.47 22.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 175.65 153.02 0.33 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.698 0.285 . . . . 0.0 111.396 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.91 136.96 51.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.659 2.24 . . . . 0.0 112.448 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.9 142.29 50.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.411 ' CE2' ' HA3' ' A' ' 130' ' ' GLY . 29.2 p90 -124.26 122.93 39.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.347 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.39 107.31 14.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 123' ' ' THR . 16.8 t -100.89 112.22 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.41 ' HE3' ' CD2' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -131.16 154.29 48.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.37 27.86 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.395 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.41 ' CG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -83.1 -27.94 29.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.776 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -170.61 -72.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.587 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.95 26.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mp -142.27 148.14 37.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.982 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.4 112.06 25.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.591 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.425 ' CG ' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -98.81 117.35 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -112.7 118.92 36.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 118' ' ' TRP . . . -113.97 109.58 2.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.596 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.86 114.9 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.788 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.8 tp -126.96 131.06 51.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.81 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.6 m -136.47 120.9 18.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 3.5 mtm -92.87 120.86 33.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.112 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.35 135.71 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.0 0.429 . . . . 0.0 111.515 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.85 130.47 24.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.47 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.84 149.28 45.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.041 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.88 145.62 12.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -93.58 146.84 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.67 170.87 14.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.58 120.09 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.14 99.85 9.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -97.56 127.15 43.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -128.9 97.74 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.1 p -96.4 103.89 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.78 135.87 12.77 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.425 HD11 ' CG ' ' A' ' 128' ' ' PHE . 3.2 mm? -121.39 125.79 47.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -119.07 102.79 9.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -130.11 134.21 47.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.169 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 5.9 p -97.72 142.32 29.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.41 ' CE1' HD11 ' A' ' 167' ' ' LEU . 20.6 m-85 -55.16 -31.13 61.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -137.09 -66.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.641 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.14 74.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 178.44 -62.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 29.8 m -104.02 112.84 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.734 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -105.54 146.71 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.538 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.41 HD11 ' CE1' ' A' ' 161' ' ' PHE . 2.0 mp -93.92 134.2 36.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.323 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 130.16 53.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 m -137.45 100.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.893 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.4 141.88 31.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -121.27 114.56 21.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -92.14 129.53 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.9 101.91 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -107.93 113.02 25.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -140.06 133.25 29.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 m -115.45 117.79 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.803 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -121.59 137.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.987 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -137.42 138.17 39.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.749 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.8 mt -126.71 129.75 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.21 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -127.12 137.43 52.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.564 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.59 54.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.283 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -135.55 170.36 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 38.8 mt -149.34 67.16 8.82 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.75 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -44.6 113.85 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.727 2.285 . . . . 0.0 112.653 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.14 129.3 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 16.7 p -136.97 158.15 45.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -143.06 90.61 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.112 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.72 -66.38 2.41 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -131.68 -36.66 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.158 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.74 136.04 56.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 74.4 m -128.06 132.55 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.888 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 240' ' ' TYR . 21.4 t -139.09 119.5 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.025 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -106.58 104.91 52.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.58 155.16 27.69 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.522 2.148 . . . . 0.0 112.309 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.53 131.93 55.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.76 176.02 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.938 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.976 0.417 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -70.93 150.07 47.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.15 118.77 31.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.836 0.351 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -118.38 119.88 35.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.406 ' CD1' HG21 ' A' ' 206' ' ' VAL . 0.6 OUTLIER -93.84 151.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -151.48 126.86 2.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.459 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -149.0 164.3 34.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.842 179.908 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.648 0.261 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.476 ' CB ' ' HB2' ' A' ' 277' ' ' ASN . 0.1 OUTLIER -117.38 166.21 12.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 111.167 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.6 m -151.95 125.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.4 p -129.81 175.33 8.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.66 159.22 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.94 128.47 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 12.5 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.63 145.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 111.04 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -129.13 131.98 6.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.54 137.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 249' ' ' SER . 58.5 m-80 -130.07 156.61 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 84.2 m-85 -149.51 137.15 20.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.762 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.21 135.08 26.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.978 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.839 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.751 0.31 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.95 132.9 14.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 1.5 t60 -117.87 127.62 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -107.64 120.53 42.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -136.71 131.78 33.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.4 114.82 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.28 116.96 4.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.453 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.93 116.13 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 0.0 111.137 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -102.77 143.73 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.83 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.763 0.316 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.41 147.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.28 151.5 47.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -150.13 141.41 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.19 146.71 50.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.097 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' HIS . . . -144.86 113.8 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.797 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.27 117.86 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.299 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -134.65 88.54 2.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 109.759 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.41 -126.69 36.11 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.899 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.83 24.98 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.72 2.28 . . . . 0.0 112.689 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -140.39 110.8 6.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.791 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 16.1 ttt180 -106.67 146.73 30.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.535 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mt -121.57 111.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.269 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.19 106.69 16.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -104.33 127.92 52.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.03 131.97 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 115.52 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.891 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.41 134.64 54.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -142.28 157.49 44.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 37.6 mtt180 . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.2 Cg_endo -74.69 127.15 10.66 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.471 2.114 . . . . 0.0 112.238 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -112.46 145.78 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.88 120.39 17.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.12 143.01 50.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.012 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 13.2 t -131.84 148.68 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.404 ' HB2' ' CB ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -118.95 135.17 54.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.051 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -135.06 87.31 2.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 138.83 34.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.56 -55.7 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.3 tp -133.66 123.68 25.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -92.79 98.78 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -151.9 122.03 7.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -58.44 -22.85 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -28.56 17.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.963 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -151.79 79.22 1.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.2 150.9 22.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -148.63 119.74 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.759 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.49 150.8 22.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.61 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.83 120.22 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 0.0 110.742 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.0 m -94.61 106.52 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.59 105.64 3.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.377 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.93 147.59 16.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.749 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.01 113.71 18.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.87 111.84 23.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.063 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -133.55 106.82 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.579 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' A' ' 109' ' ' MET . 16.7 p90 -125.27 118.55 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.328 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.382 179.769 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.761 0.315 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.61 119.68 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -105.84 124.69 49.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.46 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.417 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 mtt -94.38 129.71 40.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.323 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -95.23 149.54 21.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.04 94.92 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.796 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.53 134.65 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.04 146.57 35.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.26 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 115' ' ' ALA . 1.7 tp -138.28 143.55 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 114' ' ' ILE . . . -126.32 66.28 61.06 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 111.525 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 82.74 2.0 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 111.867 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -92.06 173.16 7.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 40.8 p-90 -155.92 122.92 5.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.809 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -99.85 137.58 38.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.6 m -139.68 117.25 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.8 135.47 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.992 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 pp -115.35 -31.63 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.918 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.1 m -142.49 162.89 34.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.695 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.68 61.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.923 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.09 -48.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.89 109.9 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -112.52 115.12 28.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.424 ' CG ' HD23 ' A' ' 157' ' ' LEU . 3.7 m-85 -91.0 136.7 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.1 118.87 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -118.63 121.21 4.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.224 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -104.93 174.25 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 111.118 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.7 mt -147.72 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.717 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.24 99.89 12.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.045 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.4 ttm -105.93 137.18 44.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.494 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -123.43 150.55 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.102 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -156.09 103.19 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.22 153.36 41.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.65 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.788 0.328 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -77.08 125.33 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -100.52 150.76 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.22 126.63 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.15 96.97 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 t -97.5 137.69 36.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -127.05 103.05 7.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 29.6 p -96.38 106.03 18.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 170' ' ' ASN . . . -130.0 167.99 21.52 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.993 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.424 HD23 ' CG ' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -134.36 129.77 35.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.738 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.77 113.33 25.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.42 ' CZ ' HD12 ' A' ' 167' ' ' LEU . 35.4 p90 -130.24 138.08 50.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.07 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER -97.29 143.73 27.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.938 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.2 -45.93 13.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.355 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.65 33.92 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.301 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 52.57 73.96 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.91 -65.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.816 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.9 p -103.87 113.19 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -108.64 136.9 47.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.495 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.42 HD12 ' CZ ' ' A' ' 159' ' ' TYR . 0.8 OUTLIER -93.9 123.61 37.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.475 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.46 122.52 46.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.326 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.47 110.57 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' A' ' 156' ' ' GLY . 4.2 p-10 -111.04 155.49 22.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 111.658 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.55 120.99 41.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.346 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.91 134.99 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.0 tp -142.04 108.86 5.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -112.24 139.32 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.968 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -137.12 121.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.801 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.572 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.84 0.352 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 132.59 39.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -147.04 110.04 4.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.85 178.49 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.43 132.73 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.12 142.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.73 153.31 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.234 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -160.0 145.54 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.04 79.36 3.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.88 113.52 3.03 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.402 2.068 . . . . 0.0 112.292 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 tt -114.36 144.83 42.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.705 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.9 p -138.04 156.23 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.21 90.52 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 109.904 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 66.79 -73.49 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.256 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -123.02 -34.63 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.53 138.0 56.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 48.1 m -128.09 134.44 49.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.417 HG11 ' CE1' ' A' ' 240' ' ' TYR . 18.3 m -146.08 124.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 14.9 p -137.02 104.88 8.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.053 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.82 165.01 15.69 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.693 2.262 . . . . 0.0 112.234 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.423 ' CZ ' ' HA3' ' A' ' 237' ' ' GLY . 47.1 p90 -141.32 133.6 28.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.62 137.64 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.994 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.3 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -76.37 141.15 26.4 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.92 129.73 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.26 102.66 11.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.417 ' CE1' HG11 ' A' ' 206' ' ' VAL . 0.3 OUTLIER -78.69 154.87 29.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.24 132.08 3.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.436 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -148.87 156.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.885 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.695 0.283 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.0 t -103.8 141.13 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.733 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.77 126.9 59.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.345 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.35 117.06 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.4 mt -115.09 124.85 52.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.77 145.28 38.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.6 m -129.61 155.73 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -155.54 169.06 33.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 249' ' ' SER . 4.5 m -131.73 116.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.647 0.261 . . . . 0.0 111.056 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 249' ' ' SER . 41.5 t30 -115.74 95.4 5.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 111.255 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 279' ' ' SER . 3.6 t80 -88.56 155.05 19.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.746 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 72.5 m -133.4 146.5 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.5 t0 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.798 0.332 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -149.17 115.1 5.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.0 123.33 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.688 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.81 120.39 39.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -127.18 134.32 50.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 pp -134.97 114.12 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.017 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.34 167.65 22.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.594 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.6 118.81 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.25 163.43 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.74 0.305 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.55 152.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.064 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 68.3 m-85 -140.27 136.9 33.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 35' ' ' TYR . 27.6 m-85 -147.15 104.48 3.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -105.28 155.26 19.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.066 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.04 113.74 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.07 116.59 29.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.24 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -134.72 88.47 2.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 109.77 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.81 -123.97 34.8 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.02 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HG2' ' CD1' ' A' ' 43' ' ' TRP . 94.0 Cg_endo -88.63 21.99 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.666 2.244 . . . . 0.0 112.76 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.488 ' CZ2' ' CE1' ' A' ' 75' ' ' TYR . 75.5 m95 -140.09 111.96 7.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.2 103.87 13.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.797 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -84.0 116.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.27 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.97 115.92 22.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 122.41 43.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.6 147.96 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -112.11 119.96 40.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.61 113.2 25.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 152.18 31.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.84 134.24 49.13 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.577 2.185 . . . . 0.0 112.046 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -115.73 123.53 48.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.151 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.37 153.83 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -154.01 143.59 21.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.03 120.43 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' CZ2' ' A' ' 43' ' ' TRP . 15.2 t80 -119.92 105.38 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.699 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -89.71 126.19 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -40.88 20.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.57 122.51 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 103.01 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -160.13 122.35 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.801 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.37 -25.2 33.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.51 -31.26 14.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.952 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -142.24 78.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -102.31 128.13 48.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.74 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.93 104.03 7.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.985 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.62 179.76 21.43 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.469 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tp -158.2 107.92 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.787 0.327 . . . . 0.0 110.788 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 m -75.53 155.96 35.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.65 108.76 0.38 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.46 167.01 19.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -139.94 129.37 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -125.43 149.49 48.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -147.75 97.82 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.27 110.64 20.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.658 179.832 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.779 0.323 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -176.22 135.88 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.196 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.39 102.35 2.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 mtp -125.82 105.43 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -83.51 135.52 34.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.42 ' HD2' ' CZ ' ' A' ' 137' ' ' PHE . 23.7 ttt180 -143.63 121.85 12.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.88 155.95 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.06 113.71 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.6 142.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.69 107.09 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.32 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.05 93.55 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.336 2.024 . . . . 0.0 112.145 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.85 136.57 51.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.018 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -139.74 122.95 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.98 114.64 14.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.9 124.07 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -109.99 115.74 30.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.732 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 -28.14 18.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.18 -171.75 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.699 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.86 28.72 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.927 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.16 -41.83 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.04 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.25 135.18 52.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -124.86 134.11 52.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.777 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 128' ' ' PHE . 4.8 m-85 -105.14 143.17 33.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -143.82 118.91 10.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.75 120.62 6.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.558 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -128.53 115.0 17.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.17 112.3 25.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.09 101.1 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.9 mtt -120.78 137.99 54.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -146.68 159.88 42.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -140.7 98.93 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 111' ' ' ARG . 1.7 m-85 -79.03 159.4 27.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.68 160.86 26.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.762 0.315 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 m -89.96 116.86 28.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -96.0 127.3 41.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.21 109.61 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.978 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.92 143.09 43.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.44 135.9 53.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -135.13 103.06 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.059 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.4 p -99.71 103.93 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.31 140.61 15.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.71 125.1 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -119.05 119.84 35.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 159' ' ' TYR . 53.2 p90 -130.14 124.98 33.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 62.4 p -84.83 140.96 30.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.129 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.19 -30.67 43.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -144.59 33.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 60.91 76.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 172.18 -61.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.606 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.6 t -107.49 112.68 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.263 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -107.0 145.29 32.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.988 0.423 . . . . 0.0 111.753 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.72 120.12 33.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.117 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.95 139.2 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.5 m -140.03 100.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.719 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.75 137.91 40.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.088 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -115.66 110.24 18.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.06 109.28 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -99.53 124.66 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.88 35.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.4 m -124.35 157.02 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -146.64 121.04 9.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.48 159.16 31.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 7.8 tp -133.39 113.22 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.145 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 11.4 mmt85 -108.29 152.15 25.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.83 140.04 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.443 ' N ' ' CD1' ' A' ' 196' ' ' TYR . 0.9 OUTLIER -145.42 174.98 10.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.802 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.39 87.24 0.76 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.04 113.71 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.436 2.091 . . . . 0.0 112.298 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.19 126.13 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.744 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.6 t -138.09 154.7 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.521 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.17 90.6 2.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.254 0.55 . . . . 0.0 110.117 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.04 -80.83 1.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.555 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -132.37 39.03 3.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 111.015 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -132.2 141.16 48.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.94 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.6 m -124.47 117.47 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.66 106.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 43.8 p -114.91 104.82 53.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.002 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.0 164.98 22.17 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.579 2.186 . . . . 0.0 112.432 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -121.11 131.91 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.9 p -131.1 157.75 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.827 0.346 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -149.25 165.78 29.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.599 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.17 134.54 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -110.03 109.05 19.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.95 142.72 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -139.99 100.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.417 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.66 118.67 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 111.009 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.777 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 3.5 pp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.641 0.258 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 69.2 m -95.94 151.94 18.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.798 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.87 127.35 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.3 m -135.11 152.28 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.8 mt -141.01 131.08 24.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 127.75 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.872 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.21 128.83 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.318 . . . . 0.0 110.997 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -136.18 152.32 21.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.729 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 20.2 t -140.85 141.7 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 0.0 110.803 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.01 95.53 2.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.058 0.456 . . . . 0.0 111.604 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 7.6 t80 -92.68 120.12 32.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.584 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 p -123.32 146.92 47.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.934 0.397 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -164.2 90.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -116.1 108.42 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -88.0 132.44 34.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -143.73 120.87 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.33 131.01 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.195 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -122.12 128.92 7.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.466 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.04 155.98 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 111.114 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.1 mmt -147.05 121.11 9.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.846 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.0 p90 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.54 150.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' A' ' 11' ' ' GLY . 10.4 p90 -146.69 156.68 43.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.76 157.96 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.21 136.4 33.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.72 113.97 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.8 122.79 36.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 34.5 t-20 -134.87 88.7 2.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -128.38 14.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.884 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -87.74 15.37 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.559 2.172 . . . . 0.0 113.177 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.425 ' CE2' ' HB3' ' A' ' 40' ' ' ASN . 60.8 p-90 -140.38 110.95 6.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.829 0.347 . . . . 0.0 111.395 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 10.6 ttm105 -102.2 110.59 22.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 tt -83.79 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.463 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.46 122.84 30.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.983 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.45 110.54 20.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.36 160.79 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -136.5 102.46 4.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.46 107.32 18.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.16 150.38 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.76 0.314 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 70.7 Cg_endo -74.8 -167.86 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.612 2.208 . . . . 0.0 112.355 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.51 156.27 36.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.971 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.93 153.95 40.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -162.1 134.55 5.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 12.4 p -128.99 150.06 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -118.66 137.68 53.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.99 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.27 87.51 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -93.0 116.25 28.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 -45.17 50.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 mt -143.43 136.96 28.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -97.97 101.97 13.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.7 148.53 25.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.8 0.85 56.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -111.03 -31.86 6.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -155.42 89.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.007 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.7 134.21 55.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.734 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -129.84 104.21 7.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.03 -175.2 22.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.162 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.16 108.79 2.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -77.7 159.25 29.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.12 91.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.37 152.21 17.36 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 4.3 m-85 -107.73 134.4 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -106.86 127.13 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.145 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -127.09 107.14 9.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.48 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.0 128.12 54.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.354 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 107' ' ' ALA . . . . . . . . 0 C--N 1.331 0.255 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.486 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.464 ' O ' ' HA2' ' A' ' 95' ' ' GLY . . . -116.43 144.68 43.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.979 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -99.65 125.5 45.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.467 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.7 ttm -107.88 124.78 50.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.344 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -91.38 140.5 29.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -152.97 104.45 2.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.832 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.31 144.6 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -142.06 103.01 4.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.64 153.53 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -161.81 117.55 1.29 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.25 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.11 92.84 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.364 2.043 . . . . 0.0 112.104 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.58 131.75 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -132.14 123.05 26.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.855 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 121.91 38.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.5 111.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -123.49 110.73 15.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -177.22 39.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.1 m -128.95 38.5 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 62.9 84.56 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.227 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 53.95 51.35 14.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.332 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.42 ' CD1' ' CD1' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -142.09 109.1 5.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.876 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.04 118.63 24.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -106.33 111.96 24.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -117.22 161.64 19.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.1 125.51 1.0 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.423 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -147.13 140.35 25.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.6 mp -102.02 98.81 8.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.833 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.08 110.49 11.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.016 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 mtt -92.95 132.3 37.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.69 137.0 45.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -141.28 152.56 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.685 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -125.95 149.42 48.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -157.14 163.32 39.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.821 0.343 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.62 129.85 41.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -125.21 129.28 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -100.68 137.3 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.03 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -121.01 100.38 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 m -93.82 125.48 38.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.61 105.5 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.1 p -101.42 103.96 14.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.93 148.1 18.89 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.909 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.8 125.42 22.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.69 0.281 . . . . 0.0 110.76 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -112.78 115.02 27.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.085 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.42 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 71.8 t80 -130.16 120.6 24.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.002 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 43.8 p -84.88 140.42 31.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.67 -29.88 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.804 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -161.66 44.35 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 61.52 76.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 176.69 -76.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.677 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.89 113.01 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -109.62 148.02 32.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.566 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.95 137.22 33.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.372 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 121.86 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.99 110.75 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.792 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -107.55 121.54 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.088 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -87.85 116.37 25.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -85.9 139.18 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.03 100.43 3.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.84 131.1 43.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 155.14 47.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.543 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.796 0.332 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.98 115.99 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -107.22 109.98 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.38 164.96 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.2 137.27 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.304 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.431 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 6.3 mmt-85 -118.34 151.88 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.624 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.73 132.55 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.952 0.406 . . . . 0.0 111.361 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.465 ' N ' ' CD1' ' A' ' 196' ' ' TYR . 0.7 OUTLIER -141.6 137.68 32.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.566 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.5 tp -109.74 75.07 0.78 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.756 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.03 113.74 3.86 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.734 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.16 156.02 25.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.441 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 34.8 m -138.04 153.26 49.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.531 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 90.41 2.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.282 0.563 . . . . 0.0 110.094 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 60.27 -85.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -117.42 29.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -132.63 130.24 39.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.624 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.02 119.04 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.83 127.2 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 30.0 p -132.55 104.93 13.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.418 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.36 165.09 14.58 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.606 2.204 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.17 131.92 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.145 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.98 123.99 17.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.748 0.308 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -161.94 172.03 38.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.516 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.87 137.0 46.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -129.21 123.33 31.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 240' ' ' TYR . 2.9 m-85 -112.24 155.08 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -137.19 110.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.549 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -119.32 114.93 23.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.982 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.831 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.66 0.267 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 277' ' ' ASN . 22.7 t -102.18 157.62 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 0.0 110.952 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.94 122.16 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 m -126.98 134.3 50.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.55 161.77 18.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -139.25 99.25 3.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.34 139.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -137.34 -176.09 14.21 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.603 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 15.1 m -149.95 155.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.652 0.263 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 249' ' ' SER . 1.4 t-20 -140.72 95.34 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 279' ' ' SER . 22.8 t80 -88.91 154.93 19.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.847 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 33.7 t -142.5 147.01 35.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.403 ' CD1' ' OH ' ' A' ' 278' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.825 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.785 0.326 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.422 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -144.33 111.94 6.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -114.26 105.16 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.415 ' HB3' ' CE1' ' A' ' 280' ' ' PHE . 0.2 OUTLIER -89.95 119.98 30.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -131.11 134.78 46.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.0 mt -118.06 113.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.81 135.83 13.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.599 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.92 129.01 18.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 0.0 110.984 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.0 ttm -122.39 141.72 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 4.5 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.39 141.51 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.046 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.9 m-85 -124.78 145.91 49.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.53 109.37 8.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.68 156.8 18.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.232 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -160.13 113.83 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.617 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 6' ' ' TRP . . . -91.89 125.48 36.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.205 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -134.69 88.6 2.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.19 -125.08 26.51 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.31 17.25 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.635 2.223 . . . . 0.0 112.763 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.41 119.45 14.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.912 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.421 ' HB3' ' CG ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -117.04 109.72 17.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.715 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.3 mt -86.75 141.96 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.82 97.83 3.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 117.44 31.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . . . -117.54 162.85 17.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 18.6 m-85 -125.87 114.69 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.0 111.39 16.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.741 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -147.81 148.88 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.812 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.699 0.285 . . . . 0.0 111.017 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 26.4 Cg_exo -62.76 -171.17 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.434 2.089 . . . . 0.0 112.196 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.06 144.55 5.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.94 157.03 29.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -147.78 149.56 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.03 148.87 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.421 ' CG ' ' HB3' ' A' ' 44' ' ' ARG . 13.8 m80 -122.86 126.36 47.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -107.28 101.45 10.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -87.46 102.17 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -78.8 -54.99 5.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.28 124.02 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.02 95.08 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.802 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -130.72 142.83 50.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.81 -22.03 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.202 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -117.51 11.33 13.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -176.47 71.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.63 116.05 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.821 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.92 123.0 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.961 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.08 163.64 22.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -158.13 107.87 2.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 0.0 110.696 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 15.7 p -89.75 159.09 17.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.62 107.22 0.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.77 -176.91 14.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.733 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -129.1 132.59 47.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.798 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -113.66 125.81 54.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -96.12 99.93 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -97.74 106.01 18.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.515 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -171.76 129.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -143.11 100.53 3.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 mtm -125.21 134.13 52.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.8 145.02 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.56 117.56 10.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.59 150.39 24.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.69 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.05 106.51 4.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.5 mt -110.31 145.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.63 84.93 11.84 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.406 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.74 90.63 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.646 2.231 . . . . 0.0 112.144 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -62.99 111.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.89 122.96 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.46 122.1 25.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.48 123.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 125.47 52.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.88 -41.85 6.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.1 p -156.22 -177.48 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.63 58.59 4.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -179.09 -49.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.94 105.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -108.83 129.09 55.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.25 144.5 26.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -142.62 122.42 13.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.99 125.09 6.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -131.62 116.85 17.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.98 98.98 8.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 99.94 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.9 140.64 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -145.56 155.63 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.44 107.02 3.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -96.17 130.88 43.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.012 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.78 179.72 7.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.3 t30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.841 0.353 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -85.14 144.74 28.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.67 115.93 31.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.82 103.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -123.6 130.15 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.019 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.0 m -102.8 142.87 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.799 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.22 106.58 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 m -100.62 103.95 15.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.811 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.02 135.13 12.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.759 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.81 124.55 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 0.0 110.79 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.18 119.32 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.206 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -130.07 110.56 11.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.952 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.418 ' CG2' ' HB1' ' A' ' 166' ' ' ALA . 28.8 p -84.6 125.77 32.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -60.99 -29.31 69.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -155.96 41.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.141 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 57.59 76.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 168.78 -64.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.504 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.6 m -103.91 112.98 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HB1' ' CG2' ' A' ' 160' ' ' THR . . . -121.15 161.65 21.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.882 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.3 138.72 41.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.064 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 113.63 26.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.74 100.84 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.509 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -95.38 140.7 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.325 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.77 116.76 27.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.92 136.72 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.8 tp -142.02 94.94 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -96.35 118.07 32.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 122.38 16.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.4 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.4 t -92.84 159.06 15.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.37 141.69 32.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.976 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.44 178.99 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 44.3 pt -148.25 136.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.289 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -134.39 138.94 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.727 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -110.01 137.77 47.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.48 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 196' ' ' TYR . 2.1 m-85 -135.63 175.09 9.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.85 72.64 0.92 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 0.0 111.017 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.84 113.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.469 2.113 . . . . 0.0 112.252 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.23 127.27 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 51.7 m -138.12 146.61 43.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.276 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 95.4 mt -140.04 90.24 2.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.214 0.53 . . . . 0.0 109.993 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.46 -65.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.467 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -143.54 35.6 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.732 0.301 . . . . 0.0 110.828 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -117.66 146.05 43.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.9 t -127.96 109.23 11.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.997 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.68 107.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.7 m -129.88 104.9 16.9 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.16 161.06 41.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 112.267 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -129.59 134.7 47.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.4 m -129.95 133.55 46.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.1 mtp85 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -128.92 132.66 7.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 mt -122.4 122.93 40.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 251' ' ' SER . 2.4 t80 -102.42 117.08 33.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -120.89 144.93 48.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 163.55 -156.43 28.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.575 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -149.06 166.09 29.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.913 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 7.8 t -97.5 161.28 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.526 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.3 m -145.95 133.5 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.277 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 239' ' ' PHE . 13.7 m -130.81 136.99 49.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 116.38 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -96.31 134.3 39.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.7 t -129.26 148.0 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.044 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -164.39 161.26 34.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.44 159.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.167 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.29 95.2 2.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.015 0.436 . . . . 0.0 111.374 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 3.4 t80 -88.86 110.6 21.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.651 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 5.4 p -109.13 142.76 39.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 8' ' ' PHE . 3.0 p90 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.831 0.348 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.74 110.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 111.99 16.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.497 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -96.97 132.54 42.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 111.12 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -115.65 122.86 46.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.766 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.445 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 20.2 mm -105.97 113.88 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.28 154.63 19.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.12 135.68 14.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtp -125.12 144.15 50.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.757 0.313 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.24 142.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.049 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.41 128.43 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.445 ' CE2' ' CD1' ' A' ' 10' ' ' ILE . 1.1 t80 -143.62 114.69 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 1.9 m120 -106.7 164.64 11.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.305 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.55 113.77 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.568 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.86 121.92 40.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.601 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.74 88.48 2.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.3 -126.33 28.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.923 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.91 19.23 1.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.683 2.255 . . . . 0.0 112.814 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -140.15 110.89 6.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.74 0.305 . . . . 0.0 111.058 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -116.42 111.79 20.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.615 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pt -92.67 148.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.356 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . . . -141.01 109.4 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.047 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.44 135.55 38.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.54 146.03 45.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.51 122.48 47.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -118.55 111.33 18.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.26 167.43 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.84 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.741 0.305 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.64 -166.37 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.52 2.147 . . . . 0.0 112.053 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -158.83 134.18 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -137.03 105.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.758 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.49 158.31 17.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 m -140.73 157.02 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.94 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -128.67 117.51 21.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.042 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -127.62 105.12 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -106.74 109.69 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.007 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -37.06 56.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.52 132.76 49.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.809 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -129.8 111.92 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.977 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -162.02 168.54 22.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.05 15.32 17.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -119.08 -43.09 2.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.765 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -159.32 92.78 1.09 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 t -87.0 150.07 24.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -130.31 104.02 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.13 177.59 17.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.37 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.08 107.81 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 64.8 m -77.04 155.34 32.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.7 79.5 0.21 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.537 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.91 129.95 10.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -120.05 120.11 35.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 0.0 110.737 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -127.83 139.9 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -131.13 129.51 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -112.23 128.13 56.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.07 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.652 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.766 0.317 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -168.91 141.76 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -156.56 99.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.2 ttp -116.83 157.63 25.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 143.04 48.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -139.96 116.71 10.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -88.12 130.21 35.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 108.14 9.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.71 147.38 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.69 107.81 3.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.71 94.32 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.31 2.007 . . . . 0.0 112.033 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.48 102.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -107.42 123.0 47.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.72 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.46 123.16 32.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.957 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.78 106.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 154.55 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -4.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.408 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 m 63.53 31.91 14.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.65 -73.86 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.71 24.62 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.004 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.11 100.49 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -106.75 128.34 54.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 157' ' ' LEU . 0.1 OUTLIER -117.06 130.71 56.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.439 ' ND2' ' CE2' ' A' ' 131' ' ' TRP . 0.2 OUTLIER -128.64 126.68 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.34 130.87 10.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.585 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.439 ' CE2' ' ND2' ' A' ' 129' ' ' ASN . 37.3 m95 -125.62 129.15 49.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.5 mp -128.8 102.36 6.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.694 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.0 p -84.62 113.06 21.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.11 116.94 31.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.715 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.74 143.84 33.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 98.97 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.44 145.49 35.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.956 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.07 170.12 19.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.07 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.963 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.854 0.359 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.2 p -111.82 137.24 50.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.11 133.43 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.04 129.82 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -136.03 115.97 13.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.1 m -96.46 137.87 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.78 107.83 9.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.61 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.717 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.97 132.24 11.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.447 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 3.4 mp -109.84 127.34 54.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.718 0.294 . . . . 0.0 110.737 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.21 111.57 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.029 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -130.16 116.51 18.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.253 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.415 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 15.9 p -84.8 134.48 34.31 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.956 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -60.76 -31.01 70.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -162.9 44.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.32 72.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 177.96 -73.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.757 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.64 112.97 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.415 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -114.97 158.75 21.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.046 0.45 . . . . 0.0 111.89 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.04 141.86 32.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.043 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.87 108.89 15.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.113 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.2 m -109.23 100.94 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -92.41 145.96 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 108.0 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.627 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -85.94 141.31 29.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.997 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 mt -141.75 99.94 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.784 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 123.2 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -133.56 144.43 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.566 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.853 0.358 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.38 107.83 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 123.81 35.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.45 158.03 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.772 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 tt -132.44 140.11 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -134.29 137.88 44.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.92 149.79 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -156.22 172.03 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.722 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.39 86.94 0.23 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.43 113.47 3.14 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.374 2.049 . . . . 0.0 112.408 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mp -114.39 132.82 56.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.735 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.4 p -138.04 155.78 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.3 mp -143.23 90.58 2.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.247 0.546 . . . . 0.0 110.04 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.79 -65.48 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.457 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.43 59.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -153.09 140.62 19.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.3 t -128.06 115.72 18.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.059 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.12 128.47 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 71.4 p -136.47 104.87 9.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.222 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.49 126.03 2.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.707 2.271 . . . . 0.0 112.134 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 30.4 p90 -112.78 137.6 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.887 0.375 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.2 p -129.55 142.4 50.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.735 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 -179.82 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -138.56 141.01 11.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.477 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.11 122.03 36.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.952 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.9 150.48 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.825 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 147.63 44.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.52 126.93 1.99 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.457 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 243' ' ' ASP . 49.0 t80 -148.77 162.9 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.099 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.406 ' O ' ' CE2' ' A' ' 242' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.461 ' CB ' ' HB3' ' A' ' 277' ' ' ASN . 0.3 OUTLIER -117.43 113.95 22.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.095 0.474 . . . . 0.0 112.105 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.82 117.18 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.9 m -127.75 169.39 13.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 111.253 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.24 129.75 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.67 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.91 123.16 46.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.316 -0.314 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 6.2 m -110.63 124.68 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -117.88 131.86 9.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.08 123.08 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . 0.461 ' HB3' ' CB ' ' A' ' 249' ' ' SER . 33.0 t30 -125.6 156.45 39.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 7.0 m-85 -149.89 155.41 39.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.894 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.94 147.1 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.678 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.782 0.325 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -157.38 95.36 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -117.36 109.98 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.24 119.98 29.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -128.06 130.22 47.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mt -115.62 137.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 131.17 6.33 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.571 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.87 128.41 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 0.0 111.062 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.88 128.96 54.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.863 0.363 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.0 t -101.72 162.32 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.66 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -155.71 135.4 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.369 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.47 155.81 49.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.352 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.12 155.41 39.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.219 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.93 113.86 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.576 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.9 117.76 29.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.83 88.58 2.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.5 -128.15 26.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.82 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.38 21.92 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.649 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -140.26 112.76 7.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.43 104.68 14.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.82 133.26 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.343 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.22 124.0 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.903 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.98 112.44 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.084 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.26 161.45 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.856 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.05 115.58 24.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -123.65 121.17 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -151.31 141.18 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.833 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.922 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.459 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.546 0.212 . . . . 0.0 110.801 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 83.5 Cg_endo -83.76 176.77 6.7 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.801 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -161.93 131.06 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mt -110.21 150.24 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.201 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.02 127.35 3.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 t -128.01 154.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.03 148.21 47.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -135.54 143.73 45.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.9 102.17 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.52 -66.28 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -125.4 133.34 52.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -120.13 106.48 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -146.86 172.17 14.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.14 15.35 10.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.431 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 4.2 m-20 -114.26 -44.99 3.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 83' ' ' PHE . 15.5 p90 -166.95 101.55 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -92.93 133.85 35.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.745 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.59 107.78 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.146 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.84 175.18 19.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.203 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 tp -158.12 107.93 2.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 0.0 110.936 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 m -79.02 155.87 28.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.29 105.04 0.24 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.567 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.36 174.9 20.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.383 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -129.85 144.12 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -122.46 117.74 26.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -105.0 112.25 25.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -125.83 100.0 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.426 -179.919 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.31 168.12 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.038 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -142.5 117.83 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.2 mtt -136.46 119.17 16.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -111.21 141.23 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.785 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.56 124.28 12.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.981 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -85.53 146.08 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.8 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -128.18 107.94 10.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.169 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.8 pt -131.3 150.72 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.3 105.69 1.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.43 93.61 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.434 2.089 . . . . 0.0 111.938 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.03 149.38 41.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -147.34 123.02 10.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.69 118.74 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.06 114.03 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -106.15 128.18 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.86 -32.82 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.01 -175.35 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -88.88 53.54 2.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -176.78 -50.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.4 mt -82.03 104.11 12.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -112.64 116.37 30.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -90.95 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -137.43 127.48 25.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.37 125.18 6.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -123.09 121.77 36.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.921 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 mp -116.37 99.03 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.5 120.6 24.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.9 mtp -128.65 129.1 45.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.8 133.07 52.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -115.92 157.41 24.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 148' ' ' ASP . 40.9 p90 -108.54 154.11 22.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -165.03 178.54 6.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.415 ' HB2' ' CE1' ' A' ' 137' ' ' PHE . 4.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 p -99.08 110.76 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 126.04 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.0 m -145.97 100.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.08 121.32 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 m -104.39 126.75 51.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -126.37 107.81 10.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.123 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.5 p -99.08 103.87 15.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.11 148.36 16.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.805 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mt -133.03 118.39 18.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -108.71 113.27 26.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -130.11 118.4 21.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.5 OUTLIER -92.28 131.48 37.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.752 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.82 7.52 26.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.693 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.04 28.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.766 0.317 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.407 ' HA ' HG23 ' A' ' 160' ' ' THR . 14.6 mm-40 51.52 64.94 1.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.112 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 178.54 -64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.85 113.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.813 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -119.03 151.97 37.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.8 mp -93.92 133.44 37.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.265 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -109.05 107.02 17.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.047 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.49 107.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.712 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -103.37 145.23 30.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.46 121.76 42.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.583 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.89 125.16 33.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.5 tt -142.02 94.82 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.748 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -126.58 148.95 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -140.1 151.04 45.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.791 0.329 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.2 m -79.03 110.96 14.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.12 131.76 54.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.55 156.99 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -116.15 131.36 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -129.23 117.96 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.08 149.11 23.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.407 ' OH ' ' CE2' ' A' ' 209' ' ' TYR . 52.5 m-85 -155.11 142.54 19.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.1 mt -136.24 71.99 60.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.1 113.72 3.15 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.29 157.16 23.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.9 p -136.62 138.08 40.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.16 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.48 89.81 2.45 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.359 0.6 . . . . 0.0 109.983 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 45.93 81.24 0.04 OUTLIER Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.884 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.85 40.22 16.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -152.05 97.57 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 41.5 m -96.84 142.74 28.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 97.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -105.01 104.75 48.46 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.087 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.81 164.94 17.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.624 2.216 . . . . 0.0 112.387 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.407 ' CE2' ' OH ' ' A' ' 196' ' ' TYR . 3.5 m-85 -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.2 m -139.1 150.45 45.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.092 -179.876 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.852 0.358 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -101.07 168.34 20.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.588 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.1 128.2 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.5 98.1 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.98 134.72 38.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -125.81 114.56 2.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.577 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.75 110.18 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.962 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.632 0.254 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' A' ' 277' ' ' ASN . 28.4 t -95.93 167.44 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.746 0.307 . . . . 0.0 110.948 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -149.28 117.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.5 m -138.92 147.1 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 5.1 mp -121.11 123.5 42.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 131.6 53.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.05 148.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -135.18 141.32 12.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.537 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 14.0 t -115.25 145.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ASN . . . . . 0.401 ' CB ' ' HB3' ' A' ' 249' ' ' SER . 1.8 t-20 -147.41 95.55 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -88.43 140.27 29.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.0 p -124.67 131.52 53.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.937 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.819 0.343 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -142.86 85.01 1.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.97 -58.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -157.84 54.9 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.33 -22.28 11.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.115 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 66.31 118.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 110.821 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.15 119.72 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -88.0 128.86 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.52 135.46 40.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 tt -155.83 126.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.27 22.21 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.47 121.33 7.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.134 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -104.88 159.38 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.23 133.03 12.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -118.38 118.01 30.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.6 mt -140.12 150.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -102.82 -165.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -97.29 26.54 4.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.1 t 54.91 30.59 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.28 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 62.96 145.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.52 -52.0 47.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.538 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.47 105.42 9.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 0.0 110.811 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.95 160.09 11.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.532 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.1 85.33 0.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.354 . . . . 0.0 110.925 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -122.94 28.56 7.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mtt -143.08 111.97 6.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.03 -66.7 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.46 121.22 5.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.42 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.0 mt -152.12 137.06 17.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.23 160.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -131.39 147.33 65.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.3 146.15 44.84 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.532 2.155 . . . . 0.0 112.289 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -103.08 119.37 38.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.64 151.95 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -148.33 142.08 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -149.82 143.91 25.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -146.38 161.56 40.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.411 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.19 113.83 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.99 116.18 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.553 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.82 88.56 2.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.704 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -126.61 35.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.031 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.66 23.14 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.0 112.689 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.433 ' CH2' ' HB ' ' A' ' 73' ' ' VAL . 14.8 t-105 -140.42 110.85 6.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 26.7 mtp180 -108.37 108.77 19.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mt -83.85 120.62 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.138 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.32 121.69 34.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.17 113.18 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.09 146.73 43.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.21 117.43 34.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.09 120.88 43.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -152.36 123.0 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -137.34 140.26 41.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.96 77.14 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.382 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.09 -79.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.54 2.16 . . . . 0.0 112.25 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 m -146.87 29.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.19 162.52 25.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.46 122.94 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.7 -67.38 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 59.97 97.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.146 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.75 -63.46 0.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.555 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.96 -69.21 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -148.38 175.34 11.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.61 138.13 8.49 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -152.75 66.37 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.371 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -112.13 -27.37 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -73.48 -67.35 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.1 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 60.96 -178.89 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.795 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.404 ' CB ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -177.11 173.18 0.75 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.932 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 68' ' ' ARG . 73.5 Cg_endo -76.27 -179.61 5.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.446 2.098 . . . . 0.0 112.326 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.2 167.34 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.95 149.12 50.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.805 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.55 140.28 24.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.433 ' HB ' ' CH2' ' A' ' 43' ' ' TRP . 15.4 m -142.11 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.461 ' N ' ' CD2' ' A' ' 74' ' ' HIS . 2.0 m-70 -112.78 139.35 48.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -138.04 104.27 5.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.77 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -95.31 111.01 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.11 -52.71 57.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 mt -129.37 145.35 51.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.69 94.95 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.72 130.38 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.39 -23.68 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.77 -44.65 26.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -151.48 80.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.3 123.93 33.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -106.75 115.8 30.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -125.54 165.9 18.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.57 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.24 107.89 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.285 . . . . 0.0 110.533 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -105.85 107.83 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.38 123.44 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.244 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 153.64 17.42 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.778 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.77 126.63 53.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -109.95 134.7 51.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.957 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -125.91 121.74 34.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.786 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.26 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.72 161.52 25.98 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.384 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 98' ' ' TYR . 3.8 t80 71.86 -73.46 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.527 0.203 . . . . 0.0 110.95 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 65.08 -70.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.143 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 96' ' ' TYR . 1.3 t80 -173.43 125.63 0.4 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.829 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.31 139.34 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.19 -39.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -84.48 109.48 20.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.79 64.63 1.82 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.438 2.092 . . . . 0.0 112.296 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.15 -45.26 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.52 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.49 139.93 53.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.922 0.391 . . . . 0.0 110.781 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.5 -49.26 72.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.785 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -112.94 149.9 32.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.78 154.94 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -108.45 125.19 51.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.75 139.7 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -108.36 134.2 51.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -143.34 129.21 19.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -90.87 148.45 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.736 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -142.09 103.71 4.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.6 144.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.87 93.28 8.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.317 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.81 87.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.172 . . . . 0.0 112.072 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 98.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -107.86 122.92 47.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.796 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -128.17 127.19 42.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.0 p -145.06 127.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 141.0 29.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.27 -32.31 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.813 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.52 177.88 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.16 54.52 3.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.5 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mp -99.37 141.86 31.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.2 144.0 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' CD2' ' CD1' ' A' ' 157' ' ' LEU . 5.6 t80 -115.65 133.31 56.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -129.8 159.33 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.02 113.56 0.59 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.21 118.96 30.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.95 102.56 12.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 t -76.06 112.96 13.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.5 mtt -116.55 118.01 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.751 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -111.35 131.95 54.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.24 105.4 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.669 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -71.85 142.96 49.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.55 137.27 15.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.031 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -145.31 -173.53 4.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.954 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.35 29.32 3.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -177.93 -62.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.9 t30 59.67 86.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 t -57.93 -51.66 68.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.102 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.2 p -123.99 -36.41 2.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.052 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 87.65 -13.33 60.9 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.919 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 63.08 -79.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.9 -175.74 2.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.48 -75.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 57.0 m -127.58 122.42 33.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.14 133.18 43.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.71 116.59 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.06 121.69 30.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.5 t -95.05 138.8 32.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.47 117.61 18.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.424 ' CG2' ' CZ ' ' A' ' 128' ' ' PHE . 26.0 m -105.14 103.91 13.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.02 135.78 12.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.573 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.433 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 1.1 tp -131.05 115.01 15.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -114.64 110.89 20.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 2.5 p90 -130.01 125.0 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -98.88 138.16 36.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.045 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.45 -50.66 30.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.384 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -150.83 53.62 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.41 ' HA ' HG22 ' A' ' 160' ' ' THR . 8.1 tt0 61.55 76.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.89 -76.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.3 m -103.91 112.8 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.557 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -112.56 140.65 47.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.86 129.94 40.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.393 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -102.51 132.53 48.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.18 103.72 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -103.26 127.82 50.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.32 110.98 23.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.79 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.33 139.33 30.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.02 94.97 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.95 138.17 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.962 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -140.04 138.08 35.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.39 150.81 37.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.479 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.1 145.26 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -141.83 158.6 43.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 6.0 ttt -98.45 34.4 2.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -64.88 176.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.84 -55.85 3.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.967 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.2 m -161.63 39.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -131.35 89.82 2.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -25.09 11.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 68.4 -71.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.829 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 161.42 77.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.519 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 174.29 4.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.58 154.22 51.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.1 p -102.51 124.02 47.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 m -101.52 128.55 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.942 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -119.43 117.49 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -105.73 136.41 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.7 mt -97.06 154.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.034 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -147.06 117.02 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -110.85 137.2 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.003 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.411 ' CE2' ' HB ' ' A' ' 207' ' ' THR . 0.3 OUTLIER -150.49 173.82 13.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -175.18 80.35 0.31 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.669 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.25 113.86 2.61 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.556 2.171 . . . . 0.0 112.541 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.21 155.86 25.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -137.99 156.97 47.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.673 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.31 90.54 2.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 61.25 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.5 31.54 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -140.25 136.39 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.4 m -117.39 139.89 50.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.992 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.411 ' HB ' ' CE2' ' A' ' 196' ' ' TYR . 10.0 p -121.81 104.66 38.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.765 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.56 165.06 18.48 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.597 2.198 . . . . 0.0 112.406 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -120.5 139.67 52.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.21 159.29 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -169.31 -57.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.82 170.38 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.164 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 179.33 -36.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.557 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.92 -179.56 5.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -161.62 121.93 2.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -145.56 -177.7 5.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -112.28 -65.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.6 116.01 31.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -167.25 142.2 3.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -133.16 156.65 47.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -77.53 164.8 25.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -111.6 162.93 14.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -110.28 -55.63 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -77.84 -31.95 51.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.81 137.57 36.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.75 140.04 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.23 37.08 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 6.0 mmt-85 -108.4 107.96 18.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -151.56 -47.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.008 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.31 39.02 0.6 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.76 31.53 3.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.67 144.78 35.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -83.5 108.17 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -161.4 160.9 30.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.57 -68.16 0.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.0 t 58.75 107.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.146 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.74 145.85 42.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 4.0 mp -118.06 113.37 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -116.38 106.38 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -90.87 146.73 23.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -132.77 111.37 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.017 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.418 ' HB2' ' HB ' ' A' ' 250' ' ' VAL . 76.5 m-85 -104.5 166.22 10.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.249 0.547 . . . . 0.0 111.503 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.2 t0 65.56 -93.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.133 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.36 29.43 1.29 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.732 0.301 . . . . 0.0 111.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.84 -54.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.08 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.64 -20.39 32.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 278' ' ' TYR . . . 126.1 -24.35 5.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.343 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 3.0 pp -105.66 126.77 52.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.9 t -95.85 123.51 39.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.96 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 242' ' ' TYR . 40.1 t -105.82 116.92 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.798 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 16.0 m -108.03 152.07 24.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.169 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.91 142.11 47.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -118.43 128.58 54.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.07 140.34 47.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -174.36 118.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -67.74 -177.22 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -101.33 126.18 48.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' TRP . . . . . 0.407 ' CE3' ' HA ' ' A' ' 258' ' ' TRP . 2.4 m95 -151.29 153.13 34.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 60.94 156.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.795 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -169.01 164.43 11.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -136.96 -47.21 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -85.14 150.05 25.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.23 31.87 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 173.2 -39.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.474 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.46 -15.18 62.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.621 0.248 . . . . 0.0 111.237 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.25 152.26 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -77.6 -49.48 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -112.49 166.17 11.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.25 -31.74 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -133.8 159.68 39.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.921 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 272' ' ' ALA . 29.3 p90 -121.24 -46.66 2.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.408 ' HB1' ' CE2' ' A' ' 271' ' ' TYR . . . -93.27 155.04 17.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.34 131.45 3.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.446 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.09 123.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -144.93 145.4 14.71 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.138 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 249' ' ' SER . 29.6 m -126.39 159.15 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.487 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 249' ' ' SER . 9.8 m120 -148.12 95.53 2.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.176 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 4.3 t80 -88.55 121.29 30.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.79 138.7 37.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.886 0.374 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.21 143.63 51.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -100.0 52.68 0.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.37 38.74 3.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -144.3 29.37 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.993 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.441 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.1 m0 -91.42 113.15 25.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -119.25 152.05 37.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.93 119.94 20.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.633 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -131.81 139.8 48.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.065 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mm -121.8 113.75 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.864 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.51 143.52 15.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.2 125.79 8.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.312 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.64 120.68 42.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.89 161.83 19.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -118.48 151.72 37.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.4 mm -76.28 138.32 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -113.84 99.79 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.9 30.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -81.46 -36.01 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -73.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.56 -123.14 1.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.456 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -99.73 153.33 19.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.8 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.19 -160.91 30.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -151.65 81.86 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.9 103.89 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.6 mmt 60.53 90.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.5 -174.34 2.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.74 -85.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.0 pp -169.85 167.76 9.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 0.0 110.909 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.47 159.74 34.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 59.98 94.42 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.39 -64.87 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.508 2.139 . . . . 0.0 112.351 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p 174.75 -179.39 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.972 0.415 . . . . 0.0 111.042 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.2 t -134.27 158.71 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.75 151.6 43.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.053 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -145.08 146.63 31.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.64 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.92 157.39 45.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 111.197 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -167.22 113.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 6' ' ' TRP . . . -90.78 126.16 35.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.836 0.351 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -134.77 88.57 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.82 -126.2 31.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.65 21.35 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.682 2.255 . . . . 0.0 112.864 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -140.14 112.8 8.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.62 112.88 24.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.515 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 45' ' ' ILE . 24.0 mm -83.99 118.36 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.61 119.54 21.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.923 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.25 155.0 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.94 147.78 32.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.042 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -100.97 113.68 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.11 122.84 48.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -156.52 138.34 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -133.06 120.72 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.85 143.02 5.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.491 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.88 112.47 3.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.483 2.122 . . . . 0.0 112.365 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t 58.91 84.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.71 132.25 45.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -95.38 170.75 9.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -120.07 138.47 53.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.72 -174.74 2.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.4 51.56 3.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.55 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp 58.59 31.39 21.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.353 . . . . 0.0 110.985 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -174.23 127.55 0.35 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.88 158.98 33.86 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.561 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 t 43.04 91.83 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.869 0.366 . . . . 0.0 111.47 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -175.59 127.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -126.8 171.28 11.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 60.21 -176.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -173.36 173.43 1.31 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 111.22 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.8 -160.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.871 2.381 . . . . 0.0 112.278 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -153.47 132.69 12.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.92 154.61 19.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -157.09 134.79 10.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 m -135.94 148.13 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.27 130.36 56.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -127.12 100.69 6.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -91.6 113.58 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -72.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -114.92 128.49 56.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -96.16 102.11 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -156.04 163.59 39.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.26 16.37 15.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.13 -43.02 2.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.882 0.372 . . . . 0.0 110.878 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 96.5 m-85 -146.0 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.75 112.75 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 83' ' ' PHE . 56.9 m-85 -114.91 121.31 42.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.043 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.26 -173.35 13.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.347 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 pp -158.15 124.27 4.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.0 m -99.95 98.96 9.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.57 134.76 11.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.49 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.13 162.76 26.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.632 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.95 121.47 42.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.861 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 118.44 36.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.984 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -110.75 98.05 7.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -113.4 126.94 55.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.95 173.62 40.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.47 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -119.55 135.41 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.4 163.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -140.25 -45.53 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.953 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 t -54.46 161.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.143 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.44 56.93 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.99 0.424 . . . . 0.0 111.075 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -128.1 72.55 79.46 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.22 124.38 13.93 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.538 2.159 . . . . 0.0 112.399 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -164.95 75.02 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.44 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? 44.88 30.53 0.57 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.726 0.298 . . . . 0.0 111.397 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.83 90.54 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.815 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m -161.58 124.93 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.95 144.39 8.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -150.66 104.37 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.7 mtt -130.8 129.56 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.21 150.48 22.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -147.22 121.28 9.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.106 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -91.24 122.77 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 108.25 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.23 146.34 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.65 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 91.04 7.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.493 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.51 86.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.961 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.12 106.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.258 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -107.35 132.64 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.495 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -138.32 128.59 25.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.201 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.2 100.87 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 156.22 40.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.47 29.05 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -32.85 11.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.598 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.9 -78.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -164.09 25.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp -142.33 152.4 42.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -102.53 111.11 23.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.619 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.95 137.93 31.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.88 118.91 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -105.01 139.85 14.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.53 120.28 16.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.77 98.97 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.846 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.4 t -87.47 110.11 20.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.8 ttp -112.12 122.88 48.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -105.24 128.79 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -108.37 98.92 8.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.54 128.56 33.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.54 135.12 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -163.63 140.3 6.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -62.03 -25.45 67.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.47 43.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -71.82 92.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.0 p -83.7 -48.87 9.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.3 m -106.03 -31.19 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.88 29.21 67.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -67.93 135.78 52.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.959 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.47 94.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.75 -42.06 13.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 t -137.09 142.08 42.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.401 ' NH1' ' HB3' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -133.59 113.01 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.812 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.0 t -102.35 137.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.045 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.49 118.74 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 m -97.18 136.51 37.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.01 101.47 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.7 m -94.99 108.41 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -107.63 134.45 12.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.699 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.3 mt -119.61 124.69 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.765 0.317 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -112.96 121.08 43.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -130.08 108.41 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.028 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.456 ' N ' ' HB3' ' A' ' 166' ' ' ALA . 0.8 OUTLIER -84.75 126.57 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.871 0.367 . . . . 0.0 110.953 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -52.5 -27.41 16.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.79 49.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 57.24 58.94 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.9 m -165.3 -73.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.72 112.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.412 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.456 ' HB3' ' N ' ' A' ' 160' ' ' THR . . . -117.83 153.16 33.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.1 0.476 . . . . 0.0 111.848 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.2 tt -100.01 138.09 37.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.998 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -112.49 125.89 54.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.305 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.02 103.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.586 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -97.36 134.7 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.03 25.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.82 132.64 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.248 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.0 mp -142.14 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.643 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -88.71 123.79 33.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 112.93 8.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -131.83 -165.44 11.36 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -111.94 149.63 31.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -133.49 157.59 45.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -171.43 172.82 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -172.4 -46.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -134.35 -50.08 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.5 -45.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.03 103.41 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.95 31.27 5.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -160.78 167.75 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 170.61 -37.74 0.18 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.389 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 77.29 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.75 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -160.25 133.22 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.94 145.08 21.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.39 120.48 39.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -122.14 129.07 51.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.26 173.78 9.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.742 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.41 139.27 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -127.87 143.98 51.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.69 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -152.76 168.66 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.9 tt -176.62 85.41 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.524 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 207' ' ' THR . 19.8 Cg_endo -60.82 113.67 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.39 2.06 . . . . 0.0 112.672 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.0 mt -114.47 116.16 28.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.387 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 29.2 p -129.49 158.21 39.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 110.83 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 9.6 tp -143.1 90.5 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.182 0.515 . . . . 0.0 109.997 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.83 -73.86 2.49 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.417 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -125.93 -35.07 2.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.715 0.293 . . . . 0.0 111.347 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -65.34 135.09 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.2 t -128.1 115.85 19.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.038 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.34 119.48 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' A' ' 198' ' ' PRO . 5.0 t -122.68 104.76 36.24 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.208 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.19 161.83 39.92 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.693 2.262 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.423 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 43.7 p90 -150.39 142.63 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.017 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.4 m -137.34 143.3 41.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.44 177.35 4.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.62 117.16 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -125.79 -50.0 0.18 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.45 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.27 101.42 4.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.87 -33.03 15.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.85 179.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -108.29 -48.96 3.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.72 170.15 22.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -116.41 155.2 28.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.7 31.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.85 150.61 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -101.09 33.93 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.765 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -127.73 112.07 14.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -157.32 -74.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 64.34 37.3 8.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.4 mt -135.98 106.48 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.111 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -108.66 87.37 2.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -135.35 148.11 49.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -76.92 149.77 36.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 71.93 123.76 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -60.53 179.86 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.86 0.362 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.76 150.51 13.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -94.53 162.95 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -129.41 31.58 4.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -163.48 106.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.2 p -159.45 124.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.418 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -98.65 159.75 20.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.467 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.5 mt -144.45 129.95 18.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.828 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.404 ' CE1' ' HG2' ' A' ' 253' ' ' GLU . 0.7 OUTLIER -112.28 99.15 7.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.914 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -84.58 151.91 24.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -164.64 106.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.476 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.2 155.09 40.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -122.73 125.87 46.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -160.36 33.37 0.17 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.048 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.409 ' CB ' ' HB2' ' A' ' 248' ' ' LEU . 28.5 mt-30 -134.7 49.48 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.9 m120 60.96 55.18 3.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.11 -24.34 25.3 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.733 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.427 ' CD1' ' HB2' ' A' ' 278' ' ' TYR . 1.9 mm? -69.54 129.49 39.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.511 0.196 . . . . 0.0 110.497 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 277' ' ' ASN . 43.1 t -95.7 166.69 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.906 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.88 117.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 24.5 t -122.58 132.46 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.83 121.48 34.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.404 ' HG2' ' CE1' ' A' ' 239' ' ' PHE . 7.9 mt-10 -96.66 106.16 18.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -83.72 122.78 29.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -72.65 -170.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -91.46 51.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.03 -166.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' TRP . . . . . 0.4 ' CE3' ' O ' ' A' ' 259' ' ' GLN . 38.9 p-90 -105.16 159.32 15.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.4 ' O ' ' CE3' ' A' ' 258' ' ' TRP . 0.9 OUTLIER -58.7 110.18 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -154.8 113.85 3.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.14 178.12 4.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.34 -66.89 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 60.76 31.76 20.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -111.67 28.84 9.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 58.86 26.51 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.997 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 44.4 m -164.8 -174.16 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.815 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -157.16 131.12 8.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -90.81 -63.05 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.62 159.77 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.64 175.46 13.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -161.47 -45.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -55.3 140.94 37.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.19 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -80.13 171.45 54.33 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.562 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 12.6 p -132.34 124.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.003 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -122.32 150.85 16.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.77 125.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.289 . . . . 0.0 111.181 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 249' ' ' SER . 8.1 m-20 -127.57 95.25 4.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.122 0.487 . . . . 0.0 111.235 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.427 ' HB2' ' CD1' ' A' ' 248' ' ' LEU . 2.3 t80 -88.7 125.74 34.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.727 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.9 141.46 45.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.29 101.32 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.834 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -101.74 -31.18 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -102.12 -25.09 13.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.079 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -94.02 43.81 1.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.9 m95 179.79 81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.77 111.56 22.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.71 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -91.21 126.09 36.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -131.98 127.31 36.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.56 122.93 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.26 160.82 13.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.99 129.27 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.4 ttm -109.92 132.95 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -142.33 125.36 16.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -86.85 136.2 33.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.3 mm -74.36 149.03 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.67 158.16 44.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.97 148.0 44.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.63 110.89 26.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.0 120.65 19.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.66 154.43 6.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.452 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -66.84 -42.0 86.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.58 -103.1 2.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.37 142.21 35.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -164.46 91.96 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -139.44 134.9 33.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.954 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.65 30.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.99 165.11 12.29 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.431 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 pp -79.89 121.03 24.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.48 128.52 52.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -135.1 92.16 18.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.48 160.69 48.15 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.451 2.1 . . . . 0.0 112.316 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.26 132.03 33.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.7 t -105.43 157.04 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.47 147.52 38.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.58 114.07 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.622 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.72 153.13 26.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.69 113.93 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.67 122.46 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.315 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -134.8 88.45 2.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.99 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.68 -123.19 32.0 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.234 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.68 25.29 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -140.11 110.74 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.61 157.31 15.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.61 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.435 HG22 HD12 ' A' ' 45' ' ' ILE . 27.1 mm -126.38 134.75 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.141 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.14 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 tt -116.73 115.97 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.34 142.71 50.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -97.91 120.59 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.014 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -112.92 106.81 15.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.99 162.13 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.753 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -105.09 153.95 20.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.71 -132.88 3.66 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.382 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.53 154.7 6.02 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.453 2.102 . . . . 0.0 112.413 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 p -177.14 -39.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.1 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -144.46 -47.6 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -161.34 127.31 3.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 m -69.58 161.35 29.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.921 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.13 168.8 8.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.58 31.12 9.04 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.5 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt 60.34 78.44 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.82 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -132.5 -47.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.63 4.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m 60.2 171.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 34.4 m95 61.14 32.75 19.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -80.96 132.4 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER 57.82 -169.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.774 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 12.5 mmt180 -157.81 163.06 25.91 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.096 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.54 -166.88 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.87 2.38 . . . . 0.0 112.375 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -146.67 123.63 11.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 155.13 17.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.05 128.36 3.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.84 157.11 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -121.25 145.13 48.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -125.27 128.39 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.74 102.27 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.949 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.84 -73.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.56 120.35 41.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -97.3 107.34 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -159.55 142.75 14.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.46 -13.4 59.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -100.17 -42.75 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.988 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -141.37 87.5 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.72 159.05 17.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -145.03 137.96 26.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.816 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -148.46 141.3 8.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.599 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 tt -120.69 122.46 40.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 0.0 110.784 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.8 m -102.66 117.14 34.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.06 116.05 4.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.448 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -130.5 147.08 18.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.6 134.93 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 -106.0 132.67 51.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -137.81 115.18 11.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -140.49 148.02 40.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.787 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.37 -166.63 39.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.545 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -135.87 157.06 47.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.82 0.343 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -177.06 95.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.72 -168.36 2.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.7 t -59.45 -67.06 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.128 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.77 -66.79 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 59.96 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.31 79.43 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.398 2.065 . . . . 0.0 112.205 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.74 84.12 0.13 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.479 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.1 mttt 63.34 122.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.841 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -152.96 30.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.5 m -162.34 129.37 3.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -166.03 148.03 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.59 100.01 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.6 mtt -118.61 142.64 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -132.53 133.33 43.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.7 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -135.76 129.66 32.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.049 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -85.94 142.89 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.585 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -127.19 133.05 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.448 . . . . 0.0 111.317 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.7 mt -131.48 143.48 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.93 66.0 31.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.24 65.99 5.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.41 2.073 . . . . 0.0 111.506 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.4 ' O ' ' CD1' ' A' ' 85' ' ' PHE . 2.8 p30 -80.47 179.48 7.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.491 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -152.88 123.85 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.527 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.85 128.71 35.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.14 100.93 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.24 152.67 48.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.156 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.65 32.78 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.37 -45.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -167.38 -42.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.419 ' HG ' ' CE1' ' A' ' 159' ' ' TYR . 2.0 mt -82.81 121.84 27.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -123.11 139.83 53.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -134.55 138.36 44.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -152.19 118.96 5.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.23 114.34 4.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.431 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -104.94 124.97 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 0.0 111.09 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.6 tt -109.24 105.62 15.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 116.68 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.955 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -96.88 118.99 34.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -104.23 119.92 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.001 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 145.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.81 151.76 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -164.8 150.34 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -160.79 -175.77 5.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 107.51 1.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.4 tt 68.37 -68.17 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -178.46 84.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.2 m -93.95 -43.15 8.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.8 t -91.56 -33.18 15.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.956 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.35 20.48 11.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.726 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 55.53 33.34 20.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 111.022 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -104.31 -177.05 3.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.35 32.18 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.7 p -102.98 109.57 21.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.016 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -146.57 170.99 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -118.52 148.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -125.03 138.63 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.638 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 34.3 m -93.92 145.35 24.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.124 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -136.88 98.99 3.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.81 108.0 20.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -110.29 141.93 16.43 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.583 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.5 mp -123.61 130.5 52.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.767 0.318 . . . . 0.0 110.913 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -117.55 113.22 21.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.958 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.419 ' CE1' ' HG ' ' A' ' 126' ' ' LEU . 27.4 t80 -130.16 116.8 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 9.4 p -84.72 137.23 33.35 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.13 -38.61 91.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -149.93 42.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 61.72 70.82 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 175.75 -64.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.729 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.98 112.77 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.197 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -118.01 150.48 39.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.111 0.482 . . . . 0.0 111.818 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.81 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.225 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.0 114.62 25.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.6 p -116.94 100.91 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.581 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.67 133.98 42.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.182 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -103.2 112.31 25.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.502 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.83 137.99 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.1 tt -141.74 94.92 2.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.632 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.41 144.67 25.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.76 157.03 47.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.776 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -145.37 148.73 20.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.536 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -134.07 118.96 18.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -125.43 117.54 23.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.986 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.19 143.12 30.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.72 31.43 20.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.25 171.02 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.6 p -99.46 34.65 2.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 60.49 30.24 19.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -98.39 -49.95 4.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -115.28 174.24 6.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.63 -28.94 13.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -105.82 31.4 5.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -148.14 129.71 14.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m -108.49 145.63 34.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 10.7 m -96.71 118.17 32.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -122.06 110.84 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -119.84 147.6 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 7.3 tp -112.51 120.02 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.412 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 0.1 OUTLIER -106.28 132.03 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -110.26 148.61 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 194' ' ' ARG . 89.4 m-85 -153.4 175.11 13.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 14.4 tp -172.29 71.32 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.69 113.7 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.27 151.31 33.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.739 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.11 157.85 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.731 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 13.0 tp -143.28 90.65 2.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.19 0.519 . . . . 0.0 110.144 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.71 -65.43 0.63 Allowed Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.408 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -148.49 32.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -123.92 154.99 38.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.2 m -128.06 128.25 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.54 112.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.6 t -125.74 105.01 26.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.056 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.3 165.07 26.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.528 2.152 . . . . 0.0 112.306 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.42 136.2 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.029 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 27.1 m -136.46 146.58 46.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.803 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.74 -39.1 2.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 24.9 mm -116.06 120.45 64.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.141 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.16 -149.67 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.461 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tp -116.93 101.98 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -104.23 169.1 8.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.84 33.27 5.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 60.08 31.43 20.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.4 t -104.57 -31.5 9.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -109.03 -31.46 7.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -117.33 114.12 23.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -134.79 155.13 51.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -176.48 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.63 162.91 22.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -138.07 -47.4 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -171.71 1.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.97 143.95 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.67 152.22 39.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.968 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -98.17 86.15 3.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 60.09 159.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 131.59 150.0 6.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.503 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.39 143.56 29.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.747 0.308 . . . . 0.0 110.866 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.61 133.68 45.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -98.54 -53.13 3.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -81.06 105.93 12.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -141.61 -69.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 p -89.83 130.89 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.086 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -74.49 156.78 50.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 34.2 mt -147.03 106.06 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.94 128.85 38.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.21 144.96 30.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -141.34 122.15 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -123.27 137.83 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.389 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.32 89.14 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.28 32.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.97 53.26 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.033 0.444 . . . . 0.0 110.737 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.2 t30 64.31 29.66 13.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.883 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 110.98 -14.71 28.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.883 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 2.8 tt -90.79 138.31 31.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.688 0.28 . . . . 0.0 110.857 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 277' ' ' ASN . 33.2 t -102.21 165.75 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.65 117.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 18.9 p -109.48 164.3 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.445 ' CD2' ' CE2' ' A' ' 254' ' ' TYR . 0.2 OUTLIER -145.58 136.31 24.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.4 113.83 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . 0.445 ' CE2' ' CD2' ' A' ' 252' ' ' LEU . 1.2 m-85 -115.19 151.24 34.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . 60.76 -175.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.15 -171.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 60.65 101.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -123.17 179.52 4.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.15 160.95 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.788 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 -34.84 11.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.851 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -83.67 118.6 23.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -132.28 122.32 24.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.88 -40.58 2.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.976 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 83.71 61.81 1.83 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -95.5 -31.42 13.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.885 0.374 . . . . 0.0 110.968 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.4 t -165.43 142.62 5.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.56 160.72 24.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -135.6 147.04 48.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.42 178.7 3.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.28 106.88 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.69 141.9 53.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.773 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -174.41 144.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -106.24 170.8 16.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.386 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.03 141.76 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -126.44 179.12 16.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 22.7 t -153.96 140.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.679 0.276 . . . . 0.0 110.976 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 249' ' ' SER . 5.5 t-20 -148.09 95.31 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 111.394 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 280' ' ' PHE . 13.0 t80 -92.71 154.99 17.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.661 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.42 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 12.6 p -143.04 146.71 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.425 ' HB2' ' CE1' ' A' ' 278' ' ' TYR . 44.2 t80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.956 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.806 0.336 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -115.82 118.08 32.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -118.85 -41.31 2.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -59.89 -27.31 66.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.977 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 65.37 28.72 11.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.956 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.69 115.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.049 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -109.65 112.14 24.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.699 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.98 135.49 33.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -149.0 132.08 16.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.1 mt -125.97 154.0 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.49 119.33 0.89 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.33 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -128.18 157.74 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.8 127.86 35.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 32' ' ' PRO . 5.9 m-85 -134.25 154.76 51.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.9 124.79 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.1 tt -119.19 118.44 57.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.053 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.38 156.65 16.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -76.0 170.84 15.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.7 m -62.76 107.1 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.04 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -163.24 91.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.69 135.78 2.59 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.577 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.99 -55.16 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.99 89.46 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.418 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -157.45 -42.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 111.017 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.89 38.43 6.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.915 0.388 . . . . 0.0 110.76 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.4 ttp -161.86 61.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -162.22 99.97 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.89 81.05 0.25 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.435 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.13 148.08 52.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.931 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.59 77.92 1.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.07 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.85 72.35 5.75 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 14' ' ' TYR . 63.3 Cg_endo -73.48 119.24 5.85 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.572 2.182 . . . . 0.0 112.429 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -97.21 143.3 28.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.736 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 t -117.16 157.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.285 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -157.46 132.96 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -134.42 157.34 46.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.747 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 149.45 33.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.4 113.83 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.727 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.49 120.58 34.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.302 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.72 88.59 2.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.65 -127.13 15.72 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.05 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -88.13 19.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.767 2.312 . . . . 0.0 112.792 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CZ3' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -140.11 121.97 15.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.906 0.384 . . . . 0.0 111.173 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 103.95 11.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.661 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 tp -83.89 139.63 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.199 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.04 119.64 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tp -104.66 148.71 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.793 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.94 157.36 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.185 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 114.64 22.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 111.8 22.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.98 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.13 156.98 42.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.55 116.04 16.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.927 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.35 149.36 27.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.56 51.54 3.91 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.696 2.264 . . . . 0.0 112.623 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.2 t 49.03 38.39 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 111.39 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.84 85.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.53 174.32 12.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -76.68 -34.25 58.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 60.52 37.99 19.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.04 -48.23 6.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.466 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -61.22 -74.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -67.61 179.02 1.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.65 49.5 0.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.497 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 p -111.88 92.88 4.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.72 0.295 . . . . 0.0 110.832 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -176.32 96.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.046 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.416 ' CD1' ' HA3' ' A' ' 95' ' ' GLY . 36.8 t80 -149.61 -75.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.53 -165.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.804 0.335 . . . . 0.0 111.141 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -174.73 168.79 1.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.958 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.47 -168.52 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.56 2.173 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.46 165.44 27.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mp -137.04 156.98 47.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.405 ' HA ' ' HA2' ' A' ' 90' ' ' GLY . 0.2 OUTLIER -146.25 152.99 40.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.997 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.9 m -143.6 141.8 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -123.27 110.12 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CE1' ' CZ3' ' A' ' 43' ' ' TRP . 2.2 t80 -96.42 86.92 4.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.32 127.19 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -84.28 -73.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 mp -145.59 143.83 30.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.004 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -104.33 94.86 5.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.721 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -161.47 172.22 16.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.39 -68.3 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.1 -44.02 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.808 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.41 ' CD2' ' HE3' ' A' ' 121' ' ' LYS . 5.8 t80 -178.62 -75.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 p -147.26 159.2 43.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.827 0.346 . . . . 0.0 111.233 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.09 106.76 3.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.78 -146.78 4.47 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mp -143.67 117.7 9.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.662 0.268 . . . . 0.0 110.45 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -79.58 122.33 26.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.25 173.17 17.76 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.42 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 72' ' ' GLU . . . -178.05 156.12 18.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.722 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -142.66 110.3 5.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 110.749 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 133.65 52.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -147.31 140.87 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -146.1 158.22 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 66' ' ' PHE . . . -81.16 -177.9 52.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.181 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.418 ' HB2' ' CB ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -143.69 89.72 2.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -60.23 158.68 11.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -152.82 -48.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.7 m -141.65 -48.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.09 30.29 14.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.403 ' CB ' ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -69.06 -60.8 3.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.862 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 101' ' ' GLU . 62.6 Cg_endo -73.54 -36.46 3.86 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.562 2.175 . . . . 0.0 112.316 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -168.45 -79.68 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.437 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.79 -77.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 110.845 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.74 50.52 12.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.083 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 p -102.87 179.88 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.56 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.418 ' CB ' ' HB2' ' A' ' 96' ' ' TYR . . . -116.79 137.68 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.726 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.33 117.61 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.32 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.25 131.04 55.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.77 137.77 51.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 111.378 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.16 135.85 41.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -104.69 138.53 40.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.142 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 134' ' ' MET . 0.1 OUTLIER -132.0 102.44 5.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.9 pp -139.61 149.47 22.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 175.65 153.02 0.33 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.698 0.285 . . . . 0.0 111.396 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.91 136.96 51.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.659 2.24 . . . . 0.0 112.448 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.9 142.29 50.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.411 ' CE2' ' HA3' ' A' ' 130' ' ' GLY . 29.2 p90 -124.26 122.93 39.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.347 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.39 107.31 14.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 123' ' ' THR . 16.8 t -100.89 112.22 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.41 ' HE3' ' CD2' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -131.16 154.29 48.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.37 27.86 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.395 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.41 ' CG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -83.1 -27.94 29.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.776 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -170.61 -72.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.587 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.95 26.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mp -142.27 148.14 37.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.982 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.4 112.06 25.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.591 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.425 ' CG ' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -98.81 117.35 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -112.7 118.92 36.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 118' ' ' TRP . . . -113.97 109.58 2.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.596 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.86 114.9 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.788 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 33.8 tp -126.96 131.06 51.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.81 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.6 m -136.47 120.9 18.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 3.5 mtm -92.87 120.86 33.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.112 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.35 135.71 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.0 0.429 . . . . 0.0 111.515 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.85 130.47 24.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.47 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.84 149.28 45.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.041 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.88 145.62 12.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -147.17 179.37 7.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.96 -35.55 80.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mp -105.55 39.81 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -58.53 99.43 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.004 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -67.35 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.812 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.1 t -110.49 -33.58 6.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.806 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.7 34.07 60.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.683 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -99.54 168.52 9.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 0.0 110.937 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.68 -175.16 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 62.26 31.54 17.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -93.58 146.84 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.67 170.87 14.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.58 120.09 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.14 99.85 9.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -97.56 127.15 43.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -128.9 97.74 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.1 p -96.4 103.89 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.78 135.87 12.77 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.425 HD11 ' CG ' ' A' ' 128' ' ' PHE . 3.2 mm? -121.39 125.79 47.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -119.07 102.79 9.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -130.11 134.21 47.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.169 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 5.9 p -97.72 142.32 29.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.41 ' CE1' HD11 ' A' ' 167' ' ' LEU . 20.6 m-85 -55.16 -31.13 61.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -137.09 -66.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.641 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.14 74.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 178.44 -62.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 29.8 m -104.02 112.84 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.734 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -105.54 146.71 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.538 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.41 HD11 ' CE1' ' A' ' 161' ' ' PHE . 2.0 mp -93.92 134.2 36.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.323 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 130.16 53.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 m -137.45 100.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.893 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.4 141.88 31.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -121.27 114.56 21.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -92.14 129.53 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.9 101.91 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -107.93 113.02 25.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -140.06 133.25 29.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -157.42 -167.11 18.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -102.24 123.16 45.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 0.0 110.943 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -128.8 119.45 24.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 3.1 mtt -98.9 -31.48 11.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.88 100.06 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -131.67 -66.97 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.1 m -141.44 28.65 1.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.975 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.8 mmt-85 57.23 27.64 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.077 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -178.56 38.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.815 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -171.2 153.68 3.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.99 46.27 0.42 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.429 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -148.17 94.78 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.24 157.71 44.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.83 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.9 t -147.04 140.41 25.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 m -115.45 117.79 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.803 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -121.59 137.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.987 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -137.42 138.17 39.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.749 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.8 mt -126.71 129.75 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.21 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -127.12 137.43 52.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.564 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.59 54.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.283 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -135.55 170.36 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 38.8 mt -149.34 67.16 8.82 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.75 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -44.6 113.85 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.727 2.285 . . . . 0.0 112.653 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.14 129.3 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 16.7 p -136.97 158.15 45.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -143.06 90.61 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.112 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.72 -66.38 2.41 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -131.68 -36.66 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.158 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.74 136.04 56.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 74.4 m -128.06 132.55 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.888 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 240' ' ' TYR . 21.4 t -139.09 119.5 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.025 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -106.58 104.91 52.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.58 155.16 27.69 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.522 2.148 . . . . 0.0 112.309 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.53 131.93 55.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.76 176.02 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.938 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.86 156.36 20.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 31.7 mt -143.5 152.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.142 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.69 -125.2 2.81 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.19 116.55 28.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.93 -28.51 8.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.019 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -40.16 76.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.005 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -78.49 130.55 36.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.2 p -176.18 125.0 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -104.14 130.32 51.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -112.98 140.23 47.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -123.28 -178.34 3.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -92.42 79.71 4.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -123.95 -177.28 3.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.948 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -116.84 31.94 6.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.5 108.09 15.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 15.5 pt -106.28 -35.08 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.114 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -132.63 111.98 11.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.24 153.28 30.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -109.74 85.98 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -121.91 28.76 5.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.551 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -77.84 158.47 29.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.969 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.45 155.08 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.15 118.43 8.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.07 168.99 8.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -99.35 -40.28 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 14.6 p 43.49 42.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.653 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -70.93 150.07 47.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.15 118.77 31.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.836 0.351 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -118.38 119.88 35.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.406 ' CD1' HG21 ' A' ' 206' ' ' VAL . 0.6 OUTLIER -93.84 151.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -151.48 126.86 2.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.459 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -149.0 164.3 34.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -129.42 152.27 49.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.842 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -89.66 8.6 30.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.397 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 58.39 28.22 16.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.865 0.364 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -136.02 22.1 3.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.066 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.25 -24.16 26.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.746 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -89.98 149.38 22.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.662 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.476 ' CB ' ' HB2' ' A' ' 277' ' ' ASN . 0.1 OUTLIER -117.38 166.21 12.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 111.167 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.6 m -151.95 125.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.4 p -129.81 175.33 8.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.66 159.22 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.94 128.47 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -133.8 118.71 18.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -144.31 171.75 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.059 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.54 -178.5 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 60.42 165.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -168.95 99.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.47 170.48 8.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.45 111.52 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -85.23 111.75 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -98.61 -44.31 6.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -143.93 143.3 31.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -97.67 28.28 15.06 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.51 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.85 -48.05 9.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.714 0.292 . . . . 0.0 110.812 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.3 t -82.17 145.54 30.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -168.81 100.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.41 171.51 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -91.4 -31.47 16.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -104.53 143.3 33.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -148.72 -74.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -128.83 -69.53 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -115.81 151.39 18.4 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.468 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 11.0 p -141.63 145.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 111.04 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -129.13 131.98 6.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.54 137.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 249' ' ' SER . 58.5 m-80 -130.07 156.61 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 84.2 m-85 -149.51 137.15 20.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.762 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.21 135.08 26.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.978 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.839 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.792 0.329 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -99.56 31.44 3.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -109.64 32.37 5.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.25 31.45 6.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -135.06 -67.6 0.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.987 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.95 132.9 14.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 38' ' ' ALA . 1.5 t60 -117.87 127.62 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -107.64 120.53 42.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -136.71 131.78 33.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.4 114.82 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.28 116.96 4.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.453 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.93 116.13 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 0.0 111.137 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -102.77 143.73 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -133.16 141.89 48.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -101.78 158.91 15.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 tp -112.99 136.95 47.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -91.98 178.05 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -129.21 129.55 45.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 p -72.83 129.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.012 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -151.25 -68.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.83 100.91 0.63 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.504 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.61 102.24 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 110.956 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.05 -156.6 9.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.506 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.92 150.9 20.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.05 155.14 41.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.1 mmt -110.16 -30.94 7.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -124.25 157.06 35.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.98 122.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.519 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.13 -67.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.779 0.323 . . . . 0.0 110.887 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.37 135.17 40.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 33.8 tt0 -138.64 64.73 37.68 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 31' ' ' GLU . 18.1 Cg_exo -66.56 -162.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.682 2.255 . . . . 0.0 112.297 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -171.87 124.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.41 147.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.28 151.5 47.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -150.13 141.41 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.19 146.71 50.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.097 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' HIS . . . -144.86 113.8 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.797 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.27 117.86 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.299 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -134.65 88.54 2.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 109.759 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.41 -126.69 36.11 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.899 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.83 24.98 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.72 2.28 . . . . 0.0 112.689 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -140.39 110.8 6.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.791 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 16.1 ttt180 -106.67 146.73 30.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.535 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 mt -121.57 111.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.269 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.19 106.69 16.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -104.33 127.92 52.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.03 131.97 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 115.52 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.891 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.41 134.64 54.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -142.28 157.49 44.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -130.42 139.49 50.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.46 166.7 10.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.46 21.34 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.856 2.371 . . . . 0.0 112.861 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t 60.14 63.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.48 143.27 43.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.819 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -100.7 133.05 45.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.0 133.32 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.5 133.66 18.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.121 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.75 -32.87 2.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.35 85.75 1.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.788 0.327 . . . . 0.0 110.911 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 59.62 163.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.906 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.99 159.48 25.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.2 t -97.6 99.47 10.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -150.02 135.74 18.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -161.0 107.27 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.75 125.83 29.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 37.6 mtt180 -128.08 52.67 9.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.054 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.2 Cg_endo -74.69 127.15 10.66 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.471 2.114 . . . . 0.0 112.238 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -112.46 145.78 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.88 120.39 17.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.12 143.01 50.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.012 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 13.2 t -131.84 148.68 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.404 ' HB2' ' CB ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -118.95 135.17 54.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.051 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -135.06 87.31 2.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 138.83 34.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.56 -55.7 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.3 tp -133.66 123.68 25.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -92.79 98.78 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -151.9 122.03 7.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -58.44 -22.85 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -28.56 17.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.963 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -151.79 79.22 1.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.2 150.9 22.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -148.63 119.74 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.759 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.49 150.8 22.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.61 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.83 120.22 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 0.0 110.742 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.0 m -94.61 106.52 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.59 105.64 3.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.377 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.93 147.59 16.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.749 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.01 113.71 18.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.87 111.84 23.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.063 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -133.55 106.82 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.579 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' A' ' 109' ' ' MET . 16.7 p90 -125.27 118.55 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.328 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.36 179.11 9.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.382 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 98' ' ' TYR . 0.8 OUTLIER -150.07 98.2 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 111.011 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -80.19 119.67 23.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.962 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 96' ' ' TYR . 32.2 p90 -156.28 149.51 24.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.831 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.4 t 64.91 158.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.57 -55.36 11.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -122.69 79.66 48.31 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.025 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.84 -38.3 4.28 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.637 2.225 . . . . 0.0 112.342 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.29 -95.8 0.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -96.41 -36.76 10.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.909 0.385 . . . . 0.0 110.831 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.77 -80.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 p -141.4 -174.82 4.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.642 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.61 119.68 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -105.84 124.69 49.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.46 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.417 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 mtt -94.38 129.71 40.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.323 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -95.23 149.54 21.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.04 94.92 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.796 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.53 134.65 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.04 146.57 35.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.26 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 115' ' ' ALA . 1.7 tp -138.28 143.55 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 114' ' ' ILE . . . -126.32 66.28 61.06 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 111.525 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 82.74 2.0 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 111.867 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -92.06 173.16 7.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 40.8 p-90 -155.92 122.92 5.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.809 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -99.85 137.58 38.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.6 m -139.68 117.25 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.8 135.47 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.992 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 pp -115.35 -31.63 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.918 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.1 m -142.49 162.89 34.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.695 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.68 61.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.923 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.09 -48.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.89 109.9 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -112.52 115.12 28.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.424 ' CG ' HD23 ' A' ' 157' ' ' LEU . 3.7 m-85 -91.0 136.7 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.1 118.87 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -118.63 121.21 4.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.224 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -104.93 174.25 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 111.118 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.7 mt -147.72 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.717 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.24 99.89 12.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.045 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.4 ttm -105.93 137.18 44.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.494 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -123.43 150.55 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.102 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -156.09 103.19 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.22 153.36 41.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.65 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -152.09 161.58 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.91 -29.84 68.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.81 -35.45 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.997 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.33 101.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.797 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -68.47 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.65 -33.22 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.28 28.3 70.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.616 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -97.55 86.46 3.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -164.08 90.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.095 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -179.87 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -77.08 125.33 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -100.52 150.76 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.22 126.63 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.15 96.97 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 t -97.5 137.69 36.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -127.05 103.05 7.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 29.6 p -96.38 106.03 18.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 170' ' ' ASN . . . -130.0 167.99 21.52 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.993 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.424 HD23 ' CG ' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -134.36 129.77 35.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.738 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.77 113.33 25.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.42 ' CZ ' HD12 ' A' ' 167' ' ' LEU . 35.4 p90 -130.24 138.08 50.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.07 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER -97.29 143.73 27.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.938 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.2 -45.93 13.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.355 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.65 33.92 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.301 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 52.57 73.96 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.91 -65.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.816 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.9 p -103.87 113.19 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -108.64 136.9 47.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.495 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.42 HD12 ' CZ ' ' A' ' 159' ' ' TYR . 0.8 OUTLIER -93.9 123.61 37.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.475 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.46 122.52 46.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.326 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.47 110.57 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.416 ' HA ' ' CA ' ' A' ' 156' ' ' GLY . 4.2 p-10 -111.04 155.49 22.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 111.658 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.55 120.99 41.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.346 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.91 134.99 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.0 tp -142.04 108.86 5.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -112.24 139.32 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.968 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -137.12 121.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.801 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -86.23 155.15 28.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.572 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -113.72 145.18 41.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.793 0.33 . . . . 0.0 110.844 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -104.16 141.55 36.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 11.3 ttt -131.44 31.26 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -142.7 -47.47 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.004 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.6 118.26 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.26 32.24 2.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.68 31.54 6.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.85 70.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.4 141.61 28.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 59.37 42.07 97.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.521 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.86 -48.86 8.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.85 146.46 6.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.61 142.16 49.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.791 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 132.59 39.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -147.04 110.04 4.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.85 178.49 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.43 132.73 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.12 142.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.73 153.31 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.234 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -160.0 145.54 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.04 79.36 3.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.88 113.52 3.03 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.402 2.068 . . . . 0.0 112.292 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.3 tt -114.36 144.83 42.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.705 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.9 p -138.04 156.23 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.21 90.52 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 109.904 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 66.79 -73.49 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.256 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -123.02 -34.63 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.53 138.0 56.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 48.1 m -128.09 134.44 49.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.417 HG11 ' CE1' ' A' ' 240' ' ' TYR . 18.3 m -146.08 124.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 14.9 p -137.02 104.88 8.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.053 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.82 165.01 15.69 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.693 2.262 . . . . 0.0 112.234 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.423 ' CZ ' ' HA3' ' A' ' 237' ' ' GLY . 47.1 p90 -141.32 133.6 28.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.62 137.64 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.994 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.42 -55.38 3.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.7 pt -107.75 131.46 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.096 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -147.15 96.31 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.447 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 12.3 mt -106.32 36.4 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 110.916 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 61.13 178.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.41 31.92 3.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -146.63 148.48 32.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.53 35.77 20.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.55 -52.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -92.68 91.12 7.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -102.12 -50.45 3.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -78.88 171.95 14.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -108.05 130.8 55.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.29 147.21 23.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.09 101.37 4.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.5 pt -141.34 163.94 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -115.4 -38.67 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 141.15 55.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -175.16 98.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -108.2 -144.09 10.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -117.4 -46.04 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.949 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.75 143.66 32.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.49 168.71 12.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -98.55 87.86 3.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.77 175.67 8.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.3 t 63.64 139.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -76.37 141.15 26.4 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.92 129.73 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.26 102.66 11.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.417 ' CE1' HG11 ' A' ' 206' ' ' VAL . 0.3 OUTLIER -78.69 154.87 29.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.24 132.08 3.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.436 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -148.87 156.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -162.33 93.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . 0.403 ' O ' ' CD2' ' A' ' 244' ' ' PHE . 40.9 t80 -177.31 36.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.062 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.3 -48.5 3.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.617 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -179.0 38.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.47 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.94 -6.0 69.27 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.613 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.5 mp -96.42 153.0 18.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.695 0.283 . . . . 0.0 110.701 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.0 t -103.8 141.13 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.733 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.77 126.9 59.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.345 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.35 117.06 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.4 mt -115.09 124.85 52.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.77 145.28 38.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.32 109.43 8.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -151.72 -172.96 4.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.078 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.45 164.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -125.87 -178.74 4.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -126.69 174.98 8.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 64.91 123.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.24 164.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.812 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -138.53 -178.27 5.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.85 -173.85 2.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -95.45 36.63 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -85.64 -12.09 73.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.763 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 62.01 43.67 8.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.907 0.384 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.5 m -105.74 98.9 8.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -86.55 106.52 17.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.27 103.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.35 83.59 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -85.35 107.05 17.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.947 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.45 -46.3 64.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.844 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.48 176.64 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.089 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 148.51 -172.54 28.7 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.52 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.6 m -129.61 155.73 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -155.54 169.06 33.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 249' ' ' SER . 4.5 m -131.73 116.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.647 0.261 . . . . 0.0 111.056 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 249' ' ' SER . 41.5 t30 -115.74 95.4 5.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 111.255 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 279' ' ' SER . 3.6 t80 -88.56 155.05 19.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.746 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 72.5 m -133.4 146.5 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.916 0.389 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 7' ' ' HIS . 7.3 mt-10 -138.19 40.69 2.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.95 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -135.36 80.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -104.6 -55.01 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -151.37 -57.08 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -149.17 115.1 5.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -114.0 123.33 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.688 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.81 120.39 39.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -127.18 134.32 50.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 pp -134.97 114.12 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.017 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.34 167.65 22.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.594 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.6 118.81 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.25 163.43 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -150.8 107.9 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.24 104.27 10.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.0 mm 60.05 158.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -104.11 -34.23 8.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.855 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -82.37 159.03 23.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -133.6 69.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 61.6 157.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.825 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.55 -118.64 0.76 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.499 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -166.66 -43.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.956 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.14 -142.23 7.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.408 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -135.94 58.46 1.75 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.358 . . . . 0.0 110.824 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -66.59 148.75 51.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.21 -169.18 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.512 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -177.52 81.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.36 69.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.53 179.35 6.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 110.871 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.75 158.49 20.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -114.02 71.97 2.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.34 114.22 3.86 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.589 2.192 . . . . 0.0 112.331 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p -113.42 111.89 22.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.55 152.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.064 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 68.3 m-85 -140.27 136.9 33.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 35' ' ' TYR . 27.6 m-85 -147.15 104.48 3.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -105.28 155.26 19.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.066 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.04 113.74 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.07 116.59 29.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.24 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -134.72 88.47 2.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 109.77 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.81 -123.97 34.8 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.02 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HG2' ' CD1' ' A' ' 43' ' ' TRP . 94.0 Cg_endo -88.63 21.99 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.666 2.244 . . . . 0.0 112.76 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.488 ' CZ2' ' CE1' ' A' ' 75' ' ' TYR . 75.5 m95 -140.09 111.96 7.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.2 103.87 13.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.797 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -84.0 116.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.27 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.97 115.92 22.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 122.41 43.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.6 147.96 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -112.11 119.96 40.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.61 113.2 25.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 152.18 31.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -126.01 151.62 46.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.53 148.62 5.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.03 98.9 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.526 2.15 . . . . 0.0 112.287 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t 61.02 88.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.99 157.85 36.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -160.99 32.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.822 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.6 t -90.26 124.6 35.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.14 79.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.047 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.23 -71.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 -32.32 7.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -98.74 155.7 17.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.28 124.92 7.8 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.523 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -88.03 179.48 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.461 ' CE3' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -59.96 97.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.461 ' CD1' ' CE3' ' A' ' 65' ' ' TRP . 22.1 m-85 60.58 106.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.22 125.55 41.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.38 80.42 63.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.84 134.24 49.13 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.577 2.185 . . . . 0.0 112.046 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -115.73 123.53 48.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.151 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.37 153.83 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -154.01 143.59 21.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 p -147.03 120.43 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' CZ2' ' A' ' 43' ' ' TRP . 15.2 t80 -119.92 105.38 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.699 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -89.71 126.19 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -40.88 20.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.57 122.51 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 103.01 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -160.13 122.35 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.801 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.37 -25.2 33.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.51 -31.26 14.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.952 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -142.24 78.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -102.31 128.13 48.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.74 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.93 104.03 7.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.985 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.62 179.76 21.43 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.469 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tp -158.2 107.92 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.787 0.327 . . . . 0.0 110.788 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 m -75.53 155.96 35.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.65 108.76 0.38 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.46 167.01 19.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -139.94 129.37 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -125.43 149.49 48.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -147.75 97.82 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.27 110.64 20.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.17 174.75 14.35 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.658 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -158.11 149.57 21.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.724 0.297 . . . . 0.0 110.749 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -79.35 -176.48 5.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -120.74 114.03 21.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.0 p -93.14 -29.61 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.068 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.04 -43.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.448 ' CB ' ' HD3' ' A' ' 102' ' ' PRO . 1.2 mt-10 -172.85 -54.61 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.448 ' HD3' ' CB ' ' A' ' 101' ' ' GLU . 35.5 Cg_exo -60.01 139.04 85.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.302 2.001 . . . . 0.0 112.175 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 124.0 39.06 0.51 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.565 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.93 -75.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 0.0 111.051 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -177.71 -74.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.6 m -163.13 129.78 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -176.22 135.88 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.196 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.39 102.35 2.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 mtp -125.82 105.43 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -83.51 135.52 34.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.42 ' HD2' ' CZ ' ' A' ' 137' ' ' PHE . 23.7 ttt180 -143.63 121.85 12.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.88 155.95 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.06 113.71 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.6 142.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.69 107.09 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.32 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.05 93.55 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.336 2.024 . . . . 0.0 112.145 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.85 136.57 51.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.018 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -139.74 122.95 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.98 114.64 14.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.9 124.07 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -109.99 115.74 30.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.732 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 -28.14 18.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.18 -171.75 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.699 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.86 28.72 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.927 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.16 -41.83 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.04 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.25 135.18 52.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -124.86 134.11 52.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.777 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 128' ' ' PHE . 4.8 m-85 -105.14 143.17 33.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -143.82 118.91 10.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.75 120.62 6.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.558 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -128.53 115.0 17.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.17 112.3 25.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.09 101.1 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.9 mtt -120.78 137.99 54.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -146.68 159.88 42.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -140.7 98.93 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 111' ' ' ARG . 1.7 m-85 -79.03 159.4 27.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.68 160.86 26.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.96 100.8 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.35 -68.95 0.16 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.99 40.47 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 19.7 m120 61.06 169.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.01 -69.61 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.5 p -111.5 -33.91 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 93.94 28.16 11.42 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.559 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -72.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -162.05 -74.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.049 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.24 30.08 18.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 m -89.96 116.86 28.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -96.0 127.3 41.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.21 109.61 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.978 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.92 143.09 43.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.44 135.9 53.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -135.13 103.06 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.059 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.4 p -99.71 103.93 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.31 140.61 15.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mp -137.71 125.1 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -119.05 119.84 35.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 159' ' ' TYR . 53.2 p90 -130.14 124.98 33.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 62.4 p -84.83 140.96 30.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.129 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.19 -30.67 43.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -144.59 33.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 60.91 76.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 172.18 -61.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.606 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.6 t -107.49 112.68 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.263 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -107.0 145.29 32.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.988 0.423 . . . . 0.0 111.753 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.72 120.12 33.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.117 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.95 139.2 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.5 m -140.03 100.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.719 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.75 137.91 40.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.088 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -115.66 110.24 18.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.06 109.28 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -99.53 124.66 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.88 35.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 144.25 -153.87 25.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -111.89 129.38 56.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 0.0 110.844 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -114.56 135.61 53.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.46 114.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.82 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.57 117.97 22.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -171.92 -42.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 58.9 p -158.59 33.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.19 103.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.11 -32.22 64.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -176.8 -46.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.9 94.62 0.38 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.5 169.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -162.14 135.99 6.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.0 m -129.86 132.85 46.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.4 m -124.35 157.02 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -146.64 121.04 9.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.48 159.16 31.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 7.8 tp -133.39 113.22 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.145 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 11.4 mmt85 -108.29 152.15 25.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.83 140.04 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.443 ' N ' ' CD1' ' A' ' 196' ' ' TYR . 0.9 OUTLIER -145.42 174.98 10.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.802 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.39 87.24 0.76 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.04 113.71 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.436 2.091 . . . . 0.0 112.298 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.19 126.13 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.744 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.6 t -138.09 154.7 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.521 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.17 90.6 2.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.254 0.55 . . . . 0.0 110.117 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.04 -80.83 1.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.555 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -132.37 39.03 3.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 111.015 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -132.2 141.16 48.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.94 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.6 m -124.47 117.47 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.66 106.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 43.8 p -114.91 104.82 53.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.002 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.0 164.98 22.17 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.579 2.186 . . . . 0.0 112.432 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -121.11 131.91 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.9 p -131.1 157.75 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -110.64 -32.17 6.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.06 -37.65 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 115.53 -42.13 1.98 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.9 155.9 49.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.315 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -97.99 25.91 5.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 55.5 96.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.09 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -144.95 157.15 44.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.64 110.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -142.6 -172.33 3.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -96.3 47.55 1.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 62.25 117.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -169.92 41.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -86.02 -175.41 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 6.9 t0 60.8 107.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.98 -178.35 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 9.2 tp -108.48 115.93 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.43 149.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.6 -61.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -163.34 134.89 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -119.68 -38.48 0.71 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.97 133.17 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.942 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -121.82 134.32 54.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -76.37 -172.16 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.2 m120 68.54 -68.87 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.936 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 60.27 159.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.89 168.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -149.25 165.78 29.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.599 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.17 134.54 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -110.03 109.05 19.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.95 142.72 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -139.99 100.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.417 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.66 118.67 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 111.009 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -134.85 97.98 3.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.777 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.41 37.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.5 -44.18 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.757 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -170.69 34.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.683 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 95.34 -3.54 66.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.742 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 3.5 pp -102.94 153.32 20.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.641 0.258 . . . . 0.0 110.813 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 69.2 m -95.94 151.94 18.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.798 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.87 127.35 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.3 m -135.11 152.28 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.8 mt -141.01 131.08 24.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 127.75 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -142.62 165.49 27.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -110.37 -56.9 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.45 103.38 7.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -95.72 151.93 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.37 -56.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -127.52 139.43 52.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.7 -55.18 4.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -83.21 170.04 15.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -138.65 170.5 15.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -100.71 171.54 7.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -96.9 48.4 1.61 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -151.05 -63.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.09 141.38 45.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.56 171.33 8.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -165.84 159.36 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -123.99 106.58 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -151.02 130.34 12.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -89.62 175.71 7.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -154.77 -179.26 7.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.8 134.51 4.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.605 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.21 128.83 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.318 . . . . 0.0 110.997 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -136.18 152.32 21.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.729 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 20.2 t -140.85 141.7 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 0.0 110.803 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.01 95.53 2.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.058 0.456 . . . . 0.0 111.604 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 7.6 t80 -92.68 120.12 32.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.584 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 p -123.32 146.92 47.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.822 0.344 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 60.41 -170.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -158.37 42.54 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.981 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -142.66 32.59 1.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.88 49.73 0.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -164.2 90.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -116.1 108.42 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -88.0 132.44 34.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -143.73 120.87 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.33 131.01 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.195 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -122.12 128.92 7.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.466 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.04 155.98 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 111.114 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.1 mmt -147.05 121.11 9.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.846 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -141.45 157.23 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -106.98 138.29 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 16' ' ' ILE . 30.3 mt -90.51 136.62 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -118.77 173.17 7.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.61 132.57 39.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.58 178.91 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -162.31 -65.08 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.48 -170.69 14.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.554 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 152.7 39.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.58 124.11 8.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -72.08 -65.92 0.71 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.853 0.359 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.42 131.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.832 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.9 tmm? 60.21 107.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.14 163.08 33.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.36 -116.84 4.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.491 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.25 108.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.766 0.317 . . . . 0.0 110.934 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.91 -69.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -167.65 64.36 0.69 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.54 149.03 67.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.638 2.226 . . . . 0.0 112.353 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.58 144.74 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.54 150.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' A' ' 11' ' ' GLY . 10.4 p90 -146.69 156.68 43.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.76 157.96 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.21 136.4 33.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.72 113.97 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.8 122.79 36.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 43' ' ' TRP . 34.5 t-20 -134.87 88.7 2.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -128.38 14.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.884 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -87.74 15.37 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.559 2.172 . . . . 0.0 113.177 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.425 ' CE2' ' HB3' ' A' ' 40' ' ' ASN . 60.8 p-90 -140.38 110.95 6.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.829 0.347 . . . . 0.0 111.395 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 10.6 ttm105 -102.2 110.59 22.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 tt -83.79 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.463 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.46 122.84 30.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.983 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.45 110.54 20.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.36 160.79 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -136.5 102.46 4.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.46 107.32 18.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.16 150.38 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.33 139.41 52.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.45 64.4 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.29 157.52 59.11 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.634 2.222 . . . . 0.0 112.336 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.07 -32.47 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.94 -173.86 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -112.66 159.18 19.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 m -80.57 164.2 23.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.77 -30.34 61.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.092 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.28 -49.52 0.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.508 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.74 44.07 11.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.956 0.408 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -69.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.958 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.77 -27.64 3.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.6 178.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -130.06 147.64 51.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.95 -26.44 14.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.004 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.81 173.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.911 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.49 170.59 3.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 70.7 Cg_endo -74.8 -167.86 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.612 2.208 . . . . 0.0 112.355 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.51 156.27 36.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.971 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.93 153.95 40.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -162.1 134.55 5.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 12.4 p -128.99 150.06 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -118.66 137.68 53.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.99 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.27 87.51 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -93.0 116.25 28.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 -45.17 50.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 mt -143.43 136.96 28.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -97.97 101.97 13.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.7 148.53 25.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.8 0.85 56.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -111.03 -31.86 6.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -155.42 89.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.007 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.7 134.21 55.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.734 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -129.84 104.21 7.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.03 -175.2 22.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.162 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.16 108.79 2.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -77.7 159.25 29.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.12 91.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.37 152.21 17.36 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 4.3 m-85 -107.73 134.4 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -106.86 127.13 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.145 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -127.09 107.14 9.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.48 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.443 ' HB3' ' CE2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -107.0 128.12 54.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.354 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 107' ' ' ALA . . . -104.92 136.33 13.05 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.486 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 2.4 p90 168.66 173.61 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.963 0.411 . . . . 0.0 111.078 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -128.0 158.01 39.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.636 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -147.57 162.5 38.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.6 m -60.27 -28.04 40.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.37 32.01 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.24 162.15 22.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.44 -34.17 49.92 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.554 2.169 . . . . 0.0 112.208 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.93 90.02 2.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.628 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.12 -73.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 0.0 110.887 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 168.97 -32.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.08 124.82 2.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.674 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.464 ' O ' ' HA2' ' A' ' 95' ' ' GLY . . . -116.43 144.68 43.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.979 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -99.65 125.5 45.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.467 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.7 ttm -107.88 124.78 50.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.344 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -91.38 140.5 29.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -152.97 104.45 2.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.832 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.31 144.6 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -142.06 103.01 4.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.64 153.53 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -161.81 117.55 1.29 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.25 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.11 92.84 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.364 2.043 . . . . 0.0 112.104 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.58 131.75 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -132.14 123.05 26.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.855 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 121.91 38.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.5 111.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -123.49 110.73 15.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -177.22 39.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.1 m -128.95 38.5 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 62.9 84.56 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.227 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 53.95 51.35 14.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.332 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.42 ' CD1' ' CD1' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -142.09 109.1 5.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.876 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.04 118.63 24.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -106.33 111.96 24.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -117.22 161.64 19.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.1 125.51 1.0 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.423 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -147.13 140.35 25.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.6 mp -102.02 98.81 8.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.833 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.08 110.49 11.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.016 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 mtt -92.95 132.3 37.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.69 137.0 45.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -141.28 152.56 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.685 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -125.95 149.42 48.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -157.14 163.32 39.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.92 -171.85 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -58.32 -30.78 66.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.946 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 mt -140.89 -58.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.85 125.77 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.23 -68.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.1 p -112.73 -35.84 5.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 83.93 29.12 32.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.548 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -130.64 -178.74 4.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.58 -76.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.062 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.36 31.01 20.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.62 129.85 41.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -125.21 129.28 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -100.68 137.3 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.03 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -121.01 100.38 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 m -93.82 125.48 38.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.61 105.5 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.1 p -101.42 103.96 14.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.93 148.1 18.89 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.909 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.8 125.42 22.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.69 0.281 . . . . 0.0 110.76 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -112.78 115.02 27.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.085 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.42 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 71.8 t80 -130.16 120.6 24.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.002 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 43.8 p -84.88 140.42 31.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.67 -29.88 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.804 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -161.66 44.35 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 61.52 76.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 176.69 -76.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.677 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.89 113.01 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -109.62 148.02 32.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.566 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.95 137.22 33.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.372 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 121.86 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.99 110.75 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.792 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -107.55 121.54 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.088 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -87.85 116.37 25.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -85.9 139.18 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.03 100.43 3.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.84 131.1 43.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 155.14 47.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.58 167.2 24.0 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.35 121.46 45.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.6 132.24 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 4.0 ttm -120.43 118.67 30.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.59 179.99 5.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -50.16 12.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 m -120.99 -65.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.48 127.54 8.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -72.5 -18.27 61.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.16 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 61.81 41.11 12.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.889 0.376 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.86 63.56 0.19 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -110.62 122.27 47.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.96 -172.95 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.75 129.91 16.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.98 115.99 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -107.22 109.98 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.38 164.96 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.2 137.27 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.304 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.431 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 6.3 mmt-85 -118.34 151.88 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.624 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.73 132.55 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.952 0.406 . . . . 0.0 111.361 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 196' ' ' TYR . 0.7 OUTLIER -141.6 137.68 32.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.566 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.5 tp -109.74 75.07 0.78 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.756 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.03 113.74 3.86 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.734 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.16 156.02 25.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.441 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 34.8 m -138.04 153.26 49.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.531 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 90.41 2.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.282 0.563 . . . . 0.0 110.094 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 60.27 -85.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -117.42 29.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -132.63 130.24 39.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.624 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.02 119.04 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.83 127.2 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 30.0 p -132.55 104.93 13.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.418 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.36 165.09 14.58 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.606 2.204 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.17 131.92 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.145 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.98 123.99 17.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -103.61 -67.27 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -172.1 137.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.982 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 158.77 74.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.502 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.52 40.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.04 100.63 13.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -112.17 168.97 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 64.74 36.84 7.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.6 t -173.88 59.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -138.64 -178.67 5.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -139.16 73.76 1.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 61.4 154.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.97 -58.32 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.58 -40.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.84 -76.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.875 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.88 37.22 26.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 15.5 pt -100.42 -34.61 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 168.4 19.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -38.88 3.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.782 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -90.44 121.63 32.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.13 28.86 4.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.592 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -163.34 89.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -111.42 172.0 7.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -77.93 170.39 16.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.61 -3.47 46.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.325 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.68 -178.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.03 -62.22 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.092 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -161.94 172.03 38.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.516 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.87 137.0 46.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -129.21 123.33 31.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 240' ' ' TYR . 2.9 m-85 -112.24 155.08 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -137.19 110.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.549 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -119.32 114.93 23.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.982 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 124.31 28.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.831 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . 0.436 ' CD2' ' CD1' ' A' ' 248' ' ' LEU . 0.1 OUTLIER -74.03 -10.33 59.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.348 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 62.44 27.24 16.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.818 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -139.24 16.62 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.993 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.11 -24.1 33.64 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.738 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.436 ' CD1' ' CD2' ' A' ' 244' ' ' PHE . 0.2 OUTLIER -94.77 136.69 34.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.66 0.267 . . . . 0.0 110.98 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 277' ' ' ASN . 22.7 t -102.18 157.62 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 0.0 110.952 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.94 122.16 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 m -126.98 134.3 50.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.55 161.77 18.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -139.25 99.25 3.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.21 145.64 27.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . 60.71 82.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -123.85 32.79 5.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.1 152.04 28.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -107.76 131.29 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.7 84.09 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -108.01 127.68 53.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -90.35 98.61 11.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -110.38 -50.0 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -160.84 -46.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 162.93 -29.02 0.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.515 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.25 98.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.841 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -100.13 35.62 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -139.98 174.9 10.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -72.59 153.49 41.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -148.9 117.49 6.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -152.52 122.74 7.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.97 120.9 14.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -146.39 177.9 8.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.051 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -158.9 179.12 34.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.536 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.34 139.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -137.34 -176.09 14.21 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.603 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 15.1 m -149.95 155.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.652 0.263 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 249' ' ' SER . 1.4 t-20 -140.72 95.34 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 279' ' ' SER . 22.8 t80 -88.91 154.93 19.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.847 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 33.7 t -142.5 147.01 35.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.403 ' CD1' ' OH ' ' A' ' 278' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.825 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.863 0.363 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -170.63 118.46 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.12 30.38 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.36 -53.63 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.745 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -157.37 92.03 1.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.726 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.422 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -144.33 111.94 6.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -114.26 105.16 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.415 ' HB3' ' CE1' ' A' ' 280' ' ' PHE . 0.2 OUTLIER -89.95 119.98 30.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -131.11 134.78 46.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.0 mt -118.06 113.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.81 135.83 13.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.599 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.92 129.01 18.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 0.0 110.984 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.0 ttm -122.39 141.72 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 4.5 m-85 -118.38 128.04 54.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -119.41 122.6 42.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.62 112.63 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.047 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -149.27 87.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -84.62 157.75 21.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 m -131.54 177.24 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -91.18 -37.64 13.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.47 -157.99 43.7 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.559 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.07 79.38 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.32 -126.0 6.97 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -125.01 43.41 3.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.337 . . . . 0.0 110.847 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.6 151.39 23.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.816 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.68 166.89 15.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t0 61.75 115.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.38 -47.01 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.531 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.36 122.62 38.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 110.921 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.19 131.71 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.07 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.2 100.61 0.29 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.65 132.55 25.43 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.389 2.059 . . . . 0.0 112.176 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.08 149.0 26.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.39 141.51 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.046 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.9 m-85 -124.78 145.91 49.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.53 109.37 8.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.68 156.8 18.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.232 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -160.13 113.83 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.617 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 6' ' ' TRP . . . -91.89 125.48 36.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.205 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -134.69 88.6 2.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.19 -125.08 26.51 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.31 17.25 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.635 2.223 . . . . 0.0 112.763 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.41 119.45 14.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.912 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.421 ' HB3' ' CG ' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -117.04 109.72 17.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.715 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.3 mt -86.75 141.96 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.82 97.83 3.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 117.44 31.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . . . -117.54 162.85 17.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 18.6 m-85 -125.87 114.69 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.0 111.39 16.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.741 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -147.81 148.88 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.27 158.94 44.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.812 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.36 -150.43 22.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.64 142.28 48.0 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.594 2.196 . . . . 0.0 112.299 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.44 -31.58 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -81.65 168.9 17.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -104.1 174.59 5.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.8 p -75.9 152.35 37.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.16 -53.35 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.18 -80.99 1.04 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -164.89 83.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.14 170.96 4.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.85 153.85 12.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.599 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 m -130.99 114.98 15.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.343 . . . . 0.0 110.831 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.84 -71.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.02 115.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 61.55 -175.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.739 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -170.44 -179.92 0.66 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 26.4 Cg_exo -62.76 -171.17 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.434 2.089 . . . . 0.0 112.196 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.06 144.55 5.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.94 157.03 29.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -147.78 149.56 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.03 148.87 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.421 ' CG ' ' HB3' ' A' ' 44' ' ' ARG . 13.8 m80 -122.86 126.36 47.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -107.28 101.45 10.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -87.46 102.17 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -78.8 -54.99 5.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.28 124.02 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.02 95.08 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.802 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -130.72 142.83 50.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.81 -22.03 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.202 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -117.51 11.33 13.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -176.47 71.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.63 116.05 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.821 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.92 123.0 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.961 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.08 163.64 22.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -158.13 107.87 2.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 0.0 110.696 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 15.7 p -89.75 159.09 17.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.62 107.22 0.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.77 -176.91 14.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.733 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -129.1 132.59 47.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.798 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -113.66 125.81 54.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -96.12 99.93 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -97.74 106.01 18.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.53 -170.19 38.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.515 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -151.13 154.54 37.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.971 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.9 176.29 5.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -106.87 173.43 6.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.4 p -98.19 -31.95 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.096 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.3 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.36 100.32 7.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.56 100.86 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.447 2.098 . . . . 0.0 112.343 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -136.08 -70.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.468 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.53 30.92 4.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -136.81 68.56 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.22 126.43 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.894 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -171.76 129.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -143.11 100.53 3.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 mtm -125.21 134.13 52.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.8 145.02 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.56 117.56 10.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.59 150.39 24.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.69 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.05 106.51 4.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.5 mt -110.31 145.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.63 84.93 11.84 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.406 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.74 90.63 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.646 2.231 . . . . 0.0 112.144 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -62.99 111.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.89 122.96 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.46 122.1 25.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.48 123.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 125.47 52.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.88 -41.85 6.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.1 p -156.22 -177.48 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.63 58.59 4.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -179.09 -49.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.94 105.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -108.83 129.09 55.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.25 144.5 26.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -142.62 122.42 13.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.99 125.09 6.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -131.62 116.85 17.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.98 98.98 8.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 99.94 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.9 140.64 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -145.56 155.63 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.44 107.02 3.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -96.17 130.88 43.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.012 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.78 179.72 7.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -132.21 170.88 14.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.19 -32.0 66.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mt -65.01 -34.28 78.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 60.15 91.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.1 p -88.42 -60.18 2.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.3 p -106.88 -36.04 6.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.006 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 79.71 1.03 86.36 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.839 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.71 86.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.357 . . . . 0.0 110.817 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -145.46 130.9 18.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.0 t70 60.18 81.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -85.14 144.74 28.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.67 115.93 31.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.82 103.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -123.6 130.15 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.019 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.0 m -102.8 142.87 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.799 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.22 106.58 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 m -100.62 103.95 15.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.811 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.02 135.13 12.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.759 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.81 124.55 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 0.0 110.79 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.18 119.32 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.206 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -130.07 110.56 11.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.952 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.418 ' CG2' ' HB1' ' A' ' 166' ' ' ALA . 28.8 p -84.6 125.77 32.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -60.99 -29.31 69.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -155.96 41.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.141 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 57.59 76.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 168.78 -64.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.504 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.6 m -103.91 112.98 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HB1' ' CG2' ' A' ' 160' ' ' THR . . . -121.15 161.65 21.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.882 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.3 138.72 41.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.064 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 113.63 26.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.74 100.84 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.509 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -95.38 140.7 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.325 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.77 116.76 27.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.92 136.72 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.8 tp -142.02 94.94 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -96.35 118.07 32.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 122.38 16.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -142.45 -174.14 14.77 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -130.1 129.12 43.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.926 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -136.14 144.37 45.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -174.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -120.68 90.59 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.61 94.28 5.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.5 t 60.63 31.24 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -147.22 -178.56 6.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -151.26 37.59 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.79 32.9 2.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -65.95 -52.5 36.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.477 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -82.71 114.94 21.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 110.824 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -157.29 174.72 15.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.4 p -150.13 102.31 3.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.4 t -92.84 159.06 15.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.37 141.69 32.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.976 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.44 178.99 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 44.3 pt -148.25 136.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.289 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -134.39 138.94 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.727 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -110.01 137.77 47.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.48 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 196' ' ' TYR . 2.1 m-85 -135.63 175.09 9.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.85 72.64 0.92 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 0.0 111.017 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.84 113.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.469 2.113 . . . . 0.0 112.252 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.23 127.27 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 51.7 m -138.12 146.61 43.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.276 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 95.4 mt -140.04 90.24 2.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.214 0.53 . . . . 0.0 109.993 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.46 -65.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.467 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -143.54 35.6 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.732 0.301 . . . . 0.0 110.828 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -117.66 146.05 43.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.9 t -127.96 109.23 11.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.997 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.68 107.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.7 m -129.88 104.9 16.9 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.16 161.06 41.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 112.267 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -129.59 134.7 47.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.4 m -129.95 133.55 46.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.1 mtp85 -90.12 -36.39 14.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 29.4 mm -110.79 103.65 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.9 157.75 17.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.48 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.28 174.54 8.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.857 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -100.29 -177.79 3.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.97 37.54 1.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -170.27 113.77 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.759 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 74.9 m 60.28 82.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -82.8 -32.62 27.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.911 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.6 176.69 11.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -107.6 92.42 4.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER 60.3 98.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.99 119.62 38.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -102.33 -177.64 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.42 149.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.0 tt -109.79 -25.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -87.19 173.88 8.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.68 122.16 44.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -107.81 32.49 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.46 134.75 8.16 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.453 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 163.8 12.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.875 0.369 . . . . 0.0 110.984 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -65.61 160.38 22.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -72.15 119.86 16.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.779 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.49 175.51 10.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 91.95 3.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m -106.19 176.85 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -128.92 132.66 7.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 mt -122.4 122.93 40.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 251' ' ' SER . 2.4 t80 -102.42 117.08 33.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -120.89 144.93 48.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 163.55 -156.43 28.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.575 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -149.06 166.09 29.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -156.33 140.41 16.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 64.08 44.71 4.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -94.06 -44.35 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -155.24 37.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 278' ' ' TYR . . . 90.07 -13.32 65.1 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.702 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.7 OUTLIER -118.95 137.07 53.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 7.8 t -97.5 161.28 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.526 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.3 m -145.95 133.5 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.277 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 239' ' ' PHE . 13.7 m -130.81 136.99 49.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 116.38 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -96.31 134.3 39.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.18 157.17 47.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -141.14 -57.38 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -88.83 -75.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 60.04 31.6 20.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -137.01 119.56 15.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -170.91 -174.55 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -138.38 38.38 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -146.62 75.63 1.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.88 -33.76 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 61.62 87.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 130.54 -46.75 1.06 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.401 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 4.4 t70 60.44 37.7 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.319 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.55 -65.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.17 165.44 13.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.91 60.21 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.22 120.92 31.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.936 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.7 173.73 3.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -86.17 88.18 7.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -140.82 170.7 15.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -97.59 144.5 17.34 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.409 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.7 t -129.26 148.0 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.044 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -164.39 161.26 34.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 30.9 m -144.44 159.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.167 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.29 95.2 2.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.015 0.436 . . . . 0.0 111.374 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' A' ' 247' ' ' GLY . 3.4 t80 -88.86 110.6 21.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.651 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 5.4 p -109.13 142.76 39.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 8' ' ' PHE . 3.0 p90 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.758 0.313 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.63 -68.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -142.33 79.67 1.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -161.15 34.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -59.69 -40.42 87.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.735 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.74 110.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 111.99 16.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.497 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -96.97 132.54 42.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 111.12 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -115.65 122.86 46.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.766 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.445 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 20.2 mm -105.97 113.88 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.28 154.63 19.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.12 135.68 14.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtp -125.12 144.15 50.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.41 140.56 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -118.11 119.23 34.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.52 140.73 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -149.33 -46.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -87.3 170.36 11.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.87 138.64 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.162 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.17 163.53 40.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.97 60.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.51 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 60.37 87.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.39 -120.17 1.39 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.15 31.13 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 0.0 110.835 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -163.3 169.99 18.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -30.99 21.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 162.81 14.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.66 -23.86 6.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.609 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 62.16 97.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.771 0.32 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.38 -74.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.057 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.411 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 2.5 tt0 -165.65 64.22 0.94 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 31' ' ' GLU . 31.1 Cg_exo -61.65 123.53 12.87 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.606 2.204 . . . . 0.0 112.251 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.3 108.69 18.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.24 142.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.049 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.41 128.43 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.445 ' CE2' ' CD1' ' A' ' 10' ' ' ILE . 1.1 t80 -143.62 114.69 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 1.9 m120 -106.7 164.64 11.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.305 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.55 113.77 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.568 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.86 121.92 40.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.601 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.74 88.48 2.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.3 -126.33 28.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.923 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.91 19.23 1.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.683 2.255 . . . . 0.0 112.814 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -140.15 110.89 6.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.74 0.305 . . . . 0.0 111.058 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -116.42 111.79 20.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.615 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pt -92.67 148.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.356 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . . . -141.01 109.4 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.047 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.44 135.55 38.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.54 146.03 45.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.51 122.48 47.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -118.55 111.33 18.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.26 167.43 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -136.38 157.75 46.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.12 79.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.44 118.47 5.71 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.52 2.146 . . . . 0.0 112.33 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.1 m 42.8 34.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.9 96.5 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -65.93 -70.33 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 t -154.26 155.22 34.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.54 -58.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.42 -27.71 4.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.528 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.51 67.61 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.92 -46.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.86 -120.37 1.74 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.544 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.6 p -146.39 -71.85 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.44 -44.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -146.75 166.25 27.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -127.94 90.73 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -108.01 82.36 1.46 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.64 -166.37 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.52 2.147 . . . . 0.0 112.053 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -158.83 134.18 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -137.03 105.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.758 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.49 158.31 17.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 m -140.73 157.02 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.94 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -128.67 117.51 21.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.042 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -127.62 105.12 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -106.74 109.69 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.007 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -37.06 56.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.52 132.76 49.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.809 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -129.8 111.92 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.977 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -162.02 168.54 22.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.05 15.32 17.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -119.08 -43.09 2.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.765 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -159.32 92.78 1.09 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 t -87.0 150.07 24.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -130.31 104.02 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.13 177.59 17.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.37 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.08 107.81 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 64.8 m -77.04 155.34 32.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.7 79.5 0.21 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.537 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.91 129.95 10.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -120.05 120.11 35.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 0.0 110.737 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -127.83 139.9 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -131.13 129.51 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -112.23 128.13 56.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.07 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 135.48 172.03 12.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.652 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.3 t80 179.95 177.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 39.83 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -58.89 165.68 2.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.58 100.67 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.094 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -179.21 90.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.942 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.413 ' CB ' ' CD ' ' A' ' 102' ' ' PRO . 1.3 mt-10 -60.58 -61.14 8.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 101' ' ' GLU . 38.7 Cg_endo -66.91 -18.1 52.1 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.476 2.118 . . . . 0.0 112.468 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.7 36.1 4.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.535 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.9 mttt 62.38 120.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -129.78 22.36 5.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 p -163.19 124.96 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.819 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -168.91 141.76 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -156.56 99.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.2 ttp -116.83 157.63 25.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 143.04 48.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -139.96 116.71 10.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -88.12 130.21 35.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 108.14 9.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.71 147.38 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.69 107.81 3.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.71 94.32 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.31 2.007 . . . . 0.0 112.033 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.48 102.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -107.42 123.0 47.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.72 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.46 123.16 32.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.957 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.78 106.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 154.55 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -4.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.408 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 m 63.53 31.91 14.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.65 -73.86 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.71 24.62 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.004 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.11 100.49 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -106.75 128.34 54.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 157' ' ' LEU . 0.1 OUTLIER -117.06 130.71 56.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.439 ' ND2' ' CE2' ' A' ' 131' ' ' TRP . 0.2 OUTLIER -128.64 126.68 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.34 130.87 10.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.585 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.439 ' CE2' ' ND2' ' A' ' 129' ' ' ASN . 37.3 m95 -125.62 129.15 49.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.5 mp -128.8 102.36 6.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.694 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.0 p -84.62 113.06 21.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.11 116.94 31.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.715 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.74 143.84 33.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 98.97 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.44 145.49 35.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.956 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.07 170.12 19.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.07 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 61.77 178.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.5 t70 68.8 -67.83 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.57 -40.4 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -77.21 108.5 10.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -52.14 65.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m -107.53 -32.13 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.39 32.48 75.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.393 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.91 158.72 19.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.855 0.359 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.37 171.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.26 78.5 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.821 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.2 p -111.82 137.24 50.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.11 133.43 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.04 129.82 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -136.03 115.97 13.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.1 m -96.46 137.87 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.78 107.83 9.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.61 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.717 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.97 132.24 11.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.447 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 3.4 mp -109.84 127.34 54.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.718 0.294 . . . . 0.0 110.737 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.21 111.57 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.029 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -130.16 116.51 18.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.253 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.415 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 15.9 p -84.8 134.48 34.31 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.956 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -60.76 -31.01 70.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -162.9 44.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.32 72.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 177.96 -73.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.757 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.64 112.97 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.415 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -114.97 158.75 21.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.046 0.45 . . . . 0.0 111.89 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.04 141.86 32.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.043 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.87 108.89 15.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.113 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.2 m -109.23 100.94 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -92.41 145.96 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 108.0 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.627 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -85.94 141.31 29.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.997 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 mt -141.75 99.94 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.784 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 123.2 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -133.56 144.43 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -152.03 154.71 25.71 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.566 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -116.19 121.33 41.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.92 160.07 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.13 35.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.995 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -103.78 112.73 25.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.21 39.19 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 m -127.41 -51.04 1.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -38.1 7.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.3 m120 60.06 29.86 19.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -121.55 30.04 6.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -118.68 27.39 7.21 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.71 125.69 17.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -142.28 162.3 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.03 108.01 19.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.38 107.83 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 123.81 35.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.45 158.03 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.772 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 tt -132.44 140.11 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -134.29 137.88 44.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -104.92 149.79 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -156.22 172.03 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.722 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.39 86.94 0.23 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.43 113.47 3.14 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.374 2.049 . . . . 0.0 112.408 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mp -114.39 132.82 56.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.735 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 67.4 p -138.04 155.78 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.3 mp -143.23 90.58 2.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.247 0.546 . . . . 0.0 110.04 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.79 -65.48 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.457 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.43 59.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -153.09 140.62 19.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.3 t -128.06 115.72 18.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.059 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.12 128.47 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 71.4 p -136.47 104.87 9.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.222 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.49 126.03 2.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.707 2.271 . . . . 0.0 112.134 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 30.4 p90 -112.78 137.6 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.887 0.375 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 40.2 p -129.55 142.4 50.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.735 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 63.76 136.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 29.6 mt -143.22 -47.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.165 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 98.58 170.32 31.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.14 44.47 12.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -131.77 57.36 1.77 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.824 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.6 ttm105 -98.91 36.05 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -145.44 110.67 5.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.808 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.72 -64.2 1.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -162.53 -55.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.4 ' CE3' ' HA ' ' A' ' 220' ' ' TRP . 1.1 m95 -145.13 98.36 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -117.92 130.41 56.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -154.82 155.18 33.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -68.51 93.16 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -169.64 99.8 0.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.66 145.78 55.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.09 173.69 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -127.97 30.81 5.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.87 -31.32 11.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.874 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 -170.13 0.25 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.736 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 136.26 44.18 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.535 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -156.51 113.69 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -97.62 103.62 15.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.73 -20.64 65.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.05 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 22.9 t30 67.58 141.02 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.85 0.357 . . . . 0.0 110.804 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.09 113.52 26.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.9 m -150.06 149.66 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -138.56 141.01 11.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.477 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.11 122.03 36.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.952 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.9 150.48 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.825 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 147.63 44.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.52 126.93 1.99 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.457 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.406 ' CE2' ' O ' ' A' ' 243' ' ' ASP . 49.0 t80 -148.77 162.9 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.099 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.406 ' O ' ' CE2' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -117.69 153.46 33.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -97.17 -38.36 9.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.975 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -177.32 49.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 61.06 98.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 126.01 -24.36 5.71 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.559 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.9 OUTLIER -102.73 135.93 43.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.461 ' CB ' ' HB3' ' A' ' 277' ' ' ASN . 0.3 OUTLIER -117.43 113.95 22.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.095 0.474 . . . . 0.0 112.105 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.82 117.18 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.9 m -127.75 169.39 13.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 111.253 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.24 129.75 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.67 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.91 123.16 46.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -127.5 107.62 10.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -141.32 158.81 43.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.87 89.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -93.36 114.8 27.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 60.64 158.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.814 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -99.38 169.3 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -176.43 -174.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.06 -177.94 3.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.812 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.38 128.54 37.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -134.66 -58.94 0.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 61.81 44.76 97.43 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.72 -49.49 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -32.0 7.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -120.41 135.56 55.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.62 159.0 15.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -124.17 129.06 50.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -70.17 -49.1 53.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 65.79 -76.76 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -167.19 105.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.069 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -80.28 123.21 5.98 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.316 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 6.2 m -110.63 124.68 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -117.88 131.86 9.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.08 123.08 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . 0.461 ' HB3' ' CB ' ' A' ' 249' ' ' SER . 33.0 t30 -125.6 156.45 39.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 7.0 m-85 -149.89 155.41 39.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.894 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.94 147.1 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.678 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.749 0.309 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -78.0 -31.12 50.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.816 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -60.81 -47.37 86.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 61.4 47.41 6.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.23 -28.91 57.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -157.38 95.36 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -117.36 109.98 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.24 119.98 29.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -128.06 130.22 47.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mt -115.62 137.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 131.17 6.33 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.571 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.87 128.41 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 0.0 111.062 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.88 128.96 54.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -145.91 163.92 33.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -112.05 134.96 53.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.4 tp -105.98 148.63 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.038 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -145.05 130.09 18.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.14 -163.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -96.09 31.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -134.69 30.39 3.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.02 27.65 3.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -123.4 72.34 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.34 -128.65 6.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.486 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -60.1 169.21 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.945 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -118.27 115.96 25.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 44.8 mmm -115.26 -40.11 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -165.47 114.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.53 114.94 3.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.477 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tp -154.15 135.7 14.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.52 -177.8 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp0 -126.68 51.18 5.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.097 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 82.2 Cg_endo -77.48 115.19 3.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.537 2.158 . . . . 0.0 112.228 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -136.68 125.44 23.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.167 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.0 t -101.72 162.32 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.66 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -155.71 135.4 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.369 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.47 155.81 49.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.352 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.12 155.41 39.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.219 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.93 113.86 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.576 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.9 117.76 29.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.83 88.58 2.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.5 -128.15 26.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.82 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.38 21.92 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.649 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -140.26 112.76 7.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.43 104.68 14.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.82 133.26 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.343 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.22 124.0 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.903 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.98 112.44 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.084 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.26 161.45 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.856 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.05 115.58 24.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -123.65 121.17 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -151.31 141.18 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.833 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -131.03 144.31 51.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.18 158.52 14.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.54 80.49 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.485 2.123 . . . . 0.0 112.326 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t 59.77 93.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -107.94 -47.84 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 59.75 27.06 16.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.978 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.85 -179.22 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.11 -73.94 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.33 57.38 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.3 45.13 11.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -116.47 114.31 24.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' A' ' 98' ' ' TYR . . . 76.35 -156.23 46.56 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.58 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.1 p 53.41 82.66 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.347 . . . . 0.0 111.152 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.418 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 81.6 m95 -102.5 25.97 8.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' A' ' 65' ' ' TRP . 3.9 m-85 -163.78 -58.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.869 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -82.8 100.34 10.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.459 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 168.85 -61.8 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 83.5 Cg_endo -83.76 176.77 6.7 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.801 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -161.93 131.06 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mt -110.21 150.24 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.201 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.02 127.35 3.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 t -128.01 154.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -124.03 148.21 47.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -135.54 143.73 45.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.9 102.17 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.52 -66.28 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -125.4 133.34 52.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -120.13 106.48 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -146.86 172.17 14.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.14 15.35 10.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.431 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 4.2 m-20 -114.26 -44.99 3.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 83' ' ' PHE . 15.5 p90 -166.95 101.55 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -92.93 133.85 35.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.745 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.59 107.78 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.146 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.84 175.18 19.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.203 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 tp -158.12 107.93 2.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 0.0 110.936 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 m -79.02 155.87 28.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.29 105.04 0.24 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.567 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.36 174.9 20.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.383 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -129.85 144.12 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -122.46 117.74 26.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -105.0 112.25 25.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -125.83 100.0 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.84 154.14 18.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.426 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.5 159.44 21.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.23 170.36 2.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.422 ' CE1' ' HA3' ' A' ' 63' ' ' GLY . 14.2 m-85 -160.99 90.79 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t 69.03 -67.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -154.14 -50.12 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.122 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -157.75 96.98 1.94 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.072 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.75 -43.34 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.474 2.116 . . . . 0.0 112.239 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.12 -26.8 2.17 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.29 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 165.32 30.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 110.768 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.46 92.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t -163.05 132.22 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.31 168.12 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.038 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -142.5 117.83 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.2 mtt -136.46 119.17 16.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -111.21 141.23 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.785 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.56 124.28 12.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.981 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -85.53 146.08 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.8 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -128.18 107.94 10.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.169 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.8 pt -131.3 150.72 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.3 105.69 1.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.43 93.61 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.434 2.089 . . . . 0.0 111.938 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.03 149.38 41.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -147.34 123.02 10.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.69 118.74 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.06 114.03 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -106.15 128.18 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.86 -32.82 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.01 -175.35 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -88.88 53.54 2.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -176.78 -50.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.4 mt -82.03 104.11 12.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -112.64 116.37 30.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -90.95 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -137.43 127.48 25.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.37 125.18 6.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -123.09 121.77 36.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.921 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 mp -116.37 99.03 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.5 120.6 24.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.9 mtp -128.65 129.1 45.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.8 133.07 52.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -115.92 157.41 24.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 148' ' ' ASP . 40.9 p90 -108.54 154.11 22.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -165.03 178.54 6.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 65.56 -70.78 0.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -118.62 81.34 1.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.63 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 pp -84.01 46.89 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -114.97 34.83 4.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.6 m -81.77 -70.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -36.04 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.977 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 74.7 27.3 65.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.545 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -113.13 -73.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -137.94 -53.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.415 ' HB2' ' CE1' ' A' ' 137' ' ' PHE . 4.2 m-20 59.18 29.22 18.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 p -99.08 110.76 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 126.04 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.0 m -145.97 100.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.08 121.32 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.0 m -104.39 126.75 51.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -126.37 107.81 10.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.123 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.5 p -99.08 103.87 15.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.11 148.36 16.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.805 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mt -133.03 118.39 18.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -108.71 113.27 26.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -130.11 118.4 21.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.5 OUTLIER -92.28 131.48 37.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.752 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.82 7.52 26.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.693 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.04 28.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.766 0.317 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.407 ' HA ' HG23 ' A' ' 160' ' ' THR . 14.6 mm-40 51.52 64.94 1.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.112 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 178.54 -64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.85 113.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.813 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -119.03 151.97 37.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.8 mp -93.92 133.44 37.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.265 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.9 ttp85 -109.05 107.02 17.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.047 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.49 107.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.712 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -103.37 145.23 30.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.46 121.76 42.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.583 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.89 125.16 33.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.5 tt -142.02 94.82 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.748 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -126.58 148.95 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -140.1 151.04 45.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 143.15 -172.58 24.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.91 121.45 42.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.333 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.38 154.47 49.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.5 ptp -73.88 120.9 20.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.63 169.64 11.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -119.91 31.55 6.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 m -149.29 -46.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.35 109.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -142.7 -48.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -86.53 99.87 11.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.74 -27.86 6.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -142.99 57.04 1.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.393 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.99 168.52 26.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 m -99.15 142.53 30.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.2 m -79.03 110.96 14.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.12 131.76 54.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.55 156.99 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -116.15 131.36 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -129.23 117.96 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.08 149.11 23.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.407 ' OH ' ' CE2' ' A' ' 209' ' ' TYR . 52.5 m-85 -155.11 142.54 19.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.1 mt -136.24 71.99 60.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.1 113.72 3.15 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.29 157.16 23.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.9 p -136.62 138.08 40.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.16 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.48 89.81 2.45 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.359 0.6 . . . . 0.0 109.983 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 45.93 81.24 0.04 OUTLIER Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.884 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.85 40.22 16.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -152.05 97.57 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 41.5 m -96.84 142.74 28.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 97.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -105.01 104.75 48.46 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.087 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.81 164.94 17.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.624 2.216 . . . . 0.0 112.387 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.407 ' CE2' ' OH ' ' A' ' 196' ' ' TYR . 3.5 m-85 -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.2 m -139.1 150.45 45.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -142.06 45.91 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.092 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.2 pt -113.86 -33.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.175 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 48.04 27.97 5.49 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.801 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 mt -131.99 127.82 37.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.963 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -87.47 100.34 12.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -102.56 126.31 49.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.81 87.08 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 80.7 p -93.65 -60.23 1.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 60.94 31.28 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.803 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -83.3 -31.67 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.18 85.06 7.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -61.25 -32.08 71.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.16 -179.16 7.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -65.49 -46.27 80.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.91 164.28 26.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.6 pp -139.65 166.78 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.64 -45.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -109.85 104.73 13.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -126.03 136.04 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -148.5 63.39 0.42 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.51 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.97 -175.06 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.837 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -146.76 33.22 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.946 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.43 159.09 13.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.91 -170.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -107.86 135.49 49.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.943 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 m -104.91 -177.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.021 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -101.07 168.34 20.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.588 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.1 128.2 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.5 98.1 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.98 134.72 38.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -125.81 114.56 2.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.577 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.75 110.18 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -137.13 -173.46 3.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.962 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 66.2 45.42 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -108.65 -34.85 6.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.732 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.1 32.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.688 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 96.23 -24.36 30.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.6 148.87 25.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.632 0.254 . . . . 0.0 110.613 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.401 ' HB3' ' CB ' ' A' ' 277' ' ' ASN . 28.4 t -95.93 167.44 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.746 0.307 . . . . 0.0 110.948 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -149.28 117.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.5 m -138.92 147.1 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 5.1 mp -121.11 123.5 42.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 131.6 53.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -131.2 124.96 31.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -148.67 32.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.132 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -82.24 98.55 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.75 -49.74 73.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.98 171.3 8.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -104.65 131.27 52.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -123.96 166.59 15.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.952 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -131.82 -62.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.54 149.53 33.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 60.69 109.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 115.11 33.52 1.64 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -92.13 -34.61 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.8 t -82.15 91.44 6.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -131.45 -56.76 1.01 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -117.92 179.04 4.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -105.7 34.47 3.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.88 151.3 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -134.14 177.27 7.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -160.11 175.04 13.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.078 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.02 -129.9 5.9 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.46 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.05 148.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -135.18 141.32 12.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.537 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 14.0 t -115.25 145.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . 0.401 ' CB ' ' HB3' ' A' ' 249' ' ' SER . 1.8 t-20 -147.41 95.55 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -88.43 140.27 29.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.0 p -124.67 131.52 53.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.937 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 66.31 118.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 110.821 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -114.15 119.72 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -88.0 128.86 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.52 135.46 40.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 10' ' ' ILE . 4.5 tt -155.83 126.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.27 22.21 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.47 121.33 7.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.134 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -104.88 159.38 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.8 0.333 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.64 151.95 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -148.33 142.08 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -149.82 143.91 25.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -146.38 161.56 40.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.411 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.19 113.83 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -94.99 116.18 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.553 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.82 88.56 2.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.704 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -126.61 35.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.031 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.66 23.14 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.0 112.689 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.442 ' CH2' ' HB ' ' A' ' 73' ' ' VAL . 14.8 t-105 -140.42 110.85 6.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 26.7 mtp180 -108.37 108.77 19.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mt -83.85 120.62 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.138 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . . . -125.32 121.69 34.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.17 113.18 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.09 146.73 43.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.21 117.43 34.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.09 120.88 43.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -152.36 123.0 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.826 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.425 ' CB ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.794 0.33 . . . . 0.0 110.932 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 68' ' ' ARG . 73.5 Cg_endo -76.27 -179.61 5.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.446 2.098 . . . . 0.0 112.326 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.2 167.34 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.95 149.12 50.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.805 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.82 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -147.55 140.28 24.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 89' ' ' GLY . 15.4 m -142.11 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -112.78 139.35 48.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 111.102 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -138.04 104.27 5.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.77 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -95.31 111.01 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.11 -52.71 57.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 mt -129.37 145.35 51.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.69 94.95 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.72 130.38 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.39 -23.68 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.832 ' O ' HG23 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -77.77 -44.65 26.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -151.48 80.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.3 123.93 33.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -106.75 115.8 30.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -125.54 165.9 18.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.57 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.24 107.89 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.285 . . . . 0.0 110.533 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.867 HG22 ' HB3' ' A' ' 115' ' ' ALA . 9.0 t -105.85 107.83 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -101.38 123.44 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.244 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 153.64 17.42 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.778 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.77 126.63 53.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -109.95 134.7 51.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.957 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -125.91 121.74 34.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.786 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.26 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.384 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.78 154.94 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -108.45 125.19 51.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.75 139.7 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -108.36 134.2 51.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -143.34 129.21 19.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -90.87 148.45 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.736 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -142.09 103.71 4.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.6 144.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.867 ' HB3' HG22 ' A' ' 88' ' ' THR . . . -140.87 93.28 8.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.317 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 41.7 Cg_exo -56.81 87.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.172 . . . . 0.0 112.072 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 98.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -107.86 122.92 47.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.796 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -128.17 127.19 42.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 82' ' ' ASP . 10.0 p -145.06 127.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 141.0 29.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.27 -32.31 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.813 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.52 177.88 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.16 54.52 3.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.5 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 159' ' ' TYR . 1.2 mp -99.37 141.86 31.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.2 144.0 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 155' ' ' THR . 5.6 t80 -115.65 133.31 56.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -129.8 159.33 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.02 113.56 0.59 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.21 118.96 30.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.95 102.56 12.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 t -76.06 112.96 13.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.5 mtt -116.55 118.01 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.751 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -111.35 131.95 54.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.24 105.4 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.669 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -71.85 142.96 49.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.55 137.27 15.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.031 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.954 -179.896 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.772 0.32 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 57.0 m -127.58 122.42 33.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.14 133.18 43.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 151' ' ' VAL . 10.9 p -141.71 116.59 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.06 121.69 30.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.5 t -95.05 138.8 32.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.47 117.61 18.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.502 HG23 ' CE1' ' A' ' 128' ' ' PHE . 26.0 m -105.14 103.91 13.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.02 135.78 12.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.573 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.433 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 1.1 tp -131.05 115.01 15.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -114.64 110.89 20.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.51 ' HB3' HD23 ' A' ' 126' ' ' LEU . 2.5 p90 -130.01 125.0 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -98.88 138.16 36.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.045 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.45 -50.66 30.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.384 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -150.83 53.62 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.448 ' C ' HG22 ' A' ' 164' ' ' THR . 8.1 tt0 61.55 76.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 179.89 -76.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.495 ' H ' HG23 ' A' ' 164' ' ' THR . 19.3 m -103.91 112.8 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.557 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.507 ' HB2' ' HB ' ' A' ' 160' ' ' THR . . . -112.56 140.65 47.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.86 129.94 40.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.393 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -102.51 132.53 48.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 169' ' ' VAL . 5.9 m -132.18 103.72 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -103.26 127.82 50.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.32 110.98 23.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.79 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.33 139.33 30.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.02 94.97 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.95 138.17 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.962 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -140.04 138.08 35.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.479 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.778 0.323 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 m -101.52 128.55 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.942 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -119.43 117.49 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -105.73 136.41 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 194' ' ' ARG . 3.7 mt -97.06 154.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.034 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 193' ' ' ILE . 23.6 mtt180 -147.06 117.02 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.401 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -110.85 137.2 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.003 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.49 173.82 13.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.904 HD12 HD11 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -175.18 80.35 0.31 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.669 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.7 ' HA ' HG22 ' A' ' 207' ' ' THR . 35.7 Cg_endo -65.25 113.86 2.61 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.556 2.171 . . . . 0.0 112.541 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.904 HD11 HD12 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -114.21 155.86 25.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -137.99 156.97 47.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.673 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.31 90.54 2.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 61.25 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.5 31.54 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -140.25 136.39 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.4 m -117.39 139.89 50.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 206' ' ' VAL . 9.6 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.992 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 198' ' ' PRO . 10.0 p -121.81 104.66 38.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.765 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.56 165.06 18.48 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.597 2.198 . . . . 0.0 112.406 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -120.5 139.67 52.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.53 HG23 HG13 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -143.21 159.29 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 210' ' ' THR . 26.0 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.808 0.337 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.74 145.85 42.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 4.0 mp -118.06 113.37 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -116.38 106.38 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -90.87 146.73 23.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -132.77 111.37 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.017 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 250' ' ' VAL . 76.5 m-85 -104.5 166.22 10.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.249 0.547 . . . . 0.0 111.503 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.133 -179.889 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 3.0 pp . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.9 t -95.85 123.51 39.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.96 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.662 ' HA ' HG12 ' A' ' 276' ' ' VAL . 40.1 t -105.82 116.92 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.798 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 16.0 m -108.03 152.07 24.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.169 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 253' ' ' GLU . 0.1 OUTLIER -133.91 142.11 47.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.585 ' H ' HD13 ' A' ' 252' ' ' LEU . 2.7 tt0 -118.43 128.58 54.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.09 123.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -144.93 145.4 14.71 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.138 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 250' ' ' VAL . 29.6 m -126.39 159.15 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.487 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 249' ' ' SER . 9.8 m120 -148.12 95.53 2.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.176 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 4.3 t80 -88.55 121.29 30.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.79 138.7 37.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.451 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.1 m0 -91.42 113.15 25.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.25 152.05 37.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.93 119.94 20.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.633 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.81 139.8 48.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.065 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mm -121.8 113.75 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.864 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.51 143.52 15.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.2 125.79 8.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.312 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.64 120.68 42.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.972 0.415 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 35' ' ' TYR . 19.2 t -134.27 158.71 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.466 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -141.75 151.6 43.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.053 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -145.08 146.63 31.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.64 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.92 157.39 45.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 111.197 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -167.22 113.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' TRP . . . -90.78 126.16 35.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.836 0.351 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -134.77 88.57 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.82 -126.2 31.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.65 21.35 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.682 2.255 . . . . 0.0 112.864 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -140.14 112.8 8.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' CB ' ' A' ' 74' ' ' HIS . 0.3 OUTLIER -94.62 112.88 24.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.515 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.0 mm -83.99 118.36 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -131.61 119.54 21.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.923 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -121.25 155.0 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 47' ' ' LEU . . . -145.94 147.78 32.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.042 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -100.97 113.68 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.11 122.84 48.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -156.52 138.34 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.866 0.365 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.8 -160.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.871 2.381 . . . . 0.0 112.278 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -153.47 132.69 12.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.92 154.61 19.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.765 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 5.7 tt0 -157.09 134.79 10.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 m -135.94 148.13 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -117.27 130.36 56.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 87' ' ' LEU . 1.2 t80 -127.12 100.69 6.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -91.6 113.58 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -72.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -114.92 128.49 56.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -96.16 102.11 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -156.04 163.59 39.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.26 16.37 15.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.13 -43.02 2.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.882 0.372 . . . . 0.0 110.878 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.435 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 96.5 m-85 -146.0 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.75 112.75 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 83' ' ' PHE . 56.9 m-85 -114.91 121.31 42.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.043 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -140.26 -173.35 13.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.347 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.8 pp -158.15 124.27 4.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.0 m -99.95 98.96 9.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.57 134.76 11.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.49 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.13 162.76 26.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.632 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.95 121.47 42.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.861 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 118.44 36.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.984 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -110.75 98.05 7.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -113.4 126.94 55.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.47 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.768 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.95 144.39 8.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -150.66 104.37 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.7 mtt -130.8 129.56 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.21 150.48 22.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -147.22 121.28 9.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.106 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -91.24 122.77 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 108.25 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.23 146.34 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.65 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 91.04 7.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.493 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 34.3 Cg_exo -57.51 86.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.961 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.12 106.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.258 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -107.35 132.64 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.495 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -138.32 128.59 25.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.201 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.2 100.87 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 156.22 40.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.47 29.05 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -32.85 11.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.598 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.9 -78.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -164.09 25.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp -142.33 152.4 42.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -102.53 111.11 23.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.619 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.95 137.93 31.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.88 118.91 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -105.01 139.85 14.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.53 120.28 16.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.77 98.97 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.846 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.4 t -87.47 110.11 20.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.719 ' HG3' HG22 ' A' ' 151' ' ' VAL . 1.8 ttp -112.12 122.88 48.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -105.24 128.79 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -108.37 98.92 8.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.54 128.56 33.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.54 135.12 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.3 p30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 t -137.09 142.08 42.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.403 ' NH1' ' HB3' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -133.59 113.01 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.812 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.719 HG22 ' HG3' ' A' ' 134' ' ' MET . 29.0 t -102.35 137.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.045 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.49 118.74 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 m -97.18 136.51 37.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.01 101.47 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.7 m -94.99 108.41 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -107.63 134.45 12.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.699 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.3 mt -119.61 124.69 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.765 0.317 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -112.96 121.08 43.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -130.08 108.41 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.028 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.996 HG23 ' HB2' ' A' ' 166' ' ' ALA . 0.8 OUTLIER -84.75 126.57 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.871 0.367 . . . . 0.0 110.953 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -52.5 -27.41 16.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.79 49.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 57.24 58.94 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.9 m -165.3 -73.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.72 112.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.412 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.996 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -117.83 153.16 33.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.1 0.476 . . . . 0.0 111.848 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.2 tt -100.01 138.09 37.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.998 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -112.49 125.89 54.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.305 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 169' ' ' VAL . 9.1 p -123.02 103.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.586 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -97.36 134.7 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.03 25.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.461 ' C ' HD12 ' A' ' 173' ' ' LEU . 0.2 OUTLIER -85.82 132.64 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.248 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 172' ' ' TYR . 5.0 mp -142.14 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.643 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -88.71 123.79 33.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 112.93 8.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.838 0.351 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.39 120.48 39.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -122.14 129.07 51.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.26 173.78 9.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.742 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.41 139.27 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -127.87 143.98 51.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.69 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -152.76 168.66 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.9 tt -176.62 85.41 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.524 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.82 113.67 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.39 2.06 . . . . 0.0 112.672 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.0 mt -114.47 116.16 28.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.387 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.806 HG22 ' HA ' ' A' ' 205' ' ' SER . 29.2 p -129.49 158.21 39.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 110.83 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 201' ' ' LEU . 9.6 tp -143.1 90.5 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.182 0.515 . . . . 0.0 109.997 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.83 -73.86 2.49 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.417 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -125.93 -35.07 2.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.715 0.293 . . . . 0.0 111.347 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -65.34 135.09 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.806 ' HA ' HG22 ' A' ' 200' ' ' THR . 13.2 t -128.1 115.85 19.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.038 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.34 119.48 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 207' ' ' THR . 5.0 t -122.68 104.76 36.24 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.208 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.19 161.83 39.92 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.693 2.262 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.43 ' CZ ' ' HA3' ' A' ' 237' ' ' GLY . 43.7 p90 -150.39 142.63 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.017 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.4 m -137.34 143.3 41.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 236' ' ' VAL . 12.2 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.812 0.339 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.43 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -98.65 159.75 20.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.467 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.5 mt -144.45 129.95 18.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.828 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 253' ' ' GLU . 0.7 OUTLIER -112.28 99.15 7.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.914 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -84.58 151.91 24.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -164.64 106.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.476 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.2 155.09 40.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.804 179.835 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 278' ' ' TYR . 1.9 mm? . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.511 0.196 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.476 ' O ' HG13 ' A' ' 276' ' ' VAL . 43.1 t -95.7 166.69 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.906 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.88 117.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 24.5 t -122.58 132.46 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.83 121.48 34.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.426 ' HG2' ' CE1' ' A' ' 239' ' ' PHE . 7.9 mt-10 -96.66 106.16 18.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 274' ' ' VAL . 12.6 p -132.34 124.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -122.32 150.85 16.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.596 HG11 HD12 ' A' ' 248' ' ' LEU . 21.3 t -125.77 125.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.289 . . . . 0.0 111.181 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 249' ' ' SER . 8.1 m-20 -127.57 95.25 4.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.122 0.487 . . . . 0.0 111.235 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.767 ' HB2' HD13 ' A' ' 248' ' ' LEU . 2.3 t80 -88.7 125.74 34.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.727 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.9 141.46 45.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.9 m95 179.79 81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -110.77 111.56 22.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.71 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -91.21 126.09 36.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 37' ' ' ASN . 3.0 m-20 -131.98 127.31 36.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.56 122.93 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.26 160.82 13.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.99 129.27 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.4 ttm -109.92 132.95 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.851 0.357 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 35' ' ' TYR . 18.7 t -105.43 157.04 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.437 ' N ' HG12 ' A' ' 34' ' ' VAL . 7.0 m-85 -141.47 147.52 38.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.016 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.58 114.07 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.622 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.402 ' CB ' ' HB2' ' A' ' 9' ' ' ASN . 0.4 OUTLIER -111.72 153.13 26.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -156.69 113.93 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.846 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -98.67 122.46 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.315 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -134.8 88.45 2.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.99 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.68 -123.19 32.0 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.234 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.68 25.29 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -140.11 110.74 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.61 157.31 15.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.61 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 27.1 mm -126.38 134.75 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.141 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -141.14 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 tt -116.73 115.97 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.34 142.71 50.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -97.91 120.59 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.014 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -112.92 106.81 15.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.99 162.13 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.753 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' CD ' ' HD2' ' A' ' 69' ' ' PRO . 12.5 mmt180 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.772 0.32 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.419 ' HD2' ' CD ' ' A' ' 68' ' ' ARG . 92.9 Cg_endo -84.54 -166.88 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.87 2.38 . . . . 0.0 112.375 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -146.67 123.63 11.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 155.13 17.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -162.05 128.36 3.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 89' ' ' GLY . 28.9 m -129.84 157.11 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -121.25 145.13 48.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -125.27 128.39 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.74 102.27 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.949 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.84 -73.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.56 120.35 41.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -97.3 107.34 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' H ' ' HG ' ' A' ' 84' ' ' SER . 22.0 t30 -159.55 142.75 14.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.46 -13.4 59.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.701 ' O ' HG23 ' A' ' 120' ' ' VAL . 8.3 t0 -100.17 -42.75 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.988 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -141.37 87.5 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.454 ' HG ' ' H ' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -108.72 159.05 17.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -145.03 137.96 26.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.816 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -148.46 141.3 8.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.599 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.987 HD21 HG23 ' A' ' 114' ' ' ILE . 5.9 tt -120.69 122.46 40.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 0.0 110.784 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.688 ' HB ' ' HB3' ' A' ' 115' ' ' ALA . 20.8 m -102.66 117.14 34.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.826 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -109.06 116.05 4.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.448 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -130.5 147.08 18.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.6 134.93 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 -106.0 132.67 51.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -137.81 115.18 11.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -140.49 148.02 40.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.787 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.545 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.771 0.32 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -166.03 148.03 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.59 100.01 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.6 mtt -118.61 142.64 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 9.9 tt0 -132.53 133.33 43.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.7 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -135.76 129.66 32.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.049 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -85.94 142.89 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.585 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -127.19 133.05 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.448 . . . . 0.0 111.317 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.987 HG23 HD21 ' A' ' 87' ' ' LEU . 10.7 mt -131.48 143.48 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.41 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.688 ' HB3' ' HB ' ' A' ' 88' ' ' THR . . . -139.93 66.0 31.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.856 ' HD3' HG22 ' A' ' 114' ' ' ILE . 68.7 Cg_endo -74.24 65.99 5.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.41 2.073 . . . . 0.0 111.506 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 131' ' ' TRP . 2.8 p30 -80.47 179.48 7.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.491 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -152.88 123.85 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.527 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.85 128.71 35.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 82' ' ' ASP . 7.6 p -145.14 100.93 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.24 152.67 48.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.156 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.65 32.78 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.37 -45.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -167.38 -42.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.426 ' HG ' ' CE1' ' A' ' 159' ' ' TYR . 2.0 mt -82.81 121.84 27.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -123.11 139.83 53.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.63 ' HB2' HG13 ' A' ' 120' ' ' VAL . 61.6 m-85 -134.55 138.36 44.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -152.19 118.96 5.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.23 114.34 4.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.431 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 117' ' ' ASP . 10.9 m0 -104.94 124.97 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 0.0 111.09 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.48 ' O ' HD23 ' A' ' 132' ' ' LEU . 8.6 tt -109.24 105.62 15.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 116.68 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.955 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.657 ' HG2' HG12 ' A' ' 151' ' ' VAL . 0.4 OUTLIER -96.88 118.99 34.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -104.23 119.92 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.001 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.401 ' HA ' HG22 ' A' ' 149' ' ' THR . 0.0 OUTLIER -123.93 145.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.435 ' H ' HG22 ' A' ' 149' ' ' THR . 0.2 OUTLIER -104.81 151.76 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -164.8 150.34 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.903 0.382 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 137' ' ' PHE . 71.7 p -102.98 109.57 21.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.016 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -146.57 170.99 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.657 HG12 ' HG2' ' A' ' 134' ' ' MET . 35.6 m -118.52 148.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -125.03 138.63 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.638 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 34.3 m -93.92 145.35 24.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.124 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -136.88 98.99 3.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.81 108.0 20.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.455 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -110.29 141.93 16.43 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.583 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 156' ' ' GLY . 10.5 mp -123.61 130.5 52.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.767 0.318 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.408 ' CG ' ' HG3' ' A' ' 168' ' ' ARG . 5.3 mt-30 -117.55 113.22 21.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.426 ' CE1' ' HG ' ' A' ' 126' ' ' LEU . 27.4 t80 -130.16 116.8 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.822 HG23 ' HB2' ' A' ' 166' ' ' ALA . 9.4 p -84.72 137.23 33.35 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.13 -38.61 91.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -149.93 42.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 61.72 70.82 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 175.75 -64.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.729 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.588 ' H ' HG23 ' A' ' 164' ' ' THR . 27.5 m -103.98 112.77 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -118.01 150.48 39.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.111 0.482 . . . . 0.0 111.818 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.81 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.225 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.408 ' HG3' ' CG ' ' A' ' 158' ' ' GLN . 0.4 OUTLIER -115.0 114.62 25.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 169' ' ' VAL . 8.6 p -116.94 100.91 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.581 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.67 133.98 42.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.182 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -103.2 112.31 25.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.502 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.83 137.99 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.1 tt -141.74 94.92 2.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.632 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.41 144.67 25.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.76 157.03 47.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.776 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.536 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.83 0.348 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 10.7 m -96.71 118.17 32.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -122.06 110.84 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -119.84 147.6 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 193' ' ' ILE . 7.3 tp -112.51 120.02 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.433 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 0.1 OUTLIER -106.28 132.03 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -110.26 148.61 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 194' ' ' ARG . 89.4 m-85 -153.4 175.11 13.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.425 HD23 HD11 ' A' ' 199' ' ' LEU . 14.4 tp -172.29 71.32 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.69 113.7 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.425 HD11 HD23 ' A' ' 197' ' ' LEU . 1.1 mt -114.27 151.31 33.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.739 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 204' ' ' HIS . 1.0 OUTLIER -138.11 157.85 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.731 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 13.0 tp -143.28 90.65 2.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.19 0.519 . . . . 0.0 110.144 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.71 -65.43 0.63 Allowed Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.408 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -148.49 32.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' HIS . . . . . 0.7 ' O ' HG22 ' A' ' 200' ' ' THR . 58.0 m80 -123.92 154.99 38.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.2 m -128.06 128.25 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.54 112.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.6 t -125.74 105.01 26.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.056 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.74 ' HB3' HD23 ' A' ' 238' ' ' LEU . 85.8 Cg_endo -78.3 165.07 26.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.528 2.152 . . . . 0.0 112.306 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.42 136.2 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.029 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.67 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 27.1 m -136.46 146.58 46.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.803 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.837 0.351 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -74.49 156.78 50.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.74 HD23 ' HB3' ' A' ' 208' ' ' PRO . 34.2 mt -147.03 106.06 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.94 128.85 38.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.21 144.96 30.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -141.34 122.15 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -123.27 137.83 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.389 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.618 HD11 HG11 ' A' ' 276' ' ' VAL . 2.8 tt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.688 0.28 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.727 ' O ' HG13 ' A' ' 276' ' ' VAL . 33.2 t -102.21 165.75 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.65 117.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 18.9 p -109.48 164.3 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.445 ' CD2' ' CE2' ' A' ' 254' ' ' TYR . 0.2 OUTLIER -145.58 136.31 24.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.4 113.83 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' TYR . . . . . 0.445 ' CE2' ' CD2' ' A' ' 252' ' ' LEU . 1.2 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.386 -0.286 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.03 141.76 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -126.44 179.12 16.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 249' ' ' SER . 22.7 t -153.96 140.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.679 0.276 . . . . 0.0 110.976 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 249' ' ' SER . 5.5 t-20 -148.09 95.31 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 111.394 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 280' ' ' PHE . 13.0 t80 -92.71 154.99 17.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.661 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.42 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 12.6 p -143.04 146.71 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.449 ' HB2' ' CE1' ' A' ' 278' ' ' TYR . 44.2 t80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.956 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.73 0.3 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.69 115.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.049 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.782 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.4 m80 -109.65 112.14 24.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.699 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.98 135.49 33.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -149.0 132.08 16.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.596 HG23 ' CE1' ' A' ' 36' ' ' PHE . 22.1 mt -125.97 154.0 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.49 119.33 0.89 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.33 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -128.18 157.74 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.8 127.86 35.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.732 0.301 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 35' ' ' TYR . 15.3 t -117.16 157.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.285 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 34' ' ' VAL . 2.5 m-85 -157.46 132.96 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CE1' HG23 ' A' ' 10' ' ' ILE . 67.6 m-85 -134.42 157.34 46.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.747 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 149.45 33.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.616 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -150.4 113.83 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.727 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -94.49 120.58 34.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.302 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.72 88.59 2.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.65 -127.13 15.72 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.05 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -88.13 19.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.767 2.312 . . . . 0.0 112.792 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CZ3' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -140.11 121.97 15.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.906 0.384 . . . . 0.0 111.173 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 103.95 11.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.661 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.616 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 3.2 tp -83.89 139.63 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.199 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.868 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -139.04 119.64 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tp -104.66 148.71 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.793 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.94 157.36 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.185 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 114.64 22.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 111.8 22.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.98 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.13 156.98 42.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.927 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.69 0.281 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.47 -168.52 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.56 2.173 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.46 165.44 27.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mp -137.04 156.98 47.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.868 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -146.25 152.99 40.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.997 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.55 HG23 ' HA3' ' A' ' 89' ' ' GLY . 16.9 m -143.6 141.8 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -123.27 110.12 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CE1' ' CZ3' ' A' ' 43' ' ' TRP . 2.2 t80 -96.42 86.92 4.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.32 127.19 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.809 ' HB3' HD12 ' A' ' 78' ' ' LEU . 14.1 m-85 -84.28 -73.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 77' ' ' PHE . 3.8 mp -145.59 143.83 30.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.004 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -104.33 94.86 5.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.721 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -161.47 172.22 16.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.39 -68.3 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.598 ' HB3' HG13 ' A' ' 120' ' ' VAL . 1.6 m-20 -119.1 -44.02 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.808 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.415 ' CD2' ' HE3' ' A' ' 121' ' ' LYS . 5.8 t80 -178.62 -75.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 p -147.26 159.2 43.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.827 0.346 . . . . 0.0 111.233 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.09 106.76 3.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.78 -146.78 4.47 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.403 HD23 ' HG3' ' A' ' 116' ' ' PRO . 1.2 mp -143.67 117.7 9.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.662 0.268 . . . . 0.0 110.45 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -79.58 122.33 26.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.64 ' HA2' HG22 ' A' ' 114' ' ' ILE . . . -108.25 173.17 17.76 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.42 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 72' ' ' GLU . . . -178.05 156.12 18.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.722 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -142.66 110.3 5.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 110.749 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 133.65 52.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -147.31 140.87 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -146.1 158.22 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.181 179.769 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.688 0.28 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.79 137.68 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.726 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.33 117.61 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.32 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.25 131.04 55.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.77 137.77 51.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 111.378 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.16 135.85 41.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -104.69 138.53 40.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.142 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 134' ' ' MET . 0.1 OUTLIER -132.0 102.44 5.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.64 HG22 ' HA2' ' A' ' 89' ' ' GLY . 2.9 pp -139.61 149.47 22.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.939 ' HB3' ' O ' ' A' ' 132' ' ' LEU . . . 175.65 153.02 0.33 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.698 0.285 . . . . 0.0 111.396 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HG3' HD23 ' A' ' 87' ' ' LEU . 22.0 Cg_exo -64.91 136.96 51.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.659 2.24 . . . . 0.0 112.448 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.9 142.29 50.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.431 ' CE2' ' HA3' ' A' ' 130' ' ' GLY . 29.2 p90 -124.26 122.93 39.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.347 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.39 107.31 14.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 82' ' ' ASP . 16.8 t -100.89 112.22 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.415 ' HE3' ' CD2' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -131.16 154.29 48.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.37 27.86 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.395 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.587 HG21 ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -83.1 -27.94 29.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.776 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -170.61 -72.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.587 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.95 26.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mp -142.27 148.14 37.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.982 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.4 112.06 25.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.591 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.496 ' CD2' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -98.81 117.35 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -112.7 118.92 36.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 118' ' ' TRP . . . -113.97 109.58 2.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.596 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.86 114.9 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.788 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.939 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 33.8 tp -126.96 131.06 51.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.81 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.6 m -136.47 120.9 18.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.831 ' HG3' HG12 ' A' ' 151' ' ' VAL . 3.5 mtm -92.87 120.86 33.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.112 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.35 135.71 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.0 0.429 . . . . 0.0 111.515 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.85 130.47 24.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.47 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.84 149.28 45.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.041 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.88 145.62 12.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -93.58 146.84 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.67 170.87 14.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.831 HG12 ' HG3' ' A' ' 134' ' ' MET . 3.7 m -141.58 120.09 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.14 99.85 9.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -97.56 127.15 43.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -128.9 97.74 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.1 p -96.4 103.89 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.714 ' C ' HD22 ' A' ' 157' ' ' LEU . . . -104.78 135.87 12.77 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.714 HD22 ' C ' ' A' ' 156' ' ' GLY . 3.2 mm? -121.39 125.79 47.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -119.07 102.79 9.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.616 ' O ' HD12 ' A' ' 167' ' ' LEU . 19.0 p90 -130.11 134.21 47.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.169 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.801 HG22 ' HB2' ' A' ' 166' ' ' ALA . 5.9 p -97.72 142.32 29.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.446 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 20.6 m-85 -55.16 -31.13 61.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.09 -66.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.641 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.14 74.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.538 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER 178.44 -62.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 165' ' ' VAL . 29.8 m -104.02 112.84 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.734 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.801 ' HB2' HG22 ' A' ' 160' ' ' THR . . . -105.54 146.71 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.538 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 159' ' ' TYR . 2.0 mp -93.92 134.2 36.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.323 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 130.16 53.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 169' ' ' VAL . 12.1 m -137.45 100.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.893 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.4 141.88 31.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -121.27 114.56 21.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -92.14 129.53 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.9 101.91 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -107.93 113.02 25.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -140.06 133.25 29.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 m -115.45 117.79 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.803 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -121.59 137.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.987 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -137.42 138.17 39.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.749 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.8 mt -126.71 129.75 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.21 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -127.12 137.43 52.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.564 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.59 54.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.283 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.645 ' O ' HD23 ' A' ' 197' ' ' LEU . 23.6 m-85 -135.55 170.36 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 196' ' ' TYR . 38.8 mt -149.34 67.16 8.82 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.75 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -44.6 113.85 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.727 2.285 . . . . 0.0 112.653 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.14 129.3 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 205' ' ' SER . 16.7 p -136.97 158.15 45.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -143.06 90.61 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.112 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.72 -66.38 2.41 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -131.68 -36.66 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.158 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.74 136.04 56.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.419 ' HA ' HG22 ' A' ' 200' ' ' THR . 74.4 m -128.06 132.55 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.888 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.41 HG22 ' CD1' ' A' ' 240' ' ' TYR . 21.4 t -139.09 119.5 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.025 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -106.58 104.91 52.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.58 155.16 27.69 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.522 2.148 . . . . 0.0 112.309 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.53 131.93 55.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.76 176.02 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.938 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 236' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.976 0.417 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -70.93 150.07 47.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 238' ' ' LEU . 5.2 mp -120.15 118.77 31.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.836 0.351 . . . . 0.0 110.913 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 251' ' ' SER . 9.1 t80 -118.38 119.88 35.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.41 ' CD1' HG22 ' A' ' 206' ' ' VAL . 0.6 OUTLIER -93.84 151.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -151.48 126.86 2.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.459 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -149.0 164.3 34.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.842 179.908 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.648 0.261 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 277' ' ' ASN . 0.1 OUTLIER -117.38 166.21 12.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 111.167 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.6 m -151.95 125.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 239' ' ' PHE . 2.4 p -129.81 175.33 8.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 273' ' ' GLY . 0.3 OUTLIER -149.66 159.22 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.94 128.47 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 12.5 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.55 ' O ' HD23 ' A' ' 252' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' A' ' 252' ' ' LEU . 11.0 p -141.63 145.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 111.04 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -129.13 131.98 6.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 16.2 m -109.54 137.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ASN . . . . . 0.494 ' HB2' ' CB ' ' A' ' 249' ' ' SER . 58.5 m-80 -130.07 156.61 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 84.2 m-85 -149.51 137.15 20.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.762 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.21 135.08 26.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.978 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.839 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.751 0.31 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.95 132.9 14.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.892 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.5 t60 -117.87 127.62 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -107.64 120.53 42.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 37' ' ' ASN . 2.7 m-20 -136.71 131.78 33.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.4 114.82 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 277' ' ' ASN . . . -109.28 116.96 4.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.453 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -117.93 116.13 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 0.0 111.137 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -102.77 143.73 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.83 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.763 0.316 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.41 147.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.5 t80 -138.28 151.5 47.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -150.13 141.41 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 9' ' ' ASN . 0.7 OUTLIER -134.19 146.71 50.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.097 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.682 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -144.86 113.8 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.797 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -104.27 117.86 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.299 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -134.65 88.54 2.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 109.759 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.41 -126.69 36.11 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.899 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.83 24.98 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.72 2.28 . . . . 0.0 112.689 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -140.39 110.8 6.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.791 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 73' ' ' VAL . 16.1 ttt180 -106.67 146.73 30.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.535 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 3.0 mt -121.57 111.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.269 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -110.19 106.69 16.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 45' ' ' ILE . 3.8 mm? -104.33 127.92 52.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . . . -135.03 131.97 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 115.52 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.891 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.41 134.64 54.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -142.28 157.49 44.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 37.6 mtt180 . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.2 Cg_endo -74.69 127.15 10.66 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.471 2.114 . . . . 0.0 112.238 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 6.6 mt-10 -112.46 145.78 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.88 120.39 17.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -124.12 143.01 50.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.012 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 44' ' ' ARG . 13.2 t -131.84 148.68 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.545 ' CD2' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -118.95 135.17 54.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.051 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -135.06 87.31 2.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 138.83 34.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.56 -55.7 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.3 tp -133.66 123.68 25.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -92.79 98.78 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -151.9 122.03 7.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -58.44 -22.85 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -28.56 17.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.963 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -151.79 79.22 1.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.2 150.9 22.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -148.63 119.74 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.759 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.49 150.8 22.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.61 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HB2' HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -130.83 120.22 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 0.0 110.742 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.545 HG23 ' CD2' ' A' ' 74' ' ' HIS . 3.0 m -94.61 106.52 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.59 105.64 3.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.377 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.93 147.59 16.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.749 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.01 113.71 18.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.87 111.84 23.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.063 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -133.55 106.82 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.579 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' A' ' 109' ' ' MET . 16.7 p90 -125.27 118.55 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.328 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.382 179.769 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.761 0.315 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.61 119.68 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -105.84 124.69 49.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.46 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.433 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 mtt -94.38 129.71 40.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.323 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -95.23 149.54 21.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.04 94.92 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.796 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.53 134.65 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.04 146.57 35.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.26 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' A' ' 87' ' ' LEU . 1.7 tp -138.28 143.55 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 88' ' ' THR . . . -126.32 66.28 61.06 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 111.525 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 82.74 2.0 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 111.867 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -92.06 173.16 7.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 40.8 p-90 -155.92 122.92 5.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.809 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -99.85 137.58 38.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.671 HG23 ' HB2' ' A' ' 128' ' ' PHE . 22.6 m -139.68 117.25 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.8 135.47 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.992 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 123' ' ' THR . 3.9 pp -115.35 -31.63 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.918 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.619 ' N ' HD12 ' A' ' 122' ' ' LEU . 43.1 m -142.49 162.89 34.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.695 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.439 ' N ' HG22 ' A' ' 123' ' ' THR . 3.3 t70 -74.68 61.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.09 -48.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.459 HD22 ' HE1' ' A' ' 128' ' ' PHE . 3.5 mt -84.89 109.9 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -112.52 115.12 28.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.671 ' HB2' HG23 ' A' ' 120' ' ' VAL . 3.7 m-85 -91.0 136.7 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.1 118.87 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -118.63 121.21 4.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.224 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -104.93 174.25 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 111.118 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.7 mt -147.72 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.717 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.24 99.89 12.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.045 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.42 ' HB3' HG22 ' A' ' 114' ' ' ILE . 3.4 ttm -105.93 137.18 44.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.494 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -123.43 150.55 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.102 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -156.09 103.19 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.22 153.36 41.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.65 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.788 0.328 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -77.08 125.33 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -100.52 150.76 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.22 126.63 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.15 96.97 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 t -97.5 137.69 36.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -127.05 103.05 7.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 29.6 p -96.38 106.03 18.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.513 ' O ' HD23 ' A' ' 157' ' ' LEU . . . -130.0 167.99 21.52 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.993 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -134.36 129.77 35.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.738 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.77 113.33 25.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.638 ' OH ' HD11 ' A' ' 167' ' ' LEU . 35.4 p90 -130.24 138.08 50.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.07 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER -97.29 143.73 27.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.938 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.2 -45.93 13.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.355 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.65 33.92 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.301 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.683 ' O ' HG23 ' A' ' 164' ' ' THR . 2.6 mt-10 52.57 73.96 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.085 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.1 OUTLIER 177.91 -65.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.816 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 165' ' ' VAL . 11.9 p -103.87 113.19 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -108.64 136.9 47.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.495 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.638 HD11 ' OH ' ' A' ' 159' ' ' TYR . 0.8 OUTLIER -93.9 123.61 37.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.475 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.46 122.52 46.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.326 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.47 110.57 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' A' ' 156' ' ' GLY . 4.2 p-10 -111.04 155.49 22.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 111.658 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.55 120.99 41.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.346 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.91 134.99 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.0 tp -142.04 108.86 5.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -112.24 139.32 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.968 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -137.12 121.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.801 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.572 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.84 0.352 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 132.59 39.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -147.04 110.04 4.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.85 178.49 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.43 132.73 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.12 142.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.548 ' HB3' ' CB ' ' A' ' 210' ' ' THR . . . -106.73 153.31 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.234 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -160.0 145.54 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -157.04 79.36 3.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.563 ' HA ' HG22 ' A' ' 207' ' ' THR . 42.1 Cg_endo -67.88 113.52 3.03 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.402 2.068 . . . . 0.0 112.292 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 200' ' ' THR . 1.3 tt -114.36 144.83 42.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.705 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.616 ' N ' HD23 ' A' ' 199' ' ' LEU . 5.9 p -138.04 156.23 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.21 90.52 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 109.904 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 66.79 -73.49 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.256 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -123.02 -34.63 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.53 138.0 56.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 48.1 m -128.09 134.44 49.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 240' ' ' TYR . 18.3 m -146.08 124.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 198' ' ' PRO . 14.9 p -137.02 104.88 8.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.053 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.82 165.01 15.69 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.693 2.262 . . . . 0.0 112.234 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.435 ' CZ ' ' HA3' ' A' ' 237' ' ' GLY . 47.1 p90 -141.32 133.6 28.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.548 ' CB ' ' HB3' ' A' ' 195' ' ' ALA . 0.4 OUTLIER -114.62 137.64 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.994 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.3 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.435 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -76.37 141.15 26.4 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.92 129.73 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.26 102.66 11.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.408 ' CD1' HG12 ' A' ' 206' ' ' VAL . 0.3 OUTLIER -78.69 154.87 29.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.24 132.08 3.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.436 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -148.87 156.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.885 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.695 0.283 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.0 t -103.8 141.13 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.733 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.77 126.9 59.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.345 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.35 117.06 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 274' ' ' VAL . 1.4 mt -115.09 124.85 52.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.77 145.28 38.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' A' ' 252' ' ' LEU . 22.6 m -129.61 155.73 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -155.54 169.06 33.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 249' ' ' SER . 4.5 m -131.73 116.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.647 0.261 . . . . 0.0 111.056 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 249' ' ' SER . 41.5 t30 -115.74 95.4 5.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 111.255 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 279' ' ' SER . 3.6 t80 -88.56 155.05 19.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.746 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 72.5 m -133.4 146.5 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.5 t0 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.798 0.332 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -149.17 115.1 5.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.751 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -114.0 123.33 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.688 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.81 120.39 39.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -127.18 134.32 50.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.426 HG22 ' CD1' ' A' ' 36' ' ' PHE . 1.3 pp -134.97 114.12 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.017 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.34 167.65 22.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.594 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.6 118.81 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.25 163.43 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.432 ' HD1' HG13 ' A' ' 274' ' ' VAL . 9.6 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.74 0.305 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.55 152.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.064 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 68.3 m-85 -140.27 136.9 33.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CD1' HG22 ' A' ' 10' ' ' ILE . 27.6 m-85 -147.15 104.48 3.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -105.28 155.26 19.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.066 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 7' ' ' HIS . . . -148.04 113.74 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.751 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -93.07 116.59 29.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.24 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -134.72 88.47 2.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 109.77 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.81 -123.97 34.8 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.02 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.416 ' HG2' ' CD1' ' A' ' 43' ' ' TRP . 94.0 Cg_endo -88.63 21.99 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.666 2.244 . . . . 0.0 112.76 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.488 ' CZ2' ' CE1' ' A' ' 75' ' ' TYR . 75.5 m95 -140.09 111.96 7.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.405 ' CB ' ' HB2' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -106.2 103.87 13.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.797 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -84.0 116.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.27 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.823 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . . . -123.97 115.92 22.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 122.41 43.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . . . -123.6 147.96 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -112.11 119.96 40.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.61 113.2 25.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 152.18 31.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.84 134.24 49.13 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.577 2.185 . . . . 0.0 112.046 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 10.4 mm-40 -115.73 123.53 48.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.151 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.37 153.83 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.823 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 5.1 mt-10 -154.01 143.59 21.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 89' ' ' GLY . 12.3 p -147.03 120.43 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.405 ' HB2' ' CB ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' CZ2' ' A' ' 43' ' ' TRP . 15.2 t80 -119.92 105.38 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.699 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -89.71 126.19 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -40.88 20.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.57 122.51 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 103.01 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -160.13 122.35 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.801 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.37 -25.2 33.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.51 -31.26 14.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.952 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -142.24 78.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -102.31 128.13 48.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.74 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.93 104.03 7.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.985 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -108.62 179.76 21.43 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.469 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 116' ' ' PRO . 3.3 tp -158.2 107.92 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.787 0.327 . . . . 0.0 110.788 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.583 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 1.2 m -75.53 155.96 35.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.697 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -153.65 108.76 0.38 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.514 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.46 167.01 19.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -139.94 129.37 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -125.43 149.49 48.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -147.75 97.82 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.27 110.64 20.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' A' ' 107' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.658 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.779 0.323 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.423 ' HB3' ' CA ' ' A' ' 95' ' ' GLY . . . -176.22 135.88 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.196 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.39 102.35 2.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 mtp -125.82 105.43 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -83.51 135.52 34.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HB2' ' CE1' ' A' ' 137' ' ' PHE . 23.7 ttt180 -143.63 121.85 12.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.88 155.95 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.06 113.71 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.6 142.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.583 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -149.69 107.09 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.32 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 87' ' ' LEU . 50.3 Cg_endo -69.05 93.55 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.336 2.024 . . . . 0.0 112.145 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.85 136.57 51.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.018 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -139.74 122.95 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.98 114.64 14.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.9 124.07 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -109.99 115.74 30.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.732 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 123' ' ' THR . 0.5 OUTLIER -90.85 -28.14 18.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.87 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -165.18 -171.75 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.699 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.86 28.72 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.927 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.16 -41.83 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.04 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.25 135.18 52.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -124.86 134.11 52.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.777 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' CE2' HD21 ' A' ' 157' ' ' LEU . 4.8 m-85 -105.14 143.17 33.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -143.82 118.91 10.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.75 120.62 6.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.558 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -128.53 115.0 17.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.736 HD11 HG23 ' A' ' 153' ' ' THR . 0.5 OUTLIER -105.17 112.3 25.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.419 ' HG ' ' HH ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -87.09 101.1 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.474 ' SD ' HD23 ' A' ' 132' ' ' LEU . 1.9 mtt -120.78 137.99 54.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.419 ' HH ' ' HG ' ' A' ' 133' ' ' SER . 20.2 m-85 -146.68 159.88 42.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -140.7 98.93 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 111' ' ' ARG . 1.7 m-85 -79.03 159.4 27.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.68 160.86 26.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.762 0.315 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 m -89.96 116.86 28.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -96.0 127.3 41.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 151' ' ' VAL . 9.9 p -131.21 109.61 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.92 143.09 43.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.736 HG23 HD11 ' A' ' 132' ' ' LEU . 0.5 OUTLIER -114.44 135.9 53.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -135.13 103.06 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.059 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.4 p -99.71 103.93 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.31 140.61 15.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.423 HD21 ' CE2' ' A' ' 128' ' ' PHE . 1.9 mp -137.71 125.1 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -119.05 119.84 35.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 159' ' ' TYR . 53.2 p90 -130.14 124.98 33.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.604 HG23 ' HB2' ' A' ' 166' ' ' ALA . 62.4 p -84.83 140.96 30.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.129 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.19 -30.67 43.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -144.59 33.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 60.91 76.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER 172.18 -61.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.606 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.584 HG13 ' HG ' ' A' ' 199' ' ' LEU . 26.6 t -107.49 112.68 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.263 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.604 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -107.0 145.29 32.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.988 0.423 . . . . 0.0 111.753 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.72 120.12 33.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.117 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.95 139.2 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 169' ' ' VAL . 15.5 m -140.03 100.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.719 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.75 137.91 40.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.088 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -115.66 110.24 18.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.06 109.28 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -99.53 124.66 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.88 35.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.4 m -124.35 157.02 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -146.64 121.04 9.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.48 159.16 31.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 193' ' ' ILE . 7.8 tp -133.39 113.22 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.145 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 11.4 mmt85 -108.29 152.15 25.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.83 140.04 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.482 ' C ' HD23 ' A' ' 197' ' ' LEU . 0.9 OUTLIER -145.42 174.98 10.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.802 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.561 HD12 ' CD1' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -167.39 87.24 0.76 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.875 ' HA ' HG22 ' A' ' 207' ' ' THR . 46.6 Cg_exo -56.04 113.71 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.436 2.091 . . . . 0.0 112.298 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.584 ' HG ' HG13 ' A' ' 165' ' ' VAL . 0.2 OUTLIER -114.19 126.13 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.744 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.6 t -138.09 154.7 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.521 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.425 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.4 OUTLIER -143.17 90.6 2.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.254 0.55 . . . . 0.0 110.117 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.04 -80.83 1.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.555 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.37 39.03 3.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 111.015 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -132.2 141.16 48.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.94 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.6 m -124.47 117.47 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.66 106.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.875 HG22 ' HA ' ' A' ' 198' ' ' PRO . 43.8 p -114.91 104.82 53.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.002 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HG2' HD21 ' A' ' 197' ' ' LEU . 96.9 Cg_endo -80.0 164.98 22.17 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.579 2.186 . . . . 0.0 112.432 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -121.11 131.91 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.9 p -131.1 157.75 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.827 0.346 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -149.25 165.78 29.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.599 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.17 134.54 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -110.03 109.05 19.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.95 142.72 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -139.99 100.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.417 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.66 118.67 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 111.009 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.777 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 248' ' ' LEU . 3.5 pp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.641 0.258 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 276' ' ' VAL . 69.2 m -95.94 151.94 18.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.798 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.87 127.35 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.3 m -135.11 152.28 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.8 mt -141.01 131.08 24.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 127.75 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.872 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.432 HG13 ' HD1' ' A' ' 14' ' ' TYR . 10.8 p -124.21 128.83 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.318 . . . . 0.0 110.997 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -136.18 152.32 21.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.729 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 249' ' ' SER . 20.2 t -140.85 141.7 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 0.0 110.803 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.01 95.53 2.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.058 0.456 . . . . 0.0 111.604 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 7.6 t80 -92.68 120.12 32.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.584 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 p -123.32 146.92 47.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.934 0.397 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -164.2 90.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 18.4 m80 -116.1 108.42 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -88.0 132.44 34.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.73 120.87 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.33 131.01 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.195 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -122.12 128.92 7.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.466 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -121.04 155.98 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.1 mmt -147.05 121.11 9.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.846 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.0 p90 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.54 150.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CE2' ' HA3' ' A' ' 11' ' ' GLY . 10.4 p90 -146.69 156.68 43.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.76 157.96 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -140.21 136.4 33.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -138.72 113.97 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -93.8 122.79 36.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 43' ' ' TRP . 34.5 t-20 -134.87 88.7 2.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -128.38 14.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.884 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -87.74 15.37 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.559 2.172 . . . . 0.0 113.177 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' A' ' 40' ' ' ASN . 60.8 p-90 -140.38 110.95 6.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.829 0.347 . . . . 0.0 111.395 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 10.6 ttm105 -102.2 110.59 22.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.67 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 5.0 tt -83.79 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.463 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -129.46 122.84 30.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.983 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.45 110.54 20.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.36 160.79 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -136.5 102.46 4.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.46 107.32 18.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.16 150.38 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.4 ' CB ' ' HD2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.76 0.314 . . . . 0.0 110.895 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 70.7 Cg_endo -74.8 -167.86 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.612 2.208 . . . . 0.0 112.355 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.51 156.27 36.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.971 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.93 153.95 40.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 12.6 tt0 -162.1 134.55 5.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.838 HG12 ' O ' ' A' ' 89' ' ' GLY . 12.4 p -128.99 150.06 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -118.66 137.68 53.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.99 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.27 87.51 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -93.0 116.25 28.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 -45.17 50.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 mt -143.43 136.96 28.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -97.97 101.97 13.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.7 148.53 25.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.8 0.85 56.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -111.03 -31.86 6.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -155.42 89.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.007 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.7 134.21 55.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.734 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -129.84 104.21 7.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -108.03 -175.2 22.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.162 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.16 108.79 2.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -77.7 159.25 29.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.838 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -174.12 91.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.37 152.21 17.36 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 4.3 m-85 -107.73 134.4 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -106.86 127.13 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.145 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -127.09 107.14 9.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.48 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.0 128.12 54.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.354 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 107' ' ' ALA . . . . . . . . 0 C--N 1.331 0.255 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.486 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.471 ' O ' ' HA2' ' A' ' 95' ' ' GLY . . . -116.43 144.68 43.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.979 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -99.65 125.5 45.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.467 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.7 ttm -107.88 124.78 50.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.344 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.566 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 6.0 mm-40 -91.38 140.5 29.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -152.97 104.45 2.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.832 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.31 144.6 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -142.06 103.01 4.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.732 HG22 ' HA2' ' A' ' 89' ' ' GLY . 1.3 pt -121.64 153.53 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -161.81 117.55 1.29 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.25 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 59.8 Cg_endo -72.11 92.84 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.364 2.043 . . . . 0.0 112.104 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.58 131.75 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -132.14 123.05 26.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.855 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 121.91 38.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.5 111.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -123.49 110.73 15.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -177.22 39.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 123' ' ' THR . 17.1 m -128.95 38.5 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 62.9 84.56 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.227 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 53.95 51.35 14.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.332 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -142.09 109.1 5.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.876 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.04 118.63 24.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -106.33 111.96 24.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -117.22 161.64 19.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.1 125.51 1.0 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.423 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -147.13 140.35 25.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.627 ' CD1' HG23 ' A' ' 153' ' ' THR . 7.6 mp -102.02 98.81 8.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.833 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.506 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 0.9 OUTLIER -77.08 110.49 11.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.016 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 mtt -92.95 132.3 37.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.69 137.0 45.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -141.28 152.56 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.685 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -125.95 149.42 48.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -157.14 163.32 39.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.821 0.343 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.62 129.85 41.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -125.21 129.28 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.53 HG21 HD23 ' A' ' 132' ' ' LEU . 12.0 p -100.68 137.3 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.03 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -121.01 100.38 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.627 HG23 ' CD1' ' A' ' 132' ' ' LEU . 1.3 m -93.82 125.48 38.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.61 105.5 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.1 p -101.42 103.96 14.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.93 148.1 18.89 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.909 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.426 HD23 ' CD2' ' A' ' 126' ' ' LEU . 3.2 mp -137.8 125.42 22.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.69 0.281 . . . . 0.0 110.76 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 3.9 tt0 -112.78 115.02 27.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.085 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CD1' HD12 ' A' ' 126' ' ' LEU . 71.8 t80 -130.16 120.6 24.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.002 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.716 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 43.8 p -84.88 140.42 31.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.67 -29.88 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.804 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -161.66 44.35 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 164' ' ' THR . 47.5 mt-10 61.52 76.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER 176.69 -76.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.677 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.89 113.01 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.716 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -109.62 148.02 32.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.566 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.472 HD11 HD11 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -93.95 137.22 33.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.372 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 121.86 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 169' ' ' VAL . 9.7 p -123.99 110.75 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.792 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -107.55 121.54 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.088 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -87.85 116.37 25.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -85.9 139.18 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.03 100.43 3.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.84 131.1 43.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.41 ' HB2' ' CG1' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -140.08 155.14 47.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.543 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.796 0.332 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.98 115.99 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -107.22 109.98 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.38 164.96 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.2 137.27 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.304 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.454 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 6.3 mmt-85 -118.34 151.88 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.624 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.73 132.55 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.952 0.406 . . . . 0.0 111.361 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 196' ' ' TYR . 0.7 OUTLIER -141.6 137.68 32.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.566 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.472 HD11 HD11 ' A' ' 167' ' ' LEU . 5.5 tp -109.74 75.07 0.78 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.756 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.416 ' HB3' HG22 ' A' ' 207' ' ' THR . 69.3 Cg_endo -74.03 113.74 3.86 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.734 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 197' ' ' LEU . 1.6 mp -114.16 156.02 25.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.441 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 204' ' ' HIS . 34.8 m -138.04 153.26 49.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.531 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 90.41 2.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.282 0.563 . . . . 0.0 110.094 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 60.27 -85.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -117.42 29.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' HIS . . . . . 0.492 ' O ' HG23 ' A' ' 200' ' ' THR . 1.1 t60 -132.63 130.24 39.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.624 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.02 119.04 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.83 127.2 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 198' ' ' PRO . 30.0 p -132.55 104.93 13.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.418 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.36 165.09 14.58 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.606 2.204 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.17 131.92 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.145 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.98 123.99 17.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.929 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.748 0.308 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -161.94 172.03 38.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.516 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.902 HD22 ' CZ ' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -132.87 137.0 46.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.861 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -129.21 123.33 31.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.902 ' CZ ' HD22 ' A' ' 238' ' ' LEU . 2.9 m-85 -112.24 155.08 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -137.19 110.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.549 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -119.32 114.93 23.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.982 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.831 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.66 0.267 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 277' ' ' ASN . 22.7 t -102.18 157.62 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 0.0 110.952 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.94 122.16 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 m -126.98 134.3 50.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.55 161.77 18.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -139.25 99.25 3.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.34 139.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -137.34 -176.09 14.21 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.603 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 15.1 m -149.95 155.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.652 0.263 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 249' ' ' SER . 1.4 t-20 -140.72 95.34 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 279' ' ' SER . 22.8 t80 -88.91 154.93 19.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.847 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 33.7 t -142.5 147.01 35.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.825 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.785 0.326 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.422 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -144.33 111.94 6.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 33.3 m-70 -114.26 105.16 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.417 ' HB3' ' CE1' ' A' ' 280' ' ' PHE . 0.2 OUTLIER -89.95 119.98 30.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -131.11 134.78 46.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.0 mt -118.06 113.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.81 135.83 13.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.599 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -143.92 129.01 18.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 0.0 110.984 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.0 ttm -122.39 141.72 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 4.5 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 49' ' ' TYR . 11.4 p -134.39 141.51 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.046 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.9 m-85 -124.78 145.91 49.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.53 109.37 8.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.68 156.8 18.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.232 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -160.13 113.83 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.617 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 44' ' ' ARG . . . -91.89 125.48 36.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.205 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -134.69 88.6 2.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.19 -125.08 26.51 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.31 17.25 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.635 2.223 . . . . 0.0 112.763 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.41 119.45 14.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.912 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -117.04 109.72 17.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.715 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.3 mt -86.75 141.96 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.904 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -139.82 97.83 3.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 117.44 31.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.713 ' HB3' ' CG ' ' A' ' 70' ' ' GLU . . . -117.54 162.85 17.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.447 ' HB2' HG12 ' A' ' 34' ' ' VAL . 18.6 m-85 -125.87 114.69 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.0 111.39 16.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.741 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -147.81 148.88 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.812 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.699 0.285 . . . . 0.0 111.017 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 26.4 Cg_exo -62.76 -171.17 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.434 2.089 . . . . 0.0 112.196 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.713 ' CG ' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -166.06 144.55 5.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 71' ' ' LEU . 4.1 mp -119.94 157.03 29.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.904 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 60.6 tt0 -147.78 149.56 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.03 148.87 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.438 ' CG ' ' HB3' ' A' ' 44' ' ' ARG . 13.8 m80 -122.86 126.36 47.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -107.28 101.45 10.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -87.46 102.17 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -78.8 -54.99 5.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.28 124.02 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.02 95.08 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.802 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -130.72 142.83 50.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.81 -22.03 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.202 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -117.51 11.33 13.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -176.47 71.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.63 116.05 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.821 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.92 123.0 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.961 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.08 163.64 22.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 87' ' ' LEU . 1.5 tm? -158.13 107.87 2.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 0.0 110.696 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 15.7 p -89.75 159.09 17.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.62 107.22 0.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.77 -176.91 14.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.733 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -129.1 132.59 47.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.798 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -113.66 125.81 54.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -96.12 99.93 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -97.74 106.01 18.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.515 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -171.76 129.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -143.11 100.53 3.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 mtm -125.21 134.13 52.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.8 145.02 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.56 117.56 10.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.753 ' CE3' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -86.59 150.39 24.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.69 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.05 106.51 4.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.753 HD11 ' CE3' ' A' ' 112' ' ' TRP . 5.5 mt -110.31 145.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.557 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -141.63 84.93 11.84 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.406 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.74 90.63 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.646 2.231 . . . . 0.0 112.144 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -62.99 111.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.89 122.96 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.46 122.1 25.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.48 123.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 125.47 52.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.88 -41.85 6.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.1 p -156.22 -177.48 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.63 58.59 4.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -179.09 -49.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.94 105.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -108.83 129.09 55.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.25 144.5 26.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -142.62 122.42 13.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.99 125.09 6.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -131.62 116.85 17.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.416 ' CD1' HG23 ' A' ' 153' ' ' THR . 0.9 OUTLIER -105.98 98.98 8.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 99.94 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.9 140.64 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -145.56 155.63 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.44 107.02 3.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -96.17 130.88 43.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.012 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.78 179.72 7.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.3 t30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.841 0.353 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -85.14 144.74 28.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.67 115.93 31.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.82 103.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -123.6 130.15 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.019 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 132' ' ' LEU . 18.0 m -102.8 142.87 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.799 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.22 106.58 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 m -100.62 103.95 15.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.811 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.02 135.13 12.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.759 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.81 124.55 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 0.0 110.79 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.18 119.32 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.206 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -130.07 110.56 11.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.952 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.723 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 28.8 p -84.6 125.77 32.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -60.99 -29.31 69.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -155.96 41.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.141 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.498 ' C ' HG22 ' A' ' 164' ' ' THR . 2.3 tm-20 57.59 76.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.547 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 168.78 -64.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.504 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.547 ' H ' HG23 ' A' ' 164' ' ' THR . 4.6 m -103.91 112.98 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.723 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -121.15 161.65 21.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.882 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.3 138.72 41.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.064 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 113.63 26.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.74 100.84 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.509 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -95.38 140.7 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.325 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.77 116.76 27.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.92 136.72 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.8 tp -142.02 94.94 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.472 ' HB2' HG23 ' A' ' 190' ' ' THR . 11.8 mt-10 -96.35 118.07 32.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 122.38 16.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.4 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 174' ' ' GLU . 2.4 t -92.84 159.06 15.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.37 141.69 32.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.976 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.44 178.99 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 44.3 pt -148.25 136.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.289 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.41 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 9.8 mtm-85 -134.39 138.94 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.727 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.842 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -110.01 137.77 47.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.48 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 196' ' ' TYR . 2.1 m-85 -135.63 175.09 9.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.85 72.64 0.92 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 0.0 111.017 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.685 ' HA ' HG23 ' A' ' 207' ' ' THR . 51.9 Cg_exo -52.84 113.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.469 2.113 . . . . 0.0 112.252 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.23 127.27 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 204' ' ' HIS . 51.7 m -138.12 146.61 43.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.276 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 95.4 mt -140.04 90.24 2.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.214 0.53 . . . . 0.0 109.993 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.46 -65.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.467 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -143.54 35.6 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.732 0.301 . . . . 0.0 110.828 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 200' ' ' THR . 1.9 m-70 -117.66 146.05 43.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.9 t -127.96 109.23 11.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.997 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.68 107.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.685 HG23 ' HA ' ' A' ' 198' ' ' PRO . 1.7 m -129.88 104.9 16.9 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.16 161.06 41.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 112.267 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -129.59 134.7 47.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.842 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 40.4 m -129.95 133.55 46.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.1 mtp85 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -128.92 132.66 7.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 mt -122.4 122.93 40.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 251' ' ' SER . 2.4 t80 -102.42 117.08 33.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -120.89 144.93 48.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 163.55 -156.43 28.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.575 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.701 ' H ' HG23 ' A' ' 250' ' ' VAL . 17.6 m-85 -149.06 166.09 29.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.913 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 278' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.411 ' HB3' ' N ' ' A' ' 277' ' ' ASN . 7.8 t -97.5 161.28 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.526 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.701 HG23 ' H ' ' A' ' 242' ' ' TYR . 15.3 m -145.95 133.5 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.277 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 239' ' ' PHE . 13.7 m -130.81 136.99 49.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 116.38 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -96.31 134.3 39.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.7 t -129.26 148.0 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.044 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -164.39 161.26 34.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.7 HG12 HG12 ' A' ' 250' ' ' VAL . 30.9 m -144.44 159.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.167 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ASN . . . . . 0.411 ' N ' ' HB3' ' A' ' 249' ' ' SER . 0.8 OUTLIER -148.29 95.2 2.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.015 0.436 . . . . 0.0 111.374 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.525 ' HD2' HD12 ' A' ' 248' ' ' LEU . 3.4 t80 -88.86 110.6 21.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.651 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 5.4 p -109.13 142.76 39.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 8' ' ' PHE . 3.0 p90 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.831 0.348 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.74 110.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -123.98 111.99 16.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.497 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 280' ' ' PHE . 51.6 m-85 -96.97 132.54 42.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 111.12 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -115.65 122.86 46.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.766 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.445 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 20.2 mm -105.97 113.88 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.28 154.63 19.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.12 135.68 14.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtp -125.12 144.15 50.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.757 0.313 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.24 142.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.049 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.41 128.43 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.445 ' CE2' ' CD1' ' A' ' 10' ' ' ILE . 1.1 t80 -143.62 114.69 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 1.9 m120 -106.7 164.64 11.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.305 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.593 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -157.55 113.77 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.568 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -97.86 121.92 40.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.601 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.74 88.48 2.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.3 -126.33 28.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.923 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.91 19.23 1.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.683 2.255 . . . . 0.0 112.814 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -140.15 110.89 6.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.74 0.305 . . . . 0.0 111.058 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -116.42 111.79 20.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.615 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.593 HG13 ' HB3' ' A' ' 38' ' ' ALA . 2.2 pt -92.67 148.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.356 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . . . -141.01 109.4 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.047 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' H ' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -96.44 135.55 38.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.886 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -136.54 146.03 45.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.51 122.48 47.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -118.55 111.33 18.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.26 167.43 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.84 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.741 0.305 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.64 -166.37 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.52 2.147 . . . . 0.0 112.053 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.842 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 22.0 tt0 -158.83 134.18 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -137.03 105.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.758 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.49 158.31 17.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 89' ' ' GLY . 16.8 m -140.73 157.02 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.94 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -128.67 117.51 21.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.042 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -127.62 105.12 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -106.74 109.69 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.007 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -37.06 56.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -127.52 132.76 49.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.809 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -129.8 111.92 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.977 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -162.02 168.54 22.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.05 15.32 17.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 120' ' ' VAL . 17.3 m-20 -119.08 -43.09 2.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.765 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' O ' HD22 ' A' ' 78' ' ' LEU . 2.3 t80 -159.32 92.78 1.09 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 t -87.0 150.07 24.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -130.31 104.02 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.13 177.59 17.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.37 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.08 107.81 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 64.8 m -77.04 155.34 32.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -148.7 79.5 0.21 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.537 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.91 129.95 10.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -120.05 120.11 35.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 0.0 110.737 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -127.83 139.9 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -131.13 129.51 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -112.23 128.13 56.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.07 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.652 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.766 0.317 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -168.91 141.76 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -156.56 99.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.2 ttp -116.83 157.63 25.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 143.04 48.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -139.96 116.71 10.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -88.12 130.21 35.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 108.14 9.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.71 147.38 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.69 107.81 3.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.71 94.32 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.31 2.007 . . . . 0.0 112.033 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.48 102.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -107.42 123.0 47.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.72 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.447 ' OD2' ' ND2' ' A' ' 129' ' ' ASN . 0.4 OUTLIER -128.46 123.16 32.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.957 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 82' ' ' ASP . 9.9 p -141.78 106.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 154.55 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -4.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.408 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 m 63.53 31.91 14.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.65 -73.86 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.71 24.62 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.004 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.11 100.49 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -106.75 128.34 54.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.775 ' CE1' HG22 ' A' ' 155' ' ' THR . 0.1 OUTLIER -117.06 130.71 56.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.447 ' ND2' ' OD2' ' A' ' 119' ' ' ASP . 4.0 t-20 -128.64 126.68 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.34 130.87 10.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.585 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -125.62 129.15 49.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.64 ' HG ' HG23 ' A' ' 153' ' ' THR . 2.5 mp -128.8 102.36 6.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.694 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.0 p -84.62 113.06 21.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.11 116.94 31.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.715 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.74 143.84 33.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 98.97 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.44 145.49 35.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.956 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.07 170.12 19.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.07 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.963 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.854 0.359 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.2 p -111.82 137.24 50.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.11 133.43 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.04 129.82 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -136.03 115.97 13.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.64 HG23 ' HG ' ' A' ' 132' ' ' LEU . 1.1 m -96.46 137.87 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.78 107.83 9.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.775 HG22 ' CE1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -98.61 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.717 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.97 132.24 11.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.556 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 3.4 mp -109.84 127.34 54.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.718 0.294 . . . . 0.0 110.737 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.21 111.57 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.029 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -130.16 116.51 18.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.253 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.71 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 15.9 p -84.8 134.48 34.31 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.956 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -60.76 -31.01 70.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -162.9 44.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 164' ' ' THR . 0.3 OUTLIER 62.32 72.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.2 OUTLIER 177.96 -73.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.757 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.64 112.97 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.71 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -114.97 158.75 21.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.046 0.45 . . . . 0.0 111.89 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.04 141.86 32.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.043 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.41 ' HB2' ' HB3' ' A' ' 196' ' ' TYR . 0.0 OUTLIER -117.87 108.89 15.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.113 -179.641 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 169' ' ' VAL . 22.2 m -109.23 100.94 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -92.41 145.96 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 108.0 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.627 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -85.94 141.31 29.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.997 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 mt -141.75 99.94 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.784 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 123.2 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -133.56 144.43 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.566 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.853 0.358 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.38 107.83 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 123.81 35.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.45 158.03 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.772 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 tt -132.44 140.11 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -134.29 137.88 44.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.584 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -104.92 149.79 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -156.22 172.03 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.722 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.39 86.94 0.23 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.775 ' HA ' HG22 ' A' ' 207' ' ' THR . 45.1 Cg_endo -68.43 113.47 3.14 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.374 2.049 . . . . 0.0 112.408 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mp -114.39 132.82 56.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.735 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 205' ' ' SER . 67.4 p -138.04 155.78 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 200' ' ' THR . 1.3 mp -143.23 90.58 2.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.247 0.546 . . . . 0.0 110.04 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.79 -65.48 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.457 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.43 59.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' HIS . . . . . 0.544 ' O ' HG22 ' A' ' 200' ' ' THR . 72.2 m80 -153.09 140.62 19.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.63 ' HA ' HG22 ' A' ' 200' ' ' THR . 5.3 t -128.06 115.72 18.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.059 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.12 128.47 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 198' ' ' PRO . 71.4 p -136.47 104.87 9.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.222 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.49 126.03 2.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.707 2.271 . . . . 0.0 112.134 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 30.4 p90 -112.78 137.6 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.887 0.375 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.731 HG22 HG12 ' A' ' 236' ' ' VAL . 40.2 p -129.55 142.4 50.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.735 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 -179.82 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.731 HG12 HG22 ' A' ' 210' ' ' THR . 17.9 m . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -138.56 141.01 11.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.477 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.11 122.03 36.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.952 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.9 150.48 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.825 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 147.63 44.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.52 126.93 1.99 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.457 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' A' ' 250' ' ' VAL . 49.0 t80 -148.77 162.9 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.099 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.406 ' O ' ' CE2' ' A' ' 242' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.751 HD23 ' HD1' ' A' ' 278' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.477 ' CB ' ' HB3' ' A' ' 277' ' ' ASN . 0.3 OUTLIER -117.43 113.95 22.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.095 0.474 . . . . 0.0 112.105 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 242' ' ' TYR . 3.2 m -117.82 117.18 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 252' ' ' LEU . 4.9 m -127.75 169.39 13.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 111.253 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 251' ' ' SER . 0.9 OUTLIER -151.24 129.75 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.67 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.91 123.16 46.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.316 -0.314 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 6.2 m -110.63 124.68 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -117.88 131.86 9.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 276' ' ' VAL . 27.3 m -126.08 123.08 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ASN . . . . . 0.477 ' HB3' ' CB ' ' A' ' 249' ' ' SER . 33.0 t30 -125.6 156.45 39.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.751 ' HD1' HD23 ' A' ' 248' ' ' LEU . 7.0 m-85 -149.89 155.41 39.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.894 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.94 147.1 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.678 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.403 ' HB3' ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.836 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.782 0.325 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -157.38 95.36 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -117.36 109.98 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.24 119.98 29.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -128.06 130.22 47.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mt -115.62 137.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 131.17 6.33 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.571 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.87 128.41 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 0.0 111.062 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.88 128.96 54.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.863 0.363 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 35' ' ' TYR . 6.0 t -101.72 162.32 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.66 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.462 ' N ' HG12 ' A' ' 34' ' ' VAL . 30.3 t80 -155.71 135.4 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.369 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.47 155.81 49.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.352 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.696 ' ND2' ' HB2' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -150.12 155.41 39.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.219 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.739 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -155.93 113.86 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.576 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.9 117.76 29.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.83 88.58 2.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.5 -128.15 26.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.82 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.38 21.92 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.649 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -140.26 112.76 7.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.43 104.68 14.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.739 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -83.82 133.26 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.343 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.85 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -135.22 124.0 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.903 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.98 112.44 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.084 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -111.26 161.45 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.856 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.05 115.58 24.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -123.65 121.17 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -151.31 141.18 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.833 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.922 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.478 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.546 0.212 . . . . 0.0 110.801 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 83.5 Cg_endo -83.76 176.77 6.7 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.801 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 4.5 tp10 -161.93 131.06 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mt -110.21 150.24 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.201 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.85 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -162.02 127.35 3.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 74' ' ' HIS . 29.1 t -128.01 154.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.409 ' N ' HG12 ' A' ' 73' ' ' VAL . 2.4 t60 -124.03 148.21 47.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -135.54 143.73 45.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.9 102.17 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.52 -66.28 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -125.4 133.34 52.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -120.13 106.48 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -146.86 172.17 14.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.14 15.35 10.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.431 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.444 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 4.2 m-20 -114.26 -44.99 3.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 82' ' ' ASP . 15.5 p90 -166.95 101.55 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -92.93 133.85 35.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.745 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.59 107.78 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.146 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.84 175.18 19.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.203 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 116' ' ' PRO . 3.1 tp -158.12 107.93 2.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 0.0 110.936 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 m -79.02 155.87 28.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.29 105.04 0.24 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.567 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.36 174.9 20.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.383 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -129.85 144.12 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -122.46 117.74 26.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -105.0 112.25 25.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -125.83 100.0 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.426 -179.919 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.31 168.12 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.038 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -142.5 117.83 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.2 mtt -136.46 119.17 16.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.718 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 13.0 tp60 -111.21 141.23 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.785 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.56 124.28 12.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.981 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -85.53 146.08 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.8 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -128.18 107.94 10.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.169 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.8 pt -131.3 150.72 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.3 105.69 1.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HB3' HD12 ' A' ' 87' ' ' LEU . 56.4 Cg_endo -70.43 93.61 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.434 2.089 . . . . 0.0 111.938 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.03 149.38 41.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -147.34 123.02 10.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.69 118.74 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.06 114.03 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -106.15 128.18 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.86 -32.82 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -145.01 -175.35 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.475 ' H ' HG22 ' A' ' 123' ' ' THR . 70.9 m-20 -88.88 53.54 2.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -176.78 -50.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 157' ' ' LEU . 5.4 mt -82.03 104.11 12.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -112.64 116.37 30.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -90.95 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -137.43 127.48 25.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.37 125.18 6.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -123.09 121.77 36.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.921 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' A' ' 153' ' ' THR . 4.3 mp -116.37 99.03 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.5 120.6 24.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.9 mtp -128.65 129.1 45.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.8 133.07 52.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -115.92 157.41 24.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 148' ' ' ASP . 40.9 p90 -108.54 154.11 22.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -165.03 178.54 6.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 137' ' ' PHE . 4.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 p -99.08 110.76 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 126.04 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 151' ' ' VAL . 16.0 m -145.97 100.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.08 121.32 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.455 HG23 ' HG ' ' A' ' 132' ' ' LEU . 10.0 m -104.39 126.75 51.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -126.37 107.81 10.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.123 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.5 p -99.08 103.87 15.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.11 148.36 16.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.805 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 126' ' ' LEU . 4.6 mt -133.03 118.39 18.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.71 113.27 26.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.429 ' N ' ' HB1' ' A' ' 166' ' ' ALA . 5.5 p90 -130.11 118.4 21.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 0.5 OUTLIER -92.28 131.48 37.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.752 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.82 7.52 26.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.693 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.04 28.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.766 0.317 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.677 ' O ' HG23 ' A' ' 164' ' ' THR . 14.6 mm-40 51.52 64.94 1.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.112 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.2 OUTLIER 178.54 -64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 199' ' ' LEU . 21.5 t -103.85 113.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.813 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.48 ' HB2' ' HB ' ' A' ' 160' ' ' THR . . . -119.03 151.97 37.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.8 mp -93.92 133.44 37.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.265 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 196' ' ' TYR . 41.9 ttp85 -109.05 107.02 17.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.047 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.49 107.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.712 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -103.37 145.23 30.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.46 121.76 42.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.583 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.89 125.16 33.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.5 tt -142.02 94.82 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.748 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -126.58 148.95 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -140.1 151.04 45.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.791 0.329 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.2 m -79.03 110.96 14.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.12 131.76 54.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.55 156.99 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -116.15 131.36 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -129.23 117.96 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -99.08 149.11 23.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.402 ' HB2' ' HB3' ' A' ' 168' ' ' ARG . 52.5 m-85 -155.11 142.54 19.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.448 ' O ' HD23 ' A' ' 199' ' ' LEU . 2.1 mt -136.24 71.99 60.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.1 113.72 3.15 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.488 ' HB3' HG13 ' A' ' 165' ' ' VAL . 0.5 OUTLIER -114.29 157.16 23.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.492 HG22 ' OG ' ' A' ' 205' ' ' SER . 2.9 p -136.62 138.08 40.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.16 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.48 89.81 2.45 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.359 0.6 . . . . 0.0 109.983 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 45.93 81.24 0.04 OUTLIER Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.884 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.5 t30 60.85 40.22 16.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -152.05 97.57 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.492 ' OG ' HG22 ' A' ' 200' ' ' THR . 41.5 m -96.84 142.74 28.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 97.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -105.01 104.75 48.46 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.087 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.81 164.94 17.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.624 2.216 . . . . 0.0 112.387 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 4.2 m -139.1 150.45 45.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.852 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.092 -179.876 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.852 0.358 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -101.07 168.34 20.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.588 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.1 128.2 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.5 98.1 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.98 134.72 38.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -125.81 114.56 2.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.577 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.75 110.18 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.962 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.632 0.254 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.587 ' O ' HG13 ' A' ' 276' ' ' VAL . 28.4 t -95.93 167.44 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.746 0.307 . . . . 0.0 110.948 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -149.28 117.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.5 m -138.92 147.1 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 5.1 mp -121.11 123.5 42.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 131.6 53.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.05 148.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -135.18 141.32 12.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.537 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 249' ' ' SER . 14.0 t -115.25 145.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ASN . . . . . 0.417 ' CB ' ' HB3' ' A' ' 249' ' ' SER . 1.8 t-20 -147.41 95.55 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -88.43 140.27 29.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.0 p -124.67 131.52 53.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.937 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.819 0.343 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -142.86 85.01 1.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.97 -58.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -157.84 54.9 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.33 -22.28 11.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.115 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 66.31 118.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 110.821 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -114.15 119.72 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -88.0 128.86 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.52 135.46 40.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 10' ' ' ILE . 4.5 tt -155.83 126.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.27 22.21 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.47 121.33 7.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.134 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -104.88 159.38 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.23 133.03 12.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -118.38 118.01 30.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.6 mt -140.12 150.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -102.82 -165.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -97.29 26.54 4.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 19' ' ' VAL . 15.1 t 54.91 30.59 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.28 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 62.96 145.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.52 -52.0 47.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.538 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.47 105.42 9.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 0.0 110.811 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.95 160.09 11.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.532 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.1 85.33 0.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.354 . . . . 0.0 110.925 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -122.94 28.56 7.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mtt -143.08 111.97 6.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.03 -66.7 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.46 121.22 5.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.42 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.0 mt -152.12 137.06 17.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.23 160.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -131.39 147.33 65.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.3 146.15 44.84 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.532 2.155 . . . . 0.0 112.289 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -103.08 119.37 38.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.64 151.95 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -148.33 142.08 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -149.82 143.91 25.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -146.38 161.56 40.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.411 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.19 113.83 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -94.99 116.18 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.553 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.82 88.56 2.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.704 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -126.61 35.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.031 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.66 23.14 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.0 112.689 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.442 ' CH2' ' HB ' ' A' ' 73' ' ' VAL . 14.8 t-105 -140.42 110.85 6.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 26.7 mtp180 -108.37 108.77 19.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mt -83.85 120.62 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.138 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . . . -125.32 121.69 34.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.17 113.18 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.09 146.73 43.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.21 117.43 34.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.09 120.88 43.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -152.36 123.0 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -137.34 140.26 41.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.96 77.14 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.382 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.09 -79.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.54 2.16 . . . . 0.0 112.25 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 m -146.87 29.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.19 162.52 25.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.46 122.94 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.7 -67.38 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 59.97 97.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.146 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.75 -63.46 0.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.555 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.96 -69.21 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -148.38 175.34 11.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.61 138.13 8.49 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -152.75 66.37 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.371 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -112.13 -27.37 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.764 ' HB2' HG21 ' A' ' 106' ' ' THR . 28.8 t80 -73.48 -67.35 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.1 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 60.96 -178.89 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.795 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.425 ' CB ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -177.11 173.18 0.75 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.932 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 68' ' ' ARG . 73.5 Cg_endo -76.27 -179.61 5.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.446 2.098 . . . . 0.0 112.326 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.2 167.34 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.95 149.12 50.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.805 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.82 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -147.55 140.28 24.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 89' ' ' GLY . 15.4 m -142.11 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -112.78 139.35 48.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 111.102 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -138.04 104.27 5.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.77 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -95.31 111.01 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.11 -52.71 57.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 mt -129.37 145.35 51.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.69 94.95 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.72 130.38 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.39 -23.68 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.832 ' O ' HG23 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -77.77 -44.65 26.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -151.48 80.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.3 123.93 33.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -106.75 115.8 30.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -125.54 165.9 18.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.57 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.24 107.89 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.285 . . . . 0.0 110.533 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.867 HG22 ' HB3' ' A' ' 115' ' ' ALA . 9.0 t -105.85 107.83 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -101.38 123.44 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.244 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 153.64 17.42 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.778 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.77 126.63 53.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -109.95 134.7 51.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.957 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -125.91 121.74 34.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.786 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.26 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.72 161.52 25.98 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.384 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.633 ' CA ' HG22 ' A' ' 106' ' ' THR . 3.8 t80 71.86 -73.46 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.527 0.203 . . . . 0.0 110.95 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 65.08 -70.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.143 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 96' ' ' TYR . 1.3 t80 -173.43 125.63 0.4 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.829 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.31 139.34 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.19 -39.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -84.48 109.48 20.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.79 64.63 1.82 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.438 2.092 . . . . 0.0 112.296 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.15 -45.26 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.52 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.49 139.93 53.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.922 0.391 . . . . 0.0 110.781 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.5 -49.26 72.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.785 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 66' ' ' PHE . 0.5 OUTLIER -112.94 149.9 32.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.78 154.94 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -108.45 125.19 51.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.75 139.7 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -108.36 134.2 51.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -143.34 129.21 19.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -90.87 148.45 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.736 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -142.09 103.71 4.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.6 144.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.867 ' HB3' HG22 ' A' ' 88' ' ' THR . . . -140.87 93.28 8.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.317 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 41.7 Cg_exo -56.81 87.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.172 . . . . 0.0 112.072 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 98.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -107.86 122.92 47.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.796 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -128.17 127.19 42.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 82' ' ' ASP . 10.0 p -145.06 127.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 141.0 29.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.27 -32.31 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.813 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.52 177.88 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.16 54.52 3.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.5 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 159' ' ' TYR . 1.2 mp -99.37 141.86 31.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.2 144.0 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 155' ' ' THR . 5.6 t80 -115.65 133.31 56.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -129.8 159.33 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.02 113.56 0.59 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.21 118.96 30.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.95 102.56 12.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 t -76.06 112.96 13.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.5 mtt -116.55 118.01 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.751 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -111.35 131.95 54.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.24 105.4 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.669 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -71.85 142.96 49.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.55 137.27 15.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.031 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -145.31 -173.53 4.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.954 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.35 29.32 3.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -177.93 -62.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.67 86.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 144' ' ' THR . 3.4 t -57.93 -51.66 68.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.102 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.419 ' N ' HG23 ' A' ' 143' ' ' THR . 44.2 p -123.99 -36.41 2.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.052 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 87.65 -13.33 60.9 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.919 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 63.08 -79.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.9 -175.74 2.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.48 -75.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 57.0 m -127.58 122.42 33.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.14 133.18 43.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 151' ' ' VAL . 10.9 p -141.71 116.59 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.06 121.69 30.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.5 t -95.05 138.8 32.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.47 117.61 18.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.502 HG23 ' CE1' ' A' ' 128' ' ' PHE . 26.0 m -105.14 103.91 13.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.02 135.78 12.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.573 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.433 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 1.1 tp -131.05 115.01 15.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -114.64 110.89 20.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.51 ' HB3' HD23 ' A' ' 126' ' ' LEU . 2.5 p90 -130.01 125.0 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -98.88 138.16 36.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.045 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.45 -50.66 30.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.384 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -150.83 53.62 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.448 ' C ' HG22 ' A' ' 164' ' ' THR . 8.1 tt0 61.55 76.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 179.89 -76.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.495 ' H ' HG23 ' A' ' 164' ' ' THR . 19.3 m -103.91 112.8 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.557 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.507 ' HB2' ' HB ' ' A' ' 160' ' ' THR . . . -112.56 140.65 47.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.86 129.94 40.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.393 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -102.51 132.53 48.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 169' ' ' VAL . 5.9 m -132.18 103.72 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -103.26 127.82 50.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.32 110.98 23.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.79 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.33 139.33 30.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.02 94.97 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.95 138.17 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.962 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -140.04 138.08 35.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.39 150.81 37.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.479 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.1 145.26 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -141.83 158.6 43.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 6.0 ttt -98.45 34.4 2.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -64.88 176.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.84 -55.85 3.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.967 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.2 m -161.63 39.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -131.35 89.82 2.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -25.09 11.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 68.4 -71.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.829 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 161.42 77.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.519 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 174.29 4.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.58 154.22 51.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.1 p -102.51 124.02 47.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 m -101.52 128.55 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.942 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -119.43 117.49 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -105.73 136.41 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 194' ' ' ARG . 3.7 mt -97.06 154.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.034 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 193' ' ' ILE . 23.6 mtt180 -147.06 117.02 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.401 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -110.85 137.2 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.003 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.49 173.82 13.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.904 HD12 HD11 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -175.18 80.35 0.31 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.669 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.7 ' HA ' HG22 ' A' ' 207' ' ' THR . 35.7 Cg_endo -65.25 113.86 2.61 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.556 2.171 . . . . 0.0 112.541 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.904 HD11 HD12 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -114.21 155.86 25.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -137.99 156.97 47.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.673 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.31 90.54 2.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 61.25 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.5 31.54 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -140.25 136.39 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.4 m -117.39 139.89 50.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 206' ' ' VAL . 9.6 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.992 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 198' ' ' PRO . 10.0 p -121.81 104.66 38.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.765 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.56 165.06 18.48 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.597 2.198 . . . . 0.0 112.406 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -120.5 139.67 52.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.53 HG23 HG13 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -143.21 159.29 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.402 ' HG2' HG23 ' A' ' 212' ' ' ILE . 4.8 ttt180 -169.31 -57.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.402 HG23 ' HG2' ' A' ' 211' ' ' ARG . 2.4 pp -136.82 170.38 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.164 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 179.33 -36.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.557 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.92 -179.56 5.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -161.62 121.93 2.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -145.56 -177.7 5.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -112.28 -65.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.6 116.01 31.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -167.25 142.2 3.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -133.16 156.65 47.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -77.53 164.8 25.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -111.6 162.93 14.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -110.28 -55.63 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -77.84 -31.95 51.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.81 137.57 36.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 228' ' ' ARG . 1.9 pp -126.75 140.04 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.23 37.08 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.495 ' H ' HD12 ' A' ' 226' ' ' ILE . 6.0 mmt-85 -108.4 107.96 18.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -151.56 -47.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.008 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.31 39.02 0.6 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.76 31.53 3.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.67 144.78 35.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -83.5 108.17 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -161.4 160.9 30.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.57 -68.16 0.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 210' ' ' THR . 26.0 t 58.75 107.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.146 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.74 145.85 42.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 4.0 mp -118.06 113.37 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -116.38 106.38 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -90.87 146.73 23.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -132.77 111.37 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.017 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 250' ' ' VAL . 76.5 m-85 -104.5 166.22 10.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.249 0.547 . . . . 0.0 111.503 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.2 t0 65.56 -93.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.133 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.36 29.43 1.29 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.732 0.301 . . . . 0.0 111.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.84 -54.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.08 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.64 -20.39 32.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 278' ' ' TYR . . . 126.1 -24.35 5.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.343 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 3.0 pp -105.66 126.77 52.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.9 t -95.85 123.51 39.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.96 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.662 ' HA ' HG12 ' A' ' 276' ' ' VAL . 40.1 t -105.82 116.92 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.798 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 16.0 m -108.03 152.07 24.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.169 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 253' ' ' GLU . 0.1 OUTLIER -133.91 142.11 47.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.585 ' H ' HD13 ' A' ' 252' ' ' LEU . 2.7 tt0 -118.43 128.58 54.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.07 140.34 47.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -174.36 118.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -67.74 -177.22 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -101.33 126.18 48.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' TRP . . . . . 0.414 ' CE3' ' HA ' ' A' ' 258' ' ' TRP . 2.4 m95 -151.29 153.13 34.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 60.94 156.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.795 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -169.01 164.43 11.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -136.96 -47.21 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -85.14 150.05 25.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.23 31.87 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 173.2 -39.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.474 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.46 -15.18 62.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.621 0.248 . . . . 0.0 111.237 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.25 152.26 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -77.6 -49.48 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -112.49 166.17 11.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.25 -31.74 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -133.8 159.68 39.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.921 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -121.24 -46.66 2.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -93.27 155.04 17.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.34 131.45 3.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.446 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.09 123.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -144.93 145.4 14.71 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.138 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 250' ' ' VAL . 29.6 m -126.39 159.15 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.487 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 249' ' ' SER . 9.8 m120 -148.12 95.53 2.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.176 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 4.3 t80 -88.55 121.29 30.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.79 138.7 37.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.886 0.374 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.21 143.63 51.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -100.0 52.68 0.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.37 38.74 3.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -144.3 29.37 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.993 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.451 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.1 m0 -91.42 113.15 25.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.25 152.05 37.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.93 119.94 20.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.633 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.81 139.8 48.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.065 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mm -121.8 113.75 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.864 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.51 143.52 15.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.2 125.79 8.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.312 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.64 120.68 42.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.89 161.83 19.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -118.48 151.72 37.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.4 mm -76.28 138.32 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -113.84 99.79 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.9 30.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -81.46 -36.01 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -73.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.56 -123.14 1.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.456 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -99.73 153.33 19.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.8 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.19 -160.91 30.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -151.65 81.86 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.9 103.89 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.6 mmt 60.53 90.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.5 -174.34 2.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.74 -85.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' HG2' ' A' ' 52' ' ' GLU . 3.0 pp -169.85 167.76 9.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 0.0 110.909 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.47 159.74 34.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 59.98 94.42 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.39 -64.87 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.508 2.139 . . . . 0.0 112.351 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p 174.75 -179.39 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.972 0.415 . . . . 0.0 111.042 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 35' ' ' TYR . 19.2 t -134.27 158.71 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.466 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -141.75 151.6 43.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.053 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -145.08 146.63 31.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.64 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.92 157.39 45.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 111.197 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -167.22 113.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' TRP . . . -90.78 126.16 35.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.836 0.351 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -134.77 88.57 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.82 -126.2 31.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.65 21.35 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.682 2.255 . . . . 0.0 112.864 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -140.14 112.8 8.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' CB ' ' A' ' 74' ' ' HIS . 0.3 OUTLIER -94.62 112.88 24.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.515 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.0 mm -83.99 118.36 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -131.61 119.54 21.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.923 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -121.25 155.0 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 47' ' ' LEU . . . -145.94 147.78 32.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.042 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -100.97 113.68 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.11 122.84 48.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -156.52 138.34 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG2' HD22 ' A' ' 29' ' ' LEU . 26.2 mt-10 -133.06 120.72 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.85 143.02 5.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.491 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.88 112.47 3.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.483 2.122 . . . . 0.0 112.365 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t 58.91 84.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.71 132.25 45.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -95.38 170.75 9.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -120.07 138.47 53.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.493 ' HB2' ' CG2' ' A' ' 64' ' ' THR . . . -121.72 -174.74 2.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.4 51.56 3.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.55 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp 58.59 31.39 21.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.353 . . . . 0.0 110.985 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -174.23 127.55 0.35 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.88 158.98 33.86 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.561 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 2.1 t 43.04 91.83 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.869 0.366 . . . . 0.0 111.47 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.562 ' HE1' HG23 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -175.59 127.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -126.8 171.28 11.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 60.21 -176.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -173.36 173.43 1.31 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 111.22 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.8 -160.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.871 2.381 . . . . 0.0 112.278 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -153.47 132.69 12.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.92 154.61 19.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.765 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 5.7 tt0 -157.09 134.79 10.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 m -135.94 148.13 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -117.27 130.36 56.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 87' ' ' LEU . 1.2 t80 -127.12 100.69 6.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -91.6 113.58 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -72.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -114.92 128.49 56.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -96.16 102.11 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -156.04 163.59 39.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.26 16.37 15.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.13 -43.02 2.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.882 0.372 . . . . 0.0 110.878 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.435 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 96.5 m-85 -146.0 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.75 112.75 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 83' ' ' PHE . 56.9 m-85 -114.91 121.31 42.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.043 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -140.26 -173.35 13.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.347 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.8 pp -158.15 124.27 4.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.0 m -99.95 98.96 9.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.57 134.76 11.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.49 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.13 162.76 26.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.632 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.95 121.47 42.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.861 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 118.44 36.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.984 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -110.75 98.05 7.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -113.4 126.94 55.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.95 173.62 40.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.47 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -119.55 135.41 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.4 163.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -140.25 -45.53 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.953 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.562 HG23 ' HE1' ' A' ' 65' ' ' TRP . 16.6 t -54.46 161.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' N ' HG12 ' A' ' 99' ' ' VAL . 1.0 OUTLIER -82.44 56.93 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.99 0.424 . . . . 0.0 111.075 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -128.1 72.55 79.46 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.22 124.38 13.93 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.538 2.159 . . . . 0.0 112.399 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 104' ' ' LYS . . . -164.95 75.02 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.44 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 103' ' ' GLY . 2.3 ptpp? 44.88 30.53 0.57 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.726 0.298 . . . . 0.0 111.397 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.83 90.54 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.815 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m -161.58 124.93 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.95 144.39 8.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -150.66 104.37 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.7 mtt -130.8 129.56 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.21 150.48 22.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -147.22 121.28 9.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.106 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -91.24 122.77 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 108.25 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.23 146.34 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.65 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 91.04 7.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.493 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 34.3 Cg_exo -57.51 86.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.961 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.12 106.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.258 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -107.35 132.64 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.495 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -138.32 128.59 25.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.201 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.2 100.87 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 156.22 40.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.47 29.05 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -32.85 11.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.598 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.9 -78.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -164.09 25.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp -142.33 152.4 42.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -102.53 111.11 23.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.619 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.95 137.93 31.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.88 118.91 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -105.01 139.85 14.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.53 120.28 16.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.77 98.97 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.846 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.4 t -87.47 110.11 20.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.719 ' HG3' HG22 ' A' ' 151' ' ' VAL . 1.8 ttp -112.12 122.88 48.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -105.24 128.79 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -108.37 98.92 8.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.54 128.56 33.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.54 135.12 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -163.63 140.3 6.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -62.03 -25.45 67.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.47 43.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -71.82 92.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.0 p -83.7 -48.87 9.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.3 m -106.03 -31.19 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.88 29.21 67.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -67.93 135.78 52.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.959 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.47 94.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.75 -42.06 13.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 t -137.09 142.08 42.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.403 ' NH1' ' HB3' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -133.59 113.01 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.812 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.719 HG22 ' HG3' ' A' ' 134' ' ' MET . 29.0 t -102.35 137.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.045 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.49 118.74 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 m -97.18 136.51 37.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.01 101.47 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.7 m -94.99 108.41 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -107.63 134.45 12.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.699 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.3 mt -119.61 124.69 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.765 0.317 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -112.96 121.08 43.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -130.08 108.41 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.028 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.996 HG23 ' HB2' ' A' ' 166' ' ' ALA . 0.8 OUTLIER -84.75 126.57 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.871 0.367 . . . . 0.0 110.953 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -52.5 -27.41 16.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.79 49.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 57.24 58.94 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.9 m -165.3 -73.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.72 112.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.412 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.996 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -117.83 153.16 33.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.1 0.476 . . . . 0.0 111.848 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.2 tt -100.01 138.09 37.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.998 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -112.49 125.89 54.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.305 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 169' ' ' VAL . 9.1 p -123.02 103.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.586 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -97.36 134.7 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.03 25.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.461 ' C ' HD12 ' A' ' 173' ' ' LEU . 0.2 OUTLIER -85.82 132.64 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.248 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 172' ' ' TYR . 5.0 mp -142.14 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.643 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -88.71 123.79 33.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 112.93 8.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -131.83 -165.44 11.36 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -111.94 149.63 31.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -133.49 157.59 45.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -171.43 172.82 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -172.4 -46.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -134.35 -50.08 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.5 -45.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.03 103.41 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.95 31.27 5.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -160.78 167.75 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 170.61 -37.74 0.18 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.389 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 77.29 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.75 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -160.25 133.22 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.94 145.08 21.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.39 120.48 39.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -122.14 129.07 51.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.26 173.78 9.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.742 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.41 139.27 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -127.87 143.98 51.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.69 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -152.76 168.66 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.9 tt -176.62 85.41 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.524 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.82 113.67 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.39 2.06 . . . . 0.0 112.672 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.0 mt -114.47 116.16 28.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.387 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.806 HG22 ' HA ' ' A' ' 205' ' ' SER . 29.2 p -129.49 158.21 39.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 110.83 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 201' ' ' LEU . 9.6 tp -143.1 90.5 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.182 0.515 . . . . 0.0 109.997 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.83 -73.86 2.49 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.417 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -125.93 -35.07 2.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.715 0.293 . . . . 0.0 111.347 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -65.34 135.09 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.806 ' HA ' HG22 ' A' ' 200' ' ' THR . 13.2 t -128.1 115.85 19.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.038 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.34 119.48 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 207' ' ' THR . 5.0 t -122.68 104.76 36.24 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.208 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.19 161.83 39.92 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.693 2.262 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.43 ' CZ ' ' HA3' ' A' ' 237' ' ' GLY . 43.7 p90 -150.39 142.63 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.017 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.4 m -137.34 143.3 41.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.44 177.35 4.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.682 ' O ' HD12 ' A' ' 212' ' ' ILE . 2.2 pp -139.62 117.16 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -125.79 -50.0 0.18 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.45 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.27 101.42 4.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.87 -33.03 15.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.85 179.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -108.29 -48.96 3.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.72 170.15 22.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -116.41 155.2 28.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.7 31.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.85 150.61 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -101.09 33.93 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.765 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -127.73 112.07 14.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -157.32 -74.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 64.34 37.3 8.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.4 mt -135.98 106.48 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.111 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -108.66 87.37 2.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -135.35 148.11 49.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -76.92 149.77 36.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 71.93 123.76 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -60.53 179.86 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.86 0.362 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.76 150.51 13.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -94.53 162.95 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -129.41 31.58 4.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -163.48 106.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 236' ' ' VAL . 12.2 p -159.45 124.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.43 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -98.65 159.75 20.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.467 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.5 mt -144.45 129.95 18.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.828 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 253' ' ' GLU . 0.7 OUTLIER -112.28 99.15 7.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.914 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -84.58 151.91 24.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -164.64 106.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.476 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.2 155.09 40.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -122.73 125.87 46.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -160.36 33.37 0.17 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.048 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . 0.426 ' CB ' ' HB2' ' A' ' 248' ' ' LEU . 28.5 mt-30 -134.7 49.48 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.9 m120 60.96 55.18 3.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.11 -24.34 25.3 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.733 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 278' ' ' TYR . 1.9 mm? -69.54 129.49 39.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.511 0.196 . . . . 0.0 110.497 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.476 ' O ' HG13 ' A' ' 276' ' ' VAL . 43.1 t -95.7 166.69 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.906 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.88 117.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 24.5 t -122.58 132.46 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.83 121.48 34.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.426 ' HG2' ' CE1' ' A' ' 239' ' ' PHE . 7.9 mt-10 -96.66 106.16 18.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' TYR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 272' ' ' ALA . 2.2 t80 -83.72 122.78 29.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -72.65 -170.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -91.46 51.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.03 -166.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' TRP . . . . . 0.4 ' CE3' ' O ' ' A' ' 259' ' ' GLN . 38.9 p-90 -105.16 159.32 15.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.4 ' O ' ' CE3' ' A' ' 258' ' ' TRP . 0.9 OUTLIER -58.7 110.18 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -154.8 113.85 3.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.14 178.12 4.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.34 -66.89 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 60.76 31.76 20.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -111.67 28.84 9.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 58.86 26.51 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.997 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 44.4 m -164.8 -174.16 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.815 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -157.16 131.12 8.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -90.81 -63.05 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.62 159.77 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.64 175.46 13.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -161.47 -45.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 254' ' ' TYR . . . -55.3 140.94 37.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.19 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -80.13 171.45 54.33 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.562 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 274' ' ' VAL . 12.6 p -132.34 124.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -122.32 150.85 16.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.596 HG11 HD12 ' A' ' 248' ' ' LEU . 21.3 t -125.77 125.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.289 . . . . 0.0 111.181 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 249' ' ' SER . 8.1 m-20 -127.57 95.25 4.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.122 0.487 . . . . 0.0 111.235 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.767 ' HB2' HD13 ' A' ' 248' ' ' LEU . 2.3 t80 -88.7 125.74 34.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.727 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.9 141.46 45.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.29 101.32 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.834 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -101.74 -31.18 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -102.12 -25.09 13.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.079 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -94.02 43.81 1.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.9 m95 179.79 81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -110.77 111.56 22.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.71 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -91.21 126.09 36.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 37' ' ' ASN . 3.0 m-20 -131.98 127.31 36.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.56 122.93 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.26 160.82 13.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.99 129.27 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.4 ttm -109.92 132.95 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -142.33 125.36 16.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -86.85 136.2 33.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.803 HD11 HG21 ' A' ' 274' ' ' VAL . 26.3 mm -74.36 149.03 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.119 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.67 158.16 44.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.97 148.0 44.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.63 110.89 26.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.0 120.65 19.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.66 154.43 6.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.452 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -66.84 -42.0 86.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.58 -103.1 2.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.37 142.21 35.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -164.46 91.96 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -139.44 134.9 33.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.954 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.65 30.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.99 165.11 12.29 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.431 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.686 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.9 pp -79.89 121.03 24.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.48 128.52 52.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -135.1 92.16 18.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.48 160.69 48.15 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.451 2.1 . . . . 0.0 112.316 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.26 132.03 33.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 35' ' ' TYR . 18.7 t -105.43 157.04 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.437 ' N ' HG12 ' A' ' 34' ' ' VAL . 7.0 m-85 -141.47 147.52 38.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.016 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.58 114.07 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.622 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.402 ' CB ' ' HB2' ' A' ' 9' ' ' ASN . 0.4 OUTLIER -111.72 153.13 26.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -156.69 113.93 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.846 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -98.67 122.46 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.315 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -134.8 88.45 2.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.99 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.68 -123.19 32.0 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.234 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.68 25.29 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -140.11 110.74 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.61 157.31 15.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.61 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 27.1 mm -126.38 134.75 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.141 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -141.14 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 tt -116.73 115.97 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.34 142.71 50.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -97.91 120.59 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.014 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -112.92 106.81 15.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.99 162.13 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.753 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -105.09 153.95 20.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.71 -132.88 3.66 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.382 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.53 154.7 6.02 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.453 2.102 . . . . 0.0 112.413 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 29' ' ' LEU . 10.8 p -177.14 -39.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 55' ' ' VAL . 1.2 t70 -144.46 -47.6 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -161.34 127.31 3.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 m -69.58 161.35 29.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.921 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.13 168.8 8.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.58 31.12 9.04 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.5 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt 60.34 78.44 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.82 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.825 ' HB2' HG22 ' A' ' 99' ' ' VAL . 4.5 mmt85 -132.5 -47.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.63 4.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 65' ' ' TRP . 1.3 m 60.2 171.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 110.908 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.452 ' H ' HG22 ' A' ' 64' ' ' THR . 34.4 m95 61.14 32.75 19.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -80.96 132.4 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER 57.82 -169.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.774 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 12.5 mmt180 -157.81 163.06 25.91 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.096 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.419 ' HD2' ' CD ' ' A' ' 68' ' ' ARG . 92.9 Cg_endo -84.54 -166.88 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.87 2.38 . . . . 0.0 112.375 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -146.67 123.63 11.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 155.13 17.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -162.05 128.36 3.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 89' ' ' GLY . 28.9 m -129.84 157.11 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -121.25 145.13 48.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -125.27 128.39 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.74 102.27 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.949 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.84 -73.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.56 120.35 41.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -97.3 107.34 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' H ' ' HG ' ' A' ' 84' ' ' SER . 22.0 t30 -159.55 142.75 14.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.46 -13.4 59.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.701 ' O ' HG23 ' A' ' 120' ' ' VAL . 8.3 t0 -100.17 -42.75 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.988 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -141.37 87.5 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.454 ' HG ' ' H ' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -108.72 159.05 17.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -145.03 137.96 26.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.816 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -148.46 141.3 8.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.599 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.987 HD21 HG23 ' A' ' 114' ' ' ILE . 5.9 tt -120.69 122.46 40.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 0.0 110.784 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.688 ' HB ' ' HB3' ' A' ' 115' ' ' ALA . 20.8 m -102.66 117.14 34.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.826 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -109.06 116.05 4.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.448 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -130.5 147.08 18.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.6 134.93 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 -106.0 132.67 51.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -137.81 115.18 11.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -140.49 148.02 40.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.787 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.37 -166.63 39.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.545 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -135.87 157.06 47.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.82 0.343 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -177.06 95.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.72 -168.36 2.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 62' ' ' ARG . 20.7 t -59.45 -67.06 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.128 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.77 -66.79 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 59.96 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.31 79.43 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.398 2.065 . . . . 0.0 112.205 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.74 84.12 0.13 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.479 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.1 mttt 63.34 122.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.841 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -152.96 30.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.5 m -162.34 129.37 3.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -166.03 148.03 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.59 100.01 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.6 mtt -118.61 142.64 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 9.9 tt0 -132.53 133.33 43.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.7 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -135.76 129.66 32.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.049 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -85.94 142.89 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.585 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -127.19 133.05 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.448 . . . . 0.0 111.317 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.987 HG23 HD21 ' A' ' 87' ' ' LEU . 10.7 mt -131.48 143.48 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.41 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.688 ' HB3' ' HB ' ' A' ' 88' ' ' THR . . . -139.93 66.0 31.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.856 ' HD3' HG22 ' A' ' 114' ' ' ILE . 68.7 Cg_endo -74.24 65.99 5.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.41 2.073 . . . . 0.0 111.506 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 131' ' ' TRP . 2.8 p30 -80.47 179.48 7.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.491 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -152.88 123.85 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.527 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.85 128.71 35.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 82' ' ' ASP . 7.6 p -145.14 100.93 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.24 152.67 48.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.156 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.65 32.78 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.37 -45.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -167.38 -42.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.426 ' HG ' ' CE1' ' A' ' 159' ' ' TYR . 2.0 mt -82.81 121.84 27.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -123.11 139.83 53.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.63 ' HB2' HG13 ' A' ' 120' ' ' VAL . 61.6 m-85 -134.55 138.36 44.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -152.19 118.96 5.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.23 114.34 4.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.431 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 117' ' ' ASP . 10.9 m0 -104.94 124.97 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 0.0 111.09 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.48 ' O ' HD23 ' A' ' 132' ' ' LEU . 8.6 tt -109.24 105.62 15.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 116.68 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.955 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.657 ' HG2' HG12 ' A' ' 151' ' ' VAL . 0.4 OUTLIER -96.88 118.99 34.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -104.23 119.92 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.001 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.401 ' HA ' HG22 ' A' ' 149' ' ' THR . 0.0 OUTLIER -123.93 145.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.557 ' CD1' HG21 ' A' ' 144' ' ' THR . 0.2 OUTLIER -104.81 151.76 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -164.8 150.34 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -160.79 -175.77 5.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 107.51 1.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 142' ' ' ASN . 5.4 tt 68.37 -68.17 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.42 ' HB2' HD23 ' A' ' 141' ' ' LEU . 2.9 t-20 -178.46 84.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.2 m -93.95 -43.15 8.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.557 HG21 ' CD1' ' A' ' 137' ' ' PHE . 1.8 t -91.56 -33.18 15.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.956 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.35 20.48 11.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.726 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 55.53 33.34 20.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 111.022 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -104.31 -177.05 3.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.35 32.18 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 137' ' ' PHE . 71.7 p -102.98 109.57 21.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.016 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -146.57 170.99 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.657 HG12 ' HG2' ' A' ' 134' ' ' MET . 35.6 m -118.52 148.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -125.03 138.63 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.638 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 34.3 m -93.92 145.35 24.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.124 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -136.88 98.99 3.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.81 108.0 20.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.455 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -110.29 141.93 16.43 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.583 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 156' ' ' GLY . 10.5 mp -123.61 130.5 52.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.767 0.318 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.408 ' CG ' ' HG3' ' A' ' 168' ' ' ARG . 5.3 mt-30 -117.55 113.22 21.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.426 ' CE1' ' HG ' ' A' ' 126' ' ' LEU . 27.4 t80 -130.16 116.8 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.822 HG23 ' HB2' ' A' ' 166' ' ' ALA . 9.4 p -84.72 137.23 33.35 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.13 -38.61 91.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -149.93 42.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 61.72 70.82 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 175.75 -64.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.729 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.588 ' H ' HG23 ' A' ' 164' ' ' THR . 27.5 m -103.98 112.77 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -118.01 150.48 39.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.111 0.482 . . . . 0.0 111.818 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.81 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.225 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.408 ' HG3' ' CG ' ' A' ' 158' ' ' GLN . 0.4 OUTLIER -115.0 114.62 25.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 169' ' ' VAL . 8.6 p -116.94 100.91 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.581 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.67 133.98 42.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.182 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -103.2 112.31 25.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.502 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.83 137.99 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.1 tt -141.74 94.92 2.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.632 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.41 144.67 25.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.76 157.03 47.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.776 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -145.37 148.73 20.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.536 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -134.07 118.96 18.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -125.43 117.54 23.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.986 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.19 143.12 30.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.72 31.43 20.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.25 171.02 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.6 p -99.46 34.65 2.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 60.49 30.24 19.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -98.39 -49.95 4.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -115.28 174.24 6.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.63 -28.94 13.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -105.82 31.4 5.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -148.14 129.71 14.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m -108.49 145.63 34.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 10.7 m -96.71 118.17 32.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -122.06 110.84 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -119.84 147.6 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 193' ' ' ILE . 7.3 tp -112.51 120.02 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.433 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 0.1 OUTLIER -106.28 132.03 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -110.26 148.61 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 194' ' ' ARG . 89.4 m-85 -153.4 175.11 13.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.425 HD23 HD11 ' A' ' 199' ' ' LEU . 14.4 tp -172.29 71.32 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.69 113.7 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.425 HD11 HD23 ' A' ' 197' ' ' LEU . 1.1 mt -114.27 151.31 33.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.739 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 204' ' ' HIS . 1.0 OUTLIER -138.11 157.85 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.731 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 13.0 tp -143.28 90.65 2.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.19 0.519 . . . . 0.0 110.144 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.71 -65.43 0.63 Allowed Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.408 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -148.49 32.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' HIS . . . . . 0.7 ' O ' HG22 ' A' ' 200' ' ' THR . 58.0 m80 -123.92 154.99 38.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.2 m -128.06 128.25 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.54 112.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.6 t -125.74 105.01 26.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.056 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.74 ' HB3' HD23 ' A' ' 238' ' ' LEU . 85.8 Cg_endo -78.3 165.07 26.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.528 2.152 . . . . 0.0 112.306 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.42 136.2 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.029 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.67 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 27.1 m -136.46 146.58 46.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.803 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.74 -39.1 2.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 24.9 mm -116.06 120.45 64.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.141 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.16 -149.67 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.461 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tp -116.93 101.98 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -104.23 169.1 8.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.84 33.27 5.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 60.08 31.43 20.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.4 t -104.57 -31.5 9.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -109.03 -31.46 7.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -117.33 114.12 23.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -134.79 155.13 51.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -176.48 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.63 162.91 22.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -138.07 -47.4 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -171.71 1.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.97 143.95 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.67 152.22 39.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.968 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -98.17 86.15 3.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 60.09 159.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 131.59 150.0 6.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.503 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.39 143.56 29.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.747 0.308 . . . . 0.0 110.866 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.61 133.68 45.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -98.54 -53.13 3.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -81.06 105.93 12.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -141.61 -69.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 p -89.83 130.89 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.086 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -74.49 156.78 50.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.74 HD23 ' HB3' ' A' ' 208' ' ' PRO . 34.2 mt -147.03 106.06 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.94 128.85 38.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.21 144.96 30.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -141.34 122.15 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -123.27 137.83 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.389 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.32 89.14 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.28 32.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.97 53.26 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.033 0.444 . . . . 0.0 110.737 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.2 t30 64.31 29.66 13.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.883 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 110.98 -14.71 28.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.883 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.618 HD11 HG11 ' A' ' 276' ' ' VAL . 2.8 tt -90.79 138.31 31.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.688 0.28 . . . . 0.0 110.857 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.727 ' O ' HG13 ' A' ' 276' ' ' VAL . 33.2 t -102.21 165.75 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.65 117.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 18.9 p -109.48 164.3 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.445 ' CD2' ' CE2' ' A' ' 254' ' ' TYR . 0.2 OUTLIER -145.58 136.31 24.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.417 ' O ' ' HB1' ' A' ' 272' ' ' ALA . 0.7 OUTLIER -107.4 113.83 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' TYR . . . . . 0.445 ' CE2' ' CD2' ' A' ' 252' ' ' LEU . 1.2 m-85 -115.19 151.24 34.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . 60.76 -175.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.15 -171.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 60.65 101.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -123.17 179.52 4.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.15 160.95 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.788 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 -34.84 11.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.851 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -83.67 118.6 23.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -132.28 122.32 24.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.88 -40.58 2.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.976 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 83.71 61.81 1.83 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -95.5 -31.42 13.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.885 0.374 . . . . 0.0 110.968 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.4 t -165.43 142.62 5.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.56 160.72 24.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -135.6 147.04 48.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.42 178.7 3.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.28 106.88 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.69 141.9 53.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.773 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 253' ' ' GLU . . . -174.41 144.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -106.24 170.8 16.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.386 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.803 HG21 HD11 ' A' ' 16' ' ' ILE . 21.5 t -138.03 141.76 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -126.44 179.12 16.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 249' ' ' SER . 22.7 t -153.96 140.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.679 0.276 . . . . 0.0 110.976 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 249' ' ' SER . 5.5 t-20 -148.09 95.31 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 111.394 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 280' ' ' PHE . 13.0 t80 -92.71 154.99 17.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.661 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.42 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 12.6 p -143.04 146.71 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.449 ' HB2' ' CE1' ' A' ' 278' ' ' TYR . 44.2 t80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.956 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.806 0.336 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -115.82 118.08 32.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -118.85 -41.31 2.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -59.89 -27.31 66.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.977 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 65.37 28.72 11.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.956 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.69 115.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.049 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.782 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.4 m80 -109.65 112.14 24.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.699 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.98 135.49 33.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -149.0 132.08 16.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.596 HG23 ' CE1' ' A' ' 36' ' ' PHE . 22.1 mt -125.97 154.0 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.49 119.33 0.89 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.33 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -128.18 157.74 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.8 127.86 35.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 32' ' ' PRO . 5.9 m-85 -134.25 154.76 51.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.9 124.79 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 16' ' ' ILE . 19.1 tt -119.19 118.44 57.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.053 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.38 156.65 16.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -76.0 170.84 15.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 19' ' ' VAL . 29.7 m -62.76 107.1 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.04 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -163.24 91.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.69 135.78 2.59 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.577 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.99 -55.16 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.99 89.46 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.418 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -157.45 -42.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 111.017 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.89 38.43 6.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.915 0.388 . . . . 0.0 110.76 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.4 ttp -161.86 61.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -162.22 99.97 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.89 81.05 0.25 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.435 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.13 148.08 52.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.931 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.59 77.92 1.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.07 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.85 72.35 5.75 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 14' ' ' TYR . 63.3 Cg_endo -73.48 119.24 5.85 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.572 2.182 . . . . 0.0 112.429 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -97.21 143.3 28.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.736 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 35' ' ' TYR . 15.3 t -117.16 157.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.285 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 34' ' ' VAL . 2.5 m-85 -157.46 132.96 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CE1' HG23 ' A' ' 10' ' ' ILE . 67.6 m-85 -134.42 157.34 46.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.747 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 149.45 33.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.616 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -150.4 113.83 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.727 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -94.49 120.58 34.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.302 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.72 88.59 2.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.65 -127.13 15.72 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.05 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -88.13 19.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.767 2.312 . . . . 0.0 112.792 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CZ3' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -140.11 121.97 15.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.906 0.384 . . . . 0.0 111.173 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 103.95 11.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.661 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.616 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 3.2 tp -83.89 139.63 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.199 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.868 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -139.04 119.64 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tp -104.66 148.71 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.793 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.94 157.36 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.185 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 114.64 22.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 111.8 22.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.98 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.13 156.98 42.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.55 116.04 16.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.927 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.35 149.36 27.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.56 51.54 3.91 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.696 2.264 . . . . 0.0 112.623 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 55' ' ' VAL . 15.2 t 49.03 38.39 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 111.39 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.84 85.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.53 174.32 12.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -76.68 -34.25 58.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 60.52 37.99 19.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.04 -48.23 6.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.466 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -61.22 -74.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -67.61 179.02 1.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.65 49.5 0.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.497 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 p -111.88 92.88 4.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.72 0.295 . . . . 0.0 110.832 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -176.32 96.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.046 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CD1' ' HA3' ' A' ' 95' ' ' GLY . 36.8 t80 -149.61 -75.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.53 -165.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.804 0.335 . . . . 0.0 111.141 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -174.73 168.79 1.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.958 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.47 -168.52 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.56 2.173 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.46 165.44 27.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mp -137.04 156.98 47.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.868 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -146.25 152.99 40.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.997 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.55 HG23 ' HA3' ' A' ' 89' ' ' GLY . 16.9 m -143.6 141.8 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -123.27 110.12 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CE1' ' CZ3' ' A' ' 43' ' ' TRP . 2.2 t80 -96.42 86.92 4.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.32 127.19 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.809 ' HB3' HD12 ' A' ' 78' ' ' LEU . 14.1 m-85 -84.28 -73.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 77' ' ' PHE . 3.8 mp -145.59 143.83 30.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.004 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -104.33 94.86 5.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.721 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -161.47 172.22 16.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.39 -68.3 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.598 ' HB3' HG13 ' A' ' 120' ' ' VAL . 1.6 m-20 -119.1 -44.02 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.808 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.415 ' CD2' ' HE3' ' A' ' 121' ' ' LYS . 5.8 t80 -178.62 -75.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 p -147.26 159.2 43.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.827 0.346 . . . . 0.0 111.233 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.09 106.76 3.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.78 -146.78 4.47 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.403 HD23 ' HG3' ' A' ' 116' ' ' PRO . 1.2 mp -143.67 117.7 9.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.662 0.268 . . . . 0.0 110.45 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -79.58 122.33 26.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.64 ' HA2' HG22 ' A' ' 114' ' ' ILE . . . -108.25 173.17 17.76 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.42 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 72' ' ' GLU . . . -178.05 156.12 18.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.722 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -142.66 110.3 5.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 110.749 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 133.65 52.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -147.31 140.87 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -146.1 158.22 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.427 ' HA3' ' CD1' ' A' ' 66' ' ' PHE . . . -81.16 -177.9 52.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.181 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.768 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -143.69 89.72 2.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -60.23 158.68 11.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -152.82 -48.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 100' ' ' ASP . 5.7 m -141.65 -48.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.416 ' N ' HG23 ' A' ' 99' ' ' VAL . 0.1 OUTLIER 55.09 30.29 14.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.403 ' CB ' ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -69.06 -60.8 3.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.862 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 101' ' ' GLU . 62.6 Cg_endo -73.54 -36.46 3.86 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.562 2.175 . . . . 0.0 112.316 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -168.45 -79.68 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.437 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.79 -77.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 110.845 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.74 50.52 12.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.083 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 p -102.87 179.88 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.56 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.768 ' HB3' ' HB2' ' A' ' 96' ' ' TYR . . . -116.79 137.68 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.726 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.33 117.61 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.32 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.25 131.04 55.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.77 137.77 51.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 111.378 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.16 135.85 41.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -104.69 138.53 40.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.142 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 134' ' ' MET . 0.1 OUTLIER -132.0 102.44 5.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.64 HG22 ' HA2' ' A' ' 89' ' ' GLY . 2.9 pp -139.61 149.47 22.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.939 ' HB3' ' O ' ' A' ' 132' ' ' LEU . . . 175.65 153.02 0.33 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.698 0.285 . . . . 0.0 111.396 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HG3' HD23 ' A' ' 87' ' ' LEU . 22.0 Cg_exo -64.91 136.96 51.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.659 2.24 . . . . 0.0 112.448 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.9 142.29 50.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.431 ' CE2' ' HA3' ' A' ' 130' ' ' GLY . 29.2 p90 -124.26 122.93 39.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.347 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.39 107.31 14.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 82' ' ' ASP . 16.8 t -100.89 112.22 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.415 ' HE3' ' CD2' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -131.16 154.29 48.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.37 27.86 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.395 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.587 HG21 ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -83.1 -27.94 29.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.776 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -170.61 -72.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.587 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.95 26.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mp -142.27 148.14 37.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.982 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.4 112.06 25.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.591 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.496 ' CD2' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -98.81 117.35 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -112.7 118.92 36.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 118' ' ' TRP . . . -113.97 109.58 2.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.596 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.86 114.9 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.788 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.939 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 33.8 tp -126.96 131.06 51.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.81 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.6 m -136.47 120.9 18.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.831 ' HG3' HG12 ' A' ' 151' ' ' VAL . 3.5 mtm -92.87 120.86 33.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.112 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.35 135.71 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.0 0.429 . . . . 0.0 111.515 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.85 130.47 24.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.47 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.84 149.28 45.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.041 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.88 145.62 12.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -147.17 179.37 7.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.96 -35.55 80.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mp -105.55 39.81 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -58.53 99.43 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.004 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -67.35 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.812 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 146' ' ' TYR . 12.1 t -110.49 -33.58 6.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.806 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.7 34.07 60.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.683 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.536 ' H ' HG23 ' A' ' 144' ' ' THR . 1.1 t80 -99.54 168.52 9.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 0.0 110.937 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.68 -175.16 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 62.26 31.54 17.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -93.58 146.84 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.67 170.87 14.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.831 HG12 ' HG3' ' A' ' 134' ' ' MET . 3.7 m -141.58 120.09 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.14 99.85 9.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -97.56 127.15 43.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -128.9 97.74 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.1 p -96.4 103.89 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.714 ' C ' HD22 ' A' ' 157' ' ' LEU . . . -104.78 135.87 12.77 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.714 HD22 ' C ' ' A' ' 156' ' ' GLY . 3.2 mm? -121.39 125.79 47.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -119.07 102.79 9.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.616 ' O ' HD12 ' A' ' 167' ' ' LEU . 19.0 p90 -130.11 134.21 47.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.169 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.801 HG22 ' HB2' ' A' ' 166' ' ' ALA . 5.9 p -97.72 142.32 29.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.446 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 20.6 m-85 -55.16 -31.13 61.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.09 -66.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.641 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.14 74.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.538 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER 178.44 -62.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 165' ' ' VAL . 29.8 m -104.02 112.84 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.734 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.801 ' HB2' HG22 ' A' ' 160' ' ' THR . . . -105.54 146.71 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.538 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 159' ' ' TYR . 2.0 mp -93.92 134.2 36.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.323 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 130.16 53.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 169' ' ' VAL . 12.1 m -137.45 100.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.893 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.4 141.88 31.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -121.27 114.56 21.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -92.14 129.53 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.9 101.91 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -107.93 113.02 25.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -140.06 133.25 29.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -157.42 -167.11 18.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -102.24 123.16 45.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 0.0 110.943 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -128.8 119.45 24.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 3.1 mtt -98.9 -31.48 11.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.88 100.06 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -131.67 -66.97 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.1 m -141.44 28.65 1.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.975 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.8 mmt-85 57.23 27.64 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.077 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -178.56 38.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.815 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -171.2 153.68 3.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.99 46.27 0.42 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.429 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -148.17 94.78 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.24 157.71 44.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.83 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.9 t -147.04 140.41 25.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 m -115.45 117.79 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.803 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -121.59 137.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.987 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -137.42 138.17 39.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.749 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.8 mt -126.71 129.75 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.21 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -127.12 137.43 52.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.564 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.59 54.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.283 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.645 ' O ' HD23 ' A' ' 197' ' ' LEU . 23.6 m-85 -135.55 170.36 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 196' ' ' TYR . 38.8 mt -149.34 67.16 8.82 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.75 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -44.6 113.85 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.727 2.285 . . . . 0.0 112.653 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.14 129.3 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 205' ' ' SER . 16.7 p -136.97 158.15 45.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -143.06 90.61 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.112 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.72 -66.38 2.41 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -131.68 -36.66 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.158 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.74 136.04 56.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.419 ' HA ' HG22 ' A' ' 200' ' ' THR . 74.4 m -128.06 132.55 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.888 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.41 HG22 ' CD1' ' A' ' 240' ' ' TYR . 21.4 t -139.09 119.5 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.025 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -106.58 104.91 52.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.58 155.16 27.69 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.522 2.148 . . . . 0.0 112.309 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.53 131.93 55.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.76 176.02 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.938 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.86 156.36 20.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 31.7 mt -143.5 152.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.142 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.69 -125.2 2.81 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.19 116.55 28.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.93 -28.51 8.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.019 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -40.16 76.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.005 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -78.49 130.55 36.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.2 p -176.18 125.0 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -104.14 130.32 51.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -112.98 140.23 47.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -123.28 -178.34 3.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -92.42 79.71 4.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -123.95 -177.28 3.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.948 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -116.84 31.94 6.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.5 108.09 15.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 15.5 pt -106.28 -35.08 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.114 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -132.63 111.98 11.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.24 153.28 30.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -109.74 85.98 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -121.91 28.76 5.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.551 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -77.84 158.47 29.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.969 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.45 155.08 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.15 118.43 8.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.07 168.99 8.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.423 ' O ' HG12 ' A' ' 236' ' ' VAL . 8.7 mtm180 -99.35 -40.28 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 236' ' ' VAL . 14.6 p 43.49 42.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.653 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -70.93 150.07 47.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 238' ' ' LEU . 5.2 mp -120.15 118.77 31.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.836 0.351 . . . . 0.0 110.913 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 251' ' ' SER . 9.1 t80 -118.38 119.88 35.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.41 ' CD1' HG22 ' A' ' 206' ' ' VAL . 0.6 OUTLIER -93.84 151.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -151.48 126.86 2.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.459 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -149.0 164.3 34.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -129.42 152.27 49.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.842 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -89.66 8.6 30.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.397 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 58.39 28.22 16.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.865 0.364 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -136.02 22.1 3.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.066 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.25 -24.16 26.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.746 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -89.98 149.38 22.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.662 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 277' ' ' ASN . 0.1 OUTLIER -117.38 166.21 12.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 111.167 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.6 m -151.95 125.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 239' ' ' PHE . 2.4 p -129.81 175.33 8.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 273' ' ' GLY . 0.3 OUTLIER -149.66 159.22 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.94 128.47 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -133.8 118.71 18.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -144.31 171.75 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.059 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.54 -178.5 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 60.42 165.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -168.95 99.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.47 170.48 8.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.45 111.52 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -85.23 111.75 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -98.61 -44.31 6.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -143.93 143.3 31.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -97.67 28.28 15.06 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.51 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.85 -48.05 9.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.714 0.292 . . . . 0.0 110.812 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.3 t -82.17 145.54 30.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -168.81 100.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.41 171.51 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -91.4 -31.47 16.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -104.53 143.3 33.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -148.72 -74.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -128.83 -69.53 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.55 ' O ' HD23 ' A' ' 252' ' ' LEU . . . -115.81 151.39 18.4 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.468 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' A' ' 252' ' ' LEU . 11.0 p -141.63 145.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 111.04 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -129.13 131.98 6.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 16.2 m -109.54 137.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.494 ' HB2' ' CB ' ' A' ' 249' ' ' SER . 58.5 m-80 -130.07 156.61 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 84.2 m-85 -149.51 137.15 20.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.762 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.21 135.08 26.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.978 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.839 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.792 0.329 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -99.56 31.44 3.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -109.64 32.37 5.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.25 31.45 6.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -135.06 -67.6 0.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.987 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.95 132.9 14.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.892 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.5 t60 -117.87 127.62 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -107.64 120.53 42.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 37' ' ' ASN . 2.7 m-20 -136.71 131.78 33.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.4 114.82 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 277' ' ' ASN . . . -109.28 116.96 4.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.453 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -117.93 116.13 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 0.0 111.137 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -102.77 143.73 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -133.16 141.89 48.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -101.78 158.91 15.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 tp -112.99 136.95 47.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -91.98 178.05 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -129.21 129.55 45.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 p -72.83 129.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.012 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -151.25 -68.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.83 100.91 0.63 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.504 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.61 102.24 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 110.956 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.05 -156.6 9.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.506 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.92 150.9 20.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.05 155.14 41.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.1 mmt -110.16 -30.94 7.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -124.25 157.06 35.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.98 122.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.519 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.13 -67.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.779 0.323 . . . . 0.0 110.887 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.37 135.17 40.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 33.8 tt0 -138.64 64.73 37.68 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 31' ' ' GLU . 18.1 Cg_exo -66.56 -162.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.682 2.255 . . . . 0.0 112.297 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -171.87 124.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.41 147.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.5 t80 -138.28 151.5 47.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -150.13 141.41 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 9' ' ' ASN . 0.7 OUTLIER -134.19 146.71 50.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.097 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.682 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -144.86 113.8 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.797 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -104.27 117.86 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.299 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -134.65 88.54 2.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 109.759 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.41 -126.69 36.11 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.899 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.83 24.98 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.72 2.28 . . . . 0.0 112.689 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -140.39 110.8 6.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.791 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 73' ' ' VAL . 16.1 ttt180 -106.67 146.73 30.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.535 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 3.0 mt -121.57 111.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.269 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -110.19 106.69 16.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 45' ' ' ILE . 3.8 mm? -104.33 127.92 52.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . . . -135.03 131.97 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 115.52 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.891 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.41 134.64 54.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -142.28 157.49 44.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -130.42 139.49 50.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.46 166.7 10.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.46 21.34 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.856 2.371 . . . . 0.0 112.861 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t 60.14 63.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.48 143.27 43.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.819 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -100.7 133.05 45.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.0 133.32 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.5 133.66 18.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.121 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.75 -32.87 2.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.35 85.75 1.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.788 0.327 . . . . 0.0 110.911 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 59.62 163.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.906 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.99 159.48 25.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 64' ' ' THR . 5.2 t -97.6 99.47 10.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -150.02 135.74 18.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -161.0 107.27 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.75 125.83 29.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 37.6 mtt180 -128.08 52.67 9.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.054 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.2 Cg_endo -74.69 127.15 10.66 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.471 2.114 . . . . 0.0 112.238 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 6.6 mt-10 -112.46 145.78 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.88 120.39 17.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -124.12 143.01 50.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.012 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 44' ' ' ARG . 13.2 t -131.84 148.68 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.545 ' CD2' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -118.95 135.17 54.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.051 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -135.06 87.31 2.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 138.83 34.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.56 -55.7 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.3 tp -133.66 123.68 25.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -92.79 98.78 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -151.9 122.03 7.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -58.44 -22.85 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -28.56 17.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.963 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -151.79 79.22 1.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.2 150.9 22.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -148.63 119.74 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.759 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.49 150.8 22.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.61 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HB2' HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -130.83 120.22 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 0.0 110.742 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.545 HG23 ' CD2' ' A' ' 74' ' ' HIS . 3.0 m -94.61 106.52 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.59 105.64 3.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.377 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.93 147.59 16.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.749 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.01 113.71 18.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.87 111.84 23.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.063 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -133.55 106.82 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.579 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' A' ' 109' ' ' MET . 16.7 p90 -125.27 118.55 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.328 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.36 179.11 9.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.382 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 98' ' ' TYR . 0.8 OUTLIER -150.07 98.2 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 111.011 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -80.19 119.67 23.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.962 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.478 ' HD1' HG23 ' A' ' 99' ' ' VAL . 32.2 p90 -156.28 149.51 24.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.831 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 100' ' ' ASP . 22.4 t 64.91 158.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.488 ' N ' HG12 ' A' ' 99' ' ' VAL . 1.3 t70 -68.57 -55.36 11.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.958 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -122.69 79.66 48.31 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.025 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.84 -38.3 4.28 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.637 2.225 . . . . 0.0 112.342 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.29 -95.8 0.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -96.41 -36.76 10.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.909 0.385 . . . . 0.0 110.831 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.77 -80.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 p -141.4 -174.82 4.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.642 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.61 119.68 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -105.84 124.69 49.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.46 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.433 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 mtt -94.38 129.71 40.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.323 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -95.23 149.54 21.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.04 94.92 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.796 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.53 134.65 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.04 146.57 35.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.26 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' A' ' 87' ' ' LEU . 1.7 tp -138.28 143.55 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 88' ' ' THR . . . -126.32 66.28 61.06 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 111.525 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 82.74 2.0 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 111.867 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -92.06 173.16 7.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 40.8 p-90 -155.92 122.92 5.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.809 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -99.85 137.58 38.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.671 HG23 ' HB2' ' A' ' 128' ' ' PHE . 22.6 m -139.68 117.25 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.8 135.47 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.992 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 123' ' ' THR . 3.9 pp -115.35 -31.63 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.918 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.619 ' N ' HD12 ' A' ' 122' ' ' LEU . 43.1 m -142.49 162.89 34.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.695 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.439 ' N ' HG22 ' A' ' 123' ' ' THR . 3.3 t70 -74.68 61.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.09 -48.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.459 HD22 ' HE1' ' A' ' 128' ' ' PHE . 3.5 mt -84.89 109.9 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -112.52 115.12 28.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.671 ' HB2' HG23 ' A' ' 120' ' ' VAL . 3.7 m-85 -91.0 136.7 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.1 118.87 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -118.63 121.21 4.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.224 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -104.93 174.25 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 111.118 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.7 mt -147.72 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.717 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.24 99.89 12.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.045 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.42 ' HB3' HG22 ' A' ' 114' ' ' ILE . 3.4 ttm -105.93 137.18 44.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.494 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -123.43 150.55 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.102 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -156.09 103.19 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.22 153.36 41.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.65 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -152.09 161.58 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.91 -29.84 68.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.81 -35.45 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.997 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.33 101.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.797 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -68.47 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.65 -33.22 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.28 28.3 70.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.616 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -97.55 86.46 3.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -164.08 90.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.095 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -179.87 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -77.08 125.33 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -100.52 150.76 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.22 126.63 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.15 96.97 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 t -97.5 137.69 36.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -127.05 103.05 7.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 29.6 p -96.38 106.03 18.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.513 ' O ' HD23 ' A' ' 157' ' ' LEU . . . -130.0 167.99 21.52 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.993 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -134.36 129.77 35.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.738 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.77 113.33 25.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.638 ' OH ' HD11 ' A' ' 167' ' ' LEU . 35.4 p90 -130.24 138.08 50.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.07 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER -97.29 143.73 27.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.938 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.2 -45.93 13.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.355 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.65 33.92 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.301 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.683 ' O ' HG23 ' A' ' 164' ' ' THR . 2.6 mt-10 52.57 73.96 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.085 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.1 OUTLIER 177.91 -65.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.816 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 165' ' ' VAL . 11.9 p -103.87 113.19 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -108.64 136.9 47.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.495 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.638 HD11 ' OH ' ' A' ' 159' ' ' TYR . 0.8 OUTLIER -93.9 123.61 37.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.475 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.46 122.52 46.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.326 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.47 110.57 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' A' ' 156' ' ' GLY . 4.2 p-10 -111.04 155.49 22.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 111.658 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.55 120.99 41.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.346 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.91 134.99 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.0 tp -142.04 108.86 5.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -112.24 139.32 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.968 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -137.12 121.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.801 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -86.23 155.15 28.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.572 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -113.72 145.18 41.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.793 0.33 . . . . 0.0 110.844 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -104.16 141.55 36.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 11.3 ttt -131.44 31.26 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -142.7 -47.47 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.004 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.6 118.26 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.26 32.24 2.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.68 31.54 6.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.85 70.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.4 141.61 28.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 59.37 42.07 97.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.521 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.86 -48.86 8.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.85 146.46 6.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.61 142.16 49.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.791 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 132.59 39.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -147.04 110.04 4.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.85 178.49 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.43 132.73 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.12 142.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.548 ' HB3' ' CB ' ' A' ' 210' ' ' THR . . . -106.73 153.31 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.234 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -160.0 145.54 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -157.04 79.36 3.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.563 ' HA ' HG22 ' A' ' 207' ' ' THR . 42.1 Cg_endo -67.88 113.52 3.03 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.402 2.068 . . . . 0.0 112.292 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 200' ' ' THR . 1.3 tt -114.36 144.83 42.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.705 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.616 ' N ' HD23 ' A' ' 199' ' ' LEU . 5.9 p -138.04 156.23 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.21 90.52 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 109.904 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 66.79 -73.49 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.256 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -123.02 -34.63 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.53 138.0 56.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 48.1 m -128.09 134.44 49.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 240' ' ' TYR . 18.3 m -146.08 124.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 198' ' ' PRO . 14.9 p -137.02 104.88 8.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.053 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.82 165.01 15.69 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.693 2.262 . . . . 0.0 112.234 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.435 ' CZ ' ' HA3' ' A' ' 237' ' ' GLY . 47.1 p90 -141.32 133.6 28.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.548 ' CB ' ' HB3' ' A' ' 195' ' ' ALA . 0.4 OUTLIER -114.62 137.64 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.994 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.42 -55.38 3.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.7 pt -107.75 131.46 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.096 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -147.15 96.31 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.447 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 12.3 mt -106.32 36.4 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 110.916 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 61.13 178.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.41 31.92 3.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -146.63 148.48 32.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.53 35.77 20.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.55 -52.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -92.68 91.12 7.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -102.12 -50.45 3.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -78.88 171.95 14.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -108.05 130.8 55.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.29 147.21 23.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.09 101.37 4.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.5 pt -141.34 163.94 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -115.4 -38.67 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 141.15 55.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -175.16 98.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -108.2 -144.09 10.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -117.4 -46.04 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.949 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.75 143.66 32.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.49 168.71 12.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -98.55 87.86 3.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.77 175.67 8.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.3 t 63.64 139.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.435 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -76.37 141.15 26.4 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.92 129.73 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.26 102.66 11.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.408 ' CD1' HG12 ' A' ' 206' ' ' VAL . 0.3 OUTLIER -78.69 154.87 29.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.24 132.08 3.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.436 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -148.87 156.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -162.33 93.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.403 ' O ' ' CD2' ' A' ' 244' ' ' PHE . 40.9 t80 -177.31 36.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.062 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.3 -48.5 3.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.617 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -179.0 38.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.47 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.94 -6.0 69.27 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.613 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.5 mp -96.42 153.0 18.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.695 0.283 . . . . 0.0 110.701 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.0 t -103.8 141.13 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.733 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.77 126.9 59.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.345 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.35 117.06 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 274' ' ' VAL . 1.4 mt -115.09 124.85 52.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.77 145.28 38.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.32 109.43 8.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -151.72 -172.96 4.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.078 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.45 164.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -125.87 -178.74 4.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -126.69 174.98 8.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 64.91 123.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.24 164.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.812 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -138.53 -178.27 5.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.85 -173.85 2.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -95.45 36.63 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -85.64 -12.09 73.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.763 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 62.01 43.67 8.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.907 0.384 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.5 m -105.74 98.9 8.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -86.55 106.52 17.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.27 103.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.35 83.59 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.673 ' NE2' ' HB3' ' A' ' 272' ' ' ALA . 23.5 t-160 -85.35 107.05 17.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.45 -46.3 64.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.844 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.673 ' HB3' ' NE2' ' A' ' 270' ' ' HIS . . . -62.48 176.64 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 148.51 -172.54 28.7 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.52 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' A' ' 252' ' ' LEU . 22.6 m -129.61 155.73 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -155.54 169.06 33.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 249' ' ' SER . 4.5 m -131.73 116.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.647 0.261 . . . . 0.0 111.056 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 249' ' ' SER . 41.5 t30 -115.74 95.4 5.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 111.255 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 279' ' ' SER . 3.6 t80 -88.56 155.05 19.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.746 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 72.5 m -133.4 146.5 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.916 0.389 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -138.19 40.69 2.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.95 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -135.36 80.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -104.6 -55.01 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -151.37 -57.08 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -149.17 115.1 5.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.751 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.2 m170 -114.0 123.33 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.688 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.81 120.39 39.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -127.18 134.32 50.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.426 HG22 ' CD1' ' A' ' 36' ' ' PHE . 1.3 pp -134.97 114.12 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.017 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.34 167.65 22.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.594 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.6 118.81 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.25 163.43 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' HD1' HG13 ' A' ' 274' ' ' VAL . 9.6 m-85 -150.8 107.9 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.24 104.27 10.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 17' ' ' GLU . 23.0 mm 60.05 158.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' N ' HG22 ' A' ' 16' ' ' ILE . 3.3 pt-20 -104.11 -34.23 8.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.402 ' H ' HG22 ' A' ' 16' ' ' ILE . 5.6 t-20 -82.37 159.03 23.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.5 p -133.6 69.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 61.6 157.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.825 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.55 -118.64 0.76 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.499 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -166.66 -43.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.956 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.14 -142.23 7.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.408 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -135.94 58.46 1.75 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.358 . . . . 0.0 110.824 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -66.59 148.75 51.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.21 -169.18 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.512 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -177.52 81.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.36 69.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.626 HD11 ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -136.53 179.35 6.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 110.871 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.75 158.49 20.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -114.02 71.97 2.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.34 114.22 3.86 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.589 2.192 . . . . 0.0 112.331 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p -113.42 111.89 22.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.55 152.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.064 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 68.3 m-85 -140.27 136.9 33.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CD1' HG22 ' A' ' 10' ' ' ILE . 27.6 m-85 -147.15 104.48 3.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -105.28 155.26 19.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.066 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 7' ' ' HIS . . . -148.04 113.74 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.751 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -93.07 116.59 29.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.24 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -134.72 88.47 2.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 109.77 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.81 -123.97 34.8 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.02 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.416 ' HG2' ' CD1' ' A' ' 43' ' ' TRP . 94.0 Cg_endo -88.63 21.99 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.666 2.244 . . . . 0.0 112.76 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.488 ' CZ2' ' CE1' ' A' ' 75' ' ' TYR . 75.5 m95 -140.09 111.96 7.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.405 ' CB ' ' HB2' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -106.2 103.87 13.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.797 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -84.0 116.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.27 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.823 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . . . -123.97 115.92 22.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 122.41 43.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . . . -123.6 147.96 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -112.11 119.96 40.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.61 113.2 25.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 152.18 31.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -126.01 151.62 46.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.53 148.62 5.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HD3' HD11 ' A' ' 29' ' ' LEU . 59.0 Cg_endo -72.03 98.9 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.526 2.15 . . . . 0.0 112.287 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t 61.02 88.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.99 157.85 36.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -160.99 32.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.822 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.6 t -90.26 124.6 35.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.14 79.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.047 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.23 -71.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 -32.32 7.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -98.74 155.7 17.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.28 124.92 7.8 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.523 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -88.03 179.48 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.461 ' CE3' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -59.96 97.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.461 ' CD1' ' CE3' ' A' ' 65' ' ' TRP . 22.1 m-85 60.58 106.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.22 125.55 41.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.38 80.42 63.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.84 134.24 49.13 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.577 2.185 . . . . 0.0 112.046 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 10.4 mm-40 -115.73 123.53 48.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.151 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.37 153.83 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.823 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 5.1 mt-10 -154.01 143.59 21.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 89' ' ' GLY . 12.3 p -147.03 120.43 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.405 ' HB2' ' CB ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' CZ2' ' A' ' 43' ' ' TRP . 15.2 t80 -119.92 105.38 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.699 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -89.71 126.19 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -40.88 20.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.57 122.51 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 103.01 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -160.13 122.35 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.801 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.37 -25.2 33.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.51 -31.26 14.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.952 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -142.24 78.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -102.31 128.13 48.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.74 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.93 104.03 7.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.985 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -108.62 179.76 21.43 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.469 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 116' ' ' PRO . 3.3 tp -158.2 107.92 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.787 0.327 . . . . 0.0 110.788 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.583 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 1.2 m -75.53 155.96 35.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.697 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -153.65 108.76 0.38 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.514 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.46 167.01 19.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -139.94 129.37 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -125.43 149.49 48.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -147.75 97.82 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.27 110.64 20.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' A' ' 107' ' ' ALA . . . 123.17 174.75 14.35 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.658 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -158.11 149.57 21.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.724 0.297 . . . . 0.0 110.749 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -79.35 -176.48 5.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -120.74 114.03 21.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.0 p -93.14 -29.61 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.068 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.04 -43.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.453 ' CB ' ' HD3' ' A' ' 102' ' ' PRO . 1.2 mt-10 -172.85 -54.61 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 101' ' ' GLU . 35.5 Cg_exo -60.01 139.04 85.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.302 2.001 . . . . 0.0 112.175 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 124.0 39.06 0.51 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.565 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.93 -75.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 0.0 111.051 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -177.71 -74.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.6 m -163.13 129.78 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.423 ' HB3' ' CA ' ' A' ' 95' ' ' GLY . . . -176.22 135.88 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.196 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.39 102.35 2.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 mtp -125.82 105.43 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -83.51 135.52 34.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HB2' ' CE1' ' A' ' 137' ' ' PHE . 23.7 ttt180 -143.63 121.85 12.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.88 155.95 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.06 113.71 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.6 142.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.583 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -149.69 107.09 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.32 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 87' ' ' LEU . 50.3 Cg_endo -69.05 93.55 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.336 2.024 . . . . 0.0 112.145 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.85 136.57 51.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.018 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -139.74 122.95 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.98 114.64 14.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.9 124.07 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -109.99 115.74 30.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.732 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 123' ' ' THR . 0.5 OUTLIER -90.85 -28.14 18.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.87 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -165.18 -171.75 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.699 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.86 28.72 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.927 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.16 -41.83 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.04 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.25 135.18 52.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -124.86 134.11 52.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.777 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' CE2' HD21 ' A' ' 157' ' ' LEU . 4.8 m-85 -105.14 143.17 33.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -143.82 118.91 10.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.75 120.62 6.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.558 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -128.53 115.0 17.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.736 HD11 HG23 ' A' ' 153' ' ' THR . 0.5 OUTLIER -105.17 112.3 25.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.419 ' HG ' ' HH ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -87.09 101.1 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.474 ' SD ' HD23 ' A' ' 132' ' ' LEU . 1.9 mtt -120.78 137.99 54.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.419 ' HH ' ' HG ' ' A' ' 133' ' ' SER . 20.2 m-85 -146.68 159.88 42.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -140.7 98.93 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 111' ' ' ARG . 1.7 m-85 -79.03 159.4 27.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.68 160.86 26.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.96 100.8 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.471 ' HB3' HD23 ' A' ' 141' ' ' LEU . 0.9 OUTLIER 68.35 -68.95 0.16 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 140' ' ' ASP . 0.6 OUTLIER -151.99 40.47 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.923 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 19.7 m120 61.06 169.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.01 -69.61 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.5 p -111.5 -33.91 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 93.94 28.16 11.42 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.559 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -72.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -162.05 -74.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.049 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.24 30.08 18.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 m -89.96 116.86 28.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -96.0 127.3 41.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 151' ' ' VAL . 9.9 p -131.21 109.61 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.92 143.09 43.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.736 HG23 HD11 ' A' ' 132' ' ' LEU . 0.5 OUTLIER -114.44 135.9 53.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -135.13 103.06 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.059 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.4 p -99.71 103.93 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.31 140.61 15.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.423 HD21 ' CE2' ' A' ' 128' ' ' PHE . 1.9 mp -137.71 125.1 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -119.05 119.84 35.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 159' ' ' TYR . 53.2 p90 -130.14 124.98 33.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.604 HG23 ' HB2' ' A' ' 166' ' ' ALA . 62.4 p -84.83 140.96 30.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.129 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.19 -30.67 43.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -144.59 33.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 60.91 76.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER 172.18 -61.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.606 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.584 HG13 ' HG ' ' A' ' 199' ' ' LEU . 26.6 t -107.49 112.68 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.263 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.604 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -107.0 145.29 32.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.988 0.423 . . . . 0.0 111.753 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.72 120.12 33.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.117 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.95 139.2 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 169' ' ' VAL . 15.5 m -140.03 100.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.719 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.75 137.91 40.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.088 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -115.66 110.24 18.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.06 109.28 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -99.53 124.66 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.88 35.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 144.25 -153.87 25.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -111.89 129.38 56.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 0.0 110.844 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -114.56 135.61 53.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.46 114.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.82 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.57 117.97 22.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -171.92 -42.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 58.9 p -158.59 33.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.19 103.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.11 -32.22 64.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -176.8 -46.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.9 94.62 0.38 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.5 169.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -162.14 135.99 6.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.0 m -129.86 132.85 46.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.4 m -124.35 157.02 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -146.64 121.04 9.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.48 159.16 31.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 193' ' ' ILE . 7.8 tp -133.39 113.22 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.145 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 11.4 mmt85 -108.29 152.15 25.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.83 140.04 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.482 ' C ' HD23 ' A' ' 197' ' ' LEU . 0.9 OUTLIER -145.42 174.98 10.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.802 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.561 HD12 ' CD1' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -167.39 87.24 0.76 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.875 ' HA ' HG22 ' A' ' 207' ' ' THR . 46.6 Cg_exo -56.04 113.71 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.436 2.091 . . . . 0.0 112.298 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.584 ' HG ' HG13 ' A' ' 165' ' ' VAL . 0.2 OUTLIER -114.19 126.13 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.744 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.6 t -138.09 154.7 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.521 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.425 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.4 OUTLIER -143.17 90.6 2.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.254 0.55 . . . . 0.0 110.117 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.04 -80.83 1.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.555 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.37 39.03 3.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 111.015 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -132.2 141.16 48.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.94 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.6 m -124.47 117.47 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.66 106.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.875 HG22 ' HA ' ' A' ' 198' ' ' PRO . 43.8 p -114.91 104.82 53.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.002 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HG2' HD21 ' A' ' 197' ' ' LEU . 96.9 Cg_endo -80.0 164.98 22.17 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.579 2.186 . . . . 0.0 112.432 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -121.11 131.91 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.9 p -131.1 157.75 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -110.64 -32.17 6.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.06 -37.65 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 115.53 -42.13 1.98 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.9 155.9 49.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.315 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -97.99 25.91 5.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 55.5 96.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.09 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -144.95 157.15 44.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.64 110.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -142.6 -172.33 3.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -96.3 47.55 1.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 62.25 117.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -169.92 41.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -86.02 -175.41 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 6.9 t0 60.8 107.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.98 -178.35 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 226' ' ' ILE . 9.2 tp -108.48 115.93 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.43 149.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.6 -61.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -163.34 134.89 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -119.68 -38.48 0.71 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.97 133.17 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.942 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -121.82 134.32 54.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -76.37 -172.16 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.2 m120 68.54 -68.87 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.936 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 60.27 159.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.89 168.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -149.25 165.78 29.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.599 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.17 134.54 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -110.03 109.05 19.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.95 142.72 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -139.99 100.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.417 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.66 118.67 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 111.009 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -134.85 97.98 3.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.777 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.41 37.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.5 -44.18 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.757 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -170.69 34.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.683 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 95.34 -3.54 66.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.742 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 248' ' ' LEU . 3.5 pp -102.94 153.32 20.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.641 0.258 . . . . 0.0 110.813 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 276' ' ' VAL . 69.2 m -95.94 151.94 18.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.798 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.87 127.35 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.3 m -135.11 152.28 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.8 mt -141.01 131.08 24.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 127.75 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -142.62 165.49 27.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -110.37 -56.9 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.45 103.38 7.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -95.72 151.93 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.37 -56.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -127.52 139.43 52.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.7 -55.18 4.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -83.21 170.04 15.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -138.65 170.5 15.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -100.71 171.54 7.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -96.9 48.4 1.61 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -151.05 -63.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.09 141.38 45.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.56 171.33 8.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -165.84 159.36 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -123.99 106.58 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -151.02 130.34 12.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -89.62 175.71 7.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -154.77 -179.26 7.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.8 134.51 4.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.605 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.432 HG13 ' HD1' ' A' ' 14' ' ' TYR . 10.8 p -124.21 128.83 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.318 . . . . 0.0 110.997 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -136.18 152.32 21.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.729 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 249' ' ' SER . 20.2 t -140.85 141.7 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 0.0 110.803 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.01 95.53 2.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.058 0.456 . . . . 0.0 111.604 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 7.6 t80 -92.68 120.12 32.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.584 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 p -123.32 146.92 47.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.822 0.344 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 60.41 -170.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -158.37 42.54 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.981 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -142.66 32.59 1.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.88 49.73 0.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -164.2 90.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 18.4 m80 -116.1 108.42 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -88.0 132.44 34.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.73 120.87 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.33 131.01 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.195 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -122.12 128.92 7.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.466 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -121.04 155.98 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.1 mmt -147.05 121.11 9.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.846 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -141.45 157.23 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -106.98 138.29 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 274' ' ' VAL . 30.3 mt -90.51 136.62 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -118.77 173.17 7.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.61 132.57 39.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.58 178.91 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -162.31 -65.08 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.48 -170.69 14.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.554 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 152.7 39.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.58 124.11 8.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -72.08 -65.92 0.71 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.853 0.359 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.42 131.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.832 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.9 tmm? 60.21 107.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.14 163.08 33.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.36 -116.84 4.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.491 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.25 108.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.766 0.317 . . . . 0.0 110.934 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.91 -69.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -167.65 64.36 0.69 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.54 149.03 67.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.638 2.226 . . . . 0.0 112.353 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.58 144.74 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.54 150.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CE2' ' HA3' ' A' ' 11' ' ' GLY . 10.4 p90 -146.69 156.68 43.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.76 157.96 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -140.21 136.4 33.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -138.72 113.97 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -93.8 122.79 36.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 43' ' ' TRP . 34.5 t-20 -134.87 88.7 2.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -128.38 14.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.884 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -87.74 15.37 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.559 2.172 . . . . 0.0 113.177 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' A' ' 40' ' ' ASN . 60.8 p-90 -140.38 110.95 6.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.829 0.347 . . . . 0.0 111.395 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 10.6 ttm105 -102.2 110.59 22.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.67 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 5.0 tt -83.79 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.463 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -129.46 122.84 30.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.983 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.45 110.54 20.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.36 160.79 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -136.5 102.46 4.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.46 107.32 18.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.16 150.38 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.33 139.41 52.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.45 64.4 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.29 157.52 59.11 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.634 2.222 . . . . 0.0 112.336 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.07 -32.47 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.94 -173.86 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -112.66 159.18 19.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 m -80.57 164.2 23.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.77 -30.34 61.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.092 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.28 -49.52 0.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.508 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.74 44.07 11.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.956 0.408 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -69.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.958 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.77 -27.64 3.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 65' ' ' TRP . 0.2 OUTLIER 61.6 178.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.478 ' H ' HG22 ' A' ' 64' ' ' THR . 6.6 m0 -130.06 147.64 51.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.95 -26.44 14.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.004 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.81 173.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.911 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.4 ' CB ' ' HD2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -169.49 170.59 3.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 70.7 Cg_endo -74.8 -167.86 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.612 2.208 . . . . 0.0 112.355 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.51 156.27 36.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.971 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.93 153.95 40.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 12.6 tt0 -162.1 134.55 5.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.838 HG12 ' O ' ' A' ' 89' ' ' GLY . 12.4 p -128.99 150.06 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -118.66 137.68 53.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.99 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.27 87.51 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -93.0 116.25 28.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 -45.17 50.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 mt -143.43 136.96 28.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -97.97 101.97 13.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.7 148.53 25.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.8 0.85 56.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -111.03 -31.86 6.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -155.42 89.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.007 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.7 134.21 55.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.734 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -129.84 104.21 7.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -108.03 -175.2 22.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.162 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.16 108.79 2.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -77.7 159.25 29.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.838 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -174.12 91.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.37 152.21 17.36 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 4.3 m-85 -107.73 134.4 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -106.86 127.13 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.145 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -127.09 107.14 9.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.48 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -107.0 128.12 54.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.354 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 107' ' ' ALA . . . -104.92 136.33 13.05 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.486 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 2.4 p90 168.66 173.61 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.963 0.411 . . . . 0.0 111.078 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -128.0 158.01 39.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.636 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 99' ' ' VAL . 1.3 t80 -147.57 162.5 38.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.404 HG22 ' CD1' ' A' ' 98' ' ' TYR . 5.6 m -60.27 -28.04 40.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.37 32.01 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.407 ' CG ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -112.24 162.15 22.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 101' ' ' GLU . 66.8 Cg_exo -51.44 -34.17 49.92 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.554 2.169 . . . . 0.0 112.208 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.93 90.02 2.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.628 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.12 -73.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 0.0 110.887 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 168.97 -32.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.08 124.82 2.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.674 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.471 ' O ' ' HA2' ' A' ' 95' ' ' GLY . . . -116.43 144.68 43.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.979 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -99.65 125.5 45.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.467 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.7 ttm -107.88 124.78 50.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.344 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.566 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 6.0 mm-40 -91.38 140.5 29.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -152.97 104.45 2.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.832 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.31 144.6 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -142.06 103.01 4.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.732 HG22 ' HA2' ' A' ' 89' ' ' GLY . 1.3 pt -121.64 153.53 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -161.81 117.55 1.29 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.25 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 59.8 Cg_endo -72.11 92.84 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.364 2.043 . . . . 0.0 112.104 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.58 131.75 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -132.14 123.05 26.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.855 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 121.91 38.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.5 111.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -123.49 110.73 15.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -177.22 39.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 123' ' ' THR . 17.1 m -128.95 38.5 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 62.9 84.56 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.227 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 53.95 51.35 14.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.332 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -142.09 109.1 5.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.876 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.04 118.63 24.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -106.33 111.96 24.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -117.22 161.64 19.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.1 125.51 1.0 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.423 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -147.13 140.35 25.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.627 ' CD1' HG23 ' A' ' 153' ' ' THR . 7.6 mp -102.02 98.81 8.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.833 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.506 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 0.9 OUTLIER -77.08 110.49 11.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.016 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 mtt -92.95 132.3 37.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.69 137.0 45.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -141.28 152.56 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.685 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -125.95 149.42 48.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -157.14 163.32 39.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.92 -171.85 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -58.32 -30.78 66.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.946 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 141' ' ' LEU . 26.7 mt -140.89 -58.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.85 125.77 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.23 -68.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.1 p -112.73 -35.84 5.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 83.93 29.12 32.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.548 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -130.64 -178.74 4.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.58 -76.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.062 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.36 31.01 20.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.62 129.85 41.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -125.21 129.28 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.53 HG21 HD23 ' A' ' 132' ' ' LEU . 12.0 p -100.68 137.3 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.03 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -121.01 100.38 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.627 HG23 ' CD1' ' A' ' 132' ' ' LEU . 1.3 m -93.82 125.48 38.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.61 105.5 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.1 p -101.42 103.96 14.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.93 148.1 18.89 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.909 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.426 HD23 ' CD2' ' A' ' 126' ' ' LEU . 3.2 mp -137.8 125.42 22.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.69 0.281 . . . . 0.0 110.76 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 3.9 tt0 -112.78 115.02 27.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.085 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CD1' HD12 ' A' ' 126' ' ' LEU . 71.8 t80 -130.16 120.6 24.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.002 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.716 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 43.8 p -84.88 140.42 31.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.67 -29.88 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.804 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -161.66 44.35 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 164' ' ' THR . 47.5 mt-10 61.52 76.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER 176.69 -76.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.677 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.89 113.01 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.716 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -109.62 148.02 32.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.566 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.472 HD11 HD11 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -93.95 137.22 33.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.372 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 121.86 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 169' ' ' VAL . 9.7 p -123.99 110.75 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.792 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -107.55 121.54 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.088 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -87.85 116.37 25.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -85.9 139.18 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.03 100.43 3.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.84 131.1 43.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.41 ' HB2' ' CG1' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -140.08 155.14 47.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.58 167.2 24.0 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.35 121.46 45.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.6 132.24 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 4.0 ttm -120.43 118.67 30.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.59 179.99 5.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -50.16 12.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 m -120.99 -65.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.48 127.54 8.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -72.5 -18.27 61.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.16 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 61.81 41.11 12.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.889 0.376 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.86 63.56 0.19 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -110.62 122.27 47.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.96 -172.95 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.75 129.91 16.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.98 115.99 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -107.22 109.98 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.38 164.96 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.2 137.27 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.304 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.454 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 6.3 mmt-85 -118.34 151.88 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.624 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.73 132.55 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.952 0.406 . . . . 0.0 111.361 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 196' ' ' TYR . 0.7 OUTLIER -141.6 137.68 32.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.566 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.472 HD11 HD11 ' A' ' 167' ' ' LEU . 5.5 tp -109.74 75.07 0.78 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.756 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.416 ' HB3' HG22 ' A' ' 207' ' ' THR . 69.3 Cg_endo -74.03 113.74 3.86 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.734 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 197' ' ' LEU . 1.6 mp -114.16 156.02 25.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.441 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 204' ' ' HIS . 34.8 m -138.04 153.26 49.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.531 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 90.41 2.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.282 0.563 . . . . 0.0 110.094 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 60.27 -85.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -117.42 29.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' HIS . . . . . 0.492 ' O ' HG23 ' A' ' 200' ' ' THR . 1.1 t60 -132.63 130.24 39.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.624 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.02 119.04 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.83 127.2 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 198' ' ' PRO . 30.0 p -132.55 104.93 13.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.418 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.36 165.09 14.58 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.606 2.204 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.17 131.92 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.145 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.98 123.99 17.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -103.61 -67.27 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -172.1 137.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.982 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 158.77 74.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.502 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.52 40.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.04 100.63 13.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -112.17 168.97 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 64.74 36.84 7.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.6 t -173.88 59.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -138.64 -178.67 5.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -139.16 73.76 1.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 61.4 154.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.97 -58.32 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.58 -40.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.84 -76.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.875 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.88 37.22 26.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 15.5 pt -100.42 -34.61 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 168.4 19.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -38.88 3.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.782 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -90.44 121.63 32.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.13 28.86 4.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.592 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -163.34 89.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -111.42 172.0 7.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -77.93 170.39 16.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.61 -3.47 46.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.325 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.68 -178.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.03 -62.22 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.092 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -161.94 172.03 38.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.516 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.902 HD22 ' CZ ' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -132.87 137.0 46.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.861 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -129.21 123.33 31.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.902 ' CZ ' HD22 ' A' ' 238' ' ' LEU . 2.9 m-85 -112.24 155.08 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -137.19 110.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.549 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -119.32 114.93 23.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.982 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 124.31 28.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.831 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.811 ' CD2' HD11 ' A' ' 248' ' ' LEU . 0.1 OUTLIER -74.03 -10.33 59.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.348 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 62.44 27.24 16.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.818 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -139.24 16.62 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.993 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.11 -24.1 33.64 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.738 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.811 HD11 ' CD2' ' A' ' 244' ' ' PHE . 0.2 OUTLIER -94.77 136.69 34.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.66 0.267 . . . . 0.0 110.98 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 277' ' ' ASN . 22.7 t -102.18 157.62 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 0.0 110.952 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.94 122.16 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 m -126.98 134.3 50.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.55 161.77 18.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -139.25 99.25 3.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.21 145.64 27.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . 60.71 82.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -123.85 32.79 5.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.1 152.04 28.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -107.76 131.29 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.7 84.09 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -108.01 127.68 53.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -90.35 98.61 11.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -110.38 -50.0 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -160.84 -46.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 162.93 -29.02 0.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.515 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.25 98.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.841 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -100.13 35.62 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -139.98 174.9 10.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -72.59 153.49 41.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -148.9 117.49 6.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -152.52 122.74 7.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.97 120.9 14.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -146.39 177.9 8.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.051 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -158.9 179.12 34.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.536 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 16' ' ' ILE . 21.3 t -149.34 139.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -137.34 -176.09 14.21 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.603 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 15.1 m -149.95 155.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.652 0.263 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 249' ' ' SER . 1.4 t-20 -140.72 95.34 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 279' ' ' SER . 22.8 t80 -88.91 154.93 19.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.847 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 33.7 t -142.5 147.01 35.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.825 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.863 0.363 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -170.63 118.46 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.12 30.38 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.36 -53.63 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.745 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -157.37 92.03 1.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.726 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.422 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -144.33 111.94 6.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 33.3 m-70 -114.26 105.16 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' HB3' ' CE1' ' A' ' 280' ' ' PHE . 0.2 OUTLIER -89.95 119.98 30.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -131.11 134.78 46.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.0 mt -118.06 113.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.81 135.83 13.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.599 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -143.92 129.01 18.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 0.0 110.984 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.0 ttm -122.39 141.72 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 4.5 m-85 -118.38 128.04 54.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -119.41 122.6 42.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.62 112.63 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.047 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -149.27 87.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -84.62 157.75 21.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 m -131.54 177.24 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -91.18 -37.64 13.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.47 -157.99 43.7 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.559 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.07 79.38 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.32 -126.0 6.97 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -125.01 43.41 3.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.337 . . . . 0.0 110.847 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.6 151.39 23.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.816 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.68 166.89 15.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t0 61.75 115.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.38 -47.01 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.531 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -123.36 122.62 38.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 110.921 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.19 131.71 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.07 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.2 100.61 0.29 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.65 132.55 25.43 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.389 2.059 . . . . 0.0 112.176 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.08 149.0 26.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 49' ' ' TYR . 11.4 p -134.39 141.51 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.046 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.9 m-85 -124.78 145.91 49.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.53 109.37 8.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.68 156.8 18.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.232 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -160.13 113.83 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.617 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 44' ' ' ARG . . . -91.89 125.48 36.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.205 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -134.69 88.6 2.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.19 -125.08 26.51 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.31 17.25 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.635 2.223 . . . . 0.0 112.763 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.41 119.45 14.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.912 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -117.04 109.72 17.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.715 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.3 mt -86.75 141.96 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.904 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -139.82 97.83 3.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 117.44 31.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.713 ' HB3' ' CG ' ' A' ' 70' ' ' GLU . . . -117.54 162.85 17.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.447 ' HB2' HG12 ' A' ' 34' ' ' VAL . 18.6 m-85 -125.87 114.69 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.0 111.39 16.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.741 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 67' ' ' ASP . 48.0 mt-30 -147.81 148.88 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.27 158.94 44.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.812 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.36 -150.43 22.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.64 142.28 48.0 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.594 2.196 . . . . 0.0 112.299 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.44 -31.58 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -81.65 168.9 17.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -104.1 174.59 5.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.8 p -75.9 152.35 37.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.16 -53.35 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.18 -80.99 1.04 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -164.89 83.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.716 ' HA ' HG11 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -173.14 170.96 4.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.85 153.85 12.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.599 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 m -130.99 114.98 15.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.343 . . . . 0.0 110.831 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.84 -71.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.02 115.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . 11.8 m-20 61.55 -175.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -170.44 -179.92 0.66 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 26.4 Cg_exo -62.76 -171.17 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.434 2.089 . . . . 0.0 112.196 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.713 ' CG ' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -166.06 144.55 5.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 71' ' ' LEU . 4.1 mp -119.94 157.03 29.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.904 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 60.6 tt0 -147.78 149.56 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.03 148.87 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.438 ' CG ' ' HB3' ' A' ' 44' ' ' ARG . 13.8 m80 -122.86 126.36 47.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -107.28 101.45 10.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -87.46 102.17 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -78.8 -54.99 5.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.28 124.02 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.02 95.08 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.802 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -130.72 142.83 50.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.81 -22.03 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.202 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -117.51 11.33 13.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -176.47 71.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.63 116.05 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.821 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.92 123.0 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.961 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.08 163.64 22.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 87' ' ' LEU . 1.5 tm? -158.13 107.87 2.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 0.0 110.696 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 15.7 p -89.75 159.09 17.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.62 107.22 0.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.77 -176.91 14.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.733 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -129.1 132.59 47.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.798 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -113.66 125.81 54.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -96.12 99.93 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -97.74 106.01 18.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.53 -170.19 38.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.515 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.468 ' H ' ' HB3' ' A' ' 107' ' ' ALA . 6.2 p90 -151.13 154.54 37.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.971 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.9 176.29 5.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -106.87 173.43 6.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.716 HG11 ' HA ' ' A' ' 62' ' ' ARG . 12.4 p -98.19 -31.95 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.096 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.3 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.36 100.32 7.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.56 100.86 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.447 2.098 . . . . 0.0 112.343 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -136.08 -70.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.468 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.53 30.92 4.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -136.81 68.56 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.22 126.43 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.894 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.468 ' HB3' ' H ' ' A' ' 96' ' ' TYR . . . -171.76 129.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -143.11 100.53 3.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 mtm -125.21 134.13 52.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.8 145.02 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.56 117.56 10.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.753 ' CE3' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -86.59 150.39 24.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.69 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.05 106.51 4.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.753 HD11 ' CE3' ' A' ' 112' ' ' TRP . 5.5 mt -110.31 145.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.557 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -141.63 84.93 11.84 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.406 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.74 90.63 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.646 2.231 . . . . 0.0 112.144 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -62.99 111.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.89 122.96 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.46 122.1 25.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.48 123.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 125.47 52.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.88 -41.85 6.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.1 p -156.22 -177.48 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.63 58.59 4.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -179.09 -49.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.94 105.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -108.83 129.09 55.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.25 144.5 26.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -142.62 122.42 13.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.99 125.09 6.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -131.62 116.85 17.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.416 ' CD1' HG23 ' A' ' 153' ' ' THR . 0.9 OUTLIER -105.98 98.98 8.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 99.94 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.9 140.64 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -145.56 155.63 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.44 107.02 3.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -96.17 130.88 43.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.012 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.78 179.72 7.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.414 HD22 HD12 ' A' ' 141' ' ' LEU . 29.3 t30 -132.21 170.88 14.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.19 -32.0 66.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.414 HD12 HD22 ' A' ' 139' ' ' ASN . 7.2 mt -65.01 -34.28 78.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 60.15 91.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.1 p -88.42 -60.18 2.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.3 p -106.88 -36.04 6.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.006 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 79.71 1.03 86.36 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.839 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.71 86.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.357 . . . . 0.0 110.817 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -145.46 130.9 18.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.0 t70 60.18 81.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -85.14 144.74 28.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.67 115.93 31.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.82 103.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -123.6 130.15 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.019 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 132' ' ' LEU . 18.0 m -102.8 142.87 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.799 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.22 106.58 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 m -100.62 103.95 15.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.811 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.02 135.13 12.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.759 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.81 124.55 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 0.0 110.79 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.18 119.32 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.206 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -130.07 110.56 11.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.952 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.723 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 28.8 p -84.6 125.77 32.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -60.99 -29.31 69.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -155.96 41.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.141 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.498 ' C ' HG22 ' A' ' 164' ' ' THR . 2.3 tm-20 57.59 76.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.547 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 168.78 -64.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.504 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.547 ' H ' HG23 ' A' ' 164' ' ' THR . 4.6 m -103.91 112.98 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.723 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -121.15 161.65 21.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.882 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.3 138.72 41.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.064 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 113.63 26.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.74 100.84 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.509 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -95.38 140.7 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.325 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.77 116.76 27.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.92 136.72 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.8 tp -142.02 94.94 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.472 ' HB2' HG23 ' A' ' 190' ' ' THR . 11.8 mt-10 -96.35 118.07 32.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 122.38 16.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -142.45 -174.14 14.77 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -130.1 129.12 43.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.926 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -136.14 144.37 45.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -174.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -120.68 90.59 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.61 94.28 5.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.5 t 60.63 31.24 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -147.22 -178.56 6.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -151.26 37.59 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.79 32.9 2.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -65.95 -52.5 36.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.477 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -82.71 114.94 21.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 110.824 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -157.29 174.72 15.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.4 p -150.13 102.31 3.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 174' ' ' GLU . 2.4 t -92.84 159.06 15.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.37 141.69 32.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.976 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.44 178.99 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 44.3 pt -148.25 136.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.289 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.41 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 9.8 mtm-85 -134.39 138.94 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.727 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.842 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -110.01 137.77 47.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.48 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 196' ' ' TYR . 2.1 m-85 -135.63 175.09 9.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.85 72.64 0.92 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 0.0 111.017 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.685 ' HA ' HG23 ' A' ' 207' ' ' THR . 51.9 Cg_exo -52.84 113.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.469 2.113 . . . . 0.0 112.252 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.23 127.27 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 204' ' ' HIS . 51.7 m -138.12 146.61 43.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.276 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 95.4 mt -140.04 90.24 2.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.214 0.53 . . . . 0.0 109.993 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.46 -65.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.467 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -143.54 35.6 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.732 0.301 . . . . 0.0 110.828 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 200' ' ' THR . 1.9 m-70 -117.66 146.05 43.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.9 t -127.96 109.23 11.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.997 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.68 107.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.685 HG23 ' HA ' ' A' ' 198' ' ' PRO . 1.7 m -129.88 104.9 16.9 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.16 161.06 41.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 112.267 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -129.59 134.7 47.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.842 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 40.4 m -129.95 133.55 46.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.1 mtp85 -90.12 -36.39 14.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 29.4 mm -110.79 103.65 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.9 157.75 17.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.48 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.28 174.54 8.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.857 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -100.29 -177.79 3.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.97 37.54 1.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -170.27 113.77 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.759 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 74.9 m 60.28 82.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -82.8 -32.62 27.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.911 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.6 176.69 11.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -107.6 92.42 4.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER 60.3 98.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.99 119.62 38.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -102.33 -177.64 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.42 149.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.0 tt -109.79 -25.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -87.19 173.88 8.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.68 122.16 44.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -107.81 32.49 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.46 134.75 8.16 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.453 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 163.8 12.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.875 0.369 . . . . 0.0 110.984 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -65.61 160.38 22.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -72.15 119.86 16.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.779 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.49 175.51 10.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 91.95 3.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m -106.19 176.85 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -128.92 132.66 7.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 mt -122.4 122.93 40.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 251' ' ' SER . 2.4 t80 -102.42 117.08 33.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -120.89 144.93 48.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 163.55 -156.43 28.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.575 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.701 ' H ' HG23 ' A' ' 250' ' ' VAL . 17.6 m-85 -149.06 166.09 29.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -156.33 140.41 16.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 64.08 44.71 4.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -94.06 -44.35 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -155.24 37.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 278' ' ' TYR . . . 90.07 -13.32 65.1 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.702 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 278' ' ' TYR . 0.7 OUTLIER -118.95 137.07 53.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.411 ' HB3' ' N ' ' A' ' 277' ' ' ASN . 7.8 t -97.5 161.28 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.526 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.701 HG23 ' H ' ' A' ' 242' ' ' TYR . 15.3 m -145.95 133.5 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.277 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 239' ' ' PHE . 13.7 m -130.81 136.99 49.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 116.38 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -96.31 134.3 39.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.18 157.17 47.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -141.14 -57.38 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -88.83 -75.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 60.04 31.6 20.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -137.01 119.56 15.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -170.91 -174.55 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -138.38 38.38 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -146.62 75.63 1.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.88 -33.76 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 61.62 87.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 130.54 -46.75 1.06 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.401 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 4.4 t70 60.44 37.7 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.319 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.55 -65.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.17 165.44 13.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.91 60.21 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.22 120.92 31.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.936 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.7 173.73 3.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -86.17 88.18 7.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -140.82 170.7 15.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -97.59 144.5 17.34 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.409 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.7 t -129.26 148.0 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.044 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -164.39 161.26 34.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.7 HG12 HG12 ' A' ' 250' ' ' VAL . 30.9 m -144.44 159.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.167 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.411 ' N ' ' HB3' ' A' ' 249' ' ' SER . 0.8 OUTLIER -148.29 95.2 2.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.015 0.436 . . . . 0.0 111.374 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.525 ' HD2' HD12 ' A' ' 248' ' ' LEU . 3.4 t80 -88.86 110.6 21.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.651 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 5.4 p -109.13 142.76 39.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 8' ' ' PHE . 3.0 p90 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.758 0.313 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.63 -68.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -142.33 79.67 1.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -161.15 34.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -59.69 -40.42 87.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.735 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.74 110.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -123.98 111.99 16.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.497 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 280' ' ' PHE . 51.6 m-85 -96.97 132.54 42.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 111.12 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -115.65 122.86 46.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.766 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.445 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 20.2 mm -105.97 113.88 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.28 154.63 19.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.12 135.68 14.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtp -125.12 144.15 50.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.61 ' HE1' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -155.41 140.56 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -118.11 119.23 34.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.52 140.73 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -149.33 -46.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -87.3 170.36 11.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.87 138.64 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.162 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.17 163.53 40.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.97 60.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.51 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 60.37 87.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.39 -120.17 1.39 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.15 31.13 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 0.0 110.835 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -163.3 169.99 18.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -30.99 21.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 162.81 14.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.66 -23.86 6.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.609 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 29' ' ' LEU . 3.4 mm? 62.16 97.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.771 0.32 . . . . 0.0 110.872 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.61 ' HB3' ' HE1' ' A' ' 14' ' ' TYR . . . -159.38 -74.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.057 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 2.5 tt0 -165.65 64.22 0.94 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 31' ' ' GLU . 31.1 Cg_exo -61.65 123.53 12.87 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.606 2.204 . . . . 0.0 112.251 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.3 108.69 18.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.24 142.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.049 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.41 128.43 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.445 ' CE2' ' CD1' ' A' ' 10' ' ' ILE . 1.1 t80 -143.62 114.69 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 1.9 m120 -106.7 164.64 11.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.305 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.593 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -157.55 113.77 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.568 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -97.86 121.92 40.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.601 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.74 88.48 2.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.3 -126.33 28.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.923 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.91 19.23 1.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.683 2.255 . . . . 0.0 112.814 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -140.15 110.89 6.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.74 0.305 . . . . 0.0 111.058 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -116.42 111.79 20.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.615 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.593 HG13 ' HB3' ' A' ' 38' ' ' ALA . 2.2 pt -92.67 148.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.356 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . . . -141.01 109.4 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.047 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' H ' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -96.44 135.55 38.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.886 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -136.54 146.03 45.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.51 122.48 47.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -118.55 111.33 18.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.26 167.43 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -136.38 157.75 46.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.12 79.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.401 ' C ' HG22 ' A' ' 55' ' ' VAL . 56.1 Cg_endo -70.44 118.47 5.71 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.52 2.146 . . . . 0.0 112.33 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG22 ' C ' ' A' ' 54' ' ' PRO . 34.1 m 42.8 34.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.9 96.5 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -65.93 -70.33 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 t -154.26 155.22 34.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.54 -58.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.42 -27.71 4.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.528 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.51 67.61 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.92 -46.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.86 -120.37 1.74 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.544 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.6 p -146.39 -71.85 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.44 -44.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -146.75 166.25 27.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -127.94 90.73 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -108.01 82.36 1.46 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.64 -166.37 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.52 2.147 . . . . 0.0 112.053 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.842 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 22.0 tt0 -158.83 134.18 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -137.03 105.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.758 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.49 158.31 17.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 89' ' ' GLY . 16.8 m -140.73 157.02 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.94 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -128.67 117.51 21.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.042 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -127.62 105.12 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -106.74 109.69 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.007 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -37.06 56.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -127.52 132.76 49.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.809 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -129.8 111.92 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.977 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -162.02 168.54 22.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.05 15.32 17.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 120' ' ' VAL . 17.3 m-20 -119.08 -43.09 2.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.765 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' O ' HD22 ' A' ' 78' ' ' LEU . 2.3 t80 -159.32 92.78 1.09 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 t -87.0 150.07 24.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -130.31 104.02 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.13 177.59 17.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.37 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.08 107.81 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 64.8 m -77.04 155.34 32.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -148.7 79.5 0.21 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.537 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.91 129.95 10.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -120.05 120.11 35.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 0.0 110.737 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -127.83 139.9 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -131.13 129.51 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -112.23 128.13 56.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.07 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 135.48 172.03 12.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.652 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.3 t80 179.95 177.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 39.83 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -58.89 165.68 2.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.58 100.67 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.094 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -179.21 90.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.942 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.422 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 1.3 mt-10 -60.58 -61.14 8.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 101' ' ' GLU . 38.7 Cg_endo -66.91 -18.1 52.1 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.476 2.118 . . . . 0.0 112.468 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.7 36.1 4.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.535 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.9 mttt 62.38 120.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 106' ' ' THR . 48.0 p30 -129.78 22.36 5.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 105' ' ' ASP . 1.1 p -163.19 124.96 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.819 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -168.91 141.76 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -156.56 99.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.2 ttp -116.83 157.63 25.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 143.04 48.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -139.96 116.71 10.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -88.12 130.21 35.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 108.14 9.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.71 147.38 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.69 107.81 3.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.71 94.32 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.31 2.007 . . . . 0.0 112.033 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.48 102.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -107.42 123.0 47.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.72 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.447 ' OD2' ' ND2' ' A' ' 129' ' ' ASN . 0.4 OUTLIER -128.46 123.16 32.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.957 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 82' ' ' ASP . 9.9 p -141.78 106.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 154.55 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -4.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.408 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 m 63.53 31.91 14.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.65 -73.86 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.71 24.62 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.004 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.11 100.49 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -106.75 128.34 54.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.775 ' CE1' HG22 ' A' ' 155' ' ' THR . 0.1 OUTLIER -117.06 130.71 56.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.447 ' ND2' ' OD2' ' A' ' 119' ' ' ASP . 4.0 t-20 -128.64 126.68 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.34 130.87 10.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.585 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -125.62 129.15 49.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.64 ' HG ' HG23 ' A' ' 153' ' ' THR . 2.5 mp -128.8 102.36 6.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.694 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.0 p -84.62 113.06 21.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.11 116.94 31.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.715 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.74 143.84 33.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 98.97 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.44 145.49 35.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.956 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.07 170.12 19.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.07 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 61.77 178.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.5 t70 68.8 -67.83 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.57 -40.4 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -77.21 108.5 10.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -52.14 65.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m -107.53 -32.13 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.39 32.48 75.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.393 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.91 158.72 19.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.855 0.359 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.37 171.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.26 78.5 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.821 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.2 p -111.82 137.24 50.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.11 133.43 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.04 129.82 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -136.03 115.97 13.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.64 HG23 ' HG ' ' A' ' 132' ' ' LEU . 1.1 m -96.46 137.87 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.78 107.83 9.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.775 HG22 ' CE1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -98.61 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.717 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.97 132.24 11.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.556 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 3.4 mp -109.84 127.34 54.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.718 0.294 . . . . 0.0 110.737 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.21 111.57 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.029 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -130.16 116.51 18.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.253 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.71 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 15.9 p -84.8 134.48 34.31 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.956 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -60.76 -31.01 70.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -162.9 44.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 164' ' ' THR . 0.3 OUTLIER 62.32 72.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.2 OUTLIER 177.96 -73.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.757 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.64 112.97 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.71 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -114.97 158.75 21.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.046 0.45 . . . . 0.0 111.89 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.04 141.86 32.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.043 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.41 ' HB2' ' HB3' ' A' ' 196' ' ' TYR . 0.0 OUTLIER -117.87 108.89 15.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.113 -179.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 169' ' ' VAL . 22.2 m -109.23 100.94 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -92.41 145.96 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 108.0 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.627 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -85.94 141.31 29.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.997 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 mt -141.75 99.94 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.784 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 123.2 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -133.56 144.43 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -152.03 154.71 25.71 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.566 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -116.19 121.33 41.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.92 160.07 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.13 35.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.995 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -103.78 112.73 25.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.21 39.19 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 m -127.41 -51.04 1.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -38.1 7.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.3 m120 60.06 29.86 19.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -121.55 30.04 6.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -118.68 27.39 7.21 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.71 125.69 17.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -142.28 162.3 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.03 108.01 19.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.38 107.83 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 123.81 35.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.45 158.03 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.772 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 tt -132.44 140.11 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -134.29 137.88 44.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.584 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -104.92 149.79 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -156.22 172.03 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.722 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.39 86.94 0.23 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.775 ' HA ' HG22 ' A' ' 207' ' ' THR . 45.1 Cg_endo -68.43 113.47 3.14 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.374 2.049 . . . . 0.0 112.408 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mp -114.39 132.82 56.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.735 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 205' ' ' SER . 67.4 p -138.04 155.78 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 200' ' ' THR . 1.3 mp -143.23 90.58 2.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.247 0.546 . . . . 0.0 110.04 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.79 -65.48 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.457 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.43 59.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' HIS . . . . . 0.544 ' O ' HG22 ' A' ' 200' ' ' THR . 72.2 m80 -153.09 140.62 19.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.63 ' HA ' HG22 ' A' ' 200' ' ' THR . 5.3 t -128.06 115.72 18.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.059 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.12 128.47 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 198' ' ' PRO . 71.4 p -136.47 104.87 9.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.222 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.49 126.03 2.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.707 2.271 . . . . 0.0 112.134 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 30.4 p90 -112.78 137.6 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.887 0.375 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.731 HG22 HG12 ' A' ' 236' ' ' VAL . 40.2 p -129.55 142.4 50.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.735 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 63.76 136.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 29.6 mt -143.22 -47.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.165 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 98.58 170.32 31.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.14 44.47 12.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -131.77 57.36 1.77 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.824 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.6 ttm105 -98.91 36.05 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -145.44 110.67 5.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.808 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.72 -64.2 1.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -162.53 -55.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.41 ' CE3' ' HA ' ' A' ' 220' ' ' TRP . 1.1 m95 -145.13 98.36 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -117.92 130.41 56.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -154.82 155.18 33.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -68.51 93.16 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -169.64 99.8 0.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.66 145.78 55.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.427 HD12 ' H ' ' A' ' 228' ' ' ARG . 1.1 pp -143.09 173.69 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -127.97 30.81 5.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.427 ' H ' HD12 ' A' ' 226' ' ' ILE . 0.0 OUTLIER -99.87 -31.32 11.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.874 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 -170.13 0.25 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.736 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 136.26 44.18 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.535 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -156.51 113.69 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -97.62 103.62 15.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.73 -20.64 65.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.05 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 22.9 t30 67.58 141.02 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.85 0.357 . . . . 0.0 110.804 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.09 113.52 26.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.731 HG12 HG22 ' A' ' 210' ' ' THR . 17.9 m -150.06 149.66 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -138.56 141.01 11.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.477 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.11 122.03 36.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.952 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.9 150.48 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.825 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 147.63 44.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.52 126.93 1.99 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.457 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' A' ' 250' ' ' VAL . 49.0 t80 -148.77 162.9 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.099 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.406 ' O ' ' CE2' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -117.69 153.46 33.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.533 ' HB3' HD22 ' A' ' 248' ' ' LEU . 0.8 OUTLIER -97.17 -38.36 9.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.975 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -177.32 49.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 61.06 98.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 126.01 -24.36 5.71 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.559 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.751 HD23 ' HD1' ' A' ' 278' ' ' TYR . 0.9 OUTLIER -102.73 135.93 43.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.477 ' CB ' ' HB3' ' A' ' 277' ' ' ASN . 0.3 OUTLIER -117.43 113.95 22.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.095 0.474 . . . . 0.0 112.105 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 242' ' ' TYR . 3.2 m -117.82 117.18 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 252' ' ' LEU . 4.9 m -127.75 169.39 13.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 111.253 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 251' ' ' SER . 0.9 OUTLIER -151.24 129.75 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.67 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.91 123.16 46.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -127.5 107.62 10.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -141.32 158.81 43.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.87 89.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -93.36 114.8 27.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 60.64 158.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.814 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -99.38 169.3 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -176.43 -174.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.06 -177.94 3.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.812 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.38 128.54 37.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -134.66 -58.94 0.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 61.81 44.76 97.43 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.72 -49.49 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -32.0 7.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -120.41 135.56 55.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.62 159.0 15.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -124.17 129.06 50.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -70.17 -49.1 53.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 65.79 -76.76 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -167.19 105.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.069 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -80.28 123.21 5.98 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.316 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 6.2 m -110.63 124.68 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -117.88 131.86 9.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 276' ' ' VAL . 27.3 m -126.08 123.08 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.477 ' HB3' ' CB ' ' A' ' 249' ' ' SER . 33.0 t30 -125.6 156.45 39.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.751 ' HD1' HD23 ' A' ' 248' ' ' LEU . 7.0 m-85 -149.89 155.41 39.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.894 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.94 147.1 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.678 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.403 ' HB3' ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.836 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.749 0.309 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -78.0 -31.12 50.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.816 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -60.81 -47.37 86.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' A' ' 39' ' ' ALA . 6.6 t-20 61.4 47.41 6.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.23 -28.91 57.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -157.38 95.36 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -117.36 109.98 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.24 119.98 29.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -128.06 130.22 47.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mt -115.62 137.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 131.17 6.33 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.571 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.87 128.41 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 0.0 111.062 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.88 128.96 54.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -145.91 163.92 33.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -112.05 134.96 53.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.4 tp -105.98 148.63 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.038 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -145.05 130.09 18.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.14 -163.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -96.09 31.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -134.69 30.39 3.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.02 27.65 3.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -123.4 72.34 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.34 -128.65 6.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.486 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -60.1 169.21 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.945 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -118.27 115.96 25.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 44.8 mmm -115.26 -40.11 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -165.47 114.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.53 114.94 3.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.477 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 53' ' ' GLY . 3.2 tp -154.15 135.7 14.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.52 -177.8 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp0 -126.68 51.18 5.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.097 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 82.2 Cg_endo -77.48 115.19 3.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.537 2.158 . . . . 0.0 112.228 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -136.68 125.44 23.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.167 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 35' ' ' TYR . 6.0 t -101.72 162.32 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.66 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.462 ' N ' HG12 ' A' ' 34' ' ' VAL . 30.3 t80 -155.71 135.4 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.369 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.47 155.81 49.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.352 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.696 ' ND2' ' HB2' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -150.12 155.41 39.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.219 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.739 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -155.93 113.86 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.576 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . . . -90.9 117.76 29.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.83 88.58 2.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.5 -128.15 26.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.82 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.38 21.92 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.649 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -140.26 112.76 7.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.43 104.68 14.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.739 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -83.82 133.26 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.343 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.85 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -135.22 124.0 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.903 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.98 112.44 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.084 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -111.26 161.45 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.856 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.05 115.58 24.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -123.65 121.17 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -151.31 141.18 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.833 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -131.03 144.31 51.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.439 ' O ' HD12 ' A' ' 29' ' ' LEU . . . 170.18 158.52 14.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.54 80.49 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.485 2.123 . . . . 0.0 112.326 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t 59.77 93.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -107.94 -47.84 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 59.75 27.06 16.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.978 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.85 -179.22 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.11 -73.94 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.33 57.38 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.3 45.13 11.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -116.47 114.31 24.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' A' ' 98' ' ' TYR . . . 76.35 -156.23 46.56 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.58 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.1 p 53.41 82.66 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.347 . . . . 0.0 111.152 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.418 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 81.6 m95 -102.5 25.97 8.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' CE2' ' ND2' ' A' ' 108' ' ' ASN . 3.9 m-85 -163.78 -58.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.869 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -82.8 100.34 10.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.478 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 168.85 -61.8 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 83.5 Cg_endo -83.76 176.77 6.7 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.801 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 4.5 tp10 -161.93 131.06 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mt -110.21 150.24 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.201 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.85 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -162.02 127.35 3.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 74' ' ' HIS . 29.1 t -128.01 154.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.409 ' N ' HG12 ' A' ' 73' ' ' VAL . 2.4 t60 -124.03 148.21 47.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -135.54 143.73 45.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.9 102.17 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.52 -66.28 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -125.4 133.34 52.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -120.13 106.48 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -146.86 172.17 14.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.14 15.35 10.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.431 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.444 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 4.2 m-20 -114.26 -44.99 3.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 82' ' ' ASP . 15.5 p90 -166.95 101.55 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -92.93 133.85 35.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.745 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.59 107.78 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.146 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.84 175.18 19.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.203 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 116' ' ' PRO . 3.1 tp -158.12 107.93 2.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 0.0 110.936 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 m -79.02 155.87 28.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.29 105.04 0.24 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.567 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.36 174.9 20.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.383 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -129.85 144.12 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -122.46 117.74 26.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -105.0 112.25 25.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -125.83 100.0 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.407 ' N ' ' HB3' ' A' ' 66' ' ' PHE . . . -173.84 154.14 18.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.426 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.5 159.44 21.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.23 170.36 2.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.434 ' CE1' ' HA3' ' A' ' 63' ' ' GLY . 14.2 m-85 -160.99 90.79 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t 69.03 -67.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -154.14 -50.12 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.122 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -157.75 96.98 1.94 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.072 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.75 -43.34 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.474 2.116 . . . . 0.0 112.239 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.12 -26.8 2.17 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.29 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 165.32 30.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 110.768 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.46 92.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t -163.05 132.22 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.31 168.12 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.038 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.44 ' ND2' ' CE2' ' A' ' 66' ' ' PHE . 34.5 m120 -142.5 117.83 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.783 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.2 mtt -136.46 119.17 16.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.718 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 13.0 tp60 -111.21 141.23 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.785 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.56 124.28 12.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.981 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -85.53 146.08 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.8 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -128.18 107.94 10.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.169 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.8 pt -131.3 150.72 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.3 105.69 1.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HB3' HD12 ' A' ' 87' ' ' LEU . 56.4 Cg_endo -70.43 93.61 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.434 2.089 . . . . 0.0 111.938 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.03 149.38 41.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -147.34 123.02 10.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.69 118.74 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.06 114.03 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -106.15 128.18 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.86 -32.82 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -145.01 -175.35 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.475 ' H ' HG22 ' A' ' 123' ' ' THR . 70.9 m-20 -88.88 53.54 2.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -176.78 -50.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 157' ' ' LEU . 5.4 mt -82.03 104.11 12.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -112.64 116.37 30.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -90.95 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -137.43 127.48 25.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.37 125.18 6.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -123.09 121.77 36.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.921 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' A' ' 153' ' ' THR . 4.3 mp -116.37 99.03 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.5 120.6 24.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.9 mtp -128.65 129.1 45.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.8 133.07 52.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -115.92 157.41 24.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 148' ' ' ASP . 40.9 p90 -108.54 154.11 22.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -165.03 178.54 6.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 65.56 -70.78 0.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -118.62 81.34 1.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.63 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 141' ' ' LEU . 1.3 pp -84.01 46.89 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -114.97 34.83 4.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.6 m -81.77 -70.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -36.04 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.977 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 74.7 27.3 65.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.545 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -113.13 -73.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -137.94 -53.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 137' ' ' PHE . 4.2 m-20 59.18 29.22 18.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 p -99.08 110.76 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 126.04 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 151' ' ' VAL . 16.0 m -145.97 100.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.08 121.32 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.455 HG23 ' HG ' ' A' ' 132' ' ' LEU . 10.0 m -104.39 126.75 51.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -126.37 107.81 10.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.123 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.5 p -99.08 103.87 15.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.11 148.36 16.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.805 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 126' ' ' LEU . 4.6 mt -133.03 118.39 18.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.71 113.27 26.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.429 ' N ' ' HB1' ' A' ' 166' ' ' ALA . 5.5 p90 -130.11 118.4 21.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 0.5 OUTLIER -92.28 131.48 37.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.752 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.82 7.52 26.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.693 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.04 28.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.766 0.317 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.677 ' O ' HG23 ' A' ' 164' ' ' THR . 14.6 mm-40 51.52 64.94 1.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.112 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.2 OUTLIER 178.54 -64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 199' ' ' LEU . 21.5 t -103.85 113.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.813 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.48 ' HB2' ' HB ' ' A' ' 160' ' ' THR . . . -119.03 151.97 37.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.8 mp -93.92 133.44 37.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.265 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 196' ' ' TYR . 41.9 ttp85 -109.05 107.02 17.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.047 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.49 107.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.712 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -103.37 145.23 30.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.46 121.76 42.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.583 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.89 125.16 33.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.5 tt -142.02 94.82 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.748 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -126.58 148.95 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -140.1 151.04 45.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 143.15 -172.58 24.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.91 121.45 42.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.333 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.38 154.47 49.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.5 ptp -73.88 120.9 20.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.63 169.64 11.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -119.91 31.55 6.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 m -149.29 -46.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.35 109.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -142.7 -48.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -86.53 99.87 11.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.74 -27.86 6.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -142.99 57.04 1.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.393 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.99 168.52 26.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 m -99.15 142.53 30.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.2 m -79.03 110.96 14.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.12 131.76 54.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.55 156.99 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -116.15 131.36 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -129.23 117.96 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -99.08 149.11 23.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.402 ' HB2' ' HB3' ' A' ' 168' ' ' ARG . 52.5 m-85 -155.11 142.54 19.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.448 ' O ' HD23 ' A' ' 199' ' ' LEU . 2.1 mt -136.24 71.99 60.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.1 113.72 3.15 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.488 ' HB3' HG13 ' A' ' 165' ' ' VAL . 0.5 OUTLIER -114.29 157.16 23.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.492 HG22 ' OG ' ' A' ' 205' ' ' SER . 2.9 p -136.62 138.08 40.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.16 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.48 89.81 2.45 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.359 0.6 . . . . 0.0 109.983 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 45.93 81.24 0.04 OUTLIER Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.884 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.5 t30 60.85 40.22 16.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -152.05 97.57 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.492 ' OG ' HG22 ' A' ' 200' ' ' THR . 41.5 m -96.84 142.74 28.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 97.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -105.01 104.75 48.46 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.087 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.81 164.94 17.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.624 2.216 . . . . 0.0 112.387 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 4.2 m -139.1 150.45 45.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.852 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -142.06 45.91 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.092 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.623 ' O ' HD12 ' A' ' 214' ' ' LEU . 1.2 pt -113.86 -33.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.175 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 48.04 27.97 5.49 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.801 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 212' ' ' ILE . 1.1 mt -131.99 127.82 37.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.963 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -87.47 100.34 12.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -102.56 126.31 49.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.81 87.08 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 80.7 p -93.65 -60.23 1.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 60.94 31.28 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.803 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -83.3 -31.67 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.18 85.06 7.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -61.25 -32.08 71.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.16 -179.16 7.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -65.49 -46.27 80.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.91 164.28 26.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.6 pp -139.65 166.78 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.64 -45.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -109.85 104.73 13.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -126.03 136.04 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -148.5 63.39 0.42 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.51 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.97 -175.06 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.837 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -146.76 33.22 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.946 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.43 159.09 13.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.91 -170.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -107.86 135.49 49.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.943 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 m -104.91 -177.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.021 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -101.07 168.34 20.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.588 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.1 128.2 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.5 98.1 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.98 134.72 38.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -125.81 114.56 2.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.577 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.75 110.18 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -137.13 -173.46 3.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.962 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 66.2 45.42 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -108.65 -34.85 6.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.732 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.1 32.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.688 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 96.23 -24.36 30.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.6 148.87 25.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.632 0.254 . . . . 0.0 110.613 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.587 ' O ' HG13 ' A' ' 276' ' ' VAL . 28.4 t -95.93 167.44 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.746 0.307 . . . . 0.0 110.948 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -149.28 117.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.5 m -138.92 147.1 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 5.1 mp -121.11 123.5 42.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 131.6 53.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -131.2 124.96 31.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -148.67 32.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.132 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -82.24 98.55 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.75 -49.74 73.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.98 171.3 8.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -104.65 131.27 52.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -123.96 166.59 15.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.952 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -131.82 -62.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.54 149.53 33.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 60.69 109.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 115.11 33.52 1.64 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -92.13 -34.61 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.8 t -82.15 91.44 6.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -131.45 -56.76 1.01 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -117.92 179.04 4.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -105.7 34.47 3.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.88 151.3 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -134.14 177.27 7.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -160.11 175.04 13.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.078 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.02 -129.9 5.9 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.46 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.05 148.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -135.18 141.32 12.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.537 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 249' ' ' SER . 14.0 t -115.25 145.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.417 ' CB ' ' HB3' ' A' ' 249' ' ' SER . 1.8 t-20 -147.41 95.55 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -88.43 140.27 29.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.0 p -124.67 131.52 53.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.937 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 66.31 118.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 110.821 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -114.15 119.72 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -88.0 128.86 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.52 135.46 40.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 10' ' ' ILE . 4.5 tt -155.83 126.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.27 22.21 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.47 121.33 7.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.134 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -104.88 159.38 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.8 0.333 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.64 151.95 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -148.33 142.08 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -149.82 143.91 25.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -146.38 161.56 40.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.411 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.19 113.83 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -94.99 116.18 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.553 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.82 88.56 2.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.704 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -126.61 35.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.031 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.66 23.14 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.0 112.689 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.442 ' CH2' ' HB ' ' A' ' 73' ' ' VAL . 14.8 t-105 -140.42 110.85 6.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 26.7 mtp180 -108.37 108.77 19.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mt -83.85 120.62 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.138 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . . . -125.32 121.69 34.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.17 113.18 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.09 146.73 43.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.21 117.43 34.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.09 120.88 43.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -152.36 123.0 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.826 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.425 ' CB ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.794 0.33 . . . . 0.0 110.932 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 68' ' ' ARG . 73.5 Cg_endo -76.27 -179.61 5.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.446 2.098 . . . . 0.0 112.326 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.2 167.34 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.95 149.12 50.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.805 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.82 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -147.55 140.28 24.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 89' ' ' GLY . 15.4 m -142.11 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 74' ' ' HIS . 2.0 m-70 -112.78 139.35 48.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -138.04 104.27 5.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.77 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -95.31 111.01 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.11 -52.71 57.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 mt -129.37 145.35 51.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.69 94.95 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.72 130.38 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.39 -23.68 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.832 ' O ' HG23 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -77.77 -44.65 26.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -151.48 80.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.3 123.93 33.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -106.75 115.8 30.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -125.54 165.9 18.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.57 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.24 107.89 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.285 . . . . 0.0 110.533 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.867 HG22 ' HB3' ' A' ' 115' ' ' ALA . 9.0 t -105.85 107.83 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -101.38 123.44 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.244 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 153.64 17.42 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.778 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.77 126.63 53.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -109.95 134.7 51.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.957 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -125.91 121.74 34.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.786 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.26 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.384 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.844 0.354 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.78 154.94 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -108.45 125.19 51.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.75 139.7 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -108.36 134.2 51.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -143.34 129.21 19.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -90.87 148.45 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.736 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -142.09 103.71 4.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.6 144.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.867 ' HB3' HG22 ' A' ' 88' ' ' THR . . . -140.87 93.28 8.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.317 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 41.7 Cg_exo -56.81 87.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.172 . . . . 0.0 112.072 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 98.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -107.86 122.92 47.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.796 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -128.17 127.19 42.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 82' ' ' ASP . 10.0 p -145.06 127.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 141.0 29.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.27 -32.31 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.813 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.52 177.88 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.16 54.52 3.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.5 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 159' ' ' TYR . 1.2 mp -99.37 141.86 31.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.2 144.0 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 155' ' ' THR . 5.6 t80 -115.65 133.31 56.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -129.8 159.33 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.02 113.56 0.59 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.21 118.96 30.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.95 102.56 12.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 t -76.06 112.96 13.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.5 mtt -116.55 118.01 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.751 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -111.35 131.95 54.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.24 105.4 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.669 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -71.85 142.96 49.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.55 137.27 15.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.031 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.954 -179.896 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.772 0.32 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 57.0 m -127.58 122.42 33.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.14 133.18 43.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 151' ' ' VAL . 10.9 p -141.71 116.59 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.06 121.69 30.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.5 t -95.05 138.8 32.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.47 117.61 18.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.502 HG23 ' CE1' ' A' ' 128' ' ' PHE . 26.0 m -105.14 103.91 13.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.02 135.78 12.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.573 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.433 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 1.1 tp -131.05 115.01 15.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -114.64 110.89 20.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.51 ' HB3' HD23 ' A' ' 126' ' ' LEU . 2.5 p90 -130.01 125.0 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -98.88 138.16 36.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.045 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.45 -50.66 30.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.384 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -150.83 53.62 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.448 ' C ' HG22 ' A' ' 164' ' ' THR . 8.1 tt0 61.55 76.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 179.89 -76.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.495 ' H ' HG23 ' A' ' 164' ' ' THR . 19.3 m -103.91 112.8 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.557 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.507 ' HB2' ' HB ' ' A' ' 160' ' ' THR . . . -112.56 140.65 47.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.86 129.94 40.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.393 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -102.51 132.53 48.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 169' ' ' VAL . 5.9 m -132.18 103.72 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -103.26 127.82 50.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.32 110.98 23.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.79 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.33 139.33 30.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.02 94.97 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.95 138.17 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.962 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -140.04 138.08 35.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.479 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.778 0.323 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 m -101.52 128.55 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.942 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -119.43 117.49 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -105.73 136.41 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 194' ' ' ARG . 3.7 mt -97.06 154.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.034 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 193' ' ' ILE . 23.6 mtt180 -147.06 117.02 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.401 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -110.85 137.2 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.003 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.49 173.82 13.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.904 HD12 HD11 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -175.18 80.35 0.31 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.669 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.7 ' HA ' HG22 ' A' ' 207' ' ' THR . 35.7 Cg_endo -65.25 113.86 2.61 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.556 2.171 . . . . 0.0 112.541 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.904 HD11 HD12 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -114.21 155.86 25.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -137.99 156.97 47.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.673 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.31 90.54 2.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 61.25 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.5 31.54 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -140.25 136.39 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.4 m -117.39 139.89 50.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 206' ' ' VAL . 9.6 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.992 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 198' ' ' PRO . 10.0 p -121.81 104.66 38.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.765 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.56 165.06 18.48 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.597 2.198 . . . . 0.0 112.406 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -120.5 139.67 52.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.53 HG23 HG13 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -143.21 159.29 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 210' ' ' THR . 26.0 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.808 0.337 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.74 145.85 42.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 4.0 mp -118.06 113.37 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -116.38 106.38 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -90.87 146.73 23.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -132.77 111.37 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.017 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 250' ' ' VAL . 76.5 m-85 -104.5 166.22 10.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.249 0.547 . . . . 0.0 111.503 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.133 -179.889 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 3.0 pp . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.9 t -95.85 123.51 39.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.96 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.662 ' HA ' HG12 ' A' ' 276' ' ' VAL . 40.1 t -105.82 116.92 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.798 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 16.0 m -108.03 152.07 24.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.169 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 253' ' ' GLU . 0.1 OUTLIER -133.91 142.11 47.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.585 ' H ' HD13 ' A' ' 252' ' ' LEU . 2.7 tt0 -118.43 128.58 54.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.09 123.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -144.93 145.4 14.71 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.138 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 250' ' ' VAL . 29.6 m -126.39 159.15 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.487 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 249' ' ' SER . 9.8 m120 -148.12 95.53 2.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.176 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 4.3 t80 -88.55 121.29 30.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.79 138.7 37.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.835 0.35 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.451 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.1 m0 -91.42 113.15 25.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -119.25 152.05 37.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.93 119.94 20.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.633 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -131.81 139.8 48.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.065 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mm -121.8 113.75 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.864 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.51 143.52 15.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.2 125.79 8.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.312 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.64 120.68 42.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.972 0.415 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 35' ' ' TYR . 19.2 t -134.27 158.71 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.466 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -141.75 151.6 43.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.053 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -145.08 146.63 31.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.64 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.92 157.39 45.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 111.197 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -167.22 113.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' TRP . . . -90.78 126.16 35.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.836 0.351 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -134.77 88.57 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.82 -126.2 31.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.65 21.35 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.682 2.255 . . . . 0.0 112.864 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -140.14 112.8 8.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' CB ' ' A' ' 74' ' ' HIS . 0.3 OUTLIER -94.62 112.88 24.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.515 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.0 mm -83.99 118.36 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -131.61 119.54 21.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.923 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -121.25 155.0 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 47' ' ' LEU . . . -145.94 147.78 32.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.042 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -100.97 113.68 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.11 122.84 48.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -156.52 138.34 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.866 0.365 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.8 -160.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.871 2.381 . . . . 0.0 112.278 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -153.47 132.69 12.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.92 154.61 19.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.765 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 5.7 tt0 -157.09 134.79 10.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 m -135.94 148.13 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -117.27 130.36 56.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 87' ' ' LEU . 1.2 t80 -127.12 100.69 6.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -91.6 113.58 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -72.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -114.92 128.49 56.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -96.16 102.11 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -156.04 163.59 39.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.26 16.37 15.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.13 -43.02 2.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.882 0.372 . . . . 0.0 110.878 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.435 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 96.5 m-85 -146.0 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.75 112.75 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 83' ' ' PHE . 56.9 m-85 -114.91 121.31 42.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.043 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -140.26 -173.35 13.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.347 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.8 pp -158.15 124.27 4.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.0 m -99.95 98.96 9.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.57 134.76 11.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.49 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.13 162.76 26.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.632 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.95 121.47 42.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.861 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 118.44 36.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.984 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -110.75 98.05 7.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -113.4 126.94 55.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.47 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.768 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.95 144.39 8.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -150.66 104.37 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.7 mtt -130.8 129.56 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.21 150.48 22.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -147.22 121.28 9.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.106 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -91.24 122.77 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 108.25 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.23 146.34 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.65 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 91.04 7.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.493 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 34.3 Cg_exo -57.51 86.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.961 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.12 106.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.258 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -107.35 132.64 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.495 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -138.32 128.59 25.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.201 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.2 100.87 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 156.22 40.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.47 29.05 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -32.85 11.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.598 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.9 -78.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -164.09 25.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp -142.33 152.4 42.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -102.53 111.11 23.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.619 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.95 137.93 31.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.88 118.91 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -105.01 139.85 14.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.53 120.28 16.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.77 98.97 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.846 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.4 t -87.47 110.11 20.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.719 ' HG3' HG22 ' A' ' 151' ' ' VAL . 1.8 ttp -112.12 122.88 48.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -105.24 128.79 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -108.37 98.92 8.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.54 128.56 33.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.54 135.12 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.3 p30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.787 0.327 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 t -137.09 142.08 42.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.403 ' NH1' ' HB3' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -133.59 113.01 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.812 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.719 HG22 ' HG3' ' A' ' 134' ' ' MET . 29.0 t -102.35 137.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.045 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.49 118.74 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 m -97.18 136.51 37.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.01 101.47 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.7 m -94.99 108.41 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -107.63 134.45 12.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.699 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.3 mt -119.61 124.69 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.765 0.317 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -112.96 121.08 43.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -130.08 108.41 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.028 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.996 HG23 ' HB2' ' A' ' 166' ' ' ALA . 0.8 OUTLIER -84.75 126.57 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.871 0.367 . . . . 0.0 110.953 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -52.5 -27.41 16.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.79 49.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 57.24 58.94 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.9 m -165.3 -73.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.72 112.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.412 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.996 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -117.83 153.16 33.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.1 0.476 . . . . 0.0 111.848 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.2 tt -100.01 138.09 37.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.998 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -112.49 125.89 54.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.305 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 169' ' ' VAL . 9.1 p -123.02 103.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.586 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -97.36 134.7 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.03 25.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.461 ' C ' HD12 ' A' ' 173' ' ' LEU . 0.2 OUTLIER -85.82 132.64 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.248 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 172' ' ' TYR . 5.0 mp -142.14 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.643 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -88.71 123.79 33.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 112.93 8.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.838 0.351 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.39 120.48 39.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -122.14 129.07 51.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.26 173.78 9.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.742 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.41 139.27 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -127.87 143.98 51.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.69 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -152.76 168.66 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.9 tt -176.62 85.41 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.524 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.82 113.67 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.39 2.06 . . . . 0.0 112.672 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.0 mt -114.47 116.16 28.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.387 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.806 HG22 ' HA ' ' A' ' 205' ' ' SER . 29.2 p -129.49 158.21 39.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 110.83 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 201' ' ' LEU . 9.6 tp -143.1 90.5 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.182 0.515 . . . . 0.0 109.997 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.83 -73.86 2.49 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.417 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -125.93 -35.07 2.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.715 0.293 . . . . 0.0 111.347 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -65.34 135.09 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.806 ' HA ' HG22 ' A' ' 200' ' ' THR . 13.2 t -128.1 115.85 19.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.038 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.34 119.48 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 207' ' ' THR . 5.0 t -122.68 104.76 36.24 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.208 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.19 161.83 39.92 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.693 2.262 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.43 ' CZ ' ' HA3' ' A' ' 237' ' ' GLY . 43.7 p90 -150.39 142.63 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.017 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.4 m -137.34 143.3 41.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 236' ' ' VAL . 12.2 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.812 0.339 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.43 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -98.65 159.75 20.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.467 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.5 mt -144.45 129.95 18.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.828 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 253' ' ' GLU . 0.7 OUTLIER -112.28 99.15 7.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.914 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -84.58 151.91 24.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -164.64 106.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.476 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.2 155.09 40.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.804 179.835 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 278' ' ' TYR . 1.9 mm? . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.511 0.196 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.476 ' O ' HG13 ' A' ' 276' ' ' VAL . 43.1 t -95.7 166.69 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.906 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.88 117.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 24.5 t -122.58 132.46 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.83 121.48 34.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.426 ' HG2' ' CE1' ' A' ' 239' ' ' PHE . 7.9 mt-10 -96.66 106.16 18.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 2.2 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 274' ' ' VAL . 12.6 p -132.34 124.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -122.32 150.85 16.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.596 HG11 HD12 ' A' ' 248' ' ' LEU . 21.3 t -125.77 125.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.289 . . . . 0.0 111.181 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 249' ' ' SER . 8.1 m-20 -127.57 95.25 4.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.122 0.487 . . . . 0.0 111.235 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.767 ' HB2' HD13 ' A' ' 248' ' ' LEU . 2.3 t80 -88.7 125.74 34.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.727 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.9 141.46 45.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.9 m95 179.79 81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -110.77 111.56 22.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.71 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -91.21 126.09 36.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 37' ' ' ASN . 3.0 m-20 -131.98 127.31 36.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.56 122.93 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.26 160.82 13.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.99 129.27 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.4 ttm -109.92 132.95 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.851 0.357 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 35' ' ' TYR . 18.7 t -105.43 157.04 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.437 ' N ' HG12 ' A' ' 34' ' ' VAL . 7.0 m-85 -141.47 147.52 38.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.016 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.58 114.07 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.622 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.402 ' CB ' ' HB2' ' A' ' 9' ' ' ASN . 0.4 OUTLIER -111.72 153.13 26.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -156.69 113.93 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.846 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -98.67 122.46 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.315 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -134.8 88.45 2.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.99 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.68 -123.19 32.0 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.234 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.68 25.29 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -140.11 110.74 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.61 157.31 15.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.61 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 27.1 mm -126.38 134.75 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.141 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -141.14 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 tt -116.73 115.97 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.34 142.71 50.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -97.91 120.59 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.014 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -112.92 106.81 15.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.99 162.13 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.753 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' CD ' ' HD2' ' A' ' 69' ' ' PRO . 12.5 mmt180 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.772 0.32 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.419 ' HD2' ' CD ' ' A' ' 68' ' ' ARG . 92.9 Cg_endo -84.54 -166.88 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.87 2.38 . . . . 0.0 112.375 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -146.67 123.63 11.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 155.13 17.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -162.05 128.36 3.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 89' ' ' GLY . 28.9 m -129.84 157.11 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -121.25 145.13 48.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -125.27 128.39 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.74 102.27 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.949 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.84 -73.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.56 120.35 41.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -97.3 107.34 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' H ' ' HG ' ' A' ' 84' ' ' SER . 22.0 t30 -159.55 142.75 14.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.46 -13.4 59.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.701 ' O ' HG23 ' A' ' 120' ' ' VAL . 8.3 t0 -100.17 -42.75 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.988 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -141.37 87.5 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.454 ' HG ' ' H ' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -108.72 159.05 17.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -145.03 137.96 26.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.816 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -148.46 141.3 8.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.599 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.987 HD21 HG23 ' A' ' 114' ' ' ILE . 5.9 tt -120.69 122.46 40.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 0.0 110.784 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.688 ' HB ' ' HB3' ' A' ' 115' ' ' ALA . 20.8 m -102.66 117.14 34.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.826 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -109.06 116.05 4.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.448 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -130.5 147.08 18.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.6 134.93 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 -106.0 132.67 51.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -137.81 115.18 11.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -140.49 148.02 40.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.787 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.545 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.771 0.32 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -166.03 148.03 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.59 100.01 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.6 mtt -118.61 142.64 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 9.9 tt0 -132.53 133.33 43.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.7 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -135.76 129.66 32.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.049 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -85.94 142.89 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.585 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -127.19 133.05 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.448 . . . . 0.0 111.317 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.987 HG23 HD21 ' A' ' 87' ' ' LEU . 10.7 mt -131.48 143.48 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.41 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.688 ' HB3' ' HB ' ' A' ' 88' ' ' THR . . . -139.93 66.0 31.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.856 ' HD3' HG22 ' A' ' 114' ' ' ILE . 68.7 Cg_endo -74.24 65.99 5.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.41 2.073 . . . . 0.0 111.506 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 131' ' ' TRP . 2.8 p30 -80.47 179.48 7.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.491 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -152.88 123.85 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.527 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.85 128.71 35.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 82' ' ' ASP . 7.6 p -145.14 100.93 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.24 152.67 48.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.156 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.65 32.78 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.37 -45.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -167.38 -42.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.426 ' HG ' ' CE1' ' A' ' 159' ' ' TYR . 2.0 mt -82.81 121.84 27.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -123.11 139.83 53.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.63 ' HB2' HG13 ' A' ' 120' ' ' VAL . 61.6 m-85 -134.55 138.36 44.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -152.19 118.96 5.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.23 114.34 4.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.431 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 117' ' ' ASP . 10.9 m0 -104.94 124.97 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 0.0 111.09 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.48 ' O ' HD23 ' A' ' 132' ' ' LEU . 8.6 tt -109.24 105.62 15.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 116.68 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.955 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.657 ' HG2' HG12 ' A' ' 151' ' ' VAL . 0.4 OUTLIER -96.88 118.99 34.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -104.23 119.92 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.001 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.401 ' HA ' HG22 ' A' ' 149' ' ' THR . 0.0 OUTLIER -123.93 145.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.435 ' H ' HG22 ' A' ' 149' ' ' THR . 0.2 OUTLIER -104.81 151.76 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -164.8 150.34 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.903 0.382 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 137' ' ' PHE . 71.7 p -102.98 109.57 21.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.016 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -146.57 170.99 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.657 HG12 ' HG2' ' A' ' 134' ' ' MET . 35.6 m -118.52 148.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -125.03 138.63 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.638 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 34.3 m -93.92 145.35 24.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.124 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -136.88 98.99 3.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.81 108.0 20.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.455 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -110.29 141.93 16.43 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.583 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 156' ' ' GLY . 10.5 mp -123.61 130.5 52.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.767 0.318 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.408 ' CG ' ' HG3' ' A' ' 168' ' ' ARG . 5.3 mt-30 -117.55 113.22 21.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.426 ' CE1' ' HG ' ' A' ' 126' ' ' LEU . 27.4 t80 -130.16 116.8 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.822 HG23 ' HB2' ' A' ' 166' ' ' ALA . 9.4 p -84.72 137.23 33.35 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.13 -38.61 91.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -149.93 42.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 61.72 70.82 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 175.75 -64.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.729 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.588 ' H ' HG23 ' A' ' 164' ' ' THR . 27.5 m -103.98 112.77 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -118.01 150.48 39.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.111 0.482 . . . . 0.0 111.818 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.81 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.225 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.408 ' HG3' ' CG ' ' A' ' 158' ' ' GLN . 0.4 OUTLIER -115.0 114.62 25.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 169' ' ' VAL . 8.6 p -116.94 100.91 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.581 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.67 133.98 42.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.182 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -103.2 112.31 25.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.502 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.83 137.99 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.1 tt -141.74 94.92 2.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.632 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.41 144.67 25.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.76 157.03 47.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.776 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.536 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.83 0.348 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 10.7 m -96.71 118.17 32.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -122.06 110.84 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -119.84 147.6 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 193' ' ' ILE . 7.3 tp -112.51 120.02 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.433 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 0.1 OUTLIER -106.28 132.03 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -110.26 148.61 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 194' ' ' ARG . 89.4 m-85 -153.4 175.11 13.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.425 HD23 HD11 ' A' ' 199' ' ' LEU . 14.4 tp -172.29 71.32 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.69 113.7 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.425 HD11 HD23 ' A' ' 197' ' ' LEU . 1.1 mt -114.27 151.31 33.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.739 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 204' ' ' HIS . 1.0 OUTLIER -138.11 157.85 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.731 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 13.0 tp -143.28 90.65 2.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.19 0.519 . . . . 0.0 110.144 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.71 -65.43 0.63 Allowed Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.408 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -148.49 32.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . 0.7 ' O ' HG22 ' A' ' 200' ' ' THR . 58.0 m80 -123.92 154.99 38.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.2 m -128.06 128.25 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.54 112.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.6 t -125.74 105.01 26.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.056 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.74 ' HB3' HD23 ' A' ' 238' ' ' LEU . 85.8 Cg_endo -78.3 165.07 26.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.528 2.152 . . . . 0.0 112.306 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.42 136.2 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.029 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.67 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 27.1 m -136.46 146.58 46.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.803 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.837 0.351 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -74.49 156.78 50.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.74 HD23 ' HB3' ' A' ' 208' ' ' PRO . 34.2 mt -147.03 106.06 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.94 128.85 38.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.21 144.96 30.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -141.34 122.15 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -123.27 137.83 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.389 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.618 HD11 HG11 ' A' ' 276' ' ' VAL . 2.8 tt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.688 0.28 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.727 ' O ' HG13 ' A' ' 276' ' ' VAL . 33.2 t -102.21 165.75 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.65 117.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 18.9 p -109.48 164.3 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.445 ' CD2' ' CE2' ' A' ' 254' ' ' TYR . 0.2 OUTLIER -145.58 136.31 24.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.4 113.83 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . 0.445 ' CE2' ' CD2' ' A' ' 252' ' ' LEU . 1.2 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.386 -0.286 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.03 141.76 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -126.44 179.12 16.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 249' ' ' SER . 22.7 t -153.96 140.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.679 0.276 . . . . 0.0 110.976 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 249' ' ' SER . 5.5 t-20 -148.09 95.31 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 111.394 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 280' ' ' PHE . 13.0 t80 -92.71 154.99 17.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.661 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.42 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 12.6 p -143.04 146.71 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.449 ' HB2' ' CE1' ' A' ' 278' ' ' TYR . 44.2 t80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.956 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.73 0.3 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.69 115.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.049 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.782 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.4 m80 -109.65 112.14 24.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.699 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.98 135.49 33.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -149.0 132.08 16.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.596 HG23 ' CE1' ' A' ' 36' ' ' PHE . 22.1 mt -125.97 154.0 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.49 119.33 0.89 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.33 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -128.18 157.74 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.8 127.86 35.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.732 0.301 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 35' ' ' TYR . 15.3 t -117.16 157.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.285 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 34' ' ' VAL . 2.5 m-85 -157.46 132.96 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CE1' HG23 ' A' ' 10' ' ' ILE . 67.6 m-85 -134.42 157.34 46.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.747 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 149.45 33.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.616 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -150.4 113.83 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.727 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -94.49 120.58 34.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.302 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.72 88.59 2.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.65 -127.13 15.72 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.05 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -88.13 19.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.767 2.312 . . . . 0.0 112.792 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CZ3' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -140.11 121.97 15.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.906 0.384 . . . . 0.0 111.173 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 103.95 11.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.661 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.616 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 3.2 tp -83.89 139.63 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.199 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.868 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -139.04 119.64 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tp -104.66 148.71 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.793 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.94 157.36 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.185 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 114.64 22.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 111.8 22.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.98 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.13 156.98 42.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.927 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.69 0.281 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.47 -168.52 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.56 2.173 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.46 165.44 27.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mp -137.04 156.98 47.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.868 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -146.25 152.99 40.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.997 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.55 HG23 ' HA3' ' A' ' 89' ' ' GLY . 16.9 m -143.6 141.8 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -123.27 110.12 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CE1' ' CZ3' ' A' ' 43' ' ' TRP . 2.2 t80 -96.42 86.92 4.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.32 127.19 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.809 ' HB3' HD12 ' A' ' 78' ' ' LEU . 14.1 m-85 -84.28 -73.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 77' ' ' PHE . 3.8 mp -145.59 143.83 30.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.004 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -104.33 94.86 5.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.721 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -161.47 172.22 16.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.39 -68.3 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.598 ' HB3' HG13 ' A' ' 120' ' ' VAL . 1.6 m-20 -119.1 -44.02 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.808 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.415 ' CD2' ' HE3' ' A' ' 121' ' ' LYS . 5.8 t80 -178.62 -75.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 p -147.26 159.2 43.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.827 0.346 . . . . 0.0 111.233 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.09 106.76 3.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.78 -146.78 4.47 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.403 HD23 ' HG3' ' A' ' 116' ' ' PRO . 1.2 mp -143.67 117.7 9.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.662 0.268 . . . . 0.0 110.45 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -79.58 122.33 26.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.64 ' HA2' HG22 ' A' ' 114' ' ' ILE . . . -108.25 173.17 17.76 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.42 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 72' ' ' GLU . . . -178.05 156.12 18.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.722 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -142.66 110.3 5.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 110.749 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 133.65 52.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -147.31 140.87 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -146.1 158.22 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.181 179.769 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.688 0.28 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.79 137.68 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.726 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.33 117.61 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.32 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.25 131.04 55.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.77 137.77 51.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 111.378 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.16 135.85 41.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -104.69 138.53 40.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.142 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 134' ' ' MET . 0.1 OUTLIER -132.0 102.44 5.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.64 HG22 ' HA2' ' A' ' 89' ' ' GLY . 2.9 pp -139.61 149.47 22.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.939 ' HB3' ' O ' ' A' ' 132' ' ' LEU . . . 175.65 153.02 0.33 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.698 0.285 . . . . 0.0 111.396 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HG3' HD23 ' A' ' 87' ' ' LEU . 22.0 Cg_exo -64.91 136.96 51.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.659 2.24 . . . . 0.0 112.448 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.9 142.29 50.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.431 ' CE2' ' HA3' ' A' ' 130' ' ' GLY . 29.2 p90 -124.26 122.93 39.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.347 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.39 107.31 14.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 82' ' ' ASP . 16.8 t -100.89 112.22 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.415 ' HE3' ' CD2' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -131.16 154.29 48.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.37 27.86 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.395 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.587 HG21 ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -83.1 -27.94 29.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.776 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -170.61 -72.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.587 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.95 26.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mp -142.27 148.14 37.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.982 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.4 112.06 25.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.591 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.496 ' CD2' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -98.81 117.35 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -112.7 118.92 36.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 118' ' ' TRP . . . -113.97 109.58 2.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.596 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.86 114.9 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.788 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.939 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 33.8 tp -126.96 131.06 51.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.81 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.6 m -136.47 120.9 18.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.831 ' HG3' HG12 ' A' ' 151' ' ' VAL . 3.5 mtm -92.87 120.86 33.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.112 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.35 135.71 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.0 0.429 . . . . 0.0 111.515 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.85 130.47 24.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.47 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.84 149.28 45.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.041 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.88 145.62 12.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -93.58 146.84 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.67 170.87 14.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.831 HG12 ' HG3' ' A' ' 134' ' ' MET . 3.7 m -141.58 120.09 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.14 99.85 9.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -97.56 127.15 43.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -128.9 97.74 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.1 p -96.4 103.89 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.714 ' C ' HD22 ' A' ' 157' ' ' LEU . . . -104.78 135.87 12.77 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.714 HD22 ' C ' ' A' ' 156' ' ' GLY . 3.2 mm? -121.39 125.79 47.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -119.07 102.79 9.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.616 ' O ' HD12 ' A' ' 167' ' ' LEU . 19.0 p90 -130.11 134.21 47.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.169 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.801 HG22 ' HB2' ' A' ' 166' ' ' ALA . 5.9 p -97.72 142.32 29.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.446 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 20.6 m-85 -55.16 -31.13 61.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -137.09 -66.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.641 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.14 74.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.538 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER 178.44 -62.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 165' ' ' VAL . 29.8 m -104.02 112.84 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.734 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.801 ' HB2' HG22 ' A' ' 160' ' ' THR . . . -105.54 146.71 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.538 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 159' ' ' TYR . 2.0 mp -93.92 134.2 36.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.323 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 130.16 53.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 169' ' ' VAL . 12.1 m -137.45 100.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.893 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.4 141.88 31.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -121.27 114.56 21.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -92.14 129.53 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.9 101.91 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -107.93 113.02 25.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -140.06 133.25 29.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 m -115.45 117.79 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.803 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -121.59 137.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.987 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -137.42 138.17 39.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.749 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.8 mt -126.71 129.75 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.21 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -127.12 137.43 52.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.564 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.59 54.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.283 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.645 ' O ' HD23 ' A' ' 197' ' ' LEU . 23.6 m-85 -135.55 170.36 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 196' ' ' TYR . 38.8 mt -149.34 67.16 8.82 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.75 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -44.6 113.85 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.727 2.285 . . . . 0.0 112.653 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.14 129.3 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 205' ' ' SER . 16.7 p -136.97 158.15 45.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -143.06 90.61 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.112 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.72 -66.38 2.41 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -131.68 -36.66 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.158 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.74 136.04 56.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.419 ' HA ' HG22 ' A' ' 200' ' ' THR . 74.4 m -128.06 132.55 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.888 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.41 HG22 ' CD1' ' A' ' 240' ' ' TYR . 21.4 t -139.09 119.5 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.025 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -106.58 104.91 52.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.58 155.16 27.69 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.522 2.148 . . . . 0.0 112.309 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.53 131.93 55.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.76 176.02 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.938 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 236' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.976 0.417 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -70.93 150.07 47.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 238' ' ' LEU . 5.2 mp -120.15 118.77 31.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.836 0.351 . . . . 0.0 110.913 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 251' ' ' SER . 9.1 t80 -118.38 119.88 35.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.41 ' CD1' HG22 ' A' ' 206' ' ' VAL . 0.6 OUTLIER -93.84 151.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -151.48 126.86 2.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.459 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -149.0 164.3 34.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.0 t70 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.842 179.908 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.648 0.261 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 277' ' ' ASN . 0.1 OUTLIER -117.38 166.21 12.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 111.167 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.6 m -151.95 125.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 239' ' ' PHE . 2.4 p -129.81 175.33 8.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 273' ' ' GLY . 0.3 OUTLIER -149.66 159.22 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.94 128.47 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 12.5 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.55 ' O ' HD23 ' A' ' 252' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' A' ' 252' ' ' LEU . 11.0 p -141.63 145.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 111.04 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -129.13 131.98 6.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 16.2 m -109.54 137.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . 0.494 ' HB2' ' CB ' ' A' ' 249' ' ' SER . 58.5 m-80 -130.07 156.61 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 84.2 m-85 -149.51 137.15 20.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.762 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.21 135.08 26.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.978 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.839 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.751 0.31 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.95 132.9 14.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.892 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.5 t60 -117.87 127.62 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -107.64 120.53 42.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 37' ' ' ASN . 2.7 m-20 -136.71 131.78 33.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.4 114.82 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 277' ' ' ASN . . . -109.28 116.96 4.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.453 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -117.93 116.13 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 0.0 111.137 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -102.77 143.73 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.83 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.763 0.316 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.41 147.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.5 t80 -138.28 151.5 47.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -150.13 141.41 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 9' ' ' ASN . 0.7 OUTLIER -134.19 146.71 50.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.097 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.682 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -144.86 113.8 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.797 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -104.27 117.86 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.299 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -134.65 88.54 2.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 109.759 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.41 -126.69 36.11 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.899 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.83 24.98 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.72 2.28 . . . . 0.0 112.689 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -140.39 110.8 6.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.791 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 73' ' ' VAL . 16.1 ttt180 -106.67 146.73 30.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.535 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 3.0 mt -121.57 111.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.269 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -110.19 106.69 16.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 45' ' ' ILE . 3.8 mm? -104.33 127.92 52.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . . . -135.03 131.97 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 115.52 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.891 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.41 134.64 54.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -142.28 157.49 44.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 37.6 mtt180 . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.2 Cg_endo -74.69 127.15 10.66 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.471 2.114 . . . . 0.0 112.238 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 6.6 mt-10 -112.46 145.78 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.88 120.39 17.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -124.12 143.01 50.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.012 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 44' ' ' ARG . 13.2 t -131.84 148.68 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.545 ' CD2' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -118.95 135.17 54.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.051 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -135.06 87.31 2.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 138.83 34.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.56 -55.7 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.3 tp -133.66 123.68 25.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -92.79 98.78 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -151.9 122.03 7.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -58.44 -22.85 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -28.56 17.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.963 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -151.79 79.22 1.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.2 150.9 22.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -148.63 119.74 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.759 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.49 150.8 22.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.61 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HB2' HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -130.83 120.22 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 0.0 110.742 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.545 HG23 ' CD2' ' A' ' 74' ' ' HIS . 3.0 m -94.61 106.52 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.59 105.64 3.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.377 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.93 147.59 16.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.749 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.01 113.71 18.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.87 111.84 23.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.063 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -133.55 106.82 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.579 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' A' ' 109' ' ' MET . 16.7 p90 -125.27 118.55 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.328 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.382 179.769 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.761 0.315 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.61 119.68 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -105.84 124.69 49.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.46 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.433 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 mtt -94.38 129.71 40.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.323 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -95.23 149.54 21.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.04 94.92 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.796 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.53 134.65 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.04 146.57 35.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.26 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' A' ' 87' ' ' LEU . 1.7 tp -138.28 143.55 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 88' ' ' THR . . . -126.32 66.28 61.06 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 111.525 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 82.74 2.0 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 111.867 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -92.06 173.16 7.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 40.8 p-90 -155.92 122.92 5.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.809 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -99.85 137.58 38.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.671 HG23 ' HB2' ' A' ' 128' ' ' PHE . 22.6 m -139.68 117.25 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.8 135.47 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.992 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 123' ' ' THR . 3.9 pp -115.35 -31.63 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.918 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.619 ' N ' HD12 ' A' ' 122' ' ' LEU . 43.1 m -142.49 162.89 34.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.695 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.439 ' N ' HG22 ' A' ' 123' ' ' THR . 3.3 t70 -74.68 61.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.09 -48.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.459 HD22 ' HE1' ' A' ' 128' ' ' PHE . 3.5 mt -84.89 109.9 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -112.52 115.12 28.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.671 ' HB2' HG23 ' A' ' 120' ' ' VAL . 3.7 m-85 -91.0 136.7 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.1 118.87 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -118.63 121.21 4.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.224 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -104.93 174.25 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 111.118 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.7 mt -147.72 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.717 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.24 99.89 12.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.045 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.42 ' HB3' HG22 ' A' ' 114' ' ' ILE . 3.4 ttm -105.93 137.18 44.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.494 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -123.43 150.55 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.102 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -156.09 103.19 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.22 153.36 41.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.65 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.788 0.328 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -77.08 125.33 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -100.52 150.76 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.22 126.63 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.15 96.97 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 t -97.5 137.69 36.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -127.05 103.05 7.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 29.6 p -96.38 106.03 18.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.513 ' O ' HD23 ' A' ' 157' ' ' LEU . . . -130.0 167.99 21.52 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.993 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -134.36 129.77 35.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.738 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.77 113.33 25.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.638 ' OH ' HD11 ' A' ' 167' ' ' LEU . 35.4 p90 -130.24 138.08 50.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.07 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER -97.29 143.73 27.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.938 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.2 -45.93 13.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.355 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.65 33.92 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.301 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.683 ' O ' HG23 ' A' ' 164' ' ' THR . 2.6 mt-10 52.57 73.96 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.085 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.1 OUTLIER 177.91 -65.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.816 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 165' ' ' VAL . 11.9 p -103.87 113.19 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -108.64 136.9 47.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.495 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.638 HD11 ' OH ' ' A' ' 159' ' ' TYR . 0.8 OUTLIER -93.9 123.61 37.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.475 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.46 122.52 46.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.326 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.47 110.57 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' A' ' 156' ' ' GLY . 4.2 p-10 -111.04 155.49 22.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 111.658 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.55 120.99 41.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.346 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.91 134.99 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.0 tp -142.04 108.86 5.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -112.24 139.32 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.968 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -137.12 121.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.801 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.572 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.84 0.352 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 132.59 39.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -147.04 110.04 4.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.85 178.49 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.43 132.73 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.12 142.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.548 ' HB3' ' CB ' ' A' ' 210' ' ' THR . . . -106.73 153.31 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.234 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -160.0 145.54 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -157.04 79.36 3.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.563 ' HA ' HG22 ' A' ' 207' ' ' THR . 42.1 Cg_endo -67.88 113.52 3.03 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.402 2.068 . . . . 0.0 112.292 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 200' ' ' THR . 1.3 tt -114.36 144.83 42.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.705 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.616 ' N ' HD23 ' A' ' 199' ' ' LEU . 5.9 p -138.04 156.23 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.21 90.52 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 109.904 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 66.79 -73.49 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.256 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -123.02 -34.63 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.53 138.0 56.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 48.1 m -128.09 134.44 49.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 240' ' ' TYR . 18.3 m -146.08 124.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 198' ' ' PRO . 14.9 p -137.02 104.88 8.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.053 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.82 165.01 15.69 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.693 2.262 . . . . 0.0 112.234 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.435 ' CZ ' ' HA3' ' A' ' 237' ' ' GLY . 47.1 p90 -141.32 133.6 28.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.548 ' CB ' ' HB3' ' A' ' 195' ' ' ALA . 0.4 OUTLIER -114.62 137.64 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.994 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.3 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.435 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -76.37 141.15 26.4 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.92 129.73 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.26 102.66 11.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.408 ' CD1' HG12 ' A' ' 206' ' ' VAL . 0.3 OUTLIER -78.69 154.87 29.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.24 132.08 3.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.436 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -148.87 156.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.885 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.695 0.283 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.0 t -103.8 141.13 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.733 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.77 126.9 59.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.345 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.35 117.06 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 274' ' ' VAL . 1.4 mt -115.09 124.85 52.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.77 145.28 38.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' A' ' 252' ' ' LEU . 22.6 m -129.61 155.73 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -155.54 169.06 33.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 249' ' ' SER . 4.5 m -131.73 116.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.647 0.261 . . . . 0.0 111.056 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 249' ' ' SER . 41.5 t30 -115.74 95.4 5.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 111.255 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 279' ' ' SER . 3.6 t80 -88.56 155.05 19.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.746 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 72.5 m -133.4 146.5 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.5 t0 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.798 0.332 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -149.17 115.1 5.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.751 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -114.0 123.33 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.688 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.81 120.39 39.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -127.18 134.32 50.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.426 HG22 ' CD1' ' A' ' 36' ' ' PHE . 1.3 pp -134.97 114.12 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.017 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.34 167.65 22.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.594 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.6 118.81 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.25 163.43 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.432 ' HD1' HG13 ' A' ' 274' ' ' VAL . 9.6 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.74 0.305 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.55 152.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.064 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 68.3 m-85 -140.27 136.9 33.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CD1' HG22 ' A' ' 10' ' ' ILE . 27.6 m-85 -147.15 104.48 3.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -105.28 155.26 19.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.066 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 7' ' ' HIS . . . -148.04 113.74 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.751 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -93.07 116.59 29.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.24 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -134.72 88.47 2.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 109.77 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.81 -123.97 34.8 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.02 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.416 ' HG2' ' CD1' ' A' ' 43' ' ' TRP . 94.0 Cg_endo -88.63 21.99 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.666 2.244 . . . . 0.0 112.76 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.488 ' CZ2' ' CE1' ' A' ' 75' ' ' TYR . 75.5 m95 -140.09 111.96 7.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.405 ' CB ' ' HB2' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -106.2 103.87 13.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.797 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -84.0 116.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.27 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.823 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . . . -123.97 115.92 22.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 122.41 43.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . . . -123.6 147.96 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -112.11 119.96 40.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.61 113.2 25.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 152.18 31.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.84 134.24 49.13 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.577 2.185 . . . . 0.0 112.046 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 10.4 mm-40 -115.73 123.53 48.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.151 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.37 153.83 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.823 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 5.1 mt-10 -154.01 143.59 21.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 89' ' ' GLY . 12.3 p -147.03 120.43 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.405 ' HB2' ' CB ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' CZ2' ' A' ' 43' ' ' TRP . 15.2 t80 -119.92 105.38 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.699 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -89.71 126.19 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -40.88 20.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.57 122.51 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 103.01 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -160.13 122.35 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.801 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.37 -25.2 33.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.51 -31.26 14.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.952 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -142.24 78.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -102.31 128.13 48.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.74 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.93 104.03 7.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.985 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -108.62 179.76 21.43 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.469 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 116' ' ' PRO . 3.3 tp -158.2 107.92 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.787 0.327 . . . . 0.0 110.788 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.583 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 1.2 m -75.53 155.96 35.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.697 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -153.65 108.76 0.38 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.514 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.46 167.01 19.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -139.94 129.37 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -125.43 149.49 48.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -147.75 97.82 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.27 110.64 20.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' A' ' 107' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.658 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.779 0.323 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.423 ' HB3' ' CA ' ' A' ' 95' ' ' GLY . . . -176.22 135.88 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.196 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.39 102.35 2.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 mtp -125.82 105.43 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -83.51 135.52 34.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HB2' ' CE1' ' A' ' 137' ' ' PHE . 23.7 ttt180 -143.63 121.85 12.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.88 155.95 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.06 113.71 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.6 142.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.583 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -149.69 107.09 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.32 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 87' ' ' LEU . 50.3 Cg_endo -69.05 93.55 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.336 2.024 . . . . 0.0 112.145 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.85 136.57 51.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.018 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -139.74 122.95 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.98 114.64 14.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.9 124.07 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -109.99 115.74 30.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.732 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 123' ' ' THR . 0.5 OUTLIER -90.85 -28.14 18.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.87 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -165.18 -171.75 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.699 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.86 28.72 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.927 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.16 -41.83 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.04 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.25 135.18 52.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -124.86 134.11 52.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.777 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' CE2' HD21 ' A' ' 157' ' ' LEU . 4.8 m-85 -105.14 143.17 33.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -143.82 118.91 10.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.75 120.62 6.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.558 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -128.53 115.0 17.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.736 HD11 HG23 ' A' ' 153' ' ' THR . 0.5 OUTLIER -105.17 112.3 25.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.419 ' HG ' ' HH ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -87.09 101.1 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.474 ' SD ' HD23 ' A' ' 132' ' ' LEU . 1.9 mtt -120.78 137.99 54.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.419 ' HH ' ' HG ' ' A' ' 133' ' ' SER . 20.2 m-85 -146.68 159.88 42.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -140.7 98.93 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 111' ' ' ARG . 1.7 m-85 -79.03 159.4 27.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.68 160.86 26.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.762 0.315 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 m -89.96 116.86 28.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -96.0 127.3 41.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 151' ' ' VAL . 9.9 p -131.21 109.61 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.92 143.09 43.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.736 HG23 HD11 ' A' ' 132' ' ' LEU . 0.5 OUTLIER -114.44 135.9 53.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -135.13 103.06 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.059 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.4 p -99.71 103.93 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.31 140.61 15.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.423 HD21 ' CE2' ' A' ' 128' ' ' PHE . 1.9 mp -137.71 125.1 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -119.05 119.84 35.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 159' ' ' TYR . 53.2 p90 -130.14 124.98 33.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.604 HG23 ' HB2' ' A' ' 166' ' ' ALA . 62.4 p -84.83 140.96 30.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.129 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.19 -30.67 43.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -144.59 33.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 60.91 76.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER 172.18 -61.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.606 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.584 HG13 ' HG ' ' A' ' 199' ' ' LEU . 26.6 t -107.49 112.68 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.263 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.604 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -107.0 145.29 32.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.988 0.423 . . . . 0.0 111.753 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.72 120.12 33.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.117 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.95 139.2 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 169' ' ' VAL . 15.5 m -140.03 100.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.719 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.75 137.91 40.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.088 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -115.66 110.24 18.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.06 109.28 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -99.53 124.66 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.88 35.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.4 m -124.35 157.02 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -146.64 121.04 9.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.48 159.16 31.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 193' ' ' ILE . 7.8 tp -133.39 113.22 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.145 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 11.4 mmt85 -108.29 152.15 25.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.83 140.04 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.482 ' C ' HD23 ' A' ' 197' ' ' LEU . 0.9 OUTLIER -145.42 174.98 10.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.802 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.561 HD12 ' CD1' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -167.39 87.24 0.76 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.875 ' HA ' HG22 ' A' ' 207' ' ' THR . 46.6 Cg_exo -56.04 113.71 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.436 2.091 . . . . 0.0 112.298 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.584 ' HG ' HG13 ' A' ' 165' ' ' VAL . 0.2 OUTLIER -114.19 126.13 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.744 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.6 t -138.09 154.7 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.521 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.425 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.4 OUTLIER -143.17 90.6 2.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.254 0.55 . . . . 0.0 110.117 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.04 -80.83 1.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.555 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -132.37 39.03 3.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 111.015 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -132.2 141.16 48.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.94 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.6 m -124.47 117.47 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.66 106.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.875 HG22 ' HA ' ' A' ' 198' ' ' PRO . 43.8 p -114.91 104.82 53.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.002 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HG2' HD21 ' A' ' 197' ' ' LEU . 96.9 Cg_endo -80.0 164.98 22.17 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.579 2.186 . . . . 0.0 112.432 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -121.11 131.91 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.9 p -131.1 157.75 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.827 0.346 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -149.25 165.78 29.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.599 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.17 134.54 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -110.03 109.05 19.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.95 142.72 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -139.99 100.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.417 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.66 118.67 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 111.009 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.777 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 248' ' ' LEU . 3.5 pp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.641 0.258 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 276' ' ' VAL . 69.2 m -95.94 151.94 18.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.798 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.87 127.35 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.3 m -135.11 152.28 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.8 mt -141.01 131.08 24.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 127.75 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.872 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.432 HG13 ' HD1' ' A' ' 14' ' ' TYR . 10.8 p -124.21 128.83 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.318 . . . . 0.0 110.997 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -136.18 152.32 21.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.729 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 249' ' ' SER . 20.2 t -140.85 141.7 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 0.0 110.803 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.01 95.53 2.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.058 0.456 . . . . 0.0 111.604 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 7.6 t80 -92.68 120.12 32.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.584 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 p -123.32 146.92 47.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.934 0.397 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -164.2 90.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 18.4 m80 -116.1 108.42 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -88.0 132.44 34.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -143.73 120.87 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.33 131.01 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.195 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -122.12 128.92 7.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.466 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -121.04 155.98 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.1 mmt -147.05 121.11 9.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.846 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.0 p90 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.54 150.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CE2' ' HA3' ' A' ' 11' ' ' GLY . 10.4 p90 -146.69 156.68 43.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.76 157.96 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.21 136.4 33.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -138.72 113.97 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -93.8 122.79 36.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 43' ' ' TRP . 34.5 t-20 -134.87 88.7 2.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -128.38 14.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.884 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -87.74 15.37 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.559 2.172 . . . . 0.0 113.177 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' A' ' 40' ' ' ASN . 60.8 p-90 -140.38 110.95 6.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.829 0.347 . . . . 0.0 111.395 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 10.6 ttm105 -102.2 110.59 22.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.67 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 5.0 tt -83.79 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.463 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -129.46 122.84 30.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.983 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.45 110.54 20.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.36 160.79 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -136.5 102.46 4.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.46 107.32 18.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.16 150.38 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.4 ' CB ' ' HD2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.76 0.314 . . . . 0.0 110.895 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 70.7 Cg_endo -74.8 -167.86 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.612 2.208 . . . . 0.0 112.355 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.51 156.27 36.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.971 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.93 153.95 40.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 12.6 tt0 -162.1 134.55 5.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.838 HG12 ' O ' ' A' ' 89' ' ' GLY . 12.4 p -128.99 150.06 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -118.66 137.68 53.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.99 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.27 87.51 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -93.0 116.25 28.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 -45.17 50.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 mt -143.43 136.96 28.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -97.97 101.97 13.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.7 148.53 25.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.8 0.85 56.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -111.03 -31.86 6.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -155.42 89.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.007 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.7 134.21 55.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.734 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -129.84 104.21 7.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -108.03 -175.2 22.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.162 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.16 108.79 2.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -77.7 159.25 29.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.838 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -174.12 91.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.37 152.21 17.36 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 4.3 m-85 -107.73 134.4 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -106.86 127.13 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.145 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -127.09 107.14 9.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.48 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.0 128.12 54.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.354 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 107' ' ' ALA . . . . . . . . 0 C--N 1.331 0.255 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.486 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.471 ' O ' ' HA2' ' A' ' 95' ' ' GLY . . . -116.43 144.68 43.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.979 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -99.65 125.5 45.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.467 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.7 ttm -107.88 124.78 50.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.344 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.566 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 6.0 mm-40 -91.38 140.5 29.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -152.97 104.45 2.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.832 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.31 144.6 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -142.06 103.01 4.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.732 HG22 ' HA2' ' A' ' 89' ' ' GLY . 1.3 pt -121.64 153.53 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -161.81 117.55 1.29 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.25 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 59.8 Cg_endo -72.11 92.84 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.364 2.043 . . . . 0.0 112.104 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.58 131.75 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -132.14 123.05 26.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.855 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 121.91 38.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.5 111.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -123.49 110.73 15.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -177.22 39.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 123' ' ' THR . 17.1 m -128.95 38.5 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 62.9 84.56 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.227 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 53.95 51.35 14.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.332 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -142.09 109.1 5.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.876 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.04 118.63 24.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -106.33 111.96 24.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -117.22 161.64 19.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.1 125.51 1.0 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.423 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -147.13 140.35 25.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.627 ' CD1' HG23 ' A' ' 153' ' ' THR . 7.6 mp -102.02 98.81 8.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.833 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.506 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 0.9 OUTLIER -77.08 110.49 11.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.016 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 mtt -92.95 132.3 37.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.69 137.0 45.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -141.28 152.56 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.685 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -125.95 149.42 48.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -157.14 163.32 39.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.821 0.343 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.62 129.85 41.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -125.21 129.28 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.53 HG21 HD23 ' A' ' 132' ' ' LEU . 12.0 p -100.68 137.3 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.03 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -121.01 100.38 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.627 HG23 ' CD1' ' A' ' 132' ' ' LEU . 1.3 m -93.82 125.48 38.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.61 105.5 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.1 p -101.42 103.96 14.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.93 148.1 18.89 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.909 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.426 HD23 ' CD2' ' A' ' 126' ' ' LEU . 3.2 mp -137.8 125.42 22.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.69 0.281 . . . . 0.0 110.76 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 1.9 tt0 -112.78 115.02 27.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.085 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CD1' HD12 ' A' ' 126' ' ' LEU . 71.8 t80 -130.16 120.6 24.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.002 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.716 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 43.8 p -84.88 140.42 31.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.67 -29.88 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.804 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -161.66 44.35 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 164' ' ' THR . 47.5 mt-10 61.52 76.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER 176.69 -76.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.677 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.89 113.01 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.716 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -109.62 148.02 32.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.566 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.472 HD11 HD11 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -93.95 137.22 33.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.372 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 121.86 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 169' ' ' VAL . 9.7 p -123.99 110.75 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.792 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -107.55 121.54 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.088 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -87.85 116.37 25.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -85.9 139.18 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.03 100.43 3.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.84 131.1 43.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.41 ' HB2' ' CG1' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -140.08 155.14 47.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.543 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.796 0.332 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.98 115.99 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -107.22 109.98 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.38 164.96 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.2 137.27 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.304 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.454 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 6.3 mmt-85 -118.34 151.88 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.624 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.73 132.55 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.952 0.406 . . . . 0.0 111.361 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 196' ' ' TYR . 0.7 OUTLIER -141.6 137.68 32.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.566 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.472 HD11 HD11 ' A' ' 167' ' ' LEU . 5.5 tp -109.74 75.07 0.78 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.756 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.416 ' HB3' HG22 ' A' ' 207' ' ' THR . 69.3 Cg_endo -74.03 113.74 3.86 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.734 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 197' ' ' LEU . 1.6 mp -114.16 156.02 25.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.441 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 204' ' ' HIS . 34.8 m -138.04 153.26 49.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.531 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 90.41 2.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.282 0.563 . . . . 0.0 110.094 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 60.27 -85.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -117.42 29.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . 0.492 ' O ' HG23 ' A' ' 200' ' ' THR . 1.1 t60 -132.63 130.24 39.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.624 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.02 119.04 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.83 127.2 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 198' ' ' PRO . 30.0 p -132.55 104.93 13.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.418 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.36 165.09 14.58 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.606 2.204 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.17 131.92 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.145 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.98 123.99 17.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.748 0.308 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -161.94 172.03 38.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.516 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.902 HD22 ' CZ ' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -132.87 137.0 46.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.861 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -129.21 123.33 31.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.902 ' CZ ' HD22 ' A' ' 238' ' ' LEU . 2.9 m-85 -112.24 155.08 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -137.19 110.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.549 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -119.32 114.93 23.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.982 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.831 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.66 0.267 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 277' ' ' ASN . 22.7 t -102.18 157.62 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 0.0 110.952 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.94 122.16 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 m -126.98 134.3 50.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.55 161.77 18.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -139.25 99.25 3.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.34 139.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -137.34 -176.09 14.21 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.603 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 15.1 m -149.95 155.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.652 0.263 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 249' ' ' SER . 1.4 t-20 -140.72 95.34 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 279' ' ' SER . 22.8 t80 -88.91 154.93 19.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.847 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 33.7 t -142.5 147.01 35.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.825 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.785 0.326 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.422 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -144.33 111.94 6.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 33.3 m-70 -114.26 105.16 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.417 ' HB3' ' CE1' ' A' ' 280' ' ' PHE . 0.2 OUTLIER -89.95 119.98 30.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -131.11 134.78 46.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.0 mt -118.06 113.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.81 135.83 13.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.599 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -143.92 129.01 18.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 0.0 110.984 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.0 ttm -122.39 141.72 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 4.5 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 49' ' ' TYR . 11.4 p -134.39 141.51 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.046 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.9 m-85 -124.78 145.91 49.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.53 109.37 8.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.68 156.8 18.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.232 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -160.13 113.83 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.617 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 44' ' ' ARG . . . -91.89 125.48 36.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.205 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -134.69 88.6 2.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.19 -125.08 26.51 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.31 17.25 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.635 2.223 . . . . 0.0 112.763 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.41 119.45 14.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.912 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -117.04 109.72 17.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.715 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.3 mt -86.75 141.96 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.904 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -139.82 97.83 3.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 117.44 31.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.713 ' HB3' ' CG ' ' A' ' 70' ' ' GLU . . . -117.54 162.85 17.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.447 ' HB2' HG12 ' A' ' 34' ' ' VAL . 18.6 m-85 -125.87 114.69 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.0 111.39 16.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.741 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -147.81 148.88 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.812 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.699 0.285 . . . . 0.0 111.017 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 26.4 Cg_exo -62.76 -171.17 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.434 2.089 . . . . 0.0 112.196 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.713 ' CG ' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -166.06 144.55 5.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 71' ' ' LEU . 4.1 mp -119.94 157.03 29.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.904 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 60.6 tt0 -147.78 149.56 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.03 148.87 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.438 ' CG ' ' HB3' ' A' ' 44' ' ' ARG . 13.8 m80 -122.86 126.36 47.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -107.28 101.45 10.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -87.46 102.17 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -78.8 -54.99 5.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.28 124.02 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.02 95.08 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.802 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -130.72 142.83 50.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.81 -22.03 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.202 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -117.51 11.33 13.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -176.47 71.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.63 116.05 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.821 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.92 123.0 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.961 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.08 163.64 22.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 87' ' ' LEU . 1.5 tm? -158.13 107.87 2.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 0.0 110.696 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 15.7 p -89.75 159.09 17.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.62 107.22 0.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.77 -176.91 14.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.733 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -129.1 132.59 47.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.798 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -113.66 125.81 54.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -96.12 99.93 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -97.74 106.01 18.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.515 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -171.76 129.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -143.11 100.53 3.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 mtm -125.21 134.13 52.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.8 145.02 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.56 117.56 10.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.753 ' CE3' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -86.59 150.39 24.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.69 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.05 106.51 4.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.753 HD11 ' CE3' ' A' ' 112' ' ' TRP . 5.5 mt -110.31 145.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.557 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -141.63 84.93 11.84 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.406 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.74 90.63 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.646 2.231 . . . . 0.0 112.144 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -62.99 111.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.89 122.96 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.46 122.1 25.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.48 123.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 125.47 52.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.88 -41.85 6.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.1 p -156.22 -177.48 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.63 58.59 4.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -179.09 -49.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.94 105.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -108.83 129.09 55.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.25 144.5 26.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -142.62 122.42 13.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.99 125.09 6.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -131.62 116.85 17.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.416 ' CD1' HG23 ' A' ' 153' ' ' THR . 0.9 OUTLIER -105.98 98.98 8.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 99.94 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.9 140.64 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -145.56 155.63 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.44 107.02 3.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -96.17 130.88 43.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.012 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.78 179.72 7.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.3 t30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.841 0.353 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -85.14 144.74 28.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.67 115.93 31.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.82 103.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -123.6 130.15 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.019 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 132' ' ' LEU . 18.0 m -102.8 142.87 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.799 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.22 106.58 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 m -100.62 103.95 15.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.811 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.02 135.13 12.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.759 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.81 124.55 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 0.0 110.79 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.18 119.32 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.206 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -130.07 110.56 11.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.952 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.723 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 28.8 p -84.6 125.77 32.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -60.99 -29.31 69.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -155.96 41.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.141 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.498 ' C ' HG22 ' A' ' 164' ' ' THR . 2.3 tm-20 57.59 76.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.547 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 168.78 -64.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.504 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.547 ' H ' HG23 ' A' ' 164' ' ' THR . 4.6 m -103.91 112.98 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.723 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -121.15 161.65 21.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.882 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.3 138.72 41.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.064 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 113.63 26.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.74 100.84 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.509 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -95.38 140.7 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.325 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.77 116.76 27.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.92 136.72 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.8 tp -142.02 94.94 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.472 ' HB2' HG23 ' A' ' 190' ' ' THR . 11.8 mt-10 -96.35 118.07 32.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 122.38 16.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.4 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 174' ' ' GLU . 2.4 t -92.84 159.06 15.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.37 141.69 32.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.976 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.44 178.99 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 44.3 pt -148.25 136.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.289 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.41 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 9.8 mtm-85 -134.39 138.94 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.727 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.842 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -110.01 137.77 47.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.48 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 196' ' ' TYR . 2.1 m-85 -135.63 175.09 9.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.85 72.64 0.92 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 0.0 111.017 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.685 ' HA ' HG23 ' A' ' 207' ' ' THR . 51.9 Cg_exo -52.84 113.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.469 2.113 . . . . 0.0 112.252 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.23 127.27 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 204' ' ' HIS . 51.7 m -138.12 146.61 43.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.276 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 95.4 mt -140.04 90.24 2.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.214 0.53 . . . . 0.0 109.993 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.46 -65.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.467 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -143.54 35.6 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.732 0.301 . . . . 0.0 110.828 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 200' ' ' THR . 1.9 m-70 -117.66 146.05 43.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.9 t -127.96 109.23 11.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.997 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.68 107.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.685 HG23 ' HA ' ' A' ' 198' ' ' PRO . 1.7 m -129.88 104.9 16.9 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.16 161.06 41.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 112.267 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -129.59 134.7 47.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.842 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 40.4 m -129.95 133.55 46.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.1 mtp85 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -128.92 132.66 7.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 mt -122.4 122.93 40.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 251' ' ' SER . 2.4 t80 -102.42 117.08 33.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -120.89 144.93 48.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 163.55 -156.43 28.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.575 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.701 ' H ' HG23 ' A' ' 250' ' ' VAL . 17.6 m-85 -149.06 166.09 29.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.913 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 278' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.411 ' HB3' ' N ' ' A' ' 277' ' ' ASN . 7.8 t -97.5 161.28 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.526 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.701 HG23 ' H ' ' A' ' 242' ' ' TYR . 15.3 m -145.95 133.5 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.277 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 239' ' ' PHE . 13.7 m -130.81 136.99 49.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 116.38 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -96.31 134.3 39.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.7 t -129.26 148.0 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.044 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -164.39 161.26 34.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.7 HG12 HG12 ' A' ' 250' ' ' VAL . 30.9 m -144.44 159.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.167 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . 0.411 ' N ' ' HB3' ' A' ' 249' ' ' SER . 0.8 OUTLIER -148.29 95.2 2.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.015 0.436 . . . . 0.0 111.374 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.525 ' HD2' HD12 ' A' ' 248' ' ' LEU . 3.4 t80 -88.86 110.6 21.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.651 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 5.4 p -109.13 142.76 39.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 8' ' ' PHE . 3.0 p90 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.831 0.348 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.74 110.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -123.98 111.99 16.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.497 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 280' ' ' PHE . 51.6 m-85 -96.97 132.54 42.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 111.12 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -115.65 122.86 46.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.766 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.445 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 20.2 mm -105.97 113.88 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.28 154.63 19.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.12 135.68 14.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtp -125.12 144.15 50.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.757 0.313 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.24 142.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.049 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.41 128.43 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.445 ' CE2' ' CD1' ' A' ' 10' ' ' ILE . 1.1 t80 -143.62 114.69 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 1.9 m120 -106.7 164.64 11.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.305 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.593 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -157.55 113.77 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.568 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -97.86 121.92 40.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.601 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.74 88.48 2.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.3 -126.33 28.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.923 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.91 19.23 1.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.683 2.255 . . . . 0.0 112.814 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -140.15 110.89 6.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.74 0.305 . . . . 0.0 111.058 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -116.42 111.79 20.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.615 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.593 HG13 ' HB3' ' A' ' 38' ' ' ALA . 2.2 pt -92.67 148.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.356 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . . . -141.01 109.4 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.047 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' H ' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -96.44 135.55 38.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.886 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -136.54 146.03 45.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.51 122.48 47.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -118.55 111.33 18.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.26 167.43 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.84 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.741 0.305 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.64 -166.37 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.52 2.147 . . . . 0.0 112.053 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.842 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 22.0 tt0 -158.83 134.18 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -137.03 105.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.758 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.49 158.31 17.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 89' ' ' GLY . 16.8 m -140.73 157.02 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.94 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -128.67 117.51 21.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.042 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -127.62 105.12 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -106.74 109.69 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.007 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -37.06 56.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -127.52 132.76 49.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.809 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -129.8 111.92 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.977 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -162.02 168.54 22.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.05 15.32 17.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 120' ' ' VAL . 17.3 m-20 -119.08 -43.09 2.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.765 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' O ' HD22 ' A' ' 78' ' ' LEU . 2.3 t80 -159.32 92.78 1.09 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 t -87.0 150.07 24.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -130.31 104.02 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.13 177.59 17.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.37 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.08 107.81 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 64.8 m -77.04 155.34 32.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -148.7 79.5 0.21 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.537 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.91 129.95 10.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -120.05 120.11 35.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 0.0 110.737 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -127.83 139.9 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -131.13 129.51 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -112.23 128.13 56.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.07 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.652 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.766 0.317 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -168.91 141.76 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -156.56 99.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.2 ttp -116.83 157.63 25.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 143.04 48.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -139.96 116.71 10.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -88.12 130.21 35.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 108.14 9.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.71 147.38 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.69 107.81 3.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.71 94.32 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.31 2.007 . . . . 0.0 112.033 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.48 102.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -107.42 123.0 47.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.72 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.46 123.16 32.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.957 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 82' ' ' ASP . 9.9 p -141.78 106.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 154.55 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -4.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.408 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 m 63.53 31.91 14.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.65 -73.86 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.71 24.62 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.004 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.11 100.49 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -106.75 128.34 54.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.775 ' CE1' HG22 ' A' ' 155' ' ' THR . 0.1 OUTLIER -117.06 130.71 56.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.439 ' ND2' ' CE2' ' A' ' 131' ' ' TRP . 0.2 OUTLIER -128.64 126.68 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.34 130.87 10.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.585 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.439 ' CE2' ' ND2' ' A' ' 129' ' ' ASN . 37.3 m95 -125.62 129.15 49.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.64 ' HG ' HG23 ' A' ' 153' ' ' THR . 2.5 mp -128.8 102.36 6.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.694 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.0 p -84.62 113.06 21.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.11 116.94 31.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.715 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.74 143.84 33.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 98.97 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.44 145.49 35.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.956 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.07 170.12 19.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.07 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.963 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.854 0.359 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.2 p -111.82 137.24 50.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.11 133.43 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.04 129.82 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -136.03 115.97 13.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.64 HG23 ' HG ' ' A' ' 132' ' ' LEU . 1.1 m -96.46 137.87 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.78 107.83 9.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.775 HG22 ' CE1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -98.61 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.717 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.97 132.24 11.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.556 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 3.4 mp -109.84 127.34 54.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.718 0.294 . . . . 0.0 110.737 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.21 111.57 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.029 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -130.16 116.51 18.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.253 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.71 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 15.9 p -84.8 134.48 34.31 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.956 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -60.76 -31.01 70.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -162.9 44.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 164' ' ' THR . 0.3 OUTLIER 62.32 72.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.2 OUTLIER 177.96 -73.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.757 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.64 112.97 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.71 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -114.97 158.75 21.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.046 0.45 . . . . 0.0 111.89 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.04 141.86 32.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.043 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.41 ' HB2' ' HB3' ' A' ' 196' ' ' TYR . 0.0 OUTLIER -117.87 108.89 15.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.113 -179.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 169' ' ' VAL . 22.2 m -109.23 100.94 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -92.41 145.96 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 108.0 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.627 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -85.94 141.31 29.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.997 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 mt -141.75 99.94 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.784 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 123.2 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -133.56 144.43 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.566 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.853 0.358 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.38 107.83 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 123.81 35.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.45 158.03 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.772 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 tt -132.44 140.11 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -134.29 137.88 44.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.584 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -104.92 149.79 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -156.22 172.03 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.722 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.39 86.94 0.23 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.775 ' HA ' HG22 ' A' ' 207' ' ' THR . 45.1 Cg_endo -68.43 113.47 3.14 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.374 2.049 . . . . 0.0 112.408 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mp -114.39 132.82 56.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.735 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 205' ' ' SER . 67.4 p -138.04 155.78 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 200' ' ' THR . 1.3 mp -143.23 90.58 2.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.247 0.546 . . . . 0.0 110.04 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.79 -65.48 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.457 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.43 59.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . 0.544 ' O ' HG22 ' A' ' 200' ' ' THR . 69.2 m-70 -153.09 140.62 19.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.63 ' HA ' HG22 ' A' ' 200' ' ' THR . 5.3 t -128.06 115.72 18.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.059 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.12 128.47 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 198' ' ' PRO . 71.4 p -136.47 104.87 9.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.222 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.49 126.03 2.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.707 2.271 . . . . 0.0 112.134 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 30.4 p90 -112.78 137.6 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.887 0.375 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.731 HG22 HG12 ' A' ' 236' ' ' VAL . 40.2 p -129.55 142.4 50.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.735 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 -179.82 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.731 HG12 HG22 ' A' ' 210' ' ' THR . 17.9 m . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -138.56 141.01 11.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.477 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.11 122.03 36.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.952 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.9 150.48 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.825 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 147.63 44.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.52 126.93 1.99 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.457 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' A' ' 250' ' ' VAL . 49.0 t80 -148.77 162.9 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.099 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.406 ' O ' ' CE2' ' A' ' 242' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.751 HD23 ' HD1' ' A' ' 278' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.477 ' CB ' ' HB3' ' A' ' 277' ' ' ASN . 0.3 OUTLIER -117.43 113.95 22.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.095 0.474 . . . . 0.0 112.105 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 242' ' ' TYR . 3.2 m -117.82 117.18 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 252' ' ' LEU . 4.9 m -127.75 169.39 13.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 111.253 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 251' ' ' SER . 0.9 OUTLIER -151.24 129.75 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.67 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.91 123.16 46.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.316 -0.314 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 6.2 m -110.63 124.68 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -117.88 131.86 9.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 276' ' ' VAL . 27.3 m -126.08 123.08 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . 0.477 ' HB3' ' CB ' ' A' ' 249' ' ' SER . 33.0 t30 -125.6 156.45 39.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.751 ' HD1' HD23 ' A' ' 248' ' ' LEU . 7.0 m-85 -149.89 155.41 39.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.894 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.94 147.1 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.678 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.403 ' HB3' ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.836 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.782 0.325 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -157.38 95.36 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -117.36 109.98 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.24 119.98 29.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -128.06 130.22 47.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mt -115.62 137.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 131.17 6.33 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.571 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.87 128.41 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 0.0 111.062 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.88 128.96 54.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.863 0.363 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 35' ' ' TYR . 6.0 t -101.72 162.32 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.66 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.462 ' N ' HG12 ' A' ' 34' ' ' VAL . 30.3 t80 -155.71 135.4 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.369 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.47 155.81 49.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.352 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.696 ' ND2' ' HB2' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -150.12 155.41 39.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.219 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.739 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -155.93 113.86 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.576 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.9 117.76 29.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.83 88.58 2.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.5 -128.15 26.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.82 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.38 21.92 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.649 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -140.26 112.76 7.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.43 104.68 14.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.739 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -83.82 133.26 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.343 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.85 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -135.22 124.0 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.903 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.98 112.44 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.084 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -111.26 161.45 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.856 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.05 115.58 24.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -123.65 121.17 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -151.31 141.18 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.833 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.922 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.478 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.546 0.212 . . . . 0.0 110.801 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 83.5 Cg_endo -83.76 176.77 6.7 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.801 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 4.5 tp10 -161.93 131.06 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mt -110.21 150.24 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.201 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.85 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -162.02 127.35 3.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 74' ' ' HIS . 29.1 t -128.01 154.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.409 ' N ' HG12 ' A' ' 73' ' ' VAL . 0.4 OUTLIER -124.03 148.21 47.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -135.54 143.73 45.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.9 102.17 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.52 -66.28 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -125.4 133.34 52.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -120.13 106.48 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -146.86 172.17 14.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.14 15.35 10.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.431 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.444 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 4.2 m-20 -114.26 -44.99 3.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 82' ' ' ASP . 15.5 p90 -166.95 101.55 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -92.93 133.85 35.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.745 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.59 107.78 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.146 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.84 175.18 19.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.203 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 116' ' ' PRO . 3.1 tp -158.12 107.93 2.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 0.0 110.936 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 m -79.02 155.87 28.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.29 105.04 0.24 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.567 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.36 174.9 20.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.383 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -129.85 144.12 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -122.46 117.74 26.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -105.0 112.25 25.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -125.83 100.0 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.426 -179.919 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.31 168.12 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.038 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -142.5 117.83 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.2 mtt -136.46 119.17 16.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.718 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 2.9 tp-100 -111.21 141.23 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.785 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.56 124.28 12.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.981 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -85.53 146.08 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.8 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -128.18 107.94 10.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.169 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.8 pt -131.3 150.72 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.3 105.69 1.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HB3' HD12 ' A' ' 87' ' ' LEU . 56.4 Cg_endo -70.43 93.61 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.434 2.089 . . . . 0.0 111.938 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.03 149.38 41.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -147.34 123.02 10.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.69 118.74 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.06 114.03 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -106.15 128.18 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.86 -32.82 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -145.01 -175.35 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.475 ' H ' HG22 ' A' ' 123' ' ' THR . 70.9 m-20 -88.88 53.54 2.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -176.78 -50.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 157' ' ' LEU . 5.4 mt -82.03 104.11 12.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -112.64 116.37 30.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -90.95 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -137.43 127.48 25.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.37 125.18 6.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -123.09 121.77 36.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.921 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' A' ' 153' ' ' THR . 4.3 mp -116.37 99.03 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.5 120.6 24.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.9 mtp -128.65 129.1 45.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.8 133.07 52.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -115.92 157.41 24.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 148' ' ' ASP . 40.9 p90 -108.54 154.11 22.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -165.03 178.54 6.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 137' ' ' PHE . 4.2 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 p -99.08 110.76 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 126.04 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 151' ' ' VAL . 16.0 m -145.97 100.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.08 121.32 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.455 HG23 ' HG ' ' A' ' 132' ' ' LEU . 10.0 m -104.39 126.75 51.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -126.37 107.81 10.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.123 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.5 p -99.08 103.87 15.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.11 148.36 16.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.805 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 126' ' ' LEU . 4.6 mt -133.03 118.39 18.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -108.71 113.27 26.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.429 ' N ' ' HB1' ' A' ' 166' ' ' ALA . 5.5 p90 -130.11 118.4 21.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 0.5 OUTLIER -92.28 131.48 37.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.752 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.82 7.52 26.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.693 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.04 28.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.766 0.317 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.677 ' O ' HG23 ' A' ' 164' ' ' THR . 14.6 mm-40 51.52 64.94 1.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.112 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.2 OUTLIER 178.54 -64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 199' ' ' LEU . 21.5 t -103.85 113.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.813 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.48 ' HB2' ' HB ' ' A' ' 160' ' ' THR . . . -119.03 151.97 37.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.8 mp -93.92 133.44 37.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.265 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 196' ' ' TYR . 41.9 ttp85 -109.05 107.02 17.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.047 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.49 107.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.712 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -103.37 145.23 30.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.46 121.76 42.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.583 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.89 125.16 33.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.5 tt -142.02 94.82 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.748 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -126.58 148.95 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -140.1 151.04 45.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.791 0.329 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.2 m -79.03 110.96 14.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.12 131.76 54.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.55 156.99 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -116.15 131.36 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -129.23 117.96 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -99.08 149.11 23.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.402 ' HB2' ' HB3' ' A' ' 168' ' ' ARG . 52.5 m-85 -155.11 142.54 19.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.448 ' O ' HD23 ' A' ' 199' ' ' LEU . 2.1 mt -136.24 71.99 60.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.1 113.72 3.15 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.488 ' HB3' HG13 ' A' ' 165' ' ' VAL . 0.5 OUTLIER -114.29 157.16 23.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.492 HG22 ' OG ' ' A' ' 205' ' ' SER . 2.9 p -136.62 138.08 40.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.16 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.48 89.81 2.45 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.359 0.6 . . . . 0.0 109.983 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 45.93 81.24 0.04 OUTLIER Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.884 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.85 40.22 16.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -152.05 97.57 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.492 ' OG ' HG22 ' A' ' 200' ' ' THR . 41.5 m -96.84 142.74 28.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 97.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -105.01 104.75 48.46 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.087 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.81 164.94 17.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.624 2.216 . . . . 0.0 112.387 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 4.2 m -139.1 150.45 45.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.852 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.092 -179.876 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.852 0.358 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -101.07 168.34 20.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.588 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.1 128.2 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.5 98.1 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.98 134.72 38.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -125.81 114.56 2.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.577 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.75 110.18 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.962 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.632 0.254 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.587 ' O ' HG13 ' A' ' 276' ' ' VAL . 28.4 t -95.93 167.44 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.746 0.307 . . . . 0.0 110.948 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -149.28 117.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.5 m -138.92 147.1 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 5.1 mp -121.11 123.5 42.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 131.6 53.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.05 148.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -135.18 141.32 12.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.537 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 249' ' ' SER . 14.0 t -115.25 145.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ASN . . . . . 0.417 ' CB ' ' HB3' ' A' ' 249' ' ' SER . 1.8 t-20 -147.41 95.55 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -88.43 140.27 29.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.0 p -124.67 131.52 53.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.937 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.819 0.343 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -142.86 85.01 1.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.97 -58.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -157.84 54.9 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.33 -22.28 11.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.115 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 66.31 118.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 110.821 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -114.15 119.72 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -88.0 128.86 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.52 135.46 40.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 10' ' ' ILE . 4.5 tt -155.83 126.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.74 163.27 22.21 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.47 121.33 7.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.134 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -104.88 159.38 15.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.23 133.03 12.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -118.38 118.01 30.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.6 mt -140.12 150.99 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -102.82 -165.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -97.29 26.54 4.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.068 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 19' ' ' VAL . 15.1 t 54.91 30.59 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.28 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 62.96 145.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.911 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.52 -52.0 47.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.538 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.47 105.42 9.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.85 0.357 . . . . 0.0 110.811 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.95 160.09 11.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.532 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.1 85.33 0.94 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.842 0.354 . . . . 0.0 110.925 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -122.94 28.56 7.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 3.2 mtt -143.08 111.97 6.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.03 -66.7 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.46 121.22 5.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.42 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.0 mt -152.12 137.06 17.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.23 160.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -131.39 147.33 65.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.3 146.15 44.84 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.532 2.155 . . . . 0.0 112.289 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -103.08 119.37 38.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.64 151.95 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -148.33 142.08 25.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -149.82 143.91 25.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.644 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -146.38 161.56 40.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.411 . . . . 0.0 111.336 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.19 113.83 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.499 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.774 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -94.99 116.18 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.553 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.82 88.56 2.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.704 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.74 -126.61 35.12 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.031 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.66 23.14 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.0 112.689 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.442 ' CH2' ' HB ' ' A' ' 73' ' ' VAL . 14.8 t-105 -140.42 110.85 6.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.802 0.334 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 26.7 mtp180 -108.37 108.77 19.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.564 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 mt -83.85 120.62 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.138 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . . . -125.32 121.69 34.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.17 113.18 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.09 146.73 43.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.21 117.43 34.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.09 120.88 43.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -152.36 123.0 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -137.34 140.26 41.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 135.96 77.14 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.382 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.09 -79.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.54 2.16 . . . . 0.0 112.25 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 m -146.87 29.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.19 162.52 25.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.46 122.94 6.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.7 -67.38 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 59.97 97.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.146 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.75 -63.46 0.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.555 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.96 -69.21 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -148.38 175.34 11.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.61 138.13 8.49 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.4 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -152.75 66.37 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.371 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -112.13 -27.37 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.764 ' HB2' HG21 ' A' ' 106' ' ' THR . 28.8 t80 -73.48 -67.35 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.1 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 60.96 -178.89 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.795 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.425 ' CB ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -177.11 173.18 0.75 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.932 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 68' ' ' ARG . 73.5 Cg_endo -76.27 -179.61 5.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.446 2.098 . . . . 0.0 112.326 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.2 167.34 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.95 149.12 50.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.805 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.82 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -147.55 140.28 24.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.976 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 89' ' ' GLY . 15.4 m -142.11 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 74' ' ' HIS . 2.0 m-70 -112.78 139.35 48.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -138.04 104.27 5.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.77 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -95.31 111.01 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.11 -52.71 57.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.6 mt -129.37 145.35 51.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.69 94.95 4.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.72 130.38 14.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.39 -23.68 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.832 ' O ' HG23 ' A' ' 120' ' ' VAL . 1.0 OUTLIER -77.77 -44.65 26.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -151.48 80.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.973 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.3 123.93 33.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -106.75 115.8 30.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -125.54 165.9 18.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.57 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.24 107.89 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.7 0.285 . . . . 0.0 110.533 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.867 HG22 ' HB3' ' A' ' 115' ' ' ALA . 9.0 t -105.85 107.83 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -101.38 123.44 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.244 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.86 153.64 17.42 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.778 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.77 126.63 53.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 110.654 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -109.95 134.7 51.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.957 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -125.91 121.74 34.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.786 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -116.26 137.02 52.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.72 161.52 25.98 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.384 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.633 ' CA ' HG22 ' A' ' 106' ' ' THR . 3.8 t80 71.86 -73.46 0.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.527 0.203 . . . . 0.0 110.95 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 65.08 -70.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.143 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.429 ' N ' ' O ' ' A' ' 96' ' ' TYR . 1.3 t80 -173.43 125.63 0.4 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.829 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.31 139.34 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.19 -39.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -84.48 109.48 20.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.79 64.63 1.82 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.438 2.092 . . . . 0.0 112.296 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.15 -45.26 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.52 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.49 139.93 53.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.922 0.391 . . . . 0.0 110.781 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.5 -49.26 72.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.785 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.764 HG21 ' HB2' ' A' ' 66' ' ' PHE . 0.5 OUTLIER -112.94 149.9 32.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.852 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.78 154.94 29.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.601 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -108.45 125.19 51.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.75 139.7 39.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -108.36 134.2 51.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -143.34 129.21 19.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -90.87 148.45 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.736 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -142.09 103.71 4.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.6 144.6 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.867 ' HB3' HG22 ' A' ' 88' ' ' THR . . . -140.87 93.28 8.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.317 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 41.7 Cg_exo -56.81 87.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.557 2.172 . . . . 0.0 112.072 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.78 98.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.947 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -107.86 122.92 47.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.796 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -128.17 127.19 42.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 82' ' ' ASP . 10.0 p -145.06 127.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 141.0 29.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -110.27 -32.31 7.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.813 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.52 177.88 9.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.16 54.52 3.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.5 -39.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 159' ' ' TYR . 1.2 mp -99.37 141.86 31.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -123.2 144.0 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 155' ' ' THR . 5.6 t80 -115.65 133.31 56.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -129.8 159.33 36.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.02 113.56 0.59 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.385 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.21 118.96 30.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.95 102.56 12.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 t -76.06 112.96 13.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 31.5 mtt -116.55 118.01 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.751 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -111.35 131.95 54.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.075 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.24 105.4 7.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.669 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -71.85 142.96 49.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.55 137.27 15.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.031 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -145.31 -173.53 4.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.954 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.35 29.32 3.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.96 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -177.93 -62.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.9 t30 59.67 86.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 144' ' ' THR . 3.4 t -57.93 -51.66 68.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.102 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.419 ' N ' HG23 ' A' ' 143' ' ' THR . 44.2 p -123.99 -36.41 2.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.052 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 87.65 -13.33 60.9 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.919 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 63.08 -79.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.802 0.334 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.9 -175.74 2.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.48 -75.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 57.0 m -127.58 122.42 33.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -99.14 133.18 43.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 151' ' ' VAL . 10.9 p -141.71 116.59 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.981 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.06 121.69 30.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.5 t -95.05 138.8 32.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.763 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.47 117.61 18.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.502 HG23 ' CE1' ' A' ' 128' ' ' PHE . 26.0 m -105.14 103.91 13.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.02 135.78 12.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.573 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.433 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 1.1 tp -131.05 115.01 15.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.97 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -114.64 110.89 20.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.51 ' HB3' HD23 ' A' ' 126' ' ' LEU . 2.5 p90 -130.01 125.0 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -98.88 138.16 36.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.045 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.45 -50.66 30.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.384 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -150.83 53.62 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.448 ' C ' HG22 ' A' ' 164' ' ' THR . 8.1 tt0 61.55 76.52 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 179.89 -76.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.495 ' H ' HG23 ' A' ' 164' ' ' THR . 19.3 m -103.91 112.8 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.557 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.507 ' HB2' ' HB ' ' A' ' 160' ' ' THR . . . -112.56 140.65 47.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 0.0 111.66 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.5 mp -93.86 129.94 40.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.393 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -102.51 132.53 48.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.051 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 169' ' ' VAL . 5.9 m -132.18 103.72 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -103.26 127.82 50.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.935 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.32 110.98 23.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.79 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.33 139.33 30.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.02 94.97 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.95 138.17 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.962 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -140.04 138.08 35.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.39 150.81 37.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.479 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.1 145.26 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 110.917 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -141.83 158.6 43.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 6.0 ttt -98.45 34.4 2.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -64.88 176.85 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -85.84 -55.85 3.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.967 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.2 m -161.63 39.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -131.35 89.82 2.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -25.09 11.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 68.4 -71.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.829 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 161.42 77.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.519 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.11 174.29 4.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.58 154.22 51.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.1 p -102.51 124.02 47.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 m -101.52 128.55 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.942 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -119.43 117.49 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -105.73 136.41 45.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 194' ' ' ARG . 3.7 mt -97.06 154.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.034 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 193' ' ' ILE . 23.6 mtt180 -147.06 117.02 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.401 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -110.85 137.2 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.003 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.49 173.82 13.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.904 HD12 HD11 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -175.18 80.35 0.31 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.669 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.7 ' HA ' HG22 ' A' ' 207' ' ' THR . 35.7 Cg_endo -65.25 113.86 2.61 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.556 2.171 . . . . 0.0 112.541 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.904 HD11 HD12 ' A' ' 197' ' ' LEU . 0.7 OUTLIER -114.21 155.86 25.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.674 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -137.99 156.97 47.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.673 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.31 90.54 2.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.154 0.502 . . . . 0.0 110.114 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 61.25 -84.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.523 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.5 31.54 5.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -140.25 136.39 33.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.4 m -117.39 139.89 50.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 206' ' ' VAL . 9.6 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.992 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 198' ' ' PRO . 10.0 p -121.81 104.66 38.86 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.765 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.56 165.06 18.48 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.597 2.198 . . . . 0.0 112.406 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -120.5 139.67 52.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.53 HG23 HG13 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -143.21 159.29 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.402 ' HG2' HG23 ' A' ' 212' ' ' ILE . 4.8 ttt180 -169.31 -57.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.402 HG23 ' HG2' ' A' ' 211' ' ' ARG . 2.4 pp -136.82 170.38 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.164 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 179.33 -36.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.557 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.92 -179.56 5.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -161.62 121.93 2.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -145.56 -177.7 5.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -112.28 -65.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.6 116.01 31.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -167.25 142.2 3.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -133.16 156.65 47.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -77.53 164.8 25.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -111.6 162.93 14.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -110.28 -55.63 2.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -77.84 -31.95 51.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.81 137.57 36.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 228' ' ' ARG . 1.9 pp -126.75 140.04 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.23 37.08 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.495 ' H ' HD12 ' A' ' 226' ' ' ILE . 6.0 mmt-85 -108.4 107.96 18.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -151.56 -47.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.008 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.31 39.02 0.6 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -135.76 31.53 3.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.67 144.78 35.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -83.5 108.17 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -161.4 160.9 30.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.57 -68.16 0.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 210' ' ' THR . 26.0 t 58.75 107.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.146 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -58.74 145.85 42.5 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 4.0 mp -118.06 113.37 21.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 111.091 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -116.38 106.38 13.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -90.87 146.73 23.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -132.77 111.37 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.017 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 250' ' ' VAL . 76.5 m-85 -104.5 166.22 10.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.249 0.547 . . . . 0.0 111.503 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 8.2 t0 65.56 -93.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.133 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.36 29.43 1.29 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.732 0.301 . . . . 0.0 111.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.84 -54.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.08 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -57.64 -20.39 32.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.4 ' O ' ' CD2' ' A' ' 278' ' ' TYR . . . 126.1 -24.35 5.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.343 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 3.0 pp -105.66 126.77 52.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.9 t -95.85 123.51 39.46 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.96 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.662 ' HA ' HG12 ' A' ' 276' ' ' VAL . 40.1 t -105.82 116.92 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.798 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 16.0 m -108.03 152.07 24.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.169 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 253' ' ' GLU . 0.1 OUTLIER -133.91 142.11 47.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.585 ' H ' HD13 ' A' ' 252' ' ' LEU . 2.7 tt0 -118.43 128.58 54.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -133.07 140.34 47.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -174.36 118.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -67.74 -177.22 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -101.33 126.18 48.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' TRP . . . . . 0.414 ' CE3' ' HA ' ' A' ' 258' ' ' TRP . 2.4 m95 -151.29 153.13 34.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 60.94 156.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.795 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -169.01 164.43 11.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -136.96 -47.21 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -85.14 150.05 25.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.23 31.87 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 173.2 -39.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.474 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.46 -15.18 62.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.621 0.248 . . . . 0.0 111.237 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.25 152.26 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -77.6 -49.48 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -112.49 166.17 11.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.25 -31.74 8.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -133.8 159.68 39.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.921 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -121.24 -46.66 2.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -93.27 155.04 17.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.063 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.34 131.45 3.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.446 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.09 123.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -144.93 145.4 14.71 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.138 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 250' ' ' VAL . 29.6 m -126.39 159.15 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 111.487 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 249' ' ' SER . 9.8 m120 -148.12 95.53 2.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.176 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 4.3 t80 -88.55 121.29 30.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.79 138.7 37.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.886 0.374 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.21 143.63 51.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -100.0 52.68 0.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.37 38.74 3.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -144.3 29.37 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.993 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.451 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 1.1 m0 -91.42 113.15 25.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -119.25 152.05 37.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.93 119.94 20.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.633 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -131.81 139.8 48.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.065 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.5 mm -121.8 113.75 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.864 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.51 143.52 15.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.2 125.79 8.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.312 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.64 120.68 42.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.89 161.83 19.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -118.48 151.72 37.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.4 mm -76.28 138.32 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -113.84 99.79 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.9 30.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -81.46 -36.01 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -73.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.56 -123.14 1.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.456 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -99.73 153.33 19.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.8 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.19 -160.91 30.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -151.65 81.86 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.9 103.89 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.6 mmt 60.53 90.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.5 -174.34 2.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.935 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.74 -85.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' HG2' ' A' ' 52' ' ' GLU . 3.0 pp -169.85 167.76 9.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 0.0 110.909 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.47 159.74 34.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 59.98 94.42 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.39 -64.87 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.508 2.139 . . . . 0.0 112.351 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 p 174.75 -179.39 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.972 0.415 . . . . 0.0 111.042 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 35' ' ' TYR . 19.2 t -134.27 158.71 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.814 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.466 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -141.75 151.6 43.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.053 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -145.08 146.63 31.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.64 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.92 157.39 45.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.427 . . . . 0.0 111.197 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -167.22 113.84 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' TRP . . . -90.78 126.16 35.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.836 0.351 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -134.77 88.57 2.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.685 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.82 -126.2 31.73 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -88.65 21.35 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.682 2.255 . . . . 0.0 112.864 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -140.14 112.8 8.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' CB ' ' A' ' 74' ' ' HIS . 0.3 OUTLIER -94.62 112.88 24.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.515 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.0 mm -83.99 118.36 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -131.61 119.54 21.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.923 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -121.25 155.0 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.591 ' N ' HD23 ' A' ' 47' ' ' LEU . . . -145.94 147.78 32.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.042 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -100.97 113.68 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.11 122.84 48.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.817 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -156.52 138.34 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.446 ' HG2' HD22 ' A' ' 29' ' ' LEU . 26.2 mt-10 -133.06 120.72 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.85 143.02 5.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.491 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.88 112.47 3.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.483 2.122 . . . . 0.0 112.365 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t 58.91 84.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.144 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.71 132.25 45.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -95.38 170.75 9.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -120.07 138.47 53.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.493 ' HB2' ' CG2' ' A' ' 64' ' ' THR . . . -121.72 -174.74 2.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.4 51.56 3.95 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.55 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp 58.59 31.39 21.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.353 . . . . 0.0 110.985 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -174.23 127.55 0.35 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.88 158.98 33.86 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.561 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 2.1 t 43.04 91.83 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.869 0.366 . . . . 0.0 111.47 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.562 ' HE1' HG23 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -175.59 127.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -126.8 171.28 11.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 60.21 -176.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -173.36 173.43 1.31 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 111.22 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.8 -160.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.871 2.381 . . . . 0.0 112.278 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -153.47 132.69 12.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.92 154.61 19.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.765 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 5.7 tt0 -157.09 134.79 10.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.3 m -135.94 148.13 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -117.27 130.36 56.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 87' ' ' LEU . 1.2 t80 -127.12 100.69 6.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -91.6 113.58 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.48 -72.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -114.92 128.49 56.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -96.16 102.11 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -156.04 163.59 39.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -94.26 16.37 15.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.13 -43.02 2.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.882 0.372 . . . . 0.0 110.878 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.435 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 96.5 m-85 -146.0 86.79 1.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.75 112.75 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 83' ' ' PHE . 56.9 m-85 -114.91 121.31 42.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.043 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -140.26 -173.35 13.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.347 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.8 pp -158.15 124.27 4.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.747 0.308 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.0 m -99.95 98.96 9.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.952 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.57 134.76 11.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.49 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -140.13 162.76 26.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.632 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.95 121.47 42.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.861 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 118.44 36.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.984 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -110.75 98.05 7.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -113.4 126.94 55.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.95 173.62 40.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.47 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -119.55 135.41 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.949 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.4 163.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -140.25 -45.53 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.953 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.562 HG23 ' HE1' ' A' ' 65' ' ' TRP . 16.6 t -54.46 161.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' N ' HG12 ' A' ' 99' ' ' VAL . 1.0 OUTLIER -82.44 56.93 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.99 0.424 . . . . 0.0 111.075 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -128.1 72.55 79.46 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.22 124.38 13.93 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.538 2.159 . . . . 0.0 112.399 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 104' ' ' LYS . . . -164.95 75.02 0.16 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.44 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 103' ' ' GLY . 2.3 ptpp? 44.88 30.53 0.57 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.726 0.298 . . . . 0.0 111.397 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.83 90.54 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.815 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m -161.58 124.93 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.95 144.39 8.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -150.66 104.37 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.7 mtt -130.8 129.56 42.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -101.21 150.48 22.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.774 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -147.22 121.28 9.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.106 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -91.24 122.77 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.88 108.25 16.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.23 146.34 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.65 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.46 91.04 7.76 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.682 0.277 . . . . 0.0 111.493 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 34.3 Cg_exo -57.51 86.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.961 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.12 106.31 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.258 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -107.35 132.64 52.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.495 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -138.32 128.59 25.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.201 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.4 t -136.2 100.87 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.43 156.22 40.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.47 29.05 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -32.85 11.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.598 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.9 -78.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.475 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -164.09 25.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.4 tp -142.33 152.4 42.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -102.53 111.11 23.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.619 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.95 137.93 31.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.126 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.88 118.91 10.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.879 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -105.01 139.85 14.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.53 120.28 16.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.822 0.344 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.77 98.97 6.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.846 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.4 t -87.47 110.11 20.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.719 ' HG3' HG22 ' A' ' 151' ' ' VAL . 1.8 ttp -112.12 122.88 48.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.842 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -105.24 128.79 53.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.0 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -108.37 98.92 8.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.54 128.56 33.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.54 135.12 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -163.63 140.3 6.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -62.03 -25.45 67.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.47 43.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -71.82 92.81 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 67.0 p -83.7 -48.87 9.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.3 m -106.03 -31.19 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 59.88 29.21 67.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -67.93 135.78 52.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.959 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.47 94.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.092 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.75 -42.06 13.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 t -137.09 142.08 42.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.403 ' NH1' ' HB3' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -133.59 113.01 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.812 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.719 HG22 ' HG3' ' A' ' 134' ' ' MET . 29.0 t -102.35 137.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.045 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -134.49 118.74 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.5 m -97.18 136.51 37.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.01 101.47 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.7 m -94.99 108.41 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -107.63 134.45 12.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.699 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.3 mt -119.61 124.69 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.765 0.317 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -112.96 121.08 43.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -130.08 108.41 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.028 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.996 HG23 ' HB2' ' A' ' 166' ' ' ALA . 0.8 OUTLIER -84.75 126.57 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.871 0.367 . . . . 0.0 110.953 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -52.5 -27.41 16.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.79 49.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.764 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 57.24 58.94 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.9 m -165.3 -73.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.72 112.75 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.412 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.996 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -117.83 153.16 33.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.1 0.476 . . . . 0.0 111.848 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.2 tt -100.01 138.09 37.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.998 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -112.49 125.89 54.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.934 0.397 . . . . 0.0 111.305 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 169' ' ' VAL . 9.1 p -123.02 103.12 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.586 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -97.36 134.7 40.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.93 113.03 25.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.402 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.461 ' C ' HD12 ' A' ' 173' ' ' LEU . 0.2 OUTLIER -85.82 132.64 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.248 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 172' ' ' TYR . 5.0 mp -142.14 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.643 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -88.71 123.79 33.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 112.93 8.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -131.83 -165.44 11.36 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -111.94 149.63 31.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -133.49 157.59 45.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -171.43 172.82 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -172.4 -46.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -134.35 -50.08 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.5 -45.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.03 103.41 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.95 31.27 5.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -160.78 167.75 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 170.61 -37.74 0.18 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.389 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 77.29 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.75 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -160.25 133.22 6.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.94 145.08 21.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.39 120.48 39.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -122.14 129.07 51.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -126.26 173.78 9.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.742 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.41 139.27 39.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -127.87 143.98 51.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.51 144.69 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -152.76 168.66 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.9 tt -176.62 85.41 0.27 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.524 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.82 113.67 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.39 2.06 . . . . 0.0 112.672 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.0 mt -114.47 116.16 28.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.387 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.806 HG22 ' HA ' ' A' ' 205' ' ' SER . 29.2 p -129.49 158.21 39.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 110.83 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 201' ' ' LEU . 9.6 tp -143.1 90.5 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.182 0.515 . . . . 0.0 109.997 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 80.83 -73.86 2.49 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.417 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -125.93 -35.07 2.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.715 0.293 . . . . 0.0 111.347 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -65.34 135.09 54.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.806 ' HA ' HG22 ' A' ' 200' ' ' THR . 13.2 t -128.1 115.85 19.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.038 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.7 t -133.34 119.48 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 207' ' ' THR . 5.0 t -122.68 104.76 36.24 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.208 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.19 161.83 39.92 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.693 2.262 . . . . 0.0 111.888 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.43 ' CZ ' ' HA3' ' A' ' 237' ' ' GLY . 43.7 p90 -150.39 142.63 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.017 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.4 m -137.34 143.3 41.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.44 177.35 4.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.682 ' O ' HD12 ' A' ' 212' ' ' ILE . 2.2 pp -139.62 117.16 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -125.79 -50.0 0.18 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.45 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.27 101.42 4.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.87 -33.03 15.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.85 179.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -108.29 -48.96 3.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.939 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.72 170.15 22.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -116.41 155.2 28.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.7 31.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.85 150.61 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -101.09 33.93 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.765 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -127.73 112.07 14.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -157.32 -74.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 64.34 37.3 8.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.4 mt -135.98 106.48 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.111 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -108.66 87.37 2.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -135.35 148.11 49.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -76.92 149.77 36.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 71.93 123.76 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -60.53 179.86 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.86 0.362 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.76 150.51 13.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -94.53 162.95 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -129.41 31.58 4.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -163.48 106.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 236' ' ' VAL . 12.2 p -159.45 124.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.43 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -98.65 159.75 20.35 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.467 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.5 mt -144.45 129.95 18.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.828 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 253' ' ' GLU . 0.7 OUTLIER -112.28 99.15 7.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.914 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -84.58 151.91 24.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -164.64 106.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.476 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -148.2 155.09 40.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -122.73 125.87 46.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -160.36 33.37 0.17 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.048 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . 0.426 ' CB ' ' HB2' ' A' ' 248' ' ' LEU . 28.5 mt-30 -134.7 49.48 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.9 m120 60.96 55.18 3.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.11 -24.34 25.3 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.733 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 278' ' ' TYR . 1.9 mm? -69.54 129.49 39.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.511 0.196 . . . . 0.0 110.497 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.476 ' O ' HG13 ' A' ' 276' ' ' VAL . 43.1 t -95.7 166.69 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.339 . . . . 0.0 110.906 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.88 117.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 24.5 t -122.58 132.46 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.83 121.48 34.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.426 ' HG2' ' CE1' ' A' ' 239' ' ' PHE . 7.9 mt-10 -96.66 106.16 18.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 272' ' ' ALA . 2.2 t80 -83.72 122.78 29.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -72.65 -170.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.137 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -91.46 51.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.03 -166.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' TRP . . . . . 0.4 ' CE3' ' O ' ' A' ' 259' ' ' GLN . 38.9 p-90 -105.16 159.32 15.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.4 ' O ' ' CE3' ' A' ' 258' ' ' TRP . 0.9 OUTLIER -58.7 110.18 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.938 -179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -154.8 113.85 3.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.14 178.12 4.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.34 -66.89 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.928 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 60.76 31.76 20.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -111.67 28.84 9.08 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 58.86 26.51 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 0.0 110.997 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 44.4 m -164.8 -174.16 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.815 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -157.16 131.12 8.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -90.81 -63.05 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.956 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.62 159.77 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.64 175.46 13.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -161.47 -45.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 254' ' ' TYR . . . -55.3 140.94 37.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.19 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -80.13 171.45 54.33 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.562 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 274' ' ' VAL . 12.6 p -132.34 124.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -122.32 150.85 16.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.43 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.596 HG11 HD12 ' A' ' 248' ' ' LEU . 21.3 t -125.77 125.71 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.289 . . . . 0.0 111.181 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 249' ' ' SER . 8.1 m-20 -127.57 95.25 4.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.122 0.487 . . . . 0.0 111.235 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.767 ' HB2' HD13 ' A' ' 248' ' ' LEU . 2.3 t80 -88.7 125.74 34.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.727 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.9 141.46 45.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.29 101.32 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.834 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -101.74 -31.18 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -102.12 -25.09 13.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.079 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -94.02 43.81 1.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.9 m95 179.79 81.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -110.77 111.56 22.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.71 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -91.21 126.09 36.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 37' ' ' ASN . 3.0 m-20 -131.98 127.31 36.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.56 122.93 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.26 160.82 13.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.64 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -160.99 129.27 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.4 ttm -109.92 132.95 53.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.945 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -142.33 125.36 16.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -86.85 136.2 33.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.803 HD11 HG21 ' A' ' 274' ' ' VAL . 26.3 mm -74.36 149.03 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.119 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.67 158.16 44.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.97 148.0 44.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.63 110.89 26.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.0 120.65 19.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.66 154.43 6.14 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.452 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -66.84 -42.0 86.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.58 -103.1 2.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -105.37 142.21 35.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -164.46 91.96 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -139.44 134.9 33.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.954 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.65 30.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.99 165.11 12.29 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.431 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.686 ' O ' HD12 ' A' ' 29' ' ' LEU . 3.9 pp -79.89 121.03 24.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -121.48 128.52 52.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -135.1 92.16 18.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.48 160.69 48.15 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.451 2.1 . . . . 0.0 112.316 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.26 132.03 33.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 35' ' ' TYR . 18.7 t -105.43 157.04 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.437 ' N ' HG12 ' A' ' 34' ' ' VAL . 7.0 m-85 -141.47 147.52 38.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.016 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.58 114.07 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.622 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.402 ' CB ' ' HB2' ' A' ' 9' ' ' ASN . 0.4 OUTLIER -111.72 153.13 26.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.185 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -156.69 113.93 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.846 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -98.67 122.46 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.315 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -134.8 88.45 2.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.99 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.68 -123.19 32.0 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.234 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.68 25.29 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 112.805 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -140.11 110.74 6.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.667 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.61 157.31 15.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.61 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.738 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 27.1 mm -126.38 134.75 65.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.141 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.754 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -141.14 97.16 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 tt -116.73 115.97 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.34 142.71 50.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -97.91 120.59 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.014 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -112.92 106.81 15.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.99 162.13 41.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.753 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -105.09 153.95 20.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -127.71 -132.88 3.66 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.382 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.53 154.7 6.02 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.453 2.102 . . . . 0.0 112.413 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 29' ' ' LEU . 10.8 p -177.14 -39.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 55' ' ' VAL . 1.2 t70 -144.46 -47.6 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -161.34 127.31 3.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 m -69.58 161.35 29.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.921 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.13 168.8 8.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.58 31.12 9.04 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.5 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt 60.34 78.44 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.832 0.349 . . . . 0.0 110.82 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.825 ' HB2' HG22 ' A' ' 99' ' ' VAL . 4.5 mmt85 -132.5 -47.01 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.63 4.56 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 65' ' ' TRP . 1.3 m 60.2 171.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 110.908 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.452 ' H ' HG22 ' A' ' 64' ' ' THR . 34.4 m95 61.14 32.75 19.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -80.96 132.4 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.821 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 0.5 OUTLIER 57.82 -169.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.774 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 12.5 mmt180 -157.81 163.06 25.91 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.096 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.419 ' HD2' ' CD ' ' A' ' 68' ' ' ARG . 92.9 Cg_endo -84.54 -166.88 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.87 2.38 . . . . 0.0 112.375 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -146.67 123.63 11.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 155.13 17.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.754 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -162.05 128.36 3.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 89' ' ' GLY . 28.9 m -129.84 157.11 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -121.25 145.13 48.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -125.27 128.39 48.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -113.74 102.27 10.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.949 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.84 -73.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.816 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.56 120.35 41.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -97.3 107.34 19.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' H ' ' HG ' ' A' ' 84' ' ' SER . 22.0 t30 -159.55 142.75 14.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -77.46 -13.4 59.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.26 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.701 ' O ' HG23 ' A' ' 120' ' ' VAL . 8.3 t0 -100.17 -42.75 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.988 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -141.37 87.5 2.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.454 ' HG ' ' H ' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -108.72 159.05 17.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -145.03 137.96 26.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.816 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -148.46 141.3 8.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.599 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.987 HD21 HG23 ' A' ' 114' ' ' ILE . 5.9 tt -120.69 122.46 40.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 0.0 110.784 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.688 ' HB ' ' HB3' ' A' ' 115' ' ' ALA . 20.8 m -102.66 117.14 34.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.826 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -109.06 116.05 4.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.448 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -130.5 147.08 18.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.528 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.6 134.93 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 -106.0 132.67 51.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -137.81 115.18 11.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -140.49 148.02 40.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.787 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.37 -166.63 39.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.545 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -135.87 157.06 47.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.82 0.343 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -177.06 95.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.72 -168.36 2.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 62' ' ' ARG . 20.7 t -59.45 -67.06 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.128 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.77 -66.79 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 59.96 104.34 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.31 79.43 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.398 2.065 . . . . 0.0 112.205 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.74 84.12 0.13 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.479 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.1 mttt 63.34 122.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.841 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -152.96 30.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.5 m -162.34 129.37 3.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -166.03 148.03 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.59 100.01 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 7.6 mtt -118.61 142.64 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 9.9 tt0 -132.53 133.33 43.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.7 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -135.76 129.66 32.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.049 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -85.94 142.89 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.585 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -127.19 133.05 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.448 . . . . 0.0 111.317 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.987 HG23 HD21 ' A' ' 87' ' ' LEU . 10.7 mt -131.48 143.48 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.41 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.688 ' HB3' ' HB ' ' A' ' 88' ' ' THR . . . -139.93 66.0 31.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.856 ' HD3' HG22 ' A' ' 114' ' ' ILE . 68.7 Cg_endo -74.24 65.99 5.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.41 2.073 . . . . 0.0 111.506 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 131' ' ' TRP . 2.8 p30 -80.47 179.48 7.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.491 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -152.88 123.85 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.527 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.85 128.71 35.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 82' ' ' ASP . 7.6 p -145.14 100.93 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.24 152.67 48.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.96 -12.34 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.156 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.65 32.78 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.37 -45.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -167.38 -42.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.426 ' HG ' ' CE1' ' A' ' 159' ' ' TYR . 2.0 mt -82.81 121.84 27.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -123.11 139.83 53.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.63 ' HB2' HG13 ' A' ' 120' ' ' VAL . 61.6 m-85 -134.55 138.36 44.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -152.19 118.96 5.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.992 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.23 114.34 4.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.431 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 117' ' ' ASP . 10.9 m0 -104.94 124.97 50.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 0.0 111.09 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.48 ' O ' HD23 ' A' ' 132' ' ' LEU . 8.6 tt -109.24 105.62 15.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.754 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.75 116.68 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.955 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.657 ' HG2' HG12 ' A' ' 151' ' ' VAL . 0.4 OUTLIER -96.88 118.99 34.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -104.23 119.92 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.001 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.401 ' HA ' HG22 ' A' ' 149' ' ' THR . 0.0 OUTLIER -123.93 145.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.557 ' CD1' HG21 ' A' ' 144' ' ' THR . 0.2 OUTLIER -104.81 151.76 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.964 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -164.8 150.34 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -160.79 -175.77 5.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 107.51 1.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 142' ' ' ASN . 5.4 tt 68.37 -68.17 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.42 ' HB2' HD23 ' A' ' 141' ' ' LEU . 2.9 t-20 -178.46 84.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.2 m -93.95 -43.15 8.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.557 HG21 ' CD1' ' A' ' 137' ' ' PHE . 1.8 t -91.56 -33.18 15.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.956 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 103.35 20.48 11.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.726 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 55.53 33.34 20.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.748 0.309 . . . . 0.0 111.022 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -104.31 -177.05 3.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.35 32.18 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 137' ' ' PHE . 71.7 p -102.98 109.57 21.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.016 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -146.57 170.99 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.657 HG12 ' HG2' ' A' ' 134' ' ' MET . 35.6 m -118.52 148.98 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.379 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -125.03 138.63 54.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.638 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 34.3 m -93.92 145.35 24.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.124 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -136.88 98.99 3.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.752 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.81 108.0 20.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.455 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -110.29 141.93 16.43 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.583 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 156' ' ' GLY . 10.5 mp -123.61 130.5 52.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.767 0.318 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.408 ' CG ' ' HG3' ' A' ' 168' ' ' ARG . 5.3 mt-30 -117.55 113.22 21.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.426 ' CE1' ' HG ' ' A' ' 126' ' ' LEU . 27.4 t80 -130.16 116.8 18.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.822 HG23 ' HB2' ' A' ' 166' ' ' ALA . 9.4 p -84.72 137.23 33.35 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.13 -38.61 91.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -149.93 42.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 61.72 70.82 0.57 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 175.75 -64.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.729 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.588 ' H ' HG23 ' A' ' 164' ' ' THR . 27.5 m -103.98 112.77 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -118.01 150.48 39.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.111 0.482 . . . . 0.0 111.818 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.81 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.225 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.408 ' HG3' ' CG ' ' A' ' 158' ' ' GLN . 0.4 OUTLIER -115.0 114.62 25.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 169' ' ' VAL . 8.6 p -116.94 100.91 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.581 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -98.67 133.98 42.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.182 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -103.2 112.31 25.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.502 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -85.83 137.99 32.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.1 tt -141.74 94.92 2.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.632 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.41 144.67 25.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.76 157.03 47.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.776 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -145.37 148.73 20.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.536 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -134.07 118.96 18.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -125.43 117.54 23.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.986 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.19 143.12 30.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.72 31.43 20.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.25 171.02 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.6 p -99.46 34.65 2.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 60.49 30.24 19.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.852 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -98.39 -49.95 4.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -115.28 174.24 6.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.947 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.63 -28.94 13.36 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -105.82 31.4 5.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -148.14 129.71 14.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m -108.49 145.63 34.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 10.7 m -96.71 118.17 32.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -122.06 110.84 16.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -119.84 147.6 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 193' ' ' ILE . 7.3 tp -112.51 120.02 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.112 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.433 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 0.1 OUTLIER -106.28 132.03 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.67 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -110.26 148.61 31.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 194' ' ' ARG . 89.4 m-85 -153.4 175.11 13.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.425 HD23 HD11 ' A' ' 199' ' ' LEU . 14.4 tp -172.29 71.32 0.44 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.69 113.7 1.82 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.575 2.183 . . . . 0.0 112.387 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.425 HD11 HD23 ' A' ' 197' ' ' LEU . 1.1 mt -114.27 151.31 33.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.739 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.7 HG22 ' O ' ' A' ' 204' ' ' HIS . 1.0 OUTLIER -138.11 157.85 45.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.731 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 13.0 tp -143.28 90.65 2.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.19 0.519 . . . . 0.0 110.144 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.71 -65.43 0.63 Allowed Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.408 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -148.49 32.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . 0.7 ' O ' HG22 ' A' ' 200' ' ' THR . 58.0 m80 -123.92 154.99 38.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 4.2 m -128.06 128.25 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.955 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -143.54 112.13 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.6 t -125.74 105.01 26.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.056 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.74 ' HB3' HD23 ' A' ' 238' ' ' LEU . 85.8 Cg_endo -78.3 165.07 26.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.528 2.152 . . . . 0.0 112.306 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -120.42 136.2 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.029 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.67 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 27.1 m -136.46 146.58 46.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.803 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.74 -39.1 2.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 24.9 mm -116.06 120.45 64.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.141 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.16 -149.67 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.461 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tp -116.93 101.98 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -104.23 169.1 8.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.84 33.27 5.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 60.08 31.43 20.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.4 t -104.57 -31.5 9.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -109.03 -31.46 7.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -117.33 114.12 23.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -134.79 155.13 51.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -176.48 -41.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.63 162.91 22.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -138.07 -47.4 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -171.71 1.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.2 mp -125.97 143.95 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.67 152.22 39.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.968 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -98.17 86.15 3.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 60.09 159.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 131.59 150.0 6.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.503 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.39 143.56 29.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.747 0.308 . . . . 0.0 110.866 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.61 133.68 45.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -98.54 -53.13 3.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -81.06 105.93 12.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -141.61 -69.19 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 p -89.83 130.89 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.086 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -74.49 156.78 50.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.74 HD23 ' HB3' ' A' ' 208' ' ' PRO . 34.2 mt -147.03 106.06 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.94 128.85 38.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.21 144.96 30.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -141.34 122.15 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -123.27 137.83 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.389 . . . . 0.0 110.866 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.32 89.14 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -169.28 32.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.988 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.97 53.26 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.033 0.444 . . . . 0.0 110.737 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.2 t30 64.31 29.66 13.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.883 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 110.98 -14.71 28.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.883 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.618 HD11 HG11 ' A' ' 276' ' ' VAL . 2.8 tt -90.79 138.31 31.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.688 0.28 . . . . 0.0 110.857 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.727 ' O ' HG13 ' A' ' 276' ' ' VAL . 33.2 t -102.21 165.75 10.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.65 117.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 18.9 p -109.48 164.3 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.445 ' CD2' ' CE2' ' A' ' 254' ' ' TYR . 0.2 OUTLIER -145.58 136.31 24.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.417 ' O ' ' HB1' ' A' ' 272' ' ' ALA . 0.7 OUTLIER -107.4 113.83 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . 0.445 ' CE2' ' CD2' ' A' ' 252' ' ' LEU . 1.2 m-85 -115.19 151.24 34.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . 60.76 -175.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.15 -171.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 60.65 101.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -123.17 179.52 4.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.15 160.95 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.788 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.43 -34.84 11.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.851 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -83.67 118.6 23.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -132.28 122.32 24.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.88 -40.58 2.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.976 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 83.71 61.81 1.83 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -95.5 -31.42 13.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.885 0.374 . . . . 0.0 110.968 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.4 t -165.43 142.62 5.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.56 160.72 24.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -135.6 147.04 48.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.42 178.7 3.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.28 106.88 1.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.69 141.9 53.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.773 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 253' ' ' GLU . . . -174.41 144.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -106.24 170.8 16.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.386 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.803 HG21 HD11 ' A' ' 16' ' ' ILE . 21.5 t -138.03 141.76 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 111.166 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -126.44 179.12 16.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.513 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 249' ' ' SER . 22.7 t -153.96 140.43 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.679 0.276 . . . . 0.0 110.976 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 249' ' ' SER . 5.5 t-20 -148.09 95.31 2.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.989 0.423 . . . . 0.0 111.394 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 280' ' ' PHE . 13.0 t80 -92.71 154.99 17.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.661 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.42 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 12.6 p -143.04 146.71 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.449 ' HB2' ' CE1' ' A' ' 278' ' ' TYR . 44.2 t80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.956 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.806 0.336 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -115.82 118.08 32.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -118.85 -41.31 2.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.586 HD22 ' HB1' ' A' ' 39' ' ' ALA . 14.8 m-20 -59.89 -27.31 66.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.977 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 65.37 28.72 11.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.956 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.69 115.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.049 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.782 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.4 m80 -109.65 112.14 24.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.699 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.98 135.49 33.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.067 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -149.0 132.08 16.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.596 HG23 ' CE1' ' A' ' 36' ' ' PHE . 22.1 mt -125.97 154.0 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.49 119.33 0.89 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.33 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -128.18 157.74 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 111.189 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.8 127.86 35.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 32' ' ' PRO . 5.9 m-85 -134.25 154.76 51.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.999 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.9 124.79 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 16' ' ' ILE . 19.1 tt -119.19 118.44 57.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.053 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.38 156.65 16.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -76.0 170.84 15.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 19' ' ' VAL . 29.7 m -62.76 107.1 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.04 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -163.24 91.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.69 135.78 2.59 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.577 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.99 -55.16 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.99 89.46 0.29 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.418 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -157.45 -42.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 111.017 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.89 38.43 6.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.915 0.388 . . . . 0.0 110.76 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.4 ttp -161.86 61.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -162.22 99.97 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.89 81.05 0.25 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.435 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.13 148.08 52.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.931 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.59 77.92 1.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.07 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.85 72.35 5.75 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 14' ' ' TYR . 63.3 Cg_endo -73.48 119.24 5.85 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.572 2.182 . . . . 0.0 112.429 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -97.21 143.3 28.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.736 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 35' ' ' TYR . 15.3 t -117.16 157.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.285 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 34' ' ' VAL . 2.5 m-85 -157.46 132.96 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CE1' HG23 ' A' ' 10' ' ' ILE . 67.6 m-85 -134.42 157.34 46.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.747 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.67 149.45 33.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.616 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -150.4 113.83 4.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.727 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -94.49 120.58 34.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.302 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -134.72 88.59 2.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.65 -127.13 15.72 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.05 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -88.13 19.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.767 2.312 . . . . 0.0 112.792 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.409 ' CZ3' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -140.11 121.97 15.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.906 0.384 . . . . 0.0 111.173 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 103.95 11.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.661 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.616 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 3.2 tp -83.89 139.63 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.199 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.868 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -139.04 119.64 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tp -104.66 148.71 26.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.793 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.94 157.36 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.185 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 114.64 22.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.4 111.8 22.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.98 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -150.13 156.98 42.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.55 116.04 16.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.927 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.35 149.36 27.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.56 51.54 3.91 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.696 2.264 . . . . 0.0 112.623 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 55' ' ' VAL . 15.2 t 49.03 38.39 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.906 0.384 . . . . 0.0 111.39 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.84 85.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.53 174.32 12.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -76.68 -34.25 58.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 60.52 37.99 19.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -81.04 -48.23 6.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.466 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -61.22 -74.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.762 0.315 . . . . 0.0 110.897 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -67.61 179.02 1.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.65 49.5 0.66 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.497 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 p -111.88 92.88 4.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.72 0.295 . . . . 0.0 110.832 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -176.32 96.76 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.046 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' CD1' ' HA3' ' A' ' 95' ' ' GLY . 36.8 t80 -149.61 -75.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.53 -165.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.804 0.335 . . . . 0.0 111.141 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -174.73 168.79 1.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.958 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.47 -168.52 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.56 2.173 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.46 165.44 27.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mp -137.04 156.98 47.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.868 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -146.25 152.99 40.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.997 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.55 HG23 ' HA3' ' A' ' 89' ' ' GLY . 16.9 m -143.6 141.8 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -123.27 110.12 14.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CE1' ' CZ3' ' A' ' 43' ' ' TRP . 2.2 t80 -96.42 86.92 4.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -94.32 127.19 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.809 ' HB3' HD12 ' A' ' 78' ' ' LEU . 14.1 m-85 -84.28 -73.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 77' ' ' PHE . 3.8 mp -145.59 143.83 30.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.004 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -104.33 94.86 5.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.721 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -161.47 172.22 16.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 77.39 -68.3 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.87 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.598 ' HB3' HG13 ' A' ' 120' ' ' VAL . 1.6 m-20 -119.1 -44.02 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.808 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.415 ' CD2' ' HE3' ' A' ' 121' ' ' LYS . 5.8 t80 -178.62 -75.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 p -147.26 159.2 43.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.827 0.346 . . . . 0.0 111.233 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.09 106.76 3.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.78 -146.78 4.47 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.45 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.403 HD23 ' HG3' ' A' ' 116' ' ' PRO . 1.2 mp -143.67 117.7 9.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.662 0.268 . . . . 0.0 110.45 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -79.58 122.33 26.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.996 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.64 ' HA2' HG22 ' A' ' 114' ' ' ILE . . . -108.25 173.17 17.76 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.42 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 72' ' ' GLU . . . -178.05 156.12 18.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.722 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -142.66 110.3 5.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.766 0.317 . . . . 0.0 110.749 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.15 133.65 52.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -147.31 140.87 25.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.824 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -146.1 158.22 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.427 ' HA3' ' CD1' ' A' ' 66' ' ' PHE . . . -81.16 -177.9 52.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.181 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.768 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -143.69 89.72 2.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -60.23 158.68 11.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -152.82 -48.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 100' ' ' ASP . 5.7 m -141.65 -48.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.416 ' N ' HG23 ' A' ' 99' ' ' VAL . 0.1 OUTLIER 55.09 30.29 14.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.403 ' CB ' ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -69.06 -60.8 3.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.862 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 101' ' ' GLU . 62.6 Cg_endo -73.54 -36.46 3.86 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.562 2.175 . . . . 0.0 112.316 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -168.45 -79.68 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.437 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.79 -77.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 110.845 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.74 50.52 12.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.083 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 p -102.87 179.88 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.56 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.768 ' HB3' ' HB2' ' A' ' 96' ' ' TYR . . . -116.79 137.68 52.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.726 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.33 117.61 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.32 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.25 131.04 55.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.314 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -114.77 137.77 51.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 111.378 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.16 135.85 41.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.457 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -104.69 138.53 40.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.142 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 134' ' ' MET . 0.1 OUTLIER -132.0 102.44 5.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.986 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.64 HG22 ' HA2' ' A' ' 89' ' ' GLY . 2.9 pp -139.61 149.47 22.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.968 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.939 ' HB3' ' O ' ' A' ' 132' ' ' LEU . . . 175.65 153.02 0.33 Allowed Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.698 0.285 . . . . 0.0 111.396 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HG3' HD23 ' A' ' 87' ' ' LEU . 22.0 Cg_exo -64.91 136.96 51.0 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.659 2.24 . . . . 0.0 112.448 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.9 142.29 50.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.451 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.431 ' CE2' ' HA3' ' A' ' 130' ' ' GLY . 29.2 p90 -124.26 122.93 39.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.347 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.39 107.31 14.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 82' ' ' ASP . 16.8 t -100.89 112.22 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.415 ' HE3' ' CD2' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -131.16 154.29 48.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.37 27.86 12.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.395 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.587 HG21 ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -83.1 -27.94 29.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.776 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -170.61 -72.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.587 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.95 26.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mp -142.27 148.14 37.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.982 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.4 112.06 25.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.591 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.496 ' CD2' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -98.81 117.35 33.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -112.7 118.92 36.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 118' ' ' TRP . . . -113.97 109.58 2.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.596 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.86 114.9 23.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.788 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.939 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 33.8 tp -126.96 131.06 51.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.81 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.6 m -136.47 120.9 18.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.831 ' HG3' HG12 ' A' ' 151' ' ' VAL . 3.5 mtm -92.87 120.86 33.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.112 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -87.35 135.71 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.0 0.429 . . . . 0.0 111.515 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.85 130.47 24.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.47 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.84 149.28 45.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.041 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.88 145.62 12.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -147.17 179.37 7.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.96 -35.55 80.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mp -105.55 39.81 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -58.53 99.43 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.004 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -67.35 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.812 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 146' ' ' TYR . 12.1 t -110.49 -33.58 6.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.806 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.7 34.07 60.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.683 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.536 ' H ' HG23 ' A' ' 144' ' ' THR . 1.1 t80 -99.54 168.52 9.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 0.0 110.937 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.68 -175.16 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 62.26 31.54 17.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -93.58 146.84 23.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.67 170.87 14.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.831 HG12 ' HG3' ' A' ' 134' ' ' MET . 3.7 m -141.58 120.09 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.14 99.85 9.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.8 m -97.56 127.15 43.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -128.9 97.74 4.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.1 p -96.4 103.89 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.714 ' C ' HD22 ' A' ' 157' ' ' LEU . . . -104.78 135.87 12.77 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.523 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.714 HD22 ' C ' ' A' ' 156' ' ' GLY . 3.2 mm? -121.39 125.79 47.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 110.949 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -119.07 102.79 9.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.616 ' O ' HD12 ' A' ' 167' ' ' LEU . 19.0 p90 -130.11 134.21 47.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.169 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.801 HG22 ' HB2' ' A' ' 166' ' ' ALA . 5.9 p -97.72 142.32 29.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.446 ' CZ ' HD11 ' A' ' 167' ' ' LEU . 20.6 m-85 -55.16 -31.13 61.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -137.09 -66.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.641 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.14 74.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.538 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER 178.44 -62.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.108 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 165' ' ' VAL . 29.8 m -104.02 112.84 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.734 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.801 ' HB2' HG22 ' A' ' 160' ' ' THR . . . -105.54 146.71 29.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.538 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 159' ' ' TYR . 2.0 mp -93.92 134.2 36.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.323 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 130.16 53.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 169' ' ' VAL . 12.1 m -137.45 100.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.893 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.4 141.88 31.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -121.27 114.56 21.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -92.14 129.53 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.984 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.9 101.91 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.794 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -107.93 113.02 25.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -140.06 133.25 29.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -157.42 -167.11 18.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -102.24 123.16 45.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 0.0 110.943 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -128.8 119.45 24.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 3.1 mtt -98.9 -31.48 11.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.88 100.06 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -131.67 -66.97 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.1 m -141.44 28.65 1.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.975 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.8 mmt-85 57.23 27.64 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.077 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -178.56 38.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.815 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -171.2 153.68 3.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.99 46.27 0.42 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.429 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -148.17 94.78 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.24 157.71 44.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.83 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.9 t -147.04 140.41 25.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.3 m -115.45 117.79 31.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.803 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -121.59 137.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.987 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -137.42 138.17 39.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.749 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.8 mt -126.71 129.75 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.21 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -127.12 137.43 52.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.564 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.3 135.59 54.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.283 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.645 ' O ' HD23 ' A' ' 197' ' ' LEU . 23.6 m-85 -135.55 170.36 16.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 196' ' ' TYR . 38.8 mt -149.34 67.16 8.82 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.75 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -44.6 113.85 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.727 2.285 . . . . 0.0 112.653 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.14 129.3 56.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.618 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 205' ' ' SER . 16.7 p -136.97 158.15 45.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.4 mt -143.06 90.61 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.112 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 75.72 -66.38 2.41 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.434 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -131.68 -36.66 1.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.676 0.274 . . . . 0.0 111.158 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.74 136.04 56.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.047 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.419 ' HA ' HG22 ' A' ' 200' ' ' THR . 74.4 m -128.06 132.55 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.888 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.41 HG22 ' CD1' ' A' ' 240' ' ' TYR . 21.4 t -139.09 119.5 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.025 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.1 m -106.58 104.91 52.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.018 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.58 155.16 27.69 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.522 2.148 . . . . 0.0 112.309 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.53 131.93 55.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.76 176.02 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.938 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.86 156.36 20.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 31.7 mt -143.5 152.87 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.142 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.69 -125.2 2.81 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.19 116.55 28.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.93 -28.51 8.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.019 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -40.16 76.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.005 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -78.49 130.55 36.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.2 p -176.18 125.0 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -104.14 130.32 51.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -112.98 140.23 47.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -123.28 -178.34 3.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -92.42 79.71 4.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -123.95 -177.28 3.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.948 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -116.84 31.94 6.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.5 108.09 15.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 15.5 pt -106.28 -35.08 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.114 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -132.63 111.98 11.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.24 153.28 30.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -109.74 85.98 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -121.91 28.76 5.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.551 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -77.84 158.47 29.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.969 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.45 155.08 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.15 118.43 8.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.07 168.99 8.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.423 ' O ' HG12 ' A' ' 236' ' ' VAL . 8.7 mtm180 -99.35 -40.28 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 236' ' ' VAL . 14.6 p 43.49 42.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.653 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -70.93 150.07 47.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 238' ' ' LEU . 5.2 mp -120.15 118.77 31.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.836 0.351 . . . . 0.0 110.913 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 251' ' ' SER . 9.1 t80 -118.38 119.88 35.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.41 ' CD1' HG22 ' A' ' 206' ' ' VAL . 0.6 OUTLIER -93.84 151.46 19.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -151.48 126.86 2.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.459 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -149.0 164.3 34.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -129.42 152.27 49.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.842 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -89.66 8.6 30.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.397 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 58.39 28.22 16.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.865 0.364 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -136.02 22.1 3.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.066 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.25 -24.16 26.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.746 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -89.98 149.38 22.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.648 0.261 . . . . 0.0 110.662 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.494 ' CB ' ' HB2' ' A' ' 277' ' ' ASN . 0.1 OUTLIER -117.38 166.21 12.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 111.167 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.6 m -151.95 125.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 239' ' ' PHE . 2.4 p -129.81 175.33 8.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.951 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 273' ' ' GLY . 0.3 OUTLIER -149.66 159.22 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.94 128.47 43.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -133.8 118.71 18.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -144.31 171.75 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.059 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.54 -178.5 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 60.42 165.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -168.95 99.06 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.47 170.48 8.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.45 111.52 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -85.23 111.75 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.976 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -98.61 -44.31 6.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -143.93 143.3 31.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -97.67 28.28 15.06 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.51 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.85 -48.05 9.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.714 0.292 . . . . 0.0 110.812 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 23.3 t -82.17 145.54 30.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -168.81 100.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.41 171.51 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -91.4 -31.47 16.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -104.53 143.3 33.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -148.72 -74.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -128.83 -69.53 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.55 ' O ' HD23 ' A' ' 252' ' ' LEU . . . -115.81 151.39 18.4 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.468 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' A' ' 252' ' ' LEU . 11.0 p -141.63 145.27 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 111.04 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -129.13 131.98 6.98 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.507 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 16.2 m -109.54 137.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.067 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.494 ' HB2' ' CB ' ' A' ' 249' ' ' SER . 58.5 m-80 -130.07 156.61 44.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.81 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 84.2 m-85 -149.51 137.15 20.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.762 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.21 135.08 26.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.978 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.839 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.792 0.329 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -99.56 31.44 3.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -109.64 32.37 5.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.25 31.45 6.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -135.06 -67.6 0.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.987 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.95 132.9 14.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.892 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.5 t60 -117.87 127.62 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -107.64 120.53 42.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.094 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 37' ' ' ASN . 2.7 m-20 -136.71 131.78 33.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.4 114.82 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.2 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 277' ' ' ASN . . . -109.28 116.96 4.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.453 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -117.93 116.13 26.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 0.0 111.137 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -102.77 143.73 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -133.16 141.89 48.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -101.78 158.91 15.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 tp -112.99 136.95 47.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -91.98 178.05 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -129.21 129.55 45.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 p -72.83 129.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.012 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -151.25 -68.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.83 100.91 0.63 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.504 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.61 102.24 1.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 110.956 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.05 -156.6 9.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.506 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.92 150.9 20.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.05 155.14 41.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.1 mmt -110.16 -30.94 7.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -124.25 157.06 35.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.98 122.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.519 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.13 -67.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.779 0.323 . . . . 0.0 110.887 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.37 135.17 40.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 33.8 tt0 -138.64 64.73 37.68 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 31' ' ' GLU . 18.1 Cg_exo -66.56 -162.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.682 2.255 . . . . 0.0 112.297 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -171.87 124.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.41 147.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 1.5 t80 -138.28 151.5 47.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -150.13 141.41 23.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.673 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 9' ' ' ASN . 0.7 OUTLIER -134.19 146.71 50.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.097 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.682 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -144.86 113.8 6.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.797 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -104.27 117.86 35.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.299 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -134.65 88.54 2.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.112 0.482 . . . . 0.0 109.759 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.41 -126.69 36.11 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.899 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -88.83 24.98 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.72 2.28 . . . . 0.0 112.689 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -140.39 110.8 6.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.791 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 73' ' ' VAL . 16.1 ttt180 -106.67 146.73 30.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.535 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 3.0 mt -121.57 111.28 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.269 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -110.19 106.69 16.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 45' ' ' ILE . 3.8 mm? -104.33 127.92 52.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . . . -135.03 131.97 37.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.98 115.52 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.891 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -114.41 134.64 54.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -142.28 157.49 44.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -130.42 139.49 50.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.46 166.7 10.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.487 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.46 21.34 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.856 2.371 . . . . 0.0 112.861 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.9 t 60.14 63.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.48 143.27 43.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.819 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -100.7 133.05 45.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.0 133.32 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.5 133.66 18.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.121 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.75 -32.87 2.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.35 85.75 1.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.788 0.327 . . . . 0.0 110.911 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 59.62 163.77 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.906 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.99 159.48 25.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 64' ' ' THR . 5.2 t -97.6 99.47 10.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -150.02 135.74 18.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -161.0 107.27 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.75 125.83 29.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 37.6 mtt180 -128.08 52.67 9.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.054 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 70.2 Cg_endo -74.69 127.15 10.66 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.471 2.114 . . . . 0.0 112.238 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 6.6 mt-10 -112.46 145.78 39.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.02 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.88 120.39 17.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -124.12 143.01 50.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.012 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 44' ' ' ARG . 13.2 t -131.84 148.68 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.545 ' CD2' HG23 ' A' ' 88' ' ' THR . 0.1 OUTLIER -118.95 135.17 54.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.051 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -135.06 87.31 2.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.792 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.46 138.83 34.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.56 -55.7 2.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.3 tp -133.66 123.68 25.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -92.79 98.78 11.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.998 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -151.9 122.03 7.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -58.44 -22.85 55.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -28.56 17.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.963 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -151.79 79.22 1.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.2 150.9 22.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -148.63 119.74 7.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.759 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.49 150.8 22.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.61 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HB2' HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -130.83 120.22 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 0.0 110.742 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.545 HG23 ' CD2' ' A' ' 74' ' ' HIS . 3.0 m -94.61 106.52 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.028 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.59 105.64 3.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.377 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.93 147.59 16.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.749 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.01 113.71 18.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.783 0.325 . . . . 0.0 110.665 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.87 111.84 23.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.063 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -133.55 106.82 7.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.579 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' A' ' 109' ' ' MET . 16.7 p90 -125.27 118.55 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.328 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.36 179.11 9.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.382 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 98' ' ' TYR . 0.8 OUTLIER -150.07 98.2 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.82 0.343 . . . . 0.0 111.011 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -80.19 119.67 23.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.962 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.478 ' HD1' HG23 ' A' ' 99' ' ' VAL . 32.2 p90 -156.28 149.51 24.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.831 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 100' ' ' ASP . 22.4 t 64.91 158.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.488 ' N ' HG12 ' A' ' 99' ' ' VAL . 1.3 t70 -68.57 -55.36 11.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.958 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -122.69 79.66 48.31 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.025 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.84 -38.3 4.28 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.637 2.225 . . . . 0.0 112.342 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.29 -95.8 0.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -96.41 -36.76 10.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.909 0.385 . . . . 0.0 110.831 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.77 -80.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.6 p -141.4 -174.82 4.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.642 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.61 119.68 36.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -105.84 124.69 49.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.46 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.433 ' HB2' ' CE2' ' A' ' 94' ' ' TYR . 1.8 mtt -94.38 129.71 40.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.323 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -95.23 149.54 21.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.179 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.04 94.92 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.796 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -71.53 134.65 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.04 146.57 35.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.26 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' A' ' 87' ' ' LEU . 1.7 tp -138.28 143.55 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.835 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 88' ' ' THR . . . -126.32 66.28 61.06 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 111.525 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.36 82.74 2.0 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 111.867 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -92.06 173.16 7.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.189 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . 40.8 p-90 -155.92 122.92 5.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.809 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -99.85 137.58 38.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.671 HG23 ' HB2' ' A' ' 128' ' ' PHE . 22.6 m -139.68 117.25 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.8 135.47 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.992 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 123' ' ' THR . 3.9 pp -115.35 -31.63 5.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.918 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.619 ' N ' HD12 ' A' ' 122' ' ' LEU . 43.1 m -142.49 162.89 34.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.695 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.439 ' N ' HG22 ' A' ' 123' ' ' THR . 3.3 t70 -74.68 61.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.09 -48.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.459 HD22 ' HE1' ' A' ' 128' ' ' PHE . 3.5 mt -84.89 109.9 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.003 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.9 mtm180 -112.52 115.12 28.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.84 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.671 ' HB2' HG23 ' A' ' 120' ' ' VAL . 3.7 m-85 -91.0 136.7 32.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.78 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.1 118.87 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -118.63 121.21 4.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.224 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -104.93 174.25 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 111.118 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.7 mt -147.72 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.717 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.24 99.89 12.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.045 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.42 ' HB3' HG22 ' A' ' 114' ' ' ILE . 3.4 ttm -105.93 137.18 44.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.494 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -123.43 150.55 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.102 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -156.09 103.19 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.22 153.36 41.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.65 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -152.09 161.58 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.91 -29.84 68.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.81 -35.45 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.997 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.33 101.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.797 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -68.47 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.65 -33.22 6.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.28 28.3 70.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.616 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -97.55 86.46 3.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -164.08 90.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.095 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -179.87 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -77.08 125.33 29.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -100.52 150.76 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.22 126.63 25.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -135.15 96.97 3.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 t -97.5 137.69 36.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -127.05 103.05 7.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.771 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 29.6 p -96.38 106.03 18.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.513 ' O ' HD23 ' A' ' 157' ' ' LEU . . . -130.0 167.99 21.52 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.993 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -134.36 129.77 35.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.68 0.276 . . . . 0.0 110.738 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.77 113.33 25.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.638 ' OH ' HD11 ' A' ' 167' ' ' LEU . 35.4 p90 -130.24 138.08 50.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.07 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER -97.29 143.73 27.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.938 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.2 -45.93 13.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.355 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.65 33.92 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.301 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.683 ' O ' HG23 ' A' ' 164' ' ' THR . 2.6 mt-10 52.57 73.96 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.085 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.1 OUTLIER 177.91 -65.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.816 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 165' ' ' VAL . 11.9 p -103.87 113.19 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 160' ' ' THR . . . -108.64 136.9 47.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.016 0.436 . . . . 0.0 111.495 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.638 HD11 ' OH ' ' A' ' 159' ' ' TYR . 0.8 OUTLIER -93.9 123.61 37.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.475 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.46 122.52 46.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.326 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.47 110.57 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' A' ' 156' ' ' GLY . 4.2 p-10 -111.04 155.49 22.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 111.658 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.55 120.99 41.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.346 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.91 134.99 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.163 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.0 tp -142.04 108.86 5.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -112.24 139.32 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.968 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -137.12 121.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.801 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -86.23 155.15 28.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.572 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -113.72 145.18 41.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.793 0.33 . . . . 0.0 110.844 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -104.16 141.55 36.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 11.3 ttt -131.44 31.26 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -142.7 -47.47 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.004 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.6 118.26 14.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.26 32.24 2.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.68 31.54 6.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.85 70.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.4 141.61 28.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 59.37 42.07 97.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.521 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.86 -48.86 8.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.85 146.46 6.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.61 142.16 49.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.791 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 132.59 39.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -147.04 110.04 4.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -122.85 178.49 5.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.43 132.73 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.211 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.12 142.68 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.548 ' HB3' ' CB ' ' A' ' 210' ' ' THR . . . -106.73 153.31 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.234 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -160.0 145.54 15.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -157.04 79.36 3.65 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.563 ' HA ' HG22 ' A' ' 207' ' ' THR . 42.1 Cg_endo -67.88 113.52 3.03 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.402 2.068 . . . . 0.0 112.292 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 200' ' ' THR . 1.3 tt -114.36 144.83 42.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.705 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.616 ' N ' HD23 ' A' ' 199' ' ' LEU . 5.9 p -138.04 156.23 48.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.21 90.52 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.161 0.505 . . . . 0.0 109.904 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 66.79 -73.49 0.17 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.256 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -123.02 -34.63 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.298 . . . . 0.0 111.021 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.53 138.0 56.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 48.1 m -128.09 134.44 49.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 240' ' ' TYR . 18.3 m -146.08 124.92 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.136 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 198' ' ' PRO . 14.9 p -137.02 104.88 8.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.053 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.82 165.01 15.69 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.693 2.262 . . . . 0.0 112.234 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.435 ' CZ ' ' HA3' ' A' ' 237' ' ' GLY . 47.1 p90 -141.32 133.6 28.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.952 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.548 ' CB ' ' HB3' ' A' ' 195' ' ' ALA . 0.4 OUTLIER -114.62 137.64 51.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.994 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.42 -55.38 3.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.7 pt -107.75 131.46 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.096 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -147.15 96.31 0.17 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.447 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 12.3 mt -106.32 36.4 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 110.916 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 61.13 178.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.41 31.92 3.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -146.63 148.48 32.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.53 35.77 20.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.55 -52.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -92.68 91.12 7.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -102.12 -50.45 3.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -78.88 171.95 14.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -108.05 130.8 55.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.29 147.21 23.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.09 101.37 4.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.5 pt -141.34 163.94 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -115.4 -38.67 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 141.15 55.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -175.16 98.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -108.2 -144.09 10.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -117.4 -46.04 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.949 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.75 143.66 32.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.49 168.71 12.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.816 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -98.55 87.86 3.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.77 175.67 8.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.3 t 63.64 139.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.435 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -76.37 141.15 26.4 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.504 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.92 129.73 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -108.26 102.66 11.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.408 ' CD1' HG12 ' A' ' 206' ' ' VAL . 0.3 OUTLIER -78.69 154.87 29.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.24 132.08 3.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.436 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -148.87 156.9 42.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -162.33 93.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.403 ' O ' ' CD2' ' A' ' 244' ' ' PHE . 40.9 t80 -177.31 36.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.062 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.3 -48.5 3.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.617 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -179.0 38.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.47 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 94.94 -6.0 69.27 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.613 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.5 mp -96.42 153.0 18.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.695 0.283 . . . . 0.0 110.701 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 276' ' ' VAL . 4.0 t -103.8 141.13 36.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.733 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.77 126.9 59.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.345 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.35 117.06 23.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 274' ' ' VAL . 1.4 mt -115.09 124.85 52.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.77 145.28 38.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.32 109.43 8.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -151.72 -172.96 4.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.078 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.45 164.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -125.87 -178.74 4.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -126.69 174.98 8.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 64.91 123.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.24 164.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.812 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -138.53 -178.27 5.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.85 -173.85 2.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -95.45 36.63 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -85.64 -12.09 73.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.763 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 62.01 43.67 8.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.907 0.384 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.5 m -105.74 98.9 8.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -86.55 106.52 17.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.985 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.27 103.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.35 83.59 0.91 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.673 ' NE2' ' HB3' ' A' ' 272' ' ' ALA . 23.5 t-160 -85.35 107.05 17.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.45 -46.3 64.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.844 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.673 ' HB3' ' NE2' ' A' ' 270' ' ' HIS . . . -62.48 176.64 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 148.51 -172.54 28.7 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.52 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' A' ' 252' ' ' LEU . 22.6 m -129.61 155.73 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -155.54 169.06 33.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 249' ' ' SER . 4.5 m -131.73 116.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.647 0.261 . . . . 0.0 111.056 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 249' ' ' SER . 41.5 t30 -115.74 95.4 5.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 111.255 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 279' ' ' SER . 3.6 t80 -88.56 155.05 19.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.746 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.443 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 72.5 m -133.4 146.5 51.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.916 0.389 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 7' ' ' HIS . 7.3 mt-10 -138.19 40.69 2.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.95 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 -135.36 80.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -104.6 -55.01 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -151.37 -57.08 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -149.17 115.1 5.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.046 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.751 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -114.0 123.33 49.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.688 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.81 120.39 39.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.138 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -127.18 134.32 50.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.426 HG22 ' CD1' ' A' ' 36' ' ' PHE . 1.3 pp -134.97 114.12 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.017 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.34 167.65 22.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.594 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.6 118.81 4.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.25 163.43 13.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' HD1' HG13 ' A' ' 274' ' ' VAL . 9.6 m-85 -150.8 107.9 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.826 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.24 104.27 10.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 17' ' ' GLU . 23.0 mm 60.05 158.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' N ' HG22 ' A' ' 16' ' ' ILE . 3.3 pt-20 -104.11 -34.23 8.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.402 ' H ' HG22 ' A' ' 16' ' ' ILE . 5.6 t-20 -82.37 159.03 23.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.5 p -133.6 69.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 61.6 157.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.825 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.55 -118.64 0.76 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.499 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -166.66 -43.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 110.956 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.14 -142.23 7.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.408 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -135.94 58.46 1.75 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.358 . . . . 0.0 110.824 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -66.59 148.75 51.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.21 -169.18 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.512 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -177.52 81.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.36 69.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.626 HD11 ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -136.53 179.35 6.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 110.871 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -163.75 158.49 20.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -114.02 71.97 2.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.34 114.22 3.86 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.589 2.192 . . . . 0.0 112.331 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p -113.42 111.89 22.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.973 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.55 152.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.064 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 68.3 m-85 -140.27 136.9 33.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CD1' HG22 ' A' ' 10' ' ' ILE . 27.6 m-85 -147.15 104.48 3.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -105.28 155.26 19.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.066 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 7' ' ' HIS . . . -148.04 113.74 5.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.751 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -93.07 116.59 29.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.24 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -134.72 88.47 2.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 109.77 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.81 -123.97 34.8 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.02 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.416 ' HG2' ' CD1' ' A' ' 43' ' ' TRP . 94.0 Cg_endo -88.63 21.99 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.666 2.244 . . . . 0.0 112.76 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.488 ' CZ2' ' CE1' ' A' ' 75' ' ' TYR . 75.5 m95 -140.09 111.96 7.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.405 ' CB ' ' HB2' ' A' ' 74' ' ' HIS . 0.1 OUTLIER -106.2 103.87 13.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.797 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -84.0 116.69 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.27 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.823 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . . . -123.97 115.92 22.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 122.41 43.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.684 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . . . -123.6 147.96 46.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -112.11 119.96 40.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.61 113.2 25.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.55 152.18 31.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -126.01 151.62 46.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.53 148.62 5.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HD3' HD11 ' A' ' 29' ' ' LEU . 59.0 Cg_endo -72.03 98.9 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.526 2.15 . . . . 0.0 112.287 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t 61.02 88.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.99 157.85 36.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.851 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -160.99 32.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.822 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.6 t -90.26 124.6 35.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.14 79.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.047 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.23 -71.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.49 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.57 -32.32 7.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -98.74 155.7 17.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.28 124.92 7.8 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.523 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -88.03 179.48 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.461 ' CE3' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -59.96 97.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.461 ' CD1' ' CE3' ' A' ' 65' ' ' TRP . 22.1 m-85 60.58 106.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.902 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.22 125.55 41.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.38 80.42 63.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.84 134.24 49.13 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.577 2.185 . . . . 0.0 112.046 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 10.4 mm-40 -115.73 123.53 48.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.151 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.37 153.83 39.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.571 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.823 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 5.1 mt-10 -154.01 143.59 21.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 111.063 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 89' ' ' GLY . 12.3 p -147.03 120.43 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.901 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.405 ' HB2' ' CB ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' CZ2' ' A' ' 43' ' ' TRP . 15.2 t80 -119.92 105.38 11.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.699 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -89.71 126.19 35.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -40.88 20.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.57 122.51 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 103.01 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -160.13 122.35 3.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.801 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.37 -25.2 33.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.51 -31.26 14.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.952 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -142.24 78.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -102.31 128.13 48.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.74 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.93 104.03 7.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.985 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -108.62 179.76 21.43 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.469 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 116' ' ' PRO . 3.3 tp -158.2 107.92 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.787 0.327 . . . . 0.0 110.788 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.583 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 1.2 m -75.53 155.96 35.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.911 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.697 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -153.65 108.76 0.38 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.514 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.46 167.01 19.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.652 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -139.94 129.37 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -125.43 149.49 48.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -147.75 97.82 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.27 110.64 20.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' A' ' 107' ' ' ALA . . . 123.17 174.75 14.35 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.658 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -158.11 149.57 21.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.724 0.297 . . . . 0.0 110.749 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -79.35 -176.48 5.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -120.74 114.03 21.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.0 p -93.14 -29.61 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.068 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.04 -43.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.453 ' CB ' ' HD3' ' A' ' 102' ' ' PRO . 1.2 mt-10 -172.85 -54.61 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 101' ' ' GLU . 35.5 Cg_exo -60.01 139.04 85.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.302 2.001 . . . . 0.0 112.175 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 124.0 39.06 0.51 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.565 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.93 -75.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 0.0 111.051 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -177.71 -74.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.6 m -163.13 129.78 3.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.423 ' HB3' ' CA ' ' A' ' 95' ' ' GLY . . . -176.22 135.88 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.196 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.39 102.35 2.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 mtp -125.82 105.43 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -83.51 135.52 34.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HB2' ' CE1' ' A' ' 137' ' ' PHE . 23.7 ttt180 -143.63 121.85 12.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.88 155.95 19.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.06 113.71 7.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.6 142.91 38.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.583 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -149.69 107.09 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.32 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 87' ' ' LEU . 50.3 Cg_endo -69.05 93.55 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.336 2.024 . . . . 0.0 112.145 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.85 136.57 51.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.018 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -139.74 122.95 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.925 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.98 114.64 14.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.9 124.07 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -109.99 115.74 30.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.732 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 123' ' ' THR . 0.5 OUTLIER -90.85 -28.14 18.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.87 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -165.18 -171.75 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.699 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.86 28.72 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.927 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.16 -41.83 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.04 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.25 135.18 52.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.906 0.384 . . . . 0.0 110.929 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -124.86 134.11 52.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.777 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' CE2' HD21 ' A' ' 157' ' ' LEU . 4.8 m-85 -105.14 143.17 33.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.026 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -143.82 118.91 10.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.75 120.62 6.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.558 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -128.53 115.0 17.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.736 HD11 HG23 ' A' ' 153' ' ' THR . 0.5 OUTLIER -105.17 112.3 25.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.419 ' HG ' ' HH ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -87.09 101.1 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.474 ' SD ' HD23 ' A' ' 132' ' ' LEU . 1.9 mtt -120.78 137.99 54.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.419 ' HH ' ' HG ' ' A' ' 133' ' ' SER . 20.2 m-85 -146.68 159.88 42.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -140.7 98.93 3.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 111' ' ' ARG . 1.7 m-85 -79.03 159.4 27.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.68 160.86 26.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.96 100.8 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.471 ' HB3' HD23 ' A' ' 141' ' ' LEU . 0.9 OUTLIER 68.35 -68.95 0.16 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 140' ' ' ASP . 0.6 OUTLIER -151.99 40.47 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.923 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 19.7 m120 61.06 169.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.01 -69.61 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.5 p -111.5 -33.91 6.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 93.94 28.16 11.42 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.559 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -72.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -162.05 -74.49 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.049 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.24 30.08 18.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 m -89.96 116.86 28.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 40.9 mtt85 -96.0 127.3 41.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 151' ' ' VAL . 9.9 p -131.21 109.61 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.978 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -111.92 143.09 43.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.736 HG23 HD11 ' A' ' 132' ' ' LEU . 0.5 OUTLIER -114.44 135.9 53.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -135.13 103.06 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.059 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.4 p -99.71 103.93 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.697 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.31 140.61 15.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.423 HD21 ' CE2' ' A' ' 128' ' ' PHE . 1.9 mp -137.71 125.1 21.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -119.05 119.84 35.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 159' ' ' TYR . 53.2 p90 -130.14 124.98 33.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.604 HG23 ' HB2' ' A' ' 166' ' ' ALA . 62.4 p -84.83 140.96 30.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.129 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.19 -30.67 43.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -144.59 33.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.991 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 60.91 76.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER 172.18 -61.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.606 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.584 HG13 ' HG ' ' A' ' 199' ' ' LEU . 26.6 t -107.49 112.68 41.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.263 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.604 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -107.0 145.29 32.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.988 0.423 . . . . 0.0 111.753 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.72 120.12 33.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.117 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.95 139.2 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 169' ' ' VAL . 15.5 m -140.03 100.92 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.719 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -102.75 137.91 40.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.088 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -115.66 110.24 18.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -88.6 137.25 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.06 109.28 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -99.53 124.66 44.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.88 35.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 144.25 -153.87 25.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -111.89 129.38 56.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 0.0 110.844 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -114.56 135.61 53.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.46 114.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.82 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.57 117.97 22.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -171.92 -42.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 58.9 p -158.59 33.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.19 103.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.11 -32.22 64.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -176.8 -46.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.9 94.62 0.38 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.5 169.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -162.14 135.99 6.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.0 m -129.86 132.85 46.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.4 m -124.35 157.02 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -146.64 121.04 9.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.48 159.16 31.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 193' ' ' ILE . 7.8 tp -133.39 113.22 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.145 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 11.4 mmt85 -108.29 152.15 25.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.772 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.83 140.04 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.482 ' C ' HD23 ' A' ' 197' ' ' LEU . 0.9 OUTLIER -145.42 174.98 10.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.802 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.561 HD12 ' CD1' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -167.39 87.24 0.76 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.875 ' HA ' HG22 ' A' ' 207' ' ' THR . 46.6 Cg_exo -56.04 113.71 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.436 2.091 . . . . 0.0 112.298 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.584 ' HG ' HG13 ' A' ' 165' ' ' VAL . 0.2 OUTLIER -114.19 126.13 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.744 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.6 t -138.09 154.7 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.521 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.425 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.4 OUTLIER -143.17 90.6 2.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.254 0.55 . . . . 0.0 110.117 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.04 -80.83 1.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.555 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -132.37 39.03 3.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.783 0.325 . . . . 0.0 111.015 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -132.2 141.16 48.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.94 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.6 m -124.47 117.47 24.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.66 106.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.875 HG22 ' HA ' ' A' ' 198' ' ' PRO . 43.8 p -114.91 104.82 53.86 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.002 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HG2' HD21 ' A' ' 197' ' ' LEU . 96.9 Cg_endo -80.0 164.98 22.17 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.579 2.186 . . . . 0.0 112.432 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -121.11 131.91 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.9 p -131.1 157.75 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -110.64 -32.17 6.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.06 -37.65 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 115.53 -42.13 1.98 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.3 mp -133.9 155.9 49.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.315 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -97.99 25.91 5.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 55.5 96.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.09 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -144.95 157.15 44.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.64 110.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -142.6 -172.33 3.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -96.3 47.55 1.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 62.25 117.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -169.92 41.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -86.02 -175.41 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 6.9 t0 60.8 107.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.98 -178.35 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 226' ' ' ILE . 9.2 tp -108.48 115.93 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.43 149.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.6 -61.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -163.34 134.89 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -119.68 -38.48 0.71 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.97 133.17 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 110.942 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -121.82 134.32 54.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -76.37 -172.16 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.2 m120 68.54 -68.87 0.16 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.936 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 60.27 159.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.89 168.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -149.25 165.78 29.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.599 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.17 134.54 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -110.03 109.05 19.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -75.95 142.72 41.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -139.99 100.96 0.29 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.417 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.66 118.67 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 111.009 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -134.85 97.98 3.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.777 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.41 37.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.981 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.5 -44.18 7.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.757 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -170.69 34.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.683 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 95.34 -3.54 66.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.742 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 248' ' ' LEU . 3.5 pp -102.94 153.32 20.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.641 0.258 . . . . 0.0 110.813 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 276' ' ' VAL . 69.2 m -95.94 151.94 18.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.798 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.87 127.35 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.3 m -135.11 152.28 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.8 mt -141.01 131.08 24.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 127.75 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -142.62 165.49 27.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -110.37 -56.9 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.45 103.38 7.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -95.72 151.93 18.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.37 -56.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -127.52 139.43 52.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.7 -55.18 4.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -83.21 170.04 15.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -138.65 170.5 15.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -100.71 171.54 7.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -96.9 48.4 1.61 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.449 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -151.05 -63.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.09 141.38 45.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.56 171.33 8.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -165.84 159.36 15.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -123.99 106.58 10.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -151.02 130.34 12.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -89.62 175.71 7.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -154.77 -179.26 7.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -150.8 134.51 4.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.605 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.432 HG13 ' HD1' ' A' ' 14' ' ' TYR . 10.8 p -124.21 128.83 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.318 . . . . 0.0 110.997 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -136.18 152.32 21.07 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.729 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 249' ' ' SER . 20.2 t -140.85 141.7 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.738 0.304 . . . . 0.0 110.803 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.01 95.53 2.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.058 0.456 . . . . 0.0 111.604 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 248' ' ' LEU . 7.6 t80 -92.68 120.12 32.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.584 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 p -123.32 146.92 47.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.822 0.344 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 60.41 -170.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -158.37 42.54 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.981 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.2 p30 -142.66 32.59 1.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.88 49.73 0.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -164.2 90.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 18.4 m80 -116.1 108.42 16.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -88.0 132.44 34.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -143.73 120.87 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.33 131.01 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.195 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 35' ' ' TYR . . . -122.12 128.92 7.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.466 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -121.04 155.98 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.391 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.1 mmt -147.05 121.11 9.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.846 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -141.45 157.23 45.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -106.98 138.29 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 274' ' ' VAL . 30.3 mt -90.51 136.62 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.1 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -118.77 173.17 7.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.61 132.57 39.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.58 178.91 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -162.31 -65.08 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.48 -170.69 14.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.554 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 152.7 39.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.58 124.11 8.13 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -72.08 -65.92 0.71 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.853 0.359 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.42 131.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.832 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 2.9 tmm? 60.21 107.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -142.14 163.08 33.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.36 -116.84 4.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.491 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.25 108.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.766 0.317 . . . . 0.0 110.934 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.91 -69.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -167.65 64.36 0.69 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.54 149.03 67.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.638 2.226 . . . . 0.0 112.353 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.58 144.74 23.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.54 150.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.144 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' CE2' ' HA3' ' A' ' 11' ' ' GLY . 10.4 p90 -146.69 156.68 43.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.76 157.96 31.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.21 136.4 33.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.67 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -138.72 113.97 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -93.8 122.79 36.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 43' ' ' TRP . 34.5 t-20 -134.87 88.7 2.46 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -128.38 14.42 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.884 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -87.74 15.37 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.559 2.172 . . . . 0.0 113.177 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' A' ' 40' ' ' ASN . 60.8 p-90 -140.38 110.95 6.76 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.829 0.347 . . . . 0.0 111.395 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 10.6 ttm105 -102.2 110.59 22.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.67 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 5.0 tt -83.79 131.39 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.463 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -129.46 122.84 30.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.983 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.45 110.54 20.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.36 160.79 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -136.5 102.46 4.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.46 107.32 18.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.16 150.38 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.33 139.41 52.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.945 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.45 64.4 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.29 157.52 59.11 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.634 2.222 . . . . 0.0 112.336 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.1 p -81.07 -32.47 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.94 -173.86 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -112.66 159.18 19.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.6 m -80.57 164.2 23.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.77 -30.34 61.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.092 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.28 -49.52 0.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.508 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.74 44.07 11.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.956 0.408 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -69.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.958 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.77 -27.64 3.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 65' ' ' TRP . 0.2 OUTLIER 61.6 178.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.478 ' H ' HG22 ' A' ' 64' ' ' THR . 6.6 m0 -130.06 147.64 51.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.95 -26.44 14.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.004 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.81 173.81 0.25 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.911 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.4 ' CB ' ' HD2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -169.49 170.59 3.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 70.7 Cg_endo -74.8 -167.86 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.612 2.208 . . . . 0.0 112.355 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.51 156.27 36.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.971 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.93 153.95 40.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 12.6 tt0 -162.1 134.55 5.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.838 HG12 ' O ' ' A' ' 89' ' ' GLY . 12.4 p -128.99 150.06 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.915 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -118.66 137.68 53.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.99 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -119.27 87.51 2.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -93.0 116.25 28.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.18 -45.17 50.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.0 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 mt -143.43 136.96 28.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.959 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -97.97 101.97 13.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.9 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.7 148.53 25.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.8 0.85 56.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -111.03 -31.86 6.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -155.42 89.9 1.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.007 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.7 134.21 55.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.734 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -129.84 104.21 7.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.135 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -108.03 -175.2 22.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.162 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.16 108.79 2.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -77.7 159.25 29.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.838 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -174.12 91.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.37 152.21 17.36 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.618 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 4.3 m-85 -107.73 134.4 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -106.86 127.13 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.145 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -127.09 107.14 9.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.48 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -107.0 128.12 54.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.354 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 107' ' ' ALA . . . -104.92 136.33 13.05 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.486 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 2.4 p90 168.66 173.61 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.963 0.411 . . . . 0.0 111.078 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -128.0 158.01 39.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.636 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 99' ' ' VAL . 1.3 t80 -147.57 162.5 38.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.404 HG22 ' CD1' ' A' ' 98' ' ' TYR . 5.6 m -60.27 -28.04 40.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.37 32.01 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.407 ' CG ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -112.24 162.15 22.74 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 101' ' ' GLU . 66.8 Cg_exo -51.44 -34.17 49.92 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.554 2.169 . . . . 0.0 112.208 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.93 90.02 2.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.628 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.12 -73.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 0.0 110.887 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 168.97 -32.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.08 124.82 2.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.674 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.471 ' O ' ' HA2' ' A' ' 95' ' ' GLY . . . -116.43 144.68 43.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.979 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -99.65 125.5 45.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.467 . . . . 0.0 111.474 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.7 ttm -107.88 124.78 50.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.344 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.566 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 6.0 mm-40 -91.38 140.5 29.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -152.97 104.45 2.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.832 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.31 144.6 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -142.06 103.01 4.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.732 HG22 ' HA2' ' A' ' 89' ' ' GLY . 1.3 pt -121.64 153.53 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.969 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -161.81 117.55 1.29 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.25 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 59.8 Cg_endo -72.11 92.84 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.364 2.043 . . . . 0.0 112.104 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -61.58 131.75 51.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -132.14 123.05 26.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.855 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 121.91 38.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.5 111.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -123.49 110.73 15.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -177.22 39.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 123' ' ' THR . 17.1 m -128.95 38.5 3.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 62.9 84.56 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.227 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 53.95 51.35 14.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.332 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.584 HD12 ' CD1' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -142.09 109.1 5.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.876 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.04 118.63 24.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -106.33 111.96 24.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -117.22 161.64 19.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.1 125.51 1.0 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.423 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -147.13 140.35 25.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.319 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.627 ' CD1' HG23 ' A' ' 153' ' ' THR . 7.6 mp -102.02 98.81 8.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.833 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.506 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 0.9 OUTLIER -77.08 110.49 11.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.016 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 mtt -92.95 132.3 37.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.69 137.0 45.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.042 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -141.28 152.56 44.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.685 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -125.95 149.42 48.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -157.14 163.32 39.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.92 -171.85 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -58.32 -30.78 66.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.946 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 141' ' ' LEU . 26.7 mt -140.89 -58.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.85 125.77 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.23 -68.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.1 p -112.73 -35.84 5.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 83.93 29.12 32.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.548 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -130.64 -178.74 4.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.58 -76.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.062 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.36 31.01 20.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.62 129.85 41.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -125.21 129.28 49.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.53 HG21 HD23 ' A' ' 132' ' ' LEU . 12.0 p -100.68 137.3 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.03 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -121.01 100.38 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.627 HG23 ' CD1' ' A' ' 132' ' ' LEU . 1.3 m -93.82 125.48 38.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.61 105.5 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.1 p -101.42 103.96 14.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.93 148.1 18.89 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.909 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.426 HD23 ' CD2' ' A' ' 126' ' ' LEU . 3.2 mp -137.8 125.42 22.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.69 0.281 . . . . 0.0 110.76 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 1.9 tt0 -112.78 115.02 27.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.085 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CD1' HD12 ' A' ' 126' ' ' LEU . 71.8 t80 -130.16 120.6 24.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.002 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.716 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 43.8 p -84.88 140.42 31.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.67 -29.88 69.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.804 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -161.66 44.35 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 164' ' ' THR . 47.5 mt-10 61.52 76.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER 176.69 -76.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.677 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.89 113.01 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.716 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -109.62 148.02 32.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.566 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.472 HD11 HD11 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -93.95 137.22 33.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.372 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 121.86 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.022 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 169' ' ' VAL . 9.7 p -123.99 110.75 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.792 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -107.55 121.54 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.088 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -87.85 116.37 25.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -85.9 139.18 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.086 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.03 100.43 3.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.84 131.1 43.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.41 ' HB2' ' CG1' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -140.08 155.14 47.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -134.58 167.2 24.0 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.35 121.46 45.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.6 132.24 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 4.0 ttm -120.43 118.67 30.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.59 179.99 5.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.03 -50.16 12.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.1 m -120.99 -65.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.48 127.54 8.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -72.5 -18.27 61.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.16 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 61.81 41.11 12.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.889 0.376 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.86 63.56 0.19 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -110.62 122.27 47.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.96 -172.95 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.75 129.91 16.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.973 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.98 115.99 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -107.22 109.98 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.38 164.96 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.614 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.2 137.27 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 0.0 111.304 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.454 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 6.3 mmt-85 -118.34 151.88 36.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.624 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.73 132.55 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.952 0.406 . . . . 0.0 111.361 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 196' ' ' TYR . 0.7 OUTLIER -141.6 137.68 32.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.566 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.472 HD11 HD11 ' A' ' 167' ' ' LEU . 5.5 tp -109.74 75.07 0.78 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.756 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.416 ' HB3' HG22 ' A' ' 207' ' ' THR . 69.3 Cg_endo -74.03 113.74 3.86 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.734 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 197' ' ' LEU . 1.6 mp -114.16 156.02 25.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.441 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 204' ' ' HIS . 34.8 m -138.04 153.26 49.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 0.0 110.531 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 90.41 2.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.282 0.563 . . . . 0.0 110.094 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 60.27 -85.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -117.42 29.3 7.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . 0.492 ' O ' HG23 ' A' ' 200' ' ' THR . 1.1 t60 -132.63 130.24 39.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.624 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.02 119.04 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.83 127.2 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 198' ' ' PRO . 30.0 p -132.55 104.93 13.14 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.418 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.36 165.09 14.58 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.606 2.204 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -114.17 131.92 56.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.145 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.98 123.99 17.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -103.61 -67.27 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -172.1 137.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.982 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 158.77 74.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.502 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.52 40.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.04 100.63 13.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -112.17 168.97 9.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 64.74 36.84 7.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.6 t -173.88 59.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -138.64 -178.67 5.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -139.16 73.76 1.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 61.4 154.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.97 -58.32 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.58 -40.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.84 -76.55 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.875 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.88 37.22 26.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 15.5 pt -100.42 -34.61 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.55 168.4 19.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -38.88 3.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.782 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -90.44 121.63 32.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.13 28.86 4.23 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.592 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -163.34 89.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -111.42 172.0 7.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -77.93 170.39 16.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.61 -3.47 46.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.325 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.68 -178.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.03 -62.22 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.092 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -161.94 172.03 38.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.516 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.902 HD22 ' CZ ' ' A' ' 240' ' ' TYR . 0.1 OUTLIER -132.87 137.0 46.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.861 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -129.21 123.33 31.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.902 ' CZ ' HD22 ' A' ' 238' ' ' LEU . 2.9 m-85 -112.24 155.08 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -137.19 110.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.549 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -119.32 114.93 23.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.982 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 124.31 28.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.831 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.811 ' CD2' HD11 ' A' ' 248' ' ' LEU . 0.1 OUTLIER -74.03 -10.33 59.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.348 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 62.44 27.24 16.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.818 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -139.24 16.62 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.993 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.11 -24.1 33.64 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.738 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.811 HD11 ' CD2' ' A' ' 244' ' ' PHE . 0.2 OUTLIER -94.77 136.69 34.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.66 0.267 . . . . 0.0 110.98 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 277' ' ' ASN . 22.7 t -102.18 157.62 16.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.353 . . . . 0.0 110.952 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.94 122.16 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 m -126.98 134.3 50.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.0 mp -115.55 161.77 18.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -139.25 99.25 3.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -100.21 145.64 27.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . 60.71 82.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.044 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -123.85 32.79 5.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.1 152.04 28.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -107.76 131.29 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.923 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.7 84.09 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -108.01 127.68 53.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -90.35 98.61 11.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -110.38 -50.0 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -160.84 -46.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 162.93 -29.02 0.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.515 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.25 98.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.841 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.8 t -100.13 35.62 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -139.98 174.9 10.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -72.59 153.49 41.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -148.9 117.49 6.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -152.52 122.74 7.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.97 120.9 14.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -146.39 177.9 8.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.051 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -158.9 179.12 34.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.536 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 16' ' ' ILE . 21.3 t -149.34 139.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.067 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -137.34 -176.09 14.21 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.603 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 15.1 m -149.95 155.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.652 0.263 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 249' ' ' SER . 1.4 t-20 -140.72 95.34 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 279' ' ' SER . 22.8 t80 -88.91 154.93 19.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.847 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 278' ' ' TYR . 33.7 t -142.5 147.01 35.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.825 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.863 0.363 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -170.63 118.46 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.12 30.38 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.36 -53.63 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.745 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -157.37 92.03 1.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.726 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.422 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -144.33 111.94 6.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 33.3 m-70 -114.26 105.16 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' HB3' ' CE1' ' A' ' 280' ' ' PHE . 0.2 OUTLIER -89.95 119.98 30.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -131.11 134.78 46.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.0 mt -118.06 113.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.81 135.83 13.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.599 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HB3' ' CG2' ' A' ' 276' ' ' VAL . . . -143.92 129.01 18.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 0.0 110.984 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.0 ttm -122.39 141.72 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 4.5 m-85 -118.38 128.04 54.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -119.41 122.6 42.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pt -117.62 112.63 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.047 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -149.27 87.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -84.62 157.75 21.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 m -131.54 177.24 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -91.18 -37.64 13.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.47 -157.99 43.7 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.559 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.07 79.38 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.32 -126.0 6.97 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -125.01 43.41 3.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.337 . . . . 0.0 110.847 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.6 151.39 23.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.816 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.68 166.89 15.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t0 61.75 115.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.38 -47.01 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.531 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -123.36 122.62 38.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 110.921 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.19 131.71 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.07 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.2 100.61 0.29 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.834 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.65 132.55 25.43 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.389 2.059 . . . . 0.0 112.176 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.08 149.0 26.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.447 HG12 ' HB2' ' A' ' 49' ' ' TYR . 11.4 p -134.39 141.51 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.046 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.9 m-85 -124.78 145.91 49.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.53 109.37 8.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.611 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.68 156.8 18.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.232 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -160.13 113.83 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.617 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 44' ' ' ARG . . . -91.89 125.48 36.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.205 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -134.69 88.6 2.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.19 -125.08 26.51 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.007 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -87.31 17.25 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.635 2.223 . . . . 0.0 112.763 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.41 119.45 14.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.912 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.476 ' HG3' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -117.04 109.72 17.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.715 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.3 mt -86.75 141.96 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.252 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.904 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -139.82 97.83 3.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 117.44 31.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.713 ' HB3' ' CG ' ' A' ' 70' ' ' GLU . . . -117.54 162.85 17.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.447 ' HB2' HG12 ' A' ' 34' ' ' VAL . 18.6 m-85 -125.87 114.69 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.0 111.39 16.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.741 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 67' ' ' ASP . 48.0 mt-30 -147.81 148.88 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.995 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.27 158.94 44.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.812 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.36 -150.43 22.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.474 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.64 142.28 48.0 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.594 2.196 . . . . 0.0 112.299 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.44 -31.58 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -81.65 168.9 17.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -104.1 174.59 5.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.8 p -75.9 152.35 37.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.16 -53.35 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.18 -80.99 1.04 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -164.89 83.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.716 ' HA ' HG11 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -173.14 170.96 4.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.85 153.85 12.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.599 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 m -130.99 114.98 15.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.343 . . . . 0.0 110.831 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -72.84 -71.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.02 115.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . 11.8 m-20 61.55 -175.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.45 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -170.44 -179.92 0.66 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 26.4 Cg_exo -62.76 -171.17 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.434 2.089 . . . . 0.0 112.196 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.713 ' CG ' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -166.06 144.55 5.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 71' ' ' LEU . 4.1 mp -119.94 157.03 29.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.904 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 60.6 tt0 -147.78 149.56 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.03 148.87 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.033 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.438 ' CG ' ' HB3' ' A' ' 44' ' ' ARG . 13.8 m80 -122.86 126.36 47.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -107.28 101.45 10.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -87.46 102.17 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -78.8 -54.99 5.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.28 124.02 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.02 95.08 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.802 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -130.72 142.83 50.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.81 -22.03 65.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.202 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -117.51 11.33 13.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -176.47 71.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.63 116.05 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.821 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.92 123.0 47.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.961 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.08 163.64 22.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.468 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 87' ' ' LEU . 1.5 tm? -158.13 107.87 2.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 0.0 110.696 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 15.7 p -89.75 159.09 17.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.62 107.22 0.3 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.363 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.77 -176.91 14.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.733 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -129.1 132.59 47.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.798 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.0 ttt-85 -113.66 125.81 54.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -96.12 99.93 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -97.74 106.01 18.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 162.53 -170.19 38.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.515 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.468 ' H ' ' HB3' ' A' ' 107' ' ' ALA . 6.2 p90 -151.13 154.54 37.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.971 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.9 176.29 5.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -106.87 173.43 6.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.914 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.716 HG11 ' HA ' ' A' ' 62' ' ' ARG . 12.4 p -98.19 -31.95 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.096 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.3 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.36 100.32 7.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.56 100.86 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.447 2.098 . . . . 0.0 112.343 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -136.08 -70.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.468 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.53 30.92 4.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -136.81 68.56 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.22 126.43 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.894 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.468 ' HB3' ' H ' ' A' ' 96' ' ' TYR . . . -171.76 129.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -143.11 100.53 3.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 mtm -125.21 134.13 52.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -85.8 145.02 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.765 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.56 117.56 10.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.753 ' CE3' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -86.59 150.39 24.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.69 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.05 106.51 4.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.977 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.753 HD11 ' CE3' ' A' ' 112' ' ' TRP . 5.5 mt -110.31 145.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.557 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -141.63 84.93 11.84 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.406 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -61.74 90.63 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.646 2.231 . . . . 0.0 112.144 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -62.99 111.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.93 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.89 122.96 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.46 122.1 25.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.48 123.83 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 125.47 52.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.88 -41.85 6.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.1 p -156.22 -177.48 6.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -82.63 58.59 4.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -179.09 -49.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.94 105.91 18.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -108.83 129.09 55.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.25 144.5 26.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.995 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -142.62 122.42 13.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -119.99 125.09 6.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -131.62 116.85 17.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.416 ' CD1' HG23 ' A' ' 153' ' ' THR . 0.9 OUTLIER -105.98 98.98 8.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 99.94 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.9 140.64 46.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -145.56 155.63 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.024 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.44 107.02 3.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -96.17 130.88 43.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.012 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.78 179.72 7.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.414 HD22 HD12 ' A' ' 141' ' ' LEU . 29.3 t30 -132.21 170.88 14.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.19 -32.0 66.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.414 HD12 HD22 ' A' ' 139' ' ' ASN . 7.2 mt -65.01 -34.28 78.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 60.15 91.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 58.1 p -88.42 -60.18 2.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.3 p -106.88 -36.04 6.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.006 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 79.71 1.03 86.36 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.839 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.71 86.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.357 . . . . 0.0 110.817 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -145.46 130.9 18.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.171 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.0 t70 60.18 81.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 p -85.14 144.74 28.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.67 115.93 31.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.82 103.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -123.6 130.15 52.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.019 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 132' ' ' LEU . 18.0 m -102.8 142.87 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.799 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.22 106.58 6.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.8 m -100.62 103.95 15.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.811 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.02 135.13 12.26 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.759 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.81 124.55 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.73 0.3 . . . . 0.0 110.79 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -107.18 119.32 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.206 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -130.07 110.56 11.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.952 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.723 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 28.8 p -84.6 125.77 32.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -60.99 -29.31 69.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -155.96 41.22 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.141 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.498 ' C ' HG22 ' A' ' 164' ' ' THR . 2.3 tm-20 57.59 76.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.547 HG23 ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 168.78 -64.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.504 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.547 ' H ' HG23 ' A' ' 164' ' ' THR . 4.6 m -103.91 112.98 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.723 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -121.15 161.65 21.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.075 0.464 . . . . 0.0 111.882 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.3 138.72 41.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.064 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 113.63 26.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.878 0.37 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.74 100.84 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.509 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -95.38 140.7 29.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.325 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.77 116.76 27.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.483 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.92 136.72 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.8 tp -142.02 94.94 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.472 ' HB2' HG23 ' A' ' 190' ' ' THR . 11.8 mt-10 -96.35 118.07 32.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 122.38 16.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.912 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -142.45 -174.14 14.77 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -130.1 129.12 43.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.926 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -136.14 144.37 45.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -174.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -120.68 90.59 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.61 94.28 5.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.825 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.5 t 60.63 31.24 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -147.22 -178.56 6.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -151.26 37.59 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.79 32.9 2.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -65.95 -52.5 36.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.477 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -82.71 114.94 21.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 110.824 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -157.29 174.72 15.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.4 p -150.13 102.31 3.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 174' ' ' GLU . 2.4 t -92.84 159.06 15.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.37 141.69 32.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.976 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.44 178.99 5.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.802 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 44.3 pt -148.25 136.48 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.289 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.41 ' HB3' ' CE1' ' A' ' 196' ' ' TYR . 9.8 mtm-85 -134.39 138.94 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.727 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.842 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -110.01 137.77 47.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.48 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 196' ' ' TYR . 2.1 m-85 -135.63 175.09 9.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.517 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.85 72.64 0.92 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 0.0 111.017 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.685 ' HA ' HG23 ' A' ' 207' ' ' THR . 51.9 Cg_exo -52.84 113.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.469 2.113 . . . . 0.0 112.252 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.23 127.27 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 204' ' ' HIS . 51.7 m -138.12 146.61 43.04 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.276 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 95.4 mt -140.04 90.24 2.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.214 0.53 . . . . 0.0 109.993 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.46 -65.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.467 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -143.54 35.6 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.732 0.301 . . . . 0.0 110.828 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 200' ' ' THR . 1.9 m-70 -117.66 146.05 43.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.9 t -127.96 109.23 11.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.997 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.68 107.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.685 HG23 ' HA ' ' A' ' 198' ' ' PRO . 1.7 m -129.88 104.9 16.9 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.16 161.06 41.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 112.267 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -129.59 134.7 47.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.991 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.842 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 40.4 m -129.95 133.55 46.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.1 mtp85 -90.12 -36.39 14.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 29.4 mm -110.79 103.65 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -102.9 157.75 17.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.48 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.28 174.54 8.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 0.0 110.857 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -100.29 -177.79 3.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.97 37.54 1.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -170.27 113.77 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.759 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 74.9 m 60.28 82.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -82.8 -32.62 27.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.911 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.6 176.69 11.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -107.6 92.42 4.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER 60.3 98.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.99 119.62 38.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -102.33 -177.64 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.42 149.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.0 tt -109.79 -25.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -87.19 173.88 8.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.68 122.16 44.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -107.81 32.49 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.46 134.75 8.16 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.453 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 163.8 12.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.875 0.369 . . . . 0.0 110.984 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -65.61 160.38 22.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -72.15 119.86 16.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.779 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.49 175.51 10.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 91.95 3.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m -106.19 176.85 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -128.92 132.66 7.28 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.5 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 5.4 mt -122.4 122.93 40.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 251' ' ' SER . 2.4 t80 -102.42 117.08 33.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -120.89 144.93 48.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 163.55 -156.43 28.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.575 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.701 ' H ' HG23 ' A' ' 250' ' ' VAL . 17.6 m-85 -149.06 166.09 29.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -156.33 140.41 16.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 64.08 44.71 4.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -94.06 -44.35 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -155.24 37.68 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 278' ' ' TYR . . . 90.07 -13.32 65.1 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.702 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 278' ' ' TYR . 0.7 OUTLIER -118.95 137.07 53.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.703 0.287 . . . . 0.0 110.668 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.411 ' HB3' ' N ' ' A' ' 277' ' ' ASN . 7.8 t -97.5 161.28 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.526 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.701 HG23 ' H ' ' A' ' 242' ' ' TYR . 15.3 m -145.95 133.5 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.277 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 239' ' ' PHE . 13.7 m -130.81 136.99 49.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.18 116.38 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -96.31 134.3 39.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.18 157.17 47.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -141.14 -57.38 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -88.83 -75.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 60.04 31.6 20.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -137.01 119.56 15.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -170.91 -174.55 1.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -138.38 38.38 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -146.62 75.63 1.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.88 -33.76 6.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 61.62 87.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 130.54 -46.75 1.06 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.401 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 4.4 t70 60.44 37.7 19.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.319 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.55 -65.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.17 165.44 13.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.91 60.21 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.22 120.92 31.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.936 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.7 173.73 3.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -86.17 88.18 7.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -140.82 170.7 15.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -97.59 144.5 17.34 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.409 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.7 t -129.26 148.0 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.044 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -164.39 161.26 34.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.7 HG12 HG12 ' A' ' 250' ' ' VAL . 30.9 m -144.44 159.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.755 0.312 . . . . 0.0 111.167 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.411 ' N ' ' HB3' ' A' ' 249' ' ' SER . 0.8 OUTLIER -148.29 95.2 2.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.015 0.436 . . . . 0.0 111.374 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.525 ' HD2' HD12 ' A' ' 248' ' ' LEU . 3.4 t80 -88.86 110.6 21.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.651 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 5.4 p -109.13 142.76 39.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 8' ' ' PHE . 3.0 p90 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.973 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.758 0.313 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.63 -68.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -142.33 79.67 1.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -161.15 34.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -59.69 -40.42 87.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.735 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.74 110.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -123.98 111.99 16.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.497 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 280' ' ' PHE . 51.6 m-85 -96.97 132.54 42.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 111.12 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -115.65 122.86 46.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.766 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.445 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 20.2 mm -105.97 113.88 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.28 154.63 19.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.447 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.12 135.68 14.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.8 mtp -125.12 144.15 50.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.61 ' HE1' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -155.41 140.56 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -118.11 119.23 34.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.52 140.73 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -149.33 -46.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -87.3 170.36 11.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.87 138.64 19.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.162 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.17 163.53 40.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.97 60.52 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.51 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 60.37 87.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.39 -120.17 1.39 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.15 31.13 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.796 0.331 . . . . 0.0 110.835 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -163.3 169.99 18.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -30.99 21.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 162.81 14.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.66 -23.86 6.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.609 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 29' ' ' LEU . 3.4 mm? 62.16 97.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.771 0.32 . . . . 0.0 110.872 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.61 ' HB3' ' HE1' ' A' ' 14' ' ' TYR . . . -159.38 -74.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.057 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 2.5 tt0 -165.65 64.22 0.94 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 31' ' ' GLU . 31.1 Cg_exo -61.65 123.53 12.87 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.606 2.204 . . . . 0.0 112.251 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.3 108.69 18.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.24 142.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.049 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.41 128.43 18.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.445 ' CE2' ' CD1' ' A' ' 10' ' ' ILE . 1.1 t80 -143.62 114.69 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 1.9 m120 -106.7 164.64 11.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.305 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.593 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -157.55 113.77 2.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.568 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -97.86 121.92 40.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.601 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.74 88.48 2.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.3 -126.33 28.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.923 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -87.91 19.23 1.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.683 2.255 . . . . 0.0 112.814 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -140.15 110.89 6.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.74 0.305 . . . . 0.0 111.058 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -116.42 111.79 20.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.615 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.593 HG13 ' HB3' ' A' ' 38' ' ' ALA . 2.2 pt -92.67 148.33 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.356 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . . . -141.01 109.4 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.047 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' H ' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -96.44 135.55 38.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.886 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.842 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -136.54 146.03 45.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.51 122.48 47.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -118.55 111.33 18.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.26 167.43 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -136.38 157.75 46.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.12 79.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.401 ' C ' HG22 ' A' ' 55' ' ' VAL . 56.1 Cg_endo -70.44 118.47 5.71 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.52 2.146 . . . . 0.0 112.33 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG22 ' C ' ' A' ' 54' ' ' PRO . 34.1 m 42.8 34.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.9 96.5 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -65.93 -70.33 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.8 t -154.26 155.22 34.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.54 -58.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.42 -27.71 4.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.528 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.51 67.61 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.92 -46.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.843 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.86 -120.37 1.74 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.544 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.6 p -146.39 -71.85 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -161.44 -44.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -146.75 166.25 27.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -127.94 90.73 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -108.01 82.36 1.46 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.64 -166.37 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.52 2.147 . . . . 0.0 112.053 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.842 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 22.0 tt0 -158.83 134.18 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.117 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -137.03 105.68 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.758 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -107.49 158.31 17.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.157 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 89' ' ' GLY . 16.8 m -140.73 157.02 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.94 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -128.67 117.51 21.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.042 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -127.62 105.12 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -106.74 109.69 21.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.007 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.83 -37.06 56.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -127.52 132.76 49.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.809 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -129.8 111.92 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.977 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -162.02 168.54 22.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.05 15.32 17.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 120' ' ' VAL . 17.3 m-20 -119.08 -43.09 2.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.765 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' O ' HD22 ' A' ' 78' ' ' LEU . 2.3 t80 -159.32 92.78 1.09 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 t -87.0 150.07 24.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -130.31 104.02 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.13 177.59 17.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.37 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.08 107.81 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 64.8 m -77.04 155.34 32.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -148.7 79.5 0.21 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.537 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.91 129.95 10.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -120.05 120.11 35.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 0.0 110.737 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -127.83 139.9 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -131.13 129.51 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -112.23 128.13 56.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.07 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 135.48 172.03 12.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.652 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.3 t80 179.95 177.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 39.83 2.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -58.89 165.68 2.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.58 100.67 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.094 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -179.21 90.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.942 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.422 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 1.3 mt-10 -60.58 -61.14 8.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.09 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 101' ' ' GLU . 38.7 Cg_endo -66.91 -18.1 52.1 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.476 2.118 . . . . 0.0 112.468 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.7 36.1 4.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.535 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.9 mttt 62.38 120.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 106' ' ' THR . 48.0 p30 -129.78 22.36 5.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 105' ' ' ASP . 1.1 p -163.19 124.96 2.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.819 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -168.91 141.76 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -156.56 99.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.2 ttp -116.83 157.63 25.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 143.04 48.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -139.96 116.71 10.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -88.12 130.21 35.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 108.14 9.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.71 147.38 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.69 107.81 3.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.413 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.71 94.32 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.31 2.007 . . . . 0.0 112.033 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.48 102.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -107.42 123.0 47.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.72 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.46 123.16 32.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.957 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 82' ' ' ASP . 9.9 p -141.78 106.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 154.55 39.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -4.11 48.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.408 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 m 63.53 31.91 14.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.65 -73.86 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.82 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.71 24.62 0.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.004 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.11 100.49 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -106.75 128.34 54.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.775 ' CE1' HG22 ' A' ' 155' ' ' THR . 0.1 OUTLIER -117.06 130.71 56.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.439 ' ND2' ' CE2' ' A' ' 131' ' ' TRP . 0.2 OUTLIER -128.64 126.68 40.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.34 130.87 10.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.585 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.439 ' CE2' ' ND2' ' A' ' 129' ' ' ASN . 37.3 m95 -125.62 129.15 49.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.64 ' HG ' HG23 ' A' ' 153' ' ' THR . 2.5 mp -128.8 102.36 6.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.694 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.0 p -84.62 113.06 21.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.11 116.94 31.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.715 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.74 143.84 33.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 98.97 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.857 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -78.44 145.49 35.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.956 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.07 170.12 19.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.07 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 61.77 178.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.963 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.5 t70 68.8 -67.83 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.57 -40.4 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -77.21 108.5 10.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -52.14 65.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m -107.53 -32.13 7.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.39 32.48 75.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.393 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.91 158.72 19.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.855 0.359 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 60.37 171.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.26 78.5 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.821 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.2 p -111.82 137.24 50.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.11 133.43 42.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.04 129.82 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -136.03 115.97 13.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.64 HG23 ' HG ' ' A' ' 132' ' ' LEU . 1.1 m -96.46 137.87 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.78 107.83 9.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.775 HG22 ' CE1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -98.61 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.717 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.97 132.24 11.04 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.556 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 3.4 mp -109.84 127.34 54.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.718 0.294 . . . . 0.0 110.737 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.21 111.57 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.029 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -130.16 116.51 18.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.253 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.71 ' CG2' ' HB2' ' A' ' 166' ' ' ALA . 15.9 p -84.8 134.48 34.31 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.956 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -60.76 -31.01 70.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -162.9 44.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 164' ' ' THR . 0.3 OUTLIER 62.32 72.11 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.2 OUTLIER 177.96 -73.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.757 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.64 112.97 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.71 ' HB2' ' CG2' ' A' ' 160' ' ' THR . . . -114.97 158.75 21.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.046 0.45 . . . . 0.0 111.89 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.04 141.86 32.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.043 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.41 ' HB2' ' HB3' ' A' ' 196' ' ' TYR . 0.0 OUTLIER -117.87 108.89 15.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.113 -179.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 169' ' ' VAL . 22.2 m -109.23 100.94 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -92.41 145.96 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.78 108.0 11.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.627 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -85.94 141.31 29.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.997 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 mt -141.75 99.94 3.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.784 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.1 123.2 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -133.56 144.43 49.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.917 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -152.03 154.71 25.71 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.566 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -116.19 121.33 41.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -92.92 160.07 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.13 35.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.995 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -103.78 112.73 25.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.21 39.19 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.3 m -127.41 -51.04 1.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -38.1 7.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.3 m120 60.06 29.86 19.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -121.55 30.04 6.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -118.68 27.39 7.21 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.71 125.69 17.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -142.28 162.3 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.03 108.01 19.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.38 107.83 18.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 123.81 35.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.971 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.45 158.03 27.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.772 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 tt -132.44 140.11 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.187 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -134.29 137.88 44.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.584 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -104.92 149.79 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -156.22 172.03 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.722 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.39 86.94 0.23 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.775 ' HA ' HG22 ' A' ' 207' ' ' THR . 45.1 Cg_endo -68.43 113.47 3.14 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.374 2.049 . . . . 0.0 112.408 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.4 mp -114.39 132.82 56.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.735 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.63 HG22 ' HA ' ' A' ' 205' ' ' SER . 67.4 p -138.04 155.78 48.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.576 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 200' ' ' THR . 1.3 mp -143.23 90.58 2.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.247 0.546 . . . . 0.0 110.04 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.79 -65.48 0.65 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.457 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.43 59.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.383 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . 0.544 ' O ' HG22 ' A' ' 200' ' ' THR . 69.2 m-70 -153.09 140.62 19.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.63 ' HA ' HG22 ' A' ' 200' ' ' THR . 5.3 t -128.06 115.72 18.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.059 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.12 128.47 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.775 HG22 ' HA ' ' A' ' 198' ' ' PRO . 71.4 p -136.47 104.87 9.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.222 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.49 126.03 2.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.707 2.271 . . . . 0.0 112.134 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 30.4 p90 -112.78 137.6 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.887 0.375 . . . . 0.0 111.111 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.731 HG22 HG12 ' A' ' 236' ' ' VAL . 40.2 p -129.55 142.4 50.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.735 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 63.76 136.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.791 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 29.6 mt -143.22 -47.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.165 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 98.58 170.32 31.58 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.14 44.47 12.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -131.77 57.36 1.77 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.824 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.6 ttm105 -98.91 36.05 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -145.44 110.67 5.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.808 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.72 -64.2 1.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -162.53 -55.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.41 ' CE3' ' HA ' ' A' ' 220' ' ' TRP . 1.1 m95 -145.13 98.36 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.959 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -117.92 130.41 56.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 12.8 t90 -154.82 155.18 33.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -68.51 93.16 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -169.64 99.8 0.32 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.66 145.78 55.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.427 HD12 ' H ' ' A' ' 228' ' ' ARG . 1.1 pp -143.09 173.69 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -127.97 30.81 5.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.427 ' H ' HD12 ' A' ' 226' ' ' ILE . 0.0 OUTLIER -99.87 -31.32 11.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.874 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 -170.13 0.25 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.736 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 136.26 44.18 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.535 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -156.51 113.69 3.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -97.62 103.62 15.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.73 -20.64 65.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.05 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 22.9 t30 67.58 141.02 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.85 0.357 . . . . 0.0 110.804 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.09 113.52 26.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.731 HG12 HG22 ' A' ' 210' ' ' THR . 17.9 m -150.06 149.66 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -138.56 141.01 11.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.477 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.11 122.03 36.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.952 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.9 150.48 21.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.825 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 147.63 44.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.52 126.93 1.99 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.457 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.475 ' HB3' HG23 ' A' ' 250' ' ' VAL . 49.0 t80 -148.77 162.9 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 111.099 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.406 ' O ' ' CE2' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -117.69 153.46 33.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.533 ' HB3' HD22 ' A' ' 248' ' ' LEU . 0.8 OUTLIER -97.17 -38.36 9.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.975 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -177.32 49.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 61.06 98.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.932 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 126.01 -24.36 5.71 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.559 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.751 HD23 ' HD1' ' A' ' 278' ' ' TYR . 0.9 OUTLIER -102.73 135.93 43.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.477 ' CB ' ' HB3' ' A' ' 277' ' ' ASN . 0.3 OUTLIER -117.43 113.95 22.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.095 0.474 . . . . 0.0 112.105 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 242' ' ' TYR . 3.2 m -117.82 117.18 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 252' ' ' LEU . 4.9 m -127.75 169.39 13.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.999 0.428 . . . . 0.0 111.253 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 251' ' ' SER . 0.9 OUTLIER -151.24 129.75 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.67 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -103.91 123.16 46.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -127.5 107.62 10.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -141.32 158.81 43.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.87 89.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -93.36 114.8 27.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 60.64 158.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.814 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -99.38 169.3 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -176.43 -174.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.06 -177.94 3.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.812 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.38 128.54 37.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -134.66 -58.94 0.81 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.933 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 61.81 44.76 97.43 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.72 -49.49 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -32.0 7.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -120.41 135.56 55.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.62 159.0 15.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -124.17 129.06 50.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -70.17 -49.1 53.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 65.79 -76.76 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -167.19 105.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.069 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -80.28 123.21 5.98 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.316 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 6.2 m -110.63 124.68 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -117.88 131.86 9.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.189 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 276' ' ' VAL . 27.3 m -126.08 123.08 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.477 ' HB3' ' CB ' ' A' ' 249' ' ' SER . 33.0 t30 -125.6 156.45 39.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.806 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.751 ' HD1' HD23 ' A' ' 248' ' ' LEU . 7.0 m-85 -149.89 155.41 39.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.894 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.94 147.1 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.678 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.403 ' HB3' ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.836 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.749 0.309 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -78.0 -31.12 50.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.816 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -60.81 -47.37 86.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' A' ' 39' ' ' ALA . 6.6 t-20 61.4 47.41 6.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.23 -28.91 57.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.003 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -157.38 95.36 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -117.36 109.98 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.24 119.98 29.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -128.06 130.22 47.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.935 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.8 mt -115.62 137.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.01 131.17 6.33 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.571 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.87 128.41 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 0.0 111.062 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 mtt -118.88 128.96 54.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -145.91 163.92 33.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -112.05 134.96 53.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.4 tp -105.98 148.63 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.038 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -145.05 130.09 18.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.14 -163.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -96.09 31.33 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -134.69 30.39 3.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.02 27.65 3.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -123.4 72.34 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.34 -128.65 6.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.486 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -60.1 169.21 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 110.945 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -118.27 115.96 25.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 44.8 mmm -115.26 -40.11 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -165.47 114.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.53 114.94 3.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.477 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 53' ' ' GLY . 3.2 tp -154.15 135.7 14.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -112.52 -177.8 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.967 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp0 -126.68 51.18 5.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.097 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 82.2 Cg_endo -77.48 115.19 3.85 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.537 2.158 . . . . 0.0 112.228 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -136.68 125.44 23.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.167 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 35' ' ' TYR . 6.0 t -101.72 162.32 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.66 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.462 ' N ' HG12 ' A' ' 34' ' ' VAL . 30.3 t80 -155.71 135.4 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 111.369 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.47 155.81 49.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.352 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.696 ' ND2' ' HB2' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -150.12 155.41 39.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.219 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.739 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . . . -155.93 113.86 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.576 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . . . -90.9 117.76 29.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.83 88.58 2.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.5 -128.15 26.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.82 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.38 21.92 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.649 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -140.26 112.76 7.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.234 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.43 104.68 14.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.739 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -83.82 133.26 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.343 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.85 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -135.22 124.0 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.903 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.98 112.44 23.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.084 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -111.26 161.45 16.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.856 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.05 115.58 24.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.939 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -123.65 121.17 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -151.31 141.18 21.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.833 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -131.03 144.31 51.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.439 ' O ' HD12 ' A' ' 29' ' ' LEU . . . 170.18 158.52 14.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.54 80.49 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.485 2.123 . . . . 0.0 112.326 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t 59.77 93.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -107.94 -47.84 3.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 59.75 27.06 16.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.978 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.85 -179.22 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.11 -73.94 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.33 57.38 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.3 45.13 11.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.865 0.364 . . . . 0.0 110.906 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -116.47 114.31 24.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' A' ' 98' ' ' TYR . . . 76.35 -156.23 46.56 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.58 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.1 p 53.41 82.66 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.347 . . . . 0.0 111.152 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.418 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 81.6 m95 -102.5 25.97 8.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' A' ' 65' ' ' TRP . 3.9 m-85 -163.78 -58.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.869 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -82.8 100.34 10.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.478 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 168.85 -61.8 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 83.5 Cg_endo -83.76 176.77 6.7 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.663 2.242 . . . . 0.0 112.801 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 4.5 tp10 -161.93 131.06 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mt -110.21 150.24 28.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.201 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.85 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -162.02 127.35 3.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 74' ' ' HIS . 29.1 t -128.01 154.48 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.409 ' N ' HG12 ' A' ' 73' ' ' VAL . 0.4 OUTLIER -124.03 148.21 47.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.895 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -135.54 143.73 45.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -137.9 102.17 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.52 -66.28 0.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.6 tp -125.4 133.34 52.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -120.13 106.48 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.826 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -146.86 172.17 14.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.14 15.35 10.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.431 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.444 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 4.2 m-20 -114.26 -44.99 3.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 82' ' ' ASP . 15.5 p90 -166.95 101.55 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.995 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.7 t -92.93 133.85 35.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.745 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.59 107.78 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.146 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.84 175.18 19.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.203 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 116' ' ' PRO . 3.1 tp -158.12 107.93 2.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.848 0.356 . . . . 0.0 110.936 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 m -79.02 155.87 28.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.685 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.29 105.04 0.24 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.567 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.36 174.9 20.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.383 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -129.85 144.12 51.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -122.46 117.74 26.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -105.0 112.25 25.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -125.83 100.0 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.407 ' N ' ' HB3' ' A' ' 66' ' ' PHE . . . -173.84 154.14 18.94 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.426 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.5 159.44 21.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.23 170.36 2.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.434 ' CE1' ' HA3' ' A' ' 63' ' ' GLY . 14.2 m-85 -160.99 90.79 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t 69.03 -67.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -154.14 -50.12 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.122 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -157.75 96.98 1.94 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.072 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.75 -43.34 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.474 2.116 . . . . 0.0 112.239 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.12 -26.8 2.17 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.29 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 165.32 30.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.863 0.363 . . . . 0.0 110.768 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.46 92.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t -163.05 132.22 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.943 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -175.31 168.12 3.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.038 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -142.5 117.83 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.2 mtt -136.46 119.17 16.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.718 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 2.9 tp-100 -111.21 141.23 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.785 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.56 124.28 12.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.981 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -85.53 146.08 27.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.8 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -128.18 107.94 10.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.169 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.8 pt -131.3 150.72 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.3 105.69 1.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.459 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HB3' HD12 ' A' ' 87' ' ' LEU . 56.4 Cg_endo -70.43 93.61 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.434 2.089 . . . . 0.0 111.938 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.03 149.38 41.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.078 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -147.34 123.02 10.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.69 118.74 25.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.06 114.03 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -106.15 128.18 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.86 -32.82 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.975 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -145.01 -175.35 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.475 ' H ' HG22 ' A' ' 123' ' ' THR . 70.9 m-20 -88.88 53.54 2.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -176.78 -50.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 157' ' ' LEU . 5.4 mt -82.03 104.11 12.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -112.64 116.37 30.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -90.95 136.71 32.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -137.43 127.48 25.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -113.37 125.18 6.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.429 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -123.09 121.77 36.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.921 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' A' ' 153' ' ' THR . 4.3 mp -116.37 99.03 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.5 120.6 24.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.9 mtp -128.65 129.1 45.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -125.8 133.07 52.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -115.92 157.41 24.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 148' ' ' ASP . 40.9 p90 -108.54 154.11 22.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 110' ' ' GLN . . . -165.03 178.54 6.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 65.56 -70.78 0.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.229 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -118.62 81.34 1.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.63 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 141' ' ' LEU . 1.3 pp -84.01 46.89 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -114.97 34.83 4.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.6 m -81.77 -70.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -36.04 4.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.977 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 74.7 27.3 65.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.545 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -113.13 -73.38 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -137.94 -53.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.013 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.437 ' HB2' ' CE1' ' A' ' 137' ' ' PHE . 4.2 m-20 59.18 29.22 18.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.4 p -99.08 110.76 23.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 126.04 40.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 151' ' ' VAL . 16.0 m -145.97 100.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -121.08 121.32 37.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.116 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.455 HG23 ' HG ' ' A' ' 132' ' ' LEU . 10.0 m -104.39 126.75 51.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.485 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -126.37 107.81 10.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.123 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.5 p -99.08 103.87 15.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -104.11 148.36 16.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.805 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 126' ' ' LEU . 4.6 mt -133.03 118.39 18.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.779 0.323 . . . . 0.0 110.79 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -108.71 113.27 26.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.429 ' N ' ' HB1' ' A' ' 166' ' ' ALA . 5.5 p90 -130.11 118.4 21.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.119 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 0.5 OUTLIER -92.28 131.48 37.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.752 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.82 7.52 26.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.693 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.04 28.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.766 0.317 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.677 ' O ' HG23 ' A' ' 164' ' ' THR . 14.6 mm-40 51.52 64.94 1.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 111.112 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 163' ' ' GLU . 0.2 OUTLIER 178.54 -64.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 199' ' ' LEU . 21.5 t -103.85 113.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.813 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.48 ' HB2' ' HB ' ' A' ' 160' ' ' THR . . . -119.03 151.97 37.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 167' ' ' LEU . 2.8 mp -93.92 133.44 37.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.265 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.402 ' HB3' ' HB2' ' A' ' 196' ' ' TYR . 41.9 ttp85 -109.05 107.02 17.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.047 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.49 107.95 23.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.712 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -103.37 145.23 30.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.46 121.76 42.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.583 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.89 125.16 33.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.5 tt -142.02 94.82 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.748 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -126.58 148.95 49.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -140.1 151.04 45.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 143.15 -172.58 24.57 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.91 121.45 42.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.333 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.38 154.47 49.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.5 ptp -73.88 120.9 20.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.63 169.64 11.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -119.91 31.55 6.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 m -149.29 -46.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.35 109.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -142.7 -48.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -86.53 99.87 11.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.74 -27.86 6.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -142.99 57.04 1.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.924 0.393 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.99 168.52 26.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 m -99.15 142.53 30.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.2 m -79.03 110.96 14.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.12 131.76 54.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.55 156.99 46.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -116.15 131.36 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.7 mmt85 -129.23 117.96 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 210' ' ' THR . . . -99.08 149.11 23.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.402 ' HB2' ' HB3' ' A' ' 168' ' ' ARG . 52.5 m-85 -155.11 142.54 19.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.448 ' O ' HD23 ' A' ' 199' ' ' LEU . 2.1 mt -136.24 71.99 60.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.638 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.1 113.72 3.15 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.488 ' HB3' HG13 ' A' ' 165' ' ' VAL . 0.5 OUTLIER -114.29 157.16 23.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.635 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.492 HG22 ' OG ' ' A' ' 205' ' ' SER . 2.9 p -136.62 138.08 40.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.16 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.4 tp -137.48 89.81 2.45 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.359 0.6 . . . . 0.0 109.983 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 45.93 81.24 0.04 OUTLIER Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.884 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.85 40.22 16.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 111.093 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -152.05 97.57 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.492 ' OG ' HG22 ' A' ' 200' ' ' THR . 41.5 m -96.84 142.74 28.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.094 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 97.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.99 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.7 m -105.01 104.75 48.46 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.087 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.81 164.94 17.97 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.624 2.216 . . . . 0.0 112.387 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.771 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 195' ' ' ALA . 4.2 m -139.1 150.45 45.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.852 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -142.06 45.91 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.092 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.623 ' O ' HD12 ' A' ' 214' ' ' LEU . 1.2 pt -113.86 -33.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.175 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 48.04 27.97 5.49 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.801 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 212' ' ' ILE . 1.1 mt -131.99 127.82 37.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.963 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -87.47 100.34 12.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -102.56 126.31 49.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -71.81 87.08 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 80.7 p -93.65 -60.23 1.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 60.94 31.28 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.803 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -83.3 -31.67 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.18 85.06 7.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -61.25 -32.08 71.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.16 -179.16 7.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -65.49 -46.27 80.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.91 164.28 26.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.6 pp -139.65 166.78 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -161.64 -45.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -109.85 104.73 13.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -126.03 136.04 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -148.5 63.39 0.42 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.51 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.97 -175.06 3.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.837 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -146.76 33.22 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.946 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.43 159.09 13.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.91 -170.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -107.86 135.49 49.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.943 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 m -104.91 -177.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.021 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -101.07 168.34 20.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.588 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.3 mt -146.1 128.2 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.5 98.1 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -76.98 134.72 38.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -125.81 114.56 2.12 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.577 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -143.75 110.18 5.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 0.0 110.818 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -137.13 -173.46 3.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.962 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 66.2 45.42 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -108.65 -34.85 6.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.732 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.1 32.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.688 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 96.23 -24.36 30.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.6 148.87 25.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.632 0.254 . . . . 0.0 110.613 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.587 ' O ' HG13 ' A' ' 276' ' ' VAL . 28.4 t -95.93 167.44 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.746 0.307 . . . . 0.0 110.948 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.4 t -149.28 117.68 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.5 m -138.92 147.1 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 5.1 mp -121.11 123.5 42.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.32 131.6 53.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -131.2 124.96 31.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -148.67 32.63 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.132 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -82.24 98.55 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -62.75 -49.74 73.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.98 171.3 8.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -104.65 131.27 52.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -123.96 166.59 15.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.952 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -131.82 -62.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.54 149.53 33.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 60.69 109.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 115.11 33.52 1.64 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -92.13 -34.61 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.8 t -82.15 91.44 6.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -131.45 -56.76 1.01 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -117.92 179.04 4.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -105.7 34.47 3.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.88 151.3 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -134.14 177.27 7.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -160.11 175.04 13.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.078 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.02 -129.9 5.9 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.46 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.05 148.41 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . -135.18 141.32 12.55 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.537 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 249' ' ' SER . 14.0 t -115.25 145.63 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . 0.417 ' CB ' ' HB3' ' A' ' 249' ' ' SER . 1.8 t-20 -147.41 95.55 2.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 111.34 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -88.43 140.27 29.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.0 p -124.67 131.52 53.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.025 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.937 179.943 . . . . . . . . 0 0 . 1 stop_ save_